rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTTGGGGACAGGGTGGGTAATGAGCAGTTCTTCGGGCCA	CASSFGDRVGNEQFF	In	VDJ	3	202	8.699696802646086E-4	0.0010074210022342803	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	3	7	2	5	18	32	43	34	48														CASSFGDRVGNEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGTTGGGGCAGGTGATGAAAAACTGTTTTTTGGCAGT	CASSLVGAGDEKLFF	In	VDJ	1	83	3.57462789415656E-4	4.1394031279923395E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	7	0	6	2	5	18	34	41	36	46														CASSLVGAGDEKLFF+TCRBV07-06+TCRBJ01-04	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCGAGACTAGCGGGGGCCGAAGAGACCCAGTACTTCGGGCCA	CASSPRLAGAEETQYF	In	VDJ	1	57	2.454864939360529E-4	2.8427226300670286E-4	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	2	2	3	4	3	18	30	46	34	49														CASSPRLAGAEETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTCCCACAGGGGGGAGTGAATGAAAAACTGTTTTTTGGCAGT	CASSFPQGGVNEKLFF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	48	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	3	1	5	3	5	18	32	43	35	48														CASSFPQGGVNEKLFF+TCRBV07-06+TCRBJ01-04	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAACTTGGGGCACAGATACGCAGTATTTTGGCCCA	CASSLTWGTDTQYF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	42	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-03	01	2	0	9	1	4	0	18	33	-1	37	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTWGTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCACCAGGATGGCTGATTATTCACCCCTCCACTTTGGGAAC	CASSTRMADYSPLHF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	4	8	2	10	18	30	36	32	46														CASSTRMADYSPLHF+TCRBV07-06+TCRBJ01-06	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCGAGCACGAGGACACAGATACGCAGTATTTTGGCCCA	CASSEHEDTDTQYF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	11	1	2	6	1	18	30	40	36	41														CASSEHEDTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCATGTATCGCTGTGTCAGCAGTTCAGAAAGTGGTCCAGCGGTGTATGCGAGCAGTACGTCGGGCCG		Out	VDJ	1	22	9.474917309812569E-5		50	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	6	5	17	15	17	18	29	49	44	66						01,02								X+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD02-01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCGTAGCATCGGACTCCTCCTACGAGCAGTACGTCGGGCCG	CASSVASDSSYEQYV	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	1	10	17	3	18	18	35	43	38	61						01,02								CASSVASDSSYEQYV+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD02-01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCTGTGTATCTCTGTGCCGCTAAAGGGACAGGGGTACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	32	1.378169790518192E-4		43	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	0	2	3	6	1	19	25	41	31	42														X+TCRBV07-05+TCRBJ02-02	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAACGGATACTAACACTGAAGCTTTCTTTGGACAA	CASSLTDTNTEAFF	In	VDJ	1	30	1.292034178610805E-4	1.496169805298436E-4	42	TCRBV07	TCRBV07-05	01				TCRBJ01	TCRBJ01-01	01	1	1	8	2	2	4	19	34	39	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTDTNTEAFF+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCAACCAATTCTACAGGGGGCGCAAGAGACCCAGTACTTCGGGCCA	CASSQPILQGAQETQYF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	51	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	0	2	11	1	19	31	51	42	52														CASSQPILQGAQETQYF+TCRBV07-05+TCRBJ02-05	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCCCTCTACGGTGCAAGAGACCCAGTACTTCGGGCCA	CASSPSTVQETQYF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	42	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	4	9	2	4	5	19	31	38	35	43						01,02								CASSPSTVQETQYF+TCRBV07-05+TCRBJ02-05	TCRBV07-05*01	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGCGAAAGCGGGGGCTATGAAGGGGATGAGCAGTTCTTCGGGCCA	CASSVGESGGYEGDEQFF	In	VDJ	16	1060	0.004565187431091511	0.0052864666453878075	54	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	6	2	8	5	11	23	39	52	44	63			01,02										Vb 1	CASSVGESGGYEGDEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCGATGGCTCGGGAAAACTGTTTTTTGGCAGT	CASSPDGSGKLFF	In	VDJ	9	633	0.002726192116868798	0.0031569182891797	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	8	4	10	10	0	23	35	-1	45	49			01,02			01,02							Vb 1	CASSPDGSGKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD02-01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTTAACGACAGGGGAGTCGATCTATGGCTACACCTTCGGTTCG	CASSLTTGESIYGYTF	In	VDJ	6	383	0.001649496968026461	0.00191011011809767	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	2	4	5	7	23	35	48	40	55			01,02										Vb 1	CASSLTTGESIYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGCCCCGGGACAGTGAACACTGAAGCTTTCTTTGGACAA	CASSVGPGTVNTEAFF	In	VDJ	4	256	0.0011025358324145535	0.0012767315671879987	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	5	0	5	0	23	39	-1	44	51			01,02										Vb 1	CASSVGPGTVNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTATATATGAACACTGAAGCTTTCTTTGGACAA	CASSVYMNTEAFF	In	VDJ	2	131	5.641882579933848E-4	6.533274816469837E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	5	9	0	0	2	23	-1	40	38	42			01,02			01,02							Vb 1	CASSVYMNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAAGGACACAATGAGCAGTTCTTCGGGCCA	CASSVEGHNEQFF	In	VDJ	2	103	4.43598401323043E-4	5.136849664857964E-4	39	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	0	1	7	5	2	0	23	39	-1	41	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVEGHNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCACCGGGGGGCGAGCAGTTCTTCGGGCCA	CASSAPGGEQFF	In	VDJ	1	91	3.919170341786108E-4	4.5383817427385894E-4	36	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	8	1	10	3	1	23	36	46	39	47			01,02										Vb 1	CASSAPGGEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGACGGGACACTTACAGATACGCAGTATTTTGGCCCA	CASSDGTLTDTQYF	In	VDJ	1	85	3.6607635060639473E-4	4.239147781678902E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	6	3	2	3	23	36	44	38	47			01,02										Vb 1	CASSDGTLTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCGTCGGGACAGGGGGCACTGAAGCTTTCTTTGGACAA	CAVGTGGTEAFF	In	VDJ	1	83	3.57462789415656E-4	4.1394031279923395E-4	36	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	0	1	4	3	0	23	29	-1	32	43			01,02										Vb 1	CAVGTGGTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGGGCGGGTTTAGAGACCCAGTACTTCGGGCCA	CASSGAGLETQYF	In	VDJ	1	82	3.5315600882028666E-4	4.0895308011490585E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	7	4	4	2	3	23	36	43	38	46			01,02			01,02							Vb 1	CASSGAGLETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCGTGGGGTGGAAATTCACCCCTCCACTTTGGGAAC	CASSPWGGNSPLHF	In	VDJ	1	80	3.4454244762954794E-4	3.989786147462496E-4	42	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-06	01	4	6	2	7	4	4	23	35	43	39	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSPWGGNSPLHF+TCRBV09-01+TCRBJ01-06	TCRBV09-01		TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGCAGGGGAGTACAGATACGCAGTATTTTGGCCCA	CASSVQGSTDTQYF	In	VDJ	1	78	3.359288864388093E-4	3.8900414937759333E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	2	3	1	3	23	37	44	38	47			01,02										Vb 1	CASSVQGSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGAATGCAGGGGGCTTTGAAAAACTGTTTTTTGGCAGT	CASSVNAGGFEKLFF	In	VDJ	1	73	3.143949834619625E-4	3.6406798595595277E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	0	7	5	2	23	37	50	42	52			01,02										Vb 1	CASSVNAGGFEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCGATGTCTACAGGGATCAACTATGGCTACACCTTCGGTTCG	CASSPMSTGINYGYTF	In	VDJ	1	71	3.057814222712238E-4	3.540935205872965E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	3	2	9	3	23	35	50	44	53			01,02										Vb 1	CASSPMSTGINYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGAGGTAGACGGCTATGGCTACACCTTCGGTTCG	CASSEVDGYGYTF	In	VDJ	1	69	2.971678610804851E-4	3.441190552186403E-4	39	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-02	01	3	2	7	4	5	2	23	36	44	41	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSEVDGYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACCTTAGCCGAGGGACTAGACCTCACAGATACGCAGTATTTTGGCCCA	CASTLAEGLDLTDTQYF	In	VDJ	1	69	2.971678610804851E-4	3.441190552186403E-4	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	8	2	10	4	23	33	51	43	55			01,02			01,02							Vb 1	CASTLAEGLDLTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGGTGGGACAGAAGCTCTGGAAACACCATATATTTTGGAGAG	CASSGWDRSSGNTIYF	In	VDJ	1	68	2.9286108048511575E-4	3.3913182253431215E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	5	0	3	3	23	36	46	39	49			01,02										Vb 1	CASSGWDRSSGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCGGGGTTTTTGACGAGCAGTACTTCGGGCCG	CASSVGVFDEQYF	In	VDJ	1	64	2.756339581036384E-4	3.191828917969997E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	8	3	5	0	6	23	-1	42	37	48			01,02										Vb 1	CASSVGVFDEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACGGCTAGTGCATACGAGCAGTACGTCGGGCCG	CASTASAYEQYV	In	VDJ	1	64	2.756339581036384E-4	3.191828917969997E-4	36	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	4	8	17	3	17	23	33	40	36	57			01,02			01,02							Vb 1	CASTASAYEQYV+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCCGACGGAGACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSDGDSGANVLTF	In	VDJ	1	59	2.5410005512679164E-4	2.9424672837535907E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	4	10	2	0	6	1	23	35	45	41	46			01,02										Vb 1	CASSSDGDSGANVLTF+TCRBV09-01+TCRBJ02-06	TCRBV09-01	TCRBD02-01*02	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCTGCAATCCGGGACAGGGGGACTTATGGCTACACCTTCGGTTCG	CASSVAAIRDRGTYGYTF	In	VDJ	1	58	2.497932745314223E-4	2.8925949569103096E-4	54	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	1	5	9	3	23	39	59	48	62			01,02										Vb 1	CASSVAAIRDRGTYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCGAGGAGGGGACGAACACTGAAGCTTTCTTTGGACAA	CASSPEEGTNTEAFF	In	VDJ	1	55	2.3687293274531423E-4	2.742977976380466E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	10	0	1	5	3	23	35	46	40	49			01,02										Vb 1	CASSPEEGTNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGTGGGACAGGGGGCTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVGQGANTGELFF	In	VDJ	1	54	2.3256615214994487E-4	2.693105649537185E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	0	2	3	1	23	34	49	37	50			01,02										Vb 1	CASSVGQGANTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCTCTGGGGGGGACAGATACGCAGTATTTTGGCCCA	CASSVALGGTDTQYF	In	VDJ	1	51	2.1964581036383683E-4	2.5434886690073414E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	9	0	3	4	0	23	39	-1	43	50			01,02										Vb 1	CASSVALGGTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCGGCCCGGTCTAACTATGGCTACACCTTCGGTTCG	CASSAARSNYGYTF	In	VDJ	1	50	2.1533902976846747E-4	2.49361634216406E-4	42	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-02	01	3	9	0	0	1	5	23	36	40	37	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSAARSNYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCGTGGACAGGGGGCGGAAGCTATGGCTACACCTTCGGTTCG	CASSPWTGGGSYGYTF	In	VDJ	1	50	2.1533902976846747E-4	2.49361634216406E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	0	4	4	5	23	35	50	39	55			01,02										Vb 1	CASSPWTGGGSYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAACGTAGAGGCTAGCGGGGGTGAGCAGTTCTTCGGGCCA	CASNVEASGGEQFF	In	VDJ	1	49	2.1103224917309814E-4	2.443744015320779E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	9	3	0	23	39	-1	42	52			01,02										Vb 1	CASNVEASGGEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAGGTCGGCACCCTCGAGGGGGATACTGAAGCTTTCTTTGGACAA	CASSEVGTLEGDTEAFF	In	VDJ	1	46	1.9811190738699006E-4	2.2941270347909352E-4	51	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	1	5	17	2	23	34	57	51	59			01,02										Vb 1	CASSEVGTLEGDTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGCGGACCCCGGGACAGGAGGCACAGATACGCAGTATTTTGGCCCA	CASSADPGTGGTDTQYF	In	VDJ	1	45	1.9380512679162073E-4	2.244254707947654E-4	51	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	4	1	10	2	23	34	52	44	54			01,02										Vb 1	CASSADPGTGGTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTTAACAGGGGACGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLTGDATNEKLFF	In	VDJ	1	45	1.9380512679162073E-4	2.244254707947654E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	2	0	3	3	23	35	45	38	48			01,02										Vb 1	CASSLTGDATNEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGACCACTAGAGACCCAGTACTTCGGGCCA	CASSVGPLETQYF	In	VDJ	1	45	1.9380512679162073E-4	2.244254707947654E-4	39	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-05	01	0	2	7	4	0	4	23	-1	42	39	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVGPLETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTTAGGGGTAGGTCAGCCCCAGCATTTTGGTGAT	CASSLGVGQPQHF	In	VDJ	1	44	1.8949834619625137E-4	2.194382381104373E-4	39	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-05	01	0	0	9	6	0	4	23	-1	42	39	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSLGVGQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGATGGGACACCCATAGAGACCCAGTACTTCGGGCCA	CASSVDGTPIETQYF	In	VDJ	1	44	1.8949834619625137E-4	2.194382381104373E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	0	6	4	2	5	23	39	47	41	52			01,02										Vb 1	CASSVDGTPIETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGATGAGCTAGATGAGCAGTTCTTCGGGCCA	CASSVDELDEQFF	In	VDJ	1	44	1.8949834619625137E-4	2.194382381104373E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	8	8	5	0	23	39	-1	44	48			01,02			01,02							Vb 1	CASSVDELDEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAGGGACGGAATTACTATGGCTACACCTTCGGTTCG	CASSVEGRNYYGYTF	In	VDJ	1	40	1.7227122381477397E-4	1.994893073731248E-4	45	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-02	01	0	0	7	3	1	6	23	39	45	40	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVEGRNYYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCCCAGGGGGCGGCTAATGAAAAACTGTTTTTTGGCAGT	CASSSQGAANEKLFF	In	VDJ	1	39	1.6796444321940464E-4	1.9450207468879667E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	0	3	3	2	23	35	46	38	48			01,02										Vb 1	CASSSQGAANEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTTAGCGGGATTACTACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	39	1.6796444321940464E-4		47	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	5	3	2	0	6	23	-1	45	37	51			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGAGACGGGACAGGGATATGAAAAACTGTTTTTTGGCAGT	CASSETGQGYEKLFF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	3	6	4	2	23	36	49	40	51			01,02										Vb 1	CASSETGQGYEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCACAGATCACACAGCGGGGGCCTGTACAATGAGCAGTTCTTCGGGCCA	CASSHRSHSGGLYNEQFF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	54	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	6	2	4	12	4	23	35	55	47	59			01,02										Vb 1	CASSHRSHSGGLYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCATCTAATAAACATGGCTACACCTTCGGTTCG	CASSASNKHGYTF	In	VDJ	1	36	1.550441014332966E-4	1.7954037663581233E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	4	9	6	3	6	23	36	42	39	48			01,02			01,02							Vb 1	CASSASNKHGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAAAATGGCCAGGTTATTGAGGGTGAAAAACTGTTTTTTGGCAGT	CASSENGQVIEGEKLFF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	11	0	7	19	0	23	34	-1	53	58			01,02										Vb 1	CASSENGQVIEGEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD02-01*02	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCTCTCACGGGGGCTACCATATATTTTGGAGAG	CASSVALTGATIYF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	42	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-03	01	0	6	0	10	7	1	23	39	52	46	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVALTGATIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01		TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCTTACTCGAGCTGGGGTGAAGCTTTCTTTGGACAA	CASSAYSSWGEAFF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	42	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	3	6	2	7	12	0	23	36	-1	48	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSAYSSWGEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCTGGACAGACTTCGAGCACAGATACGCAGTATTTTGGCCCA	CASSPGQTSSTDTQYF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	5	0	3	6	23	35	44	38	50			01,02										Vb 1	CASSPGQTSSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAGGGCTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSEGYSNQPQHF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	11	0	0	1	3	23	34	40	35	43			01,02										Vb 1	CASSEGYSNQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD02-01*02	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGTGGACTAAACTACGAGCAGTACTTCGGGCCG	CASSVGGLNYEQYF	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	1	9	3	2	2	23	39	47	41	49			01,02			01,02							Vb 1	CASSVGGLNYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCGGGGCTACTGAAGCTTTCTTTGGACAA	CASSAGATEAFF	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	36	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	3	7	0	5	2	1	23	36	43	38	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSAGATEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCAGAGGGACAGGGGTTGATGGCCCTCCACTTTGGGAAC	CASSPEGQGLMALHF	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	0	2	14	5	7	23	35	50	40	57			01,02										Vb 1	CASSPEGQGLMALHF+TCRBV09-01+TCRBJ01-06	TCRBV09-01	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCTTTGGGGGCGGGGTCAGATACGCAGTATTTTGGCCCA	CASSVALGAGSDTQYF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	48	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-03	01	0	6	0	4	4	5	23	39	49	43	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVALGAGSDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGTGGACTAGCGGGGTTCGACGAGCAGTACTTCGGGCCG	CASSGGLAGFDEQYF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	1	3	5	2	4	23	36	50	38	54			01,02										Vb 1	CASSGGLAGFDEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGTGGGACAGGGGGCAATGAGCAGTTCTTCGGGCCA	CASGTGGNEQFF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	36	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	1	6	1	0	23	31	-1	32	43			01,02										Vb 1	CASGTGGNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGTCAGCAGCGTGTTCACGGGAGGCTACACCTTCGGTTCG	CVSSVFTGGYTF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	36	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	8	3	8	5	0	23	37	-1	42	47			01,02										Vb 1	CVSSVFTGGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGGACTTTGCGGGGACTGAAGCTTTCTTTGGACAA	CASSVDFAGTEAFF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	7	3	5	7	0	23	37	-1	44	50			01,02										Vb 1	CASSVDFAGTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTCCACYAGGTCGGGCACTGAAGCTTTCTTTGGACAA	CASSSTRSGTEAFF	In	VDJ	1	47	2.0241868798235942E-4	2.3439993616342165E-4	42	TCRBV11	TCRBV11-01	01	unresolved			TCRBJ01	TCRBJ01-01	01	4	3	8	4	2	6	19	32	39	34	45				TCRBD01,TCRBD02										CASSSTRSGTEAFF+TCRBV11-01+TCRBJ01-01	TCRBV11-01*01	unresolved	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAAATCCCTGCGGAGTACACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASKSLRSTQSRANVLTF	In	VDJ	1	39	1.6796444321940464E-4	1.9450207468879667E-4	54	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	7	7	5	5	7	13	19	29	40	36	53						01,02								CASKSLRSTQSRANVLTF+TCRBV11-01+TCRBJ02-06	TCRBV11-01*01	TCRBD02-01	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCTCCGCCCTAGGGGGGACCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSALGGTANTGELFF	In	VDJ	32	2168	0.00933710033076075	0.010812320459623364	51	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-02	01	8	5	1	0	8	5	29	38	52	46	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSALGGTANTGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01		TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATGGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSQWSSYNSPLHF	In	VDJ	3	201	8.656628996692393E-4	0.001002433769549952	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	2	10	2	0	1	0	29	44	-1	45	49													Vb 16	CASSQWSSYNSPLHF+TCRBV14-01+TCRBJ01-06	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TATTTCTGTGCCAGCAGCCAGCCTCGGACTAGCGGGGGTATACTACTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSQPRTSGGILLAKNIQYF	In	VDJ	2	155	6.675509922822491E-4	7.730210660708586E-4	63	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	3	1	2	0	5	9	6	20	38	25	47													Vb 16	CASSQPRTSGGILLAKNIQYF+TCRBV14-01+TCRBJ02-04	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAAAGAGGAGATCCGGTGGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	130	5.598814773980155E-4		40	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	10	10	2	6	4	9	29	36	44	40	53													Vb 16	X+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAATCACATACAGTACTTCGGGCCA		Out	VDJ	2	116	4.995865490628446E-4		34	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	3	6	11	3	2	29	46	52	49	54													Vb 16	X+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCACCAGCAAGAGAAATCAGAGGGGGCGAGGTCCACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	102	4.3929162072767365E-4		56	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	5	0	4	17	6	25	35	59	52	65													Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGATATGGCAAGATGAACACTGAAGCTTTCTTTGGACAA	CASSQGYGKMNTEAFF	In	VDJ	1	86	3.7038313120176403E-4	4.289020108522183E-4	48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	9	0	0	5	4	29	45	53	50	57													Vb 16	CASSQGYGKMNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCTAGGGCAGGGGGCGGGAGTGAGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	81	3.488492282249173E-4		56	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	0	2	6	9	25	38	52	44	61													Vb 16	X+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTCTCGGGGGGGTTAGATGAGCAGTTCTTCGGGCCA	CASSQVSGGLDEQFF	In	VDJ	1	78	3.359288864388093E-4	3.8900414937759333E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	8	0	8	3	4	29	45	56	48	60													Vb 16	CASSQVSGGLDEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCGGGCAGGCGACCCTTACAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	61	2.627136163175303E-4		47	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	4	2	3	10	29	41	48	44	58													Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCGATGGACCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQDRWTGANVLTF	In	VDJ	1	55	2.3687293274531423E-4	2.742977976380466E-4	48	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-06	01	0	1	7	4	5	1	29	46	55	51	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQDRWTGANVLTF+TCRBV14-01+TCRBJ02-06	TCRBV14-01*01		TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCTTACGGGGGAATCACTGAAGCTTTCTTTGGACAA	CASSPYGGITEAFF	In	VDJ	1	51	2.1964581036383683E-4	2.5434886690073414E-4	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	8	2	4	4	3	29	42	52	46	55													Vb 16	CASSPYGGITEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCATGTCACCTACCGGGTGTATTTTGGCCCA	CASSHVTYRVYF	In	VDJ	1	49	2.1103224917309814E-4	2.443744015320779E-4	36	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	8	4	14	10	1	29	43	57	53	58						01,02							Vb 16	CASSHVTYRVYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTAGAGCGGAACATTCAGTACTTCGGCGCC	CASSQVERNIQYF	In	VDJ	1	46	1.9811190738699006E-4	2.2941270347909352E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	1	6	5	7	3	0	29	45	-1	48	53						01,02							Vb 16	CASSQVERNIQYF+TCRBV14-01+TCRBJ02-04	TCRBV14-01*01	TCRBD02-01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCACCACCTTTGATGGTCCGGCGGTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	44	1.8949834619625137E-4		55	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	7	5	0	17	2	26	36	57	53	59						01,02							Vb 16	X+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01	TCRBD02-01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTCTCCACAGATACGCAGTATTTTGGCCCA	CASSLSTDTQYF	In	VDJ	1	42	1.8088478500551269E-4	2.0946377274178103E-4	36	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	10	2	1	1	29	42	45	43	46						01,02							Vb 16	CASSLSTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTGGGGACACTTTACACTGAAGCTTTTTTTGGACAA	CASSLGTLYTEAFF	In	VDJ	1	40	1.7227122381477397E-4	1.994893073731248E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	6	17	2	18	29	42	50	44	68													Vb 16	CASSLGTLYTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTCCAGGGCCAGCCCCAGCATTTTGGTGAT	CASSQVQGQPQHF	In	VDJ	1	40	1.7227122381477397E-4	1.994893073731248E-4	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	3	7	2	1	29	45	52	47	53													Vb 16	CASSQVQGQPQHF+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCACGGAAGAGGGTCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	37	1.5935088202866592E-4		41	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	11	0	4	5	1	29	43	53	48	54													Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACCAGGGGGAGAGACCCAGTACTTCGGGCCA	CASSQPGGETQYF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	1	4	1	0	29	44	-1	45	52													Vb 16	CASSQPGGETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGGCGGTTGGCTACACCTTCGGTTCG	CASSQGAVGYTF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	36	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	1	8	0	7	0	3	29	-1	49	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQGAVGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGGACAGGAGTACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	21	9.044239250275634E-5		47	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	0	4	3	0	3	29	-1	53	45	56													Vb 16	X+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCACCGAAGGAGCGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSTEGAGGTDTQYF	In	VDJ	4	270	0.0011628307607497244	0.0013465528247685924	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	2	1	7	0	24	37	-1	44	52														CASSTEGAGGTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCGACAGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSSTGGTDTQYF	In	VDJ	1	71	3.057814222712238E-4	3.540935205872965E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	2	1	2	0	24	36	-1	38	46														CASSSTGGTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTGGCGGGGCAGGGGTAGACCCCTCCACTTTGGGAAC	CASSWRGRGRPLHF	In	VDJ	1	70	3.0147464167585447E-4	3.491062879029684E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-06	01	5	4	2	12	8	3	24	36	50	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWRGRGRPLHF+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01		TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGAGGGAGGGGGGAAAGAGACCCAGTACTTCGGGCCA	CASSEGGGKETQYF	In	VDJ	1	63	2.71327177508269E-4	3.141956591126716E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	9	0	3	2	4	24	36	45	38	49														CASSEGGGKETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAATAGGGACCTATAATTCACCCCTCCACTTTGGGAAC	CASSVIGTYNSPLHF	In	VDJ	1	48	2.0672546857772878E-4	2.3938716884774975E-4	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-06	01	5	0	8	2	6	0	24	36	-1	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVIGTYNSPLHF+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01		TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGATGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRMNTGELFF	In	VDJ	1	46	1.9811190738699006E-4	2.2941270347909352E-4	36	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-02	01	6	2	8	1	0	1	24	-1	37	35	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRMNTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01		TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAACTCAGGGGCGGGGGTAAACACCGGGGAGCTGTTTTTTGGAGAA	CASNSGAGVNTGELFF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	10	7	2	2	11	2	24	31	49	42	51														CASNSGAGVNTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTACAGGGTTGGGGTCAGCCCCAGCATTTTGGTGAT	CASSLQGWGQPQHF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	3	6	2	6	24	36	44	38	50														CASSLQGWGQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGGACAGGGGAGGAAGCTTTCTTTGGACAA	CASSVGTGEEAFF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	2	8	3	2	24	36	49	39	51														CASSVGTGEEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCCTCGACGGGACAGGGTACTATGGCTACACCTTCGGTTCG	CASSPLDGTGYYGYTF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	3	9	1	24	36	54	45	55														CASSPLDGTGYYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAATCGGAGAGACAATGAGCAGTTCTTCGGGCCA	CASSNRRDNEQFF	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	2	5	2	2	24	38	44	40	46														CASSNRRDNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGGATAAGACAGGGGCAGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	18	7.75220507166483E-5		40	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	2	2	4	6	3	24	31	45	37	48														X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGAGCTGACAGGGGGGGATACGCAGTATTTTGGCCCA	CASSELTGGDTQYF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	1	6	6	1	24	35	50	41	51														CASSELTGGDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAACGAGAAAGGGTTCTAAGAGACCCAGTACTTCGGGCCA	CASNEKGF*ETQYF	Stop	VDJ	1	18	7.75220507166483E-5		42	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-05	01	10	5	3	3	10	4	24	31	45	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNEKGF*ETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCACCAGGGGCAAATCAGCCCCAGCATTTTGGTGAT	CASSEAPGANQPQHF	In	VDJ	32	2155	0.009281112183020948	0.010747486434727099	45	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	2	4	2	2	23	40	48	42	50														CASSEAPGANQPQHF+TCRBV06-01+TCRBJ01-05	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGCCCGGGCAGAATCAGCCCCAGCATTTTGGTGAT	CASSEAPGQNQPQHF	In	VDJ	14	952	0.004100055126791621	0.00474784551548037	45	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-05	01	0	8	0	4	4	2	23	40	48	44	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEAPGQNQPQHF+TCRBV06-01+TCRBJ01-05	TCRBV06-01*01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGGGGGATTCACCCCTCCACTTTGGGAAC	CASSEAGDSPLHF	In	VDJ	1	71	3.057814222712238E-4	3.540935205872965E-4	39	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-06	01	0	6	1	8	0	0	23	-1	-1	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEAGDSPLHF+TCRBV06-01+TCRBJ01-06	TCRBV06-01*01		TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGCCCAACGGGGAGACCCAGTACTTCGGGCCA	CASSEAPNGETQYF	In	VDJ	1	58	2.497932745314223E-4	2.8925949569103096E-4	42	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	8	4	5	6	0	23	40	-1	46	50						01,02								CASSEAPNGETQYF+TCRBV06-01+TCRBJ02-05	TCRBV06-01*01	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAAGGGTCGGTATGGCTACACCTTCGGTTCG		Out	VDJ	1	31	1.3351019845644983E-4		37	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	8	5	5	3	0	23	39	-1	42	45						01,02								X+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGGGCCTCCTTCATAGTGGTGAGCAGTTCTTCGGGCCA	CASSEAGLLHSGEQFF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	48	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	8	0	9	0	14	23	-1	44	40	58														CASSEAGLLHSGEQFF+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGTCCGGGGTAGCTATGGCTACACCTTCGGTTCG	CASSEVRGSYGYTF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	42	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	1	8	3	4	2	3	23	39	46	41	49														CASSEVRGSYGYTF+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01	TCRBD02-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCTGTCCTCTATGTGGGCTACACCTTCGGTTCG	CASSEAVLYVGYTF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	42	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	4	9	8	6	4	23	40	49	46	53						01,02								CASSEAVLYVGYTF+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTAGCTGATTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	61	2.627136163175303E-4		40	TCRBV07	TCRBV07-04	01				TCRBJ01	TCRBJ01-02	01	0	2	8	1	1	1	22	39	42	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-04+TCRBJ01-02	TCRBV07-04*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTAGCGCCCGCGGGGATACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	60	2.58406835722161E-4		47	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	7	3	3	4	2	22	39	49	43	51														X+TCRBV07-04+TCRBJ02-03	TCRBV07-04*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCCAGGTGGTAGCGAATGAGCAGTTCTTCGGGCCA	CASSQVVANEQFF	In	VDJ	1	41	1.7657800441014333E-4	2.0447654005745293E-4	39	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	6	7	7	0	22	34	-1	41	46						01,02								CASSQVVANEQFF+TCRBV07-04+TCRBJ02-01	TCRBV07-04*01	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTATCAGCCCCGCGAGGACCTGTCGATACGCAGTATTTTGGCCCA	CASSLSAPRGPVDTQYF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	51	TCRBV07	TCRBV07-04	01				TCRBJ02	TCRBJ02-03	01	2	1	7	6	12	5	22	37	53	49	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSAPRGPVDTQYF+TCRBV07-04+TCRBJ02-03	TCRBV07-04*01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTCCCTGGTGGGTACGAGCAGTACTTCGGGCCG	CASSFPGGYEQYF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	39	TCRBV07	TCRBV07-04	01				TCRBJ02	TCRBJ02-07	01	3	0	9	4	7	0	22	36	-1	43	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFPGGYEQYF+TCRBV07-04+TCRBJ02-07	TCRBV07-04*01		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCCCCGGGCCTCCATCAATTTACACCTTCGGTTCG	CASSPGPPSIYTF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	39	TCRBV07	TCRBV07-04	01				TCRBJ01	TCRBJ01-02	01	5	8	0	11	3	11	22	34	41	37	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGPPSIYTF+TCRBV07-04+TCRBJ01-02	TCRBV07-04*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTTCTGATCTAGCCAAAAACATTCAGTACTTCGGCGCC	CAWSVSDLAKNIQYF	In	VDJ	34	2261	0.009737630926130099	0.01127613309926588	45	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-04	01	0	2	8	0	4	3	26	40	46	44	49			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVSDLAKNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*01		TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACGGCGGCAGGGGATGGCTACACCTTCGGTTCG	CAWTAAGDGYTF	In	VDJ	22	1461	0.00629220644983462	0.0072863469518033835	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	2	6	6	0	26	36	-1	42	48			unresolved										Vb 20	CAWTAAGDGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCCGGACAGCAATGAGCAGTTCTTCGGGCCA	CAWSPDSNEQFF	In	VDJ	12	828	0.0035660143329658213	0.0041294286626236834	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	1	5	6	3	0	26	37	-1	40	46													Vb 20	CAWSPDSNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCTGACAGGGGCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	11	754	0.0032473125689084894		41	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	2	0	3	1	26	35	46	38	47			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCATGGGGCAAGGTGAAGCTTTCTTTGGACAA	CAWSMGQGEAFF	In	VDJ	11	712	0.003066427783902977	0.0035509096712416214	36	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	7	0	7	3	4	26	37	45	40	49			unresolved										Vb 20	CAWSMGQGEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAACAGCGACATTCACCCCTCCACTTTGGGAAC	CAWSEQRHSPLHF	In	VDJ	9	627	0.0027003514332965823	0.0031269948930737314	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-06	01	1	3	5	8	1	4	26	39	44	40	48			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSEQRHSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01		TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCGGGGAATCACAATGAGCAGTTCTTCGGGCCA	CAWAGNHNEQFF	In	VDJ	5	343	0.0014772257442116868	0.0017106208107245452	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	3	5	0	4	26	-1	41	35	45													Vb 20	CAWAGNHNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGAAACAGGGGTGGAATCACTGAAGCTTTCTTTGGACAA	CAWRNRGGITEAFF	In	VDJ	5	338	0.00145569184123484	0.0016856846473029046	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	2	4	2	6	26	37	46	39	52			unresolved										Vb 20	CAWRNRGGITEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGATTCAAATGAGCAGTTCTTCGGGCCA	CAWSVDSNEQFF	In	VDJ	4	246	0.00105946802646086	0.0012268592403447175	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	0	2	8	7	1	4	26	40	43	41	47			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVDSNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGAACGTGATCGGGACAGGGAACCACGAGCAGTACTTCGGGCCG		Out	VDJ	4	245	0.0010551612458654907		44	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	5	9	4	26	34	52	43	56			unresolved										Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCCGGGGACAGCAATGAGCAGTTCTTCGGGCCA	CAWAGDSNEQFF	In	VDJ	4	243	0.001046547684674752	0.0012118975422917332	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	5	6	4	0	26	35	-1	39	46			unresolved										Vb 20	CAWAGDSNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCGGGGGGCTTAGGCACTGAAGCTTTCTTTGGACAA	CAWAGGLGTEAFF	In	VDJ	3	231	9.948663175303198E-4	0.0011520507500797958	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	7	1	4	0	6	26	-1	43	35	49			unresolved										Vb 20	CAWAGGLGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTGGCGTCCAACTCTGGAAACACCATATATTTTGGAGAG	CALASNSGNTIYF	In	VDJ	3	218	9.388781697905182E-4	0.0010872167251835302	39	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-03	01	7	9	0	0	1	6	26	33	37	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CALASNSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*02		TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAGGGGTTCGTAAGCAATCAGCCCCAGCATTTTGGTGAT	CAWSEGFVSNQPQHF	In	VDJ	3	180	7.752205071664829E-4	8.977018831790616E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	5	2	1	0	6	26	-1	44	39	50													Vb 20	CAWSEGFVSNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGCGGGGTTAGGGAAAGCTTTCTTTGGACAA	CAWSVAGLGKAFF	In	VDJ	3	180	7.752205071664829E-4	8.977018831790616E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	6	3	9	0	7	26	-1	47	40	54			unresolved										Vb 20	CAWSVAGLGKAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAAGCTAGCGGGGGTTTGGAGACCCAGTACTTCGGGCCA	CAWKASGGLETQYF	In	VDJ	3	179	7.709137265711135E-4	8.927146504947335E-4	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	4	2	5	3	4	26	36	49	39	53			unresolved										Vb 20	CAWKASGGLETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCACCGGGACAGACCACAAAAACATTCAGTACTTCGGCGCC	CAWSTGTDHKNIQYF	In	VDJ	3	172	7.407662624035281E-4	8.578040217044366E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	0	5	3	4	4	26	37	48	41	52													Vb 20	CAWSTGTDHKNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGACCCTGGCAGAGACAGATACGCAGTATTTTGGCCCA	CAWKTLAETDTQYF	In	VDJ	2	156	6.718577728776186E-4	7.780082987551867E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-03	01	4	2	7	3	1	10	26	36	40	37	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWKTLAETDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACGGGCAGGCCCAAGAGACCCAGTACTTCGGGCCA	CAWNGQAQETQYF	In	VDJ	2	155	6.675509922822491E-4	7.730210660708586E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-05	01	4	4	4	1	5	1	26	36	45	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWNGQAQETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGGACCTGAATGAGCAGTTCTTCGGGCCA	CAWSGDLNEQFF	In	VDJ	2	154	6.632442116868798E-4	7.680338333865305E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	1	0	7	7	0	3	26	-1	44	39	47			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSGDLNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCGGACTCGAATGAGCAGTTCTTCGGGCCA	CAWSPDSNEQFF	In	VDJ	2	147	6.330967475192944E-4	7.331232045962336E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	1	10	7	2	2	26	38	45	40	47			unresolved			01,02							Vb 20	CAWSPDSNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCGGACAGCTGAAGATCAGCCCCAGCATTTTGGTGAT	CAWSRTAEDQPQHF	In	VDJ	2	139	5.986425027563396E-4	6.932253431216087E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	1	5	5	1	6	26	38	45	39	51													Vb 20	CAWSRTAEDQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAAATACAGGGACGAAACACCATATATTTTGGAGAG	CAWEIQGRNTIYF	In	VDJ	2	132	5.684950385887542E-4	6.583147143313119E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	3	5	5	2	26	35	46	40	48													Vb 20	CAWEIQGRNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGAAAGGGGGGATCAGCCCCAGCATTTTGGTGAT	CAWRERGDQPQHF	In	VDJ	2	126	5.42654355016538E-4	6.283913182253432E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	3	5	1	5	4	1	26	37	47	41	48			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWRERGDQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGGGGAAGAGAAGGCAACCAGCCCCAGCATTTTGGTGAT	CAWSVRGREGNQPQHF	In	VDJ	2	125	5.383475744211687E-4	6.23404085541015E-4	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	0	8	3	7	1	13	26	40	46	41	59													Vb 20	CAWSVRGREGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCGACAGGAGGCTGTAGATACGCAGTATTTTGGCCCA	CAWSRQEAVDTQYF	In	VDJ	2	124	5.340407938257993E-4	6.184168528566869E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	2	4	5	1	7	26	38	45	39	52													Vb 20	CAWSRQEAVDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAGGGGGGGCTCGGAGGGCAGTACTTCGGGCCG	CAWEGGLGGQYF	In	VDJ	2	121	5.211204520396913E-4	6.034551548037025E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	9	0	9	2	8	26	35	44	37	52			unresolved										Vb 20	CAWEGGLGGQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCCTGCGCTGGGTCCACAATGAGCAGTTCTTCGGGCCA	CALRWVHNEQFF	In	VDJ	2	115	4.952797684674751E-4	5.735317586977338E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	8	0	9	5	7	3	26	32	42	39	45			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CALRWVHNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAAAATGAGGCCTATGGCTACACCTTCGGTTCG	CAWENEAYGYTF	In	VDJ	2	114	4.909729878721058E-4	5.685445260134057E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	11	1	4	6	1	26	35	45	41	46			unresolved										Vb 20	CAWENEAYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGCGGGGACGTCAGATACGCAGTATTTTGGCCCA	CAWSVAGTSDTQYF	In	VDJ	2	109	4.694390848952591E-4	5.436083625917651E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	6	3	4	0	4	26	-1	47	40	51													Vb 20	CAWSVAGTSDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAATGACCACAATGAGCAGTTCTTCGGGCCA	CAWSNDHNEQFF	In	VDJ	2	108	4.6513230429988975E-4	5.38621129907437E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	2	2	7	5	3	1	26	38	44	41	45			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSNDHNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCCGGGGACAGCCGGCTAACTATGGCTACACCTTCGGTTCG	CARGQPANYGYTF	In	VDJ	2	105	4.522119625137817E-4	5.236594318544526E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	0	5	0	2	4	26	32	41	34	45													Vb 20	CARGQPANYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTCTGGACAGGGGGTAACGAAAAACTGTTTTTTGGCAGT	CAWSLWTGGNEKLFF	In	VDJ	2	104	4.4790518191841237E-4	5.186721991701245E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	1	1	8	4	4	26	38	52	42	56													Vb 20	CAWSLWTGGNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGTCCCGCGGACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	103	4.43598401323043E-4		47	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	0	7	5	0	6	1	26	40	50	46	51			unresolved			01,02							Vb 20	X+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD02-01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGAAAGGCGGGACTGTGGAAACTGAAGCTTTCTTTGGACAA	CAWKKGGTVETEAFF	In	VDJ	1	95	4.091441565600882E-4	4.737871050111714E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	0	10	5	8	6	26	36	50	44	56			unresolved			01,02							Vb 20	CAWKKGGTVETEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGCCGGGTGGGGCACTGAAGCTTTCTTTGGACAA	CAWSVAGWGTEAFF	In	VDJ	1	89	3.833034729878721E-4	4.438637089052027E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	0	6	2	4	8	0	26	40	-1	48	52			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVAGWGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGCCGGACAGGGTCTGGAAACACCATATATTTTGGAGAG	CAWSSRTGSGNTIYF	In	VDJ	1	80	3.4454244762954794E-4	3.989786147462496E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	1	3	1	4	0	26	38	-1	42	50													Vb 20	CAWSSRTGSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATTTTGCGCGGAATCACAGATACGCAGTATTTTGGCCCA	CAWILRGITDTQYF	In	VDJ	1	76	3.2731532524807056E-4	3.7902968400893713E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	7	5	2	6	3	26	36	46	42	49			unresolved			01,02							Vb 20	CAWILRGITDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGAGGGACAGTAACCTACGAGCAGTACTTCGGGCCG	CAWSGGTVTYEQYF	In	VDJ	1	72	3.100882028665932E-4	3.5908075327162467E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	5	2	2	3	26	39	48	41	51													Vb 20	CAWSGGTVTYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCACACTGAGACAGGGAGTAGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	71	3.057814222712238E-4		47	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	3	5	8	6	26	37	52	45	58													Vb 20	X+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCCCGGGACAGTGAATACAATGAGCAGTTCTTCGGGCCA	CASRDSEYNEQFF	In	VDJ	1	68	2.9286108048511575E-4	3.3913182253431215E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	5	4	3	4	26	33	43	36	47			unresolved										Vb 20	CASRDSEYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGACCGGGACAGGGGCTCTAGAGCTTTCTTTGGACAA	CAWDRDRGSRAFF	In	VDJ	1	64	2.756339581036384E-4	3.191828917969997E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	2	10	4	6	26	35	49	39	55			unresolved										Vb 20	CAWDRDRGSRAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGGGGGACAGTACACAGATACGCAGTATTTTGGCCCA	CAWSGGQYTDTQYF	In	VDJ	1	61	2.627136163175303E-4	3.042211937440153E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	5	2	3	2	26	37	47	40	49													Vb 20	CAWSGGQYTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCGGGGACCTTAATGAAAAACTGTTTTTTGGCAGT	CAGDLNEKLFF	In	VDJ	1	59	2.5410005512679164E-4	2.9424672837535907E-4	33	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-04	01	8	0	7	4	1	2	26	32	38	33	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAGDLNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTGGGGTATCTGAGGACAATGAGCAGTTCTTCGGGCCA	CAWSVGVSEDNEQFF	In	VDJ	1	55	2.3687293274531423E-4	2.742977976380466E-4	45	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	0	6	2	5	1	9	26	40	45	41	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVGVSEDNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCTATAACTCGAGAGGTGATACGCAGTATTTTGGCCCA	CAWSYNSRGDTQYF	In	VDJ	1	54	2.3256615214994487E-4	2.693105649537185E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	11	1	6	11	1	26	37	52	48	53													Vb 20	CAWSYNSRGDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGGGCGGAAACACCATATATTTTGGAGAG	CAWSVGGNTIYF	In	VDJ	1	54	2.3256615214994487E-4	2.693105649537185E-4	36	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	8	0	4	0	0	26	-1	-1	40	44													Vb 20	CAWSVGGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGGACCGCAATGAGCAGTTCTTCGGGCCA	CAWSGDRNEQFF	In	VDJ	1	53	2.2825937155457552E-4	2.6432333226939034E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	1	0	7	6	0	2	26	-1	44	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSGDRNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACACAGGCCTACGAGCAGTACTTCGGGCCG	CAWTQAYEQYF	In	VDJ	1	53	2.2825937155457552E-4	2.6432333226939034E-4	33	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	4	2	1	0	26	36	-1	37	42			unresolved										Vb 20	CAWTQAYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGGCCGAGGCCGGGGAGCTGTTTTTTGGAGAA	CAWGAEAGELFF	In	VDJ	1	51	2.1964581036383683E-4	2.5434886690073414E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	7	0	6	0	5	26	-1	40	35	45													Vb 20	CAWGAEAGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGTAAGAGGTCGGGGGCGGAAGAGACCCAGTACTTCGGGCCA	CACKRSGAEETQYF	In	VDJ	1	47	2.0241868798235942E-4	2.3439993616342165E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-05	01	6	6	0	3	9	2	26	34	49	43	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CACKRSGAEETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGGGGCCGGCCGCTAGCAATCAGCCCCAGCATTTTGGTGAT	CAWSGGPAASNQPQHF	In	VDJ	1	46	1.9811190738699006E-4	2.2941270347909352E-4	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	6	0	0	0	7	26	-1	45	39	52			unresolved										Vb 20	CAWSGGPAASNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCATCCCTTAGGCCCCCCATCGAGAGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	45	1.9380512679162073E-4		55	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-05	01	5	5	4	1	8	14	26	35	46	43	60			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGCGACAGGGGTGGACTGAAGCTTTCTTTGGACAA	CAWRRQGWTEAFF	In	VDJ	1	45	1.9380512679162073E-4	2.244254707947654E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	2	5	2	3	26	37	47	39	50			unresolved										Vb 20	CAWRRQGWTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTTTCGGGACCATCCTTTGGACAA	CAWSVLSGPSF	In	VDJ	1	44	1.8949834619625137E-4	2.194382381104373E-4	33	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	0	0	7	16	6	4	26	40	51	46	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVLSGPSF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACCTAGGTCCCTTGGAGGGCTACACCTTCGGTTCG	CAWNLGPLEGYTF	In	VDJ	1	39	1.6796444321940464E-4	1.9450207468879667E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	4	8	8	2	11	26	36	42	38	53			unresolved			01,02							Vb 20	CAWNLGPLEGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACGGACAGCAATGAGCAGTTCTTCGGGCCA	CAWSTDSNEQFF	In	VDJ	1	38	1.6365766262403528E-4	1.8951484200446856E-4	36	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	5	6	2	0	26	38	-1	40	46													Vb 20	CAWSTDSNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATGACGGCCTTTGGGGGGAGACCCAGTACTTCGGGCCA	CAWNDGLWGETQYF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	42	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-05	01	4	6	1	5	12	0	26	36	-1	48	53			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWNDGLWGETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCAGTGACCTCAATGAGCAGTTCTTCGGGCCA	CAWSSDLNEQFF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	3	2	7	6	4	2	26	37	44	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSSDLNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGTCGGACAGAGCCGGTGGGGCTACACCTTCGGTTCG	CAWVGQSRWGYTF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	5	8	3	9	26	35	44	38	53			unresolved										Vb 20	CAWVGQSRWGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGCCGAAGCAGGGATGGGAACTGAAGCTTTCTTTGGACAA	CAWSAEAGMGTEAFF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	3	5	8	6	26	37	50	45	56													Vb 20	CAWSAEAGMGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCCAGGGAGACCGGGCGATCAGCCCCAGCATTTTGGTGAT	CAWSPGRPGDQPQHF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	45	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	3	4	3	5	2	10	26	37	44	39	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSPGRPGDQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTATCTATACAGGGGGCGCGTGCAACACGAGGAGCTGTTTTTTGGAGAA	CAWSYLYRGRVQHEELFF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	54	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	3	0	10	7	13	26	38	54	45	67													Vb 20	CAWSYLYRGRVQHEELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGCCCGGGGGGAGACACTGAAGCTTTCTTTGGACAA	CAWGPGGDTEAFF	In	VDJ	1	30	1.292034178610805E-4	1.496169805298436E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	1	3	4	2	26	35	46	39	48			unresolved										Vb 20	CAWGPGGDTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGCTAGCGGGGGGGCGGGAGACCCAGTACTTCGGGCCA	CAWKLAGGRETQYF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	4	0	5	2	3	26	36	50	38	53													Vb 20	CAWKLAGGRETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGGACACCCCCACAGAAGCTTTCTTTGGACAA	CAWGDTPTEAFF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	8	1	8	26	35	42	36	50													Vb 20	CAWGDTPTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACGGACAGACGCTCAACTAATGAAAAACTGTTTTTTGGCAGT	CAWTDRRSTNEKLFF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	1	5	0	1	5	26	36	43	37	48			unresolved										Vb 20	CAWTDRRSTNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCAGGGACGGCTACGAGCAGTACTTCGGGCCG	CAWTRDGYEQYF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	4	0	7	3	3	2	26	36	44	39	46			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWTRDGYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACGCGAGGTGACACTGAAGCTTTCTTTGGACAA	CAWTRGDTEAFF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	11	1	3	3	2	26	36	43	39	45													Vb 20	CAWTRGDTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACAGGGGCACTGAAGCTTTCTTTGGACAA	CAWNRGTEAFF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	33	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	2	4	0	0	26	-1	-1	36	43													Vb 20	CAWNRGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCTCGGCAGGGGATGGCTACACCTTCGGTTCG	CAWTSAGDGYTF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	2	6	6	0	26	36	-1	42	48													Vb 20	CAWTSAGDGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGACGACGACAATGAGCAGTTCTTCGGGCCA	CAWSDDDNEQFF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	1	2	7	5	2	1	26	39	44	41	45			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSDDDNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTTGACAGGGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CAFDRGGNQPQHF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	1	2	2	1	26	33	44	35	45													Vb 20	CAFDRGGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCGGAGCGGGGACCTCTGGAAACACCATATATTTTGGAGAG	CAGAGTSGNTIYF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	8	6	3	0	2	2	26	32	41	34	43			unresolved										Vb 20	CAGAGTSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCGAGATCGAGAACACTGAAGCTTTCTTTGGACAA	CAWTEIENTEAFF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	11	2	1	2	5	26	36	41	38	46			unresolved										Vb 20	CAWTEIENTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCGTGGGCAGGACGGGGGGAAAATTGATGAAGCTTTCTTTGGACAA	CASSRGQDGGKIDEAFF	In	VDJ	1	95	4.091441565600882E-4	4.737871050111714E-4	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	8	1	7	11	8	19	31	49	42	57													Vb 5.1	CASSRGQDGGKIDEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGATCTTATCTCACGGGGACGGAGTATGGCTACACCTTCGGTTCG	CARSYLTGTEYGYTF	In	VDJ	1	78	3.359288864388093E-4	3.8900414937759333E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-02	01	8	0	7	5	13	4	19	27	45	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CARSYLTGTEYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGACGGCGAGGGGAGACCCAGTACTTCGGGCCA	CASSLGRRGETQYF	In	VDJ	1	68	2.9286108048511575E-4	3.3913182253431215E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	11	0	5	6	0	19	35	-1	41	46													Vb 5.1	CASSLGRRGETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGATGGGAGGGGTCGAGGAAAAACTGTTTTTTGGCAGT	CASSLMGGVEEKLFF	In	VDJ	1	62	2.6702039691289966E-4	3.092084264283434E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	1	9	0	8	2	6	19	34	43	36	49													Vb 5.1	CASSLMGGVEEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCGAGGGGGGAGGGAATGAGCAGTTCTTCGGGCCA	CASSPEGGGNEQFF	In	VDJ	1	53	2.2825937155457552E-4	2.6432333226939034E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	9	0	7	8	0	19	31	-1	39	46													Vb 5.1	CASSPEGGGNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAAGGAAGGAACAGGGGACTACAATGAGCAGTTCTTCGGGCCA	CASKEGTGDYNEQFF	In	VDJ	1	53	2.2825937155457552E-4	2.6432333226939034E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	2	3	8	1	19	29	44	37	45													Vb 5.1	CASKEGTGDYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGATACAGGGGACGAACACTGAAGCTTTCTTTGGACAA	CASSSIQGTNTEAFF	In	VDJ	1	48	2.0672546857772878E-4	2.3938716884774975E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	2	1	4	2	19	32	43	36	45													Vb 5.1	CASSSIQGTNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGGTTAGAACCCGGGGGACTCAATGAGCAGTTCTTCGGGCCA	CASRLEPGGLNEQFF	In	VDJ	1	44	1.8949834619625137E-4	2.194382381104373E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	6	12	0	19	30	-1	42	48						01,02							Vb 5.1	CASRLEPGGLNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCGGGACAGCCACTATGAACACTGAAGCTTTCTTTGGACAA	CASSLAGTATMNTEAFF	In	VDJ	1	43	1.8519156560088202E-4	2.1445100542610916E-4	51	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	5	0	2	6	19	35	44	37	50													Vb 5.1	CASSLAGTATMNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGACAGAAGGGAGTCAGCACAGATACGCAGTATTTTGGCCCA	CASRQKGVSTDTQYF	In	VDJ	1	43	1.8519156560088202E-4	2.1445100542610916E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	9	2	0	6	2	19	30	41	36	43													Vb 5.1	CASRQKGVSTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCCACAGCTTGAACACTGAAGCTTTCTTTGGACAA	CASSLAHSLNTEAFF	In	VDJ	1	38	1.6365766262403528E-4	1.8951484200446856E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	5	0	3	2	19	35	42	38	44													Vb 5.1	CASSLAHSLNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCGGGACAATCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGTINTGELFF	In	VDJ	1	38	1.6365766262403528E-4	1.8951484200446856E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	6	2	3	3	19	31	40	34	43													Vb 5.1	CASSPGTINTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGGCACAGGGTTATGTTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	36	1.550441014332966E-4		49	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	3	0	3	6	19	31	40	34	46													Vb 5.1	X+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGCAGGGTTGGGCCTATGGCTACACCTTCGGTTCG	CASSSQGWAYGYTF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	3	4	2	6	19	32	39	34	45													Vb 5.1	CASSSQGWAYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCACCTCCCTTACTTCGGACCCCTCGGAGACCCAGTACTTCGGGCCA	CATSLTSDPSETQYF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-05	01	9	1	7	5	13	6	19	26	43	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CATSLTSDPSETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGGACAGGGTGAAGGGAAAACTGTTTTTTGGCAGT	CASSLGDRVKGKLFF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	0	3	10	0	7	19	-1	44	35	51													Vb 5.1	CASSLGDRVKGKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTGCAAGCGGGGGGACCACAGATACGCAGTATTTTGGCCCA	CASSFASGGTTDTQYF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	6	1	2	4	2	19	33	46	37	48													Vb 5.1	CASSFASGGTTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGGGGCTTGCTAACTATGGCTACACCTTCGGTTCG	CASSSGLANYGYTF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-02	01	3	7	0	0	1	3	19	32	38	33	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSSGLANYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCACCGCTAGCGGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSTASGGNTGELFF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	4	2	1	4	0	19	31	-1	35	45													Vb 5.1	CASSTASGGNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCGATGGCGCAGGGAATATCGACGAGCAGTACTTCGGGCCG	CASSLADGAGNIDEQYF	In	VDJ	1	30	1.292034178610805E-4	1.496169805298436E-4	51	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	5	9	7	19	35	49	44	56													Vb 5.1	CASSLADGAGNIDEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGGACAGTATTTATGGCTACACCTTCGGTTCG	CASSLGDSIYGYTF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	5	5	0	4	19	-1	42	35	46													Vb 5.1	CASSLGDSIYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGCACTAGCGAATGGAAATACAATGAGCAGTTCTTCGGGCCA	CASSCTSEWKYNEQFF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	3	6	4	2	8	19	32	41	34	49						01,02							Vb 5.1	CASSCTSEWKYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCAACTCGGGACAGGGTGACGAGCAGTACTTCGGGCCG	CASSNSGQGDEQYF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	5	5	2	19	31	45	36	47													Vb 5.1	CASSNSGQGDEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTCCCTGGTATAACAGGGTTGCATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	27	1.1628307607497244E-4		49	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	3	5	11	4	19	30	47	41	51													Vb 5.1	X+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGCGATGGGACCCTTGGAGAGACCCAGTACTTCGGGCCA	CASSLGDGTLGETQYF	In	VDJ	1	27	1.1628307607497244E-4	1.3465528247685925E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-05	01	0	0	7	4	5	6	19	35	45	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLGDGTLGETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCCCGTACAGGAATCTCGTGGCTACACCTTCGGTTCG		Out	VDJ	1	27	1.1628307607497244E-4		47	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	4	7	6	7	19	35	46	41	53													Vb 5.1	X+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCCTGGAGGAGCCGAACACTGAAGCTTTCTTTGGACAA	CASSSLEEPNTEAFF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	1	1	4	4	19	32	41	36	45													Vb 5.1	CASSSLEEPNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCACCCGGATAGAGCAAGAGACCCAGTACTTCGGGCCA	CASSSTRIEQETQYF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-05	01	3	1	8	2	6	5	19	32	41	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSSTRIEQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTACGCCCCGGACCGAGCTGAAGCTTTCTTTGGACAA	CASSYAPDRAEAFF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-01	01	3	1	7	6	7	4	19	32	43	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSYAPDRAEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCACCCGAGATTCCTCTGGAAACACCATATATTTTGGAGAG	CASTRDSSGNTIYF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	6	11	2	0	3	4	19	29	35	32	39													Vb 5.1	CASTRDSSGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTCTACCTCTGGGCACAGATACGCAGTATTTTGGCCCA	CASSFLPLGTDTQYF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	9	1	1	7	19	33	37	34	44						01,02							Vb 5.1	CASSFLPLGTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCCGGGCGGTTCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	20	8.613561190738698E-5		47	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-06	01	7	8	0	5	1	13	19	28	33	29	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ02-06	TCRBV05-01*01		TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCAGGGAGGCAGATGAAAAACTGTTTTTTGGCAGT	CASSFREADEKLFF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	2	9	1	6	2	3	19	33	41	35	44													Vb 5.1	CASSFREADEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCGGGGAGAGAGCACATACCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	19	8.182883131201764E-5		49	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	9	2	0	1	13	19	28	34	29	47													Vb 5.1	X+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAAGGGGCTAAGGAGACCCAGTACTTCGGGCCA	CASSLEGAKETQYF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	5	2	5	1	5	19	35	41	36	46													Vb 5.1	CASSLEGAKETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGTGTCCCCGACGCAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVSPTQGNTGELFF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	51	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	3	1	12	0	19	31	-1	43	48													Vb 5.1	CASSVSPTQGNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCGTACCCCGGGACAGGGTCCATTTGGCAATGAGCAGTTCTTCGGGCCA	CASSRTPGQGPFGNEQFF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	54	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	3	6	8	9	19	31	48	39	57													Vb 5.1	CASSRTPGQGPFGNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCACGGGACAGGGAGTAAATGAGCAGTTCTTCGGGCCA	CASSTGQGVNEQFF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	3	7	2	4	19	31	42	33	46													Vb 5.1	CASSTGQGVNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GAGGGACTCAGCCGTGTATCTCTACAGTAGCGCCGGCACTATCTGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	29	1.2489663726571114E-4		52	TCRBV17	TCRBV17-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	1	6	5	12	5	22	32	49	44	54														X+TCRBV17-01+TCRBJ02-06	TCRBV17-01*01	TCRBD01-01*01	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAACGGTAGCGGACAGGGTCGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	210	9.044239250275633E-4		52	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	3	3	9	3	25	40	57	49	60													Vb 3	X+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACCTCCGGCCGGGGCATCGGACACTGAAGCTTTCTTTGGACAA	CASRPPAGASDTEAFF	In	VDJ	2	137	5.900289415656009E-4	6.832508777529524E-4	48	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	6	7	0	3	10	5	25	36	51	46	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRPPAGASDTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGCCCTGAATACGGTGAACACTGAAGCTTTCTTTGGACAA	CASALNTVNTEAFF	In	VDJ	2	128	5.512679162072767E-4	6.383657835939994E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	8	8	5	0	10	0	25	34	-1	44	47						01,02							Vb 3	CASALNTVNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CACCAACCAGACATCTATGTACCTCTGTGCCATCAGATTTGCGGGACTCAATCAGCCCCAGCATTTTGGTGAT	CAIRFAGLNQPQHF	In	VDJ	2	114	4.909729878721058E-4	5.685445260134057E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	0	10	3	6	0	25	36	-1	42	48						01,02							Vb 3	CAIRFAGLNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGCAGGAACACTGAAGCTTTCTTTGGACAA	CASSLGRNTEAFF	In	VDJ	2	104	4.4790518191841237E-4	5.186721991701245E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	5	1	2	0	25	40	-1	42	45													Vb 3	CASSLGRNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCCTTCACTCGGGGGGAATGGGGAGCTGTTTTTTGGAGAA	CASTPSLGGNGELFF	In	VDJ	1	101	4.349848401323043E-4	5.037105011171402E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	8	1	8	10	3	25	35	52	45	55													Vb 3	CASTPSLGGNGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACGGACTCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSTDSTNEKLFF	In	VDJ	1	83	3.57462789415656E-4	4.1394031279923395E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	1	10	0	2	0	25	37	-1	39	44						01,02							Vb 3	CASSTDSTNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCTCAAACTATGGCTACACCTTCGGTTCG	CASSPSNYGYTF	In	VDJ	1	74	3.1870176405733185E-4	3.6905521864028087E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	5	4	6	2	4	0	25	37	-1	41	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPSNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATCCCTTGGCAGGAGAACACTGAAGCTTTCTTTGGACAA	CASIPWQENTEAFF	In	VDJ	1	66	2.842475192943771E-4	3.2915735716565594E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	4	1	8	1	25	35	47	43	48													Vb 3	CASIPWQENTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCGAGGGAGGTGGGGGAGACTCGAACACTGAAGCTTTCTTTGGACAA	CASSEGGGGDSNTEAFF	In	VDJ	1	60	2.58406835722161E-4	2.992339610596872E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	1	1	3	12	25	36	45	39	57													Vb 3	CASSEGGGGDSNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCAAACACTAACTGAAGCTTTCTTTGGACAA	CASSQTLTEAFF	In	VDJ	1	54	2.3256615214994487E-4	2.693105649537185E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	3	9	5	6	0	25	36	-1	42	46						01,02							Vb 3	CASSQTLTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTTTCGAAGGGCTGAACACTGAAGCTTTCTTTGGACAA	CASSSFEGLNTEAFF	In	VDJ	1	49	2.1103224917309814E-4	2.443744015320779E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	4	5	3	0	7	1	25	38	49	45	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSFEGLNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGGCCCGGGGCGGGGATACGCAATGAGCAGTTCTTCGGGCCA	CASSRPGAGIRNEQFF	In	VDJ	1	49	2.1103224917309814E-4	2.443744015320779E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	7	3	6	10	5	25	36	52	46	57													Vb 3	CASSRPGAGIRNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCTACCGGACGGGGAATTCACCCCTCCACTTTGGGAAC	CASSFYRTGNSPLHF	In	VDJ	1	47	2.0241868798235942E-4	2.3439993616342165E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	3	8	3	7	8	0	25	39	-1	47	52													Vb 3	CASSFYRTGNSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTTCCAGTGAACACTGAAGCTTTCTTTGGACAA	CASSLFPVNTEAFF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	5	0	3	0	25	41	-1	44	47													Vb 3	CASSLFPVNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGACAGGGGTGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	35	1.5073732083792723E-4		47	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	2	1	0	2	25	-1	50	40	52													Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTTTATCGGGGCAGGGGACTATGGCTACACCTTCGGTTCG	CASSFIGAGDYGYTF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	2	3	11	0	25	36	-1	47	53													Vb 3	CASSFIGAGDYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTCCTTGGGGTCGAACACTGAAGCTTTCTTTGGACAA	CASSSLGSNTEAFF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	6	6	2	1	6	2	25	36	46	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSLGSNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTTTACAGGGTCCGGCTACACCTTCGGTTCG	CASSFTGSGYTF	In	VDJ	1	30	1.292034178610805E-4	1.496169805298436E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	8	4	3	25	36	46	40	49													Vb 3	CASSFTGSGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCTGCGGGTTTCCAAGAGACCCAGTACTTCGGGCCA	CASSPAGFQETQYF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	7	4	1	4	3	25	36	45	40	48						01,02							Vb 3	CASSPAGFQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCTAATGGGAGGGGGCTTGGTGGAGACCCAGTACTTCGGGCCA	CASTLMGGGLVETQYF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	48	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	7	5	0	5	10	6	25	35	52	45	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASTLMGGGLVETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGGTCACCTCCTACGAGCAGTACTTCGGGCCG	CASSQGVTSYEQYF	In	VDJ	18	1197	0.0051552163726571116	0.005969717523140759	42	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-07	01	1	0	9	0	0	4	23	-1	42	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGVTSYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGTCTAGCGGGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQGLAGANTGELFF	In	VDJ	8	556	0.0023945700110253585	0.002772901372486435	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	4	2	0	2	0	23	39	-1	41	51														CASSQGLAGANTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATTGGGTTTTCACAGATACGCAGTATTTTGGCCCA	CASSQDWVFTDTQYF	In	VDJ	6	384	0.0016538037486218302	0.001915097350781998	45	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-03	01	0	0	9	2	2	4	23	40	45	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDWVFTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAACTCGGAACAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQELGTATNEKLFF	In	VDJ	4	300	0.0012920341786108048	0.0014961698052984361	51	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	3	5	0	7	0	23	40	-1	47	51														CASSQELGTATNEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAACTGGGGACCGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQELGTATNEKLFF	In	VDJ	2	161	6.933916758544653E-4	8.029444621768273E-4	51	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-04	01	0	0	7	0	4	2	23	40	49	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQELGTATNEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCCGGCCGGGGACTCCAAGAGACCCAGTACTTCGGGCCA	CASSPGRGLQETQYF	In	VDJ	2	133	5.728018191841235E-4	6.6330194701564E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	10	1	7	0	23	36	-1	43	49						01,02								CASSPGRGLQETQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGACCCCCGGGGGTAGCGGGGGGGCAGGGTGAGCAGTTCTTCGGGCCA		Out	VDJ	2	127	5.469611356119073E-4		56	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	0	9	10	5	23	40	61	50	66														X+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGGAGGAGCAGGGGGAAAAACTGTTTTTTGGCAGT	CASSQEEEQGEKLFF	In	VDJ	2	105	4.522119625137817E-4	5.236594318544526E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	2	8	7	0	23	40	-1	47	53														CASSQEEEQGEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCGCGTGGAGGGGTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	87	3.746899117971334E-4		46	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	10	0	5	6	2	23	40	52	46	54														X+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCCCAACAGGGCTACACCATATATTTTGGAGAG	CASSPQQGYTIYF	In	VDJ	1	80	3.4454244762954794E-4	3.989786147462496E-4	39	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	3	8	4	2	23	36	46	40	48														CASSPQQGYTIYF+TCRBV01-01+TCRBJ01-03	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGACTCAGCTGCGTATCTCTGCGCCAGCAATTCCTCGTGGAGGGCCATCACCTCTAACCTCTGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	76	3.2731532524807056E-4		62	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	7	10	0	2	9	19	19	29	44	38	63														X+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAAATGAGGGAGGGAACACTGAAGCTTTCTTTGGACAA	CASSQNEGGNTEAFF	In	VDJ	1	70	3.0147464167585447E-4	3.491062879029684E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	1	1	5	0	23	38	-1	43	49														CASSQNEGGNTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGTGGGGGACGTACAATGAGCAGTTCTTCGGGCCA	CASSQGWGTYNEQFF	In	VDJ	1	68	2.9286108048511575E-4	3.3913182253431215E-4	45	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-01	01	1	0	7	4	5	1	23	39	49	44	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGWGTYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCTTAGCCCAACGGACAGGTGAAGCTTTCTTTGGACAA	CASSLAQRTGEAFF	In	VDJ	1	59	2.5410005512679164E-4	2.9424672837535907E-4	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	4	7	10	0	23	35	-1	45	52														CASSLAQRTGEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATGGGGCTAGCGGGGGCCTCTACAATGAGCAGTTCTTCGGGCCA	CASSQDGASGGLYNEQFF	In	VDJ	1	56	2.4117971334068356E-4	2.792850303223747E-4	54	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	3	5	3	23	40	55	45	58														CASSQDGASGGLYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATGCGGGGGGGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	56	2.4117971334068356E-4		44	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	7	0	2	1	0	23	40	-1	41	50														X+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGACCCCTGGGACACCACTTGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSQDPWDTTWAGELFF	In	VDJ	1	55	2.3687293274531423E-4	2.742977976380466E-4	54	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	0	6	6	5	9	23	40	51	45	60														CASSQDPWDTTWAGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGGACAACCATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	55	2.3687293274531423E-4		46	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	2	6	0	0	4	23	-1	43	39	47														X+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGCTACTAGGACCGAAGAGACCCAGTACTTCGGGCCA	CASSQATRTEETQYF	In	VDJ	1	51	2.1964581036383683E-4	2.5434886690073414E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	3	8	3	2	5	23	39	46	41	51						01,02								CASSQATRTEETQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATGGCGGCTCACCCGTCCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	51	2.1964581036383683E-4		53	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	7	5	0	2	10	23	40	46	42	56						01,02								X+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGTGGGGACAGGGGGATTATTCACCCCTCCACTTTGGGAAC	CASSQGWGQGDYSPLHF	In	VDJ	1	40	1.7227122381477397E-4	1.994893073731248E-4	51	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	0	1	8	4	3	23	39	54	43	57														CASSQGWGQGDYSPLHF+TCRBV01-01+TCRBJ01-06	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAACGCGAGTGGAGAGCAGAGACCCAGTACTTCGGGCCA	CASSQREWRAETQYF	In	VDJ	1	40	1.7227122381477397E-4	1.994893073731248E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	10	2	4	7	3	23	38	49	45	52														CASSQREWRAETQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCATCGGGACAGGGAGAGTTATGGCTGGCTACACCTTCGGTTCG	CASSIGTGRVMAGYTF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	7	3	11	23	35	47	38	58														CASSIGTGRVMAGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCCGAGGGGAGGAGTGAGCAGTTCTTCGGGCCA	CASSPEGRSEQFF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	39	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	9	1	9	5	2	23	36	47	41	49														CASSPEGRSEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGGAGGGTGTCGGAACTGATACGCAGTATTTTGGCCCA	CASSQGEGVGTDTQYF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	9	0	6	0	10	23	-1	46	39	56														CASSQGEGVGTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCGCGAGCTGACAATGCAGATACGCAGTATTTTGGCCCA	CASSPRADNADTQYF	In	VDJ	1	30	1.292034178610805E-4	1.496169805298436E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	6	4	8	3	23	36	48	44	51														CASSPRADNADTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGCTGCGGAAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSQAAESSYEQYF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	7	5	0	2	4	23	39	45	41	49						01,02								CASSQAAESSYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCTAGCGGGACAACTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	27	1.1628307607497244E-4		46	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	4	5	3	3	0	3	23	-1	44	36	47														X+TCRBV01-01+TCRBJ01-06	TCRBV01-01*01	TCRBD02-01*02	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGGCGGGGGTGAGCACAGATACGCAGTATTTTGGCCCA	CASSQGAGVSTDTQYF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	7	2	0	2	2	23	39	48	41	50														CASSQGAGVSTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTCGAGGAAGCCGGGGAGCTGTTTTTTGGAGAA	CASSQVEEAGELFF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	11	1	6	2	3	23	39	45	41	48														CASSQVEEAGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCTGTGTATCTCTGTGCAAGTCGCTTAGCGGGGGGGCGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	8	545	0.0023471954244762955		46	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	9	0	4	0	3	19	-1	43	36	46														X+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCACCCAGCCCGGGGACAGTCGCAATGAGCAGTTCTTCGGGCCA	CATQPGDSRNEQFF	In	VDJ	2	109	4.694390848952591E-4	5.436083625917651E-4	42	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	12	0	5	6	11	3	18	23	41	34	44														CATQPGDSRNEQFF+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAGCGAGCTGTTCTCCTGGCTACACCTTCGGTTCG	CASRLASCSPGYTF	In	VDJ	1	83	3.57462789415656E-4	4.1394031279923395E-4	42	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	6	7	7	1	8	18	35	39	36	47						01,02								CASRLASCSPGYTF+TCRBV12-02+TCRBJ01-02	TCRBV12-02*01	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGTGACCCGGGACAGGGATACCAGCCCCAGCATTTTGGTGAT	CASDPGQGYQPQHF	In	VDJ	1	67	2.885542998897464E-4	3.3414458984998405E-4	42	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	0	3	7	5	4	18	27	41	32	45														CASDPGQGYQPQHF+TCRBV12-02+TCRBJ01-05	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAGCCACGTTTGGTGGGACTCGGCCGTGTATGGCTGTGCAAGGCGCTTAGCGGGGGGGCGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	34	1.4643054024255788E-4		46	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	9	0	4	0	3	35	-1	59	52	62														X+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAGCGGGGGGCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASRLAGGGTGELFF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	45	TCRBV12	TCRBV12-02	01				TCRBJ02	TCRBJ02-02	01	0	6	0	4	1	2	18	35	42	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRLAGGGTGELFF+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01		TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAGCCACGTTTGGTGGGACTCGGCCGTGTATGTCTGGGCAAGGCGCTTAGCGGGGGGGCGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	32	1.378169790518192E-4		46	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	9	0	4	0	3	35	-1	59	52	62														X+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAGCCACGTTTGGGGGGACTCGGCCGTGTATGGCTGGGCAAGGCGCTTAGCGGGGGGGCGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	29	1.2489663726571114E-4		46	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	9	0	4	0	3	35	-1	59	52	62														X+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAGCCACGTTTGGTGGGACTCGGCCGGGTATGTCTGTGCAAGKCGCTTAGCGGGGGGGCGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	18	7.75220507166483E-5		46	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	9	0	4	0	3	35	-1	59	52	62														X+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAGCCACGTTTGGGGGGACTCGGCCGTGTATGGCTGTGCAAGGCGCTTAGCGGGGGGGCGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	18	7.75220507166483E-5		46	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	9	0	4	0	3	35	-1	59	52	62														X+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAGCCACGGTTGGGGGGACGCGGCCGTGTATGGCTGGGCAAGGCGCGTAGCGGGGGGGCGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	18	7.75220507166483E-5		46	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	9	0	4	0	3	35	-1	59	52	62														X+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAAACCAGCGGTCACAGATACGCAGTATTTTGGCCCA	CASKPAVTDTQYF	In	VDJ	1	41	1.7657800441014333E-4	2.0447654005745293E-4	39	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	6	5	2	4	1	23	33	42	37	43						01,02							Vb 14	CASKPAVTDTQYF+TCRBV27-01+TCRBJ02-03	TCRBV27-01*01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTATAGTGGGACAGGTAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	26	1.1197629547960309E-4		46	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	0	4	4	3	1	23	39	50	42	51													Vb 14	X+TCRBV27-01+TCRBJ01-05	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTATACCCGGACGCGCCGGGTGGCTACACCTTCGGTTCG	CASSLYPDAPGGYTF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	45	TCRBV27	TCRBV27-01	01				TCRBJ01	TCRBJ01-02	01	1	1	7	7	4	8	23	39	47	43	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 14	CASSLYPDAPGGYTF+TCRBV27-01+TCRBJ01-02	TCRBV27-01*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGAAGTATAGGTATCACTGAAGCTTTCTTTGGACAA	CASRSIGITEAFF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	39	TCRBV27	TCRBV27-01	01				TCRBJ01	TCRBJ01-01	01	6	5	4	4	6	3	23	34	43	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 14	CASRSIGITEAFF+TCRBV27-01+TCRBJ01-01	TCRBV27-01*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAACAGGGAAGGCTCAGCCCCAGCATTTTGGTGAT	CSVETGKAQPQHF	In	VDJ	49	3322	0.014307125137816979	0.016567586977338015	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	6	0	5	25	-1	43	37	48													Vb 4	CSVETGKAQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTKGACGAGACAGGGGACACTGAAGCTTTCTTTGGACAA	CSVDETGDTEAFF	In	VDJ	20	1315	0.005663416482910694	0.006558210979891478	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	3	6	0	25	33	-1	39	47													Vb 4	CSVDETGDTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTAGATATTCCACGGGACAGCACATGAACACTGAAGCTTTCTTTGGACAA	CSARYSTGQHMNTEAFF	In	VDJ	18	1223	0.005267192668136715	0.006099385572933291	51	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	5	0	13	4	25	32	52	45	56													Vb 4	CSARYSTGQHMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAACTCTGGCGGTCGGGACCGGGGAGCTGTTTTTTGGAGAA	CSVTLAVGTGELFF	In	VDJ	4	301	0.0012963409592061741	0.0015011570379827642	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	7	5	5	7	5	25	33	44	40	49						01,02							Vb 4	CSVTLAVGTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGAGGGACAGCCACCTCCAGCCCCAGCATTTTGGTGAT	CSVRDSHLQPQHF	In	VDJ	4	296	0.0012748070562293274	0.0014762208745611235	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	5	7	2	7	25	33	42	35	49													Vb 4	CSVRDSHLQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGAGGGCAGGTCAAGAGACCCAGTACTTCGGGCCA	CSVRAGQETQYF	In	VDJ	4	295	0.001270500275633958	0.0014712336418767954	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	11	0	2	0	5	25	-1	38	33	43													Vb 4	CSVRAGQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCAAGACACATTCAGATACGCAGTATTTTGGCCCA	CSVKTHSDTQYF	In	VDJ	3	194	8.355154355016538E-4	9.675231407596553E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	6	4	3	4	25	33	40	36	44													Vb 4	CSVKTHSDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGACGCAGGGGGATGGCTATGGCTACACCTTCGGTTCG	CSGTQGDGYGYTF	In	VDJ	2	147	6.330967475192944E-4	7.331232045962336E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	1	4	5	4	25	32	44	37	48													Vb 4	CSGTQGDGYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGCTTTCCGGACAGGGCCTTAGTGGCTACACCTTCGGTTCG	CSVELSGQGLSGYTF	In	VDJ	2	139	5.986425027563396E-4	6.932253431216087E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	3	7	7	6	25	36	51	43	57													Vb 4	CSVELSGQGLSGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCAGTCCGAAGGGGGGCTGGAGACCCAGTACTTCGGGCCA	CSVQSEGGLETQYF	In	VDJ	2	124	5.340407938257993E-4	6.184168528566869E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-05	01	5	5	1	5	8	4	25	34	48	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVQSEGGLETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGGGGGCGCAGATCAGCCCCAGCATTTTGGTGAT	CSVEGGADQPQHF	In	VDJ	2	105	4.522119625137817E-4	5.236594318544526E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	3	6	0	5	1	4	25	36	43	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEGGADQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATTACGACTTAACGGATGGCTACACCTTCGGTTCG	CSVDYDLTDGYTF	In	VDJ	2	104	4.4790518191841237E-4	5.186721991701245E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	2	10	6	4	6	25	36	44	40	50						01,02							Vb 4	CSVDYDLTDGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCTACGGCATAGAGGGAGGAAACACCATATATTTTGGAGAG	CSVVYGIEGGNTIYF	In	VDJ	2	102	4.3929162072767365E-4	5.086977338014683E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	4	11	0	4	11	1	25	35	51	46	52													Vb 4	CSVVYGIEGGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTCCCCGAGGGAGGGAACACTGAAGCTTTCTTTGGACAA	CSVLPEGGNTEAFF	In	VDJ	1	94	4.0483737596471884E-4	4.687998723268433E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	1	1	8	0	25	34	-1	42	48													Vb 4	CSVLPEGGNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGACTACAGGGAGAACTAATGAAAAACTGTTTTTTGGCAGT	CSVTTGRTNEKLFF	In	VDJ	1	91	3.919170341786108E-4	4.5383817427385894E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	3	1	4	2	25	33	43	37	45													Vb 4	CSVTTGRTNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCGACAGGGGGCGACCACAATGAGCAGTTCTTCGGGCCA	CSVATGGDHNEQFF	In	VDJ	1	89	3.833034729878721E-4	4.438637089052027E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	0	5	1	4	25	35	46	36	50													Vb 4	CSVATGGDHNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAATACTAGCGGGGGGCAAGGTAGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	89	3.833034729878721E-4		50	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	3	1	5	2	9	25	37	51	39	60													Vb 4	X+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAGTCCGGGGGAACACTGAAGCTTTCTTTGGACAA	CSVVRGNTEAFF	In	VDJ	1	86	3.7038313120176403E-4	4.289020108522183E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	3	1	4	0	25	33	-1	37	42													Vb 4	CSVVRGNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCACAGGGTTAATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	79	3.4023566703417864E-4		41	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	3	3	0	2	4	25	32	40	34	44													Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGAGGGGAACAGGGGTGAGGGAGATGGCTACACCTTCGGTTCG	CSVEGNRGEGDGYTF	In	VDJ	1	78	3.359288864388093E-4	3.8900414937759333E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	2	6	8	8	25	33	48	41	56													Vb 4	CSVEGNRGEGDGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCTCGGACCTCTCCGAAACGGCTTTCTTTGGACAA	CSASDLSETAFF	In	VDJ	1	77	3.316221058434399E-4	3.8401691669326523E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	7	1	7	11	4	12	25	32	40	36	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSASDLSETAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCATACGGGACAGCAACACCGGGGAGCTGTTTTTTGGAGAA	CSIRDSNTGELFF	In	VDJ	1	74	3.1870176405733185E-4	3.6905521864028087E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	0	5	2	4	1	25	31	42	35	43													Vb 4	CSIRDSNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAACCACAGACAGTCTTAGGTTATGGCTACACCTTCGGTTCG	CSVEPQTVLGYGYTF	In	VDJ	1	71	3.057814222712238E-4	3.540935205872965E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	5	5	5	8	25	37	47	42	55													Vb 4	CSVEPQTVLGYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATGTGGGGACAGGGGGCTATGGCTACACCTTCGGTTCG	CSVDVGTGGYGYTF	In	VDJ	1	70	3.0147464167585447E-4	3.491062879029684E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	1	4	4	0	25	36	-1	40	51													Vb 4	CSVDVGTGGYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGGGGACAGCCTCTATGGCTACACCTTCGGTTCG	CSVEGDSLYGYTF	In	VDJ	1	68	2.9286108048511575E-4	3.3913182253431215E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	5	4	2	3	25	36	45	38	48													Vb 4	CSVEGDSLYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATGACTCCAGAGGAGGTGGCTACACCTTCGGTTCG	CSVDDSRGGGYTF	In	VDJ	1	61	2.627136163175303E-4	3.042211937440153E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	10	1	7	10	0	25	36	-1	46	51													Vb 4	CSVDDSRGGGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCGTGGGGTGCAAGAGACCCAGTACTTCGGGCCA	CSVRGVQETQYF	In	VDJ	1	61	2.627136163175303E-4	3.042211937440153E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-05	01	6	6	2	2	4	2	25	33	41	37	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVRGVQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGCGGGGACAGCCGCTCCTACGAGCAGTACTTCGGGCCG	CSGGDSRSYEQYF	In	VDJ	1	61	2.627136163175303E-4	3.042211937440153E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	5	0	3	3	25	32	42	35	45													Vb 4	CSGGDSRSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCTAGCGGTGGGGCCTACGAGGCAGATACGCAGTATTTTGGCCCA	CSVSSGGAYEADTQYF	In	VDJ	1	57	2.454864939360529E-4	2.8427226300670286E-4	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	5	4	1	14	25	34	42	35	56						01,02							Vb 4	CSVSSGGAYEADTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGGAACAGTAAACACTGAAGCTTTCTTTGGACAA	CSVGGTVNTEAFF	In	VDJ	1	57	2.454864939360529E-4	2.8427226300670286E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	4	0	8	2	1	6	25	35	40	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVGGTVNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCAGGGGGTTTGAACACTGAAGCTTTCTTTGGACAA	CSVAGGLNTEAFF	In	VDJ	1	57	2.454864939360529E-4	2.8427226300670286E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	1	0	0	2	25	-1	42	35	44													Vb 4	CSVAGGLNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGGGGGCTGGGGCTAAGAGACCCAGTACTTCGGGCCA	CSAGGWG*ETQYF	Stop	VDJ	1	57	2.454864939360529E-4		39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-05	01	7	6	0	3	2	7	25	32	40	34	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSAGGWG*ETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGCCGAGGGGACAGCAGCTAACTATGGCTACACCTTCGGTTCG	CSVAEGTAANYGYTF	In	VDJ	1	56	2.4117971334068356E-4	2.792850303223747E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	0	7	3	25	33	47	40	50													Vb 4	CSVAEGTAANYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGACGTAGGACAGGGGAAGGAGGTGAGCAGTTCTTCGGGCCA	CSGRRTGEGGEQFF	In	VDJ	1	56	2.4117971334068356E-4	2.792850303223747E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	1	2	9	6	7	25	32	47	38	54													Vb 4	CSGRRTGEGGEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGGGCAGTTATGGGGAGACAAACGGCTACACCTTCGGTTCG	CSGGSYGETNGYTF	In	VDJ	1	54	2.3256615214994487E-4	2.693105649537185E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	7	7	0	8	0	18	25	-1	37	32	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSGGSYGETNGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGCGCGTAACGGGGGGCTACTATGGCTACACCTTCGGTTCG	CSVERVTGGYYGYTF	In	VDJ	1	53	2.2825937155457552E-4	2.6432333226939034E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	8	1	3	8	2	25	36	51	44	53													Vb 4	CSVERVTGGYYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTACTAATTATCCGGGACAGGGAGGCGAGACCCAGTACTTCGGGCCA	CSVTNYPGQGGETQYF	In	VDJ	1	51	2.1964581036383683E-4	2.5434886690073414E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	3	5	11	4	25	34	54	45	58													Vb 4	CSVTNYPGQGGETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCTTTGACTACAGGGCTTACTGAAGCTTTCTTTGGACAA	CSVALTTGLTEAFF	In	VDJ	1	45	1.9380512679162073E-4	2.244254707947654E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	5	8	3	25	35	49	43	52													Vb 4	CSVALTTGLTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTTGCGGGGCCAGGGGAGAATGGCTACACCTTCGGTTCG	CSVLAGPGENGYTF	In	VDJ	1	44	1.8949834619625137E-4	2.194382381104373E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	5	4	2	6	10	3	25	34	50	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVLAGPGENGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGTCCCTAATACTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	43	1.8519156560088202E-4		41	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	4	9	2	5	3	25	35	43	40	46						01,02							Vb 4	X+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD02-01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGAGCAACCAGCGGGGGATTATAAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	41	1.7657800441014333E-4		44	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	6	2	5	7	6	25	32	47	39	53													Vb 4	X+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGCCTCGTCCTGGGCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	39	1.6796444321940464E-4		40	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	8	0	3	10	0	25	32	-1	42	46													Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCGGGACAGGTTCGGAGGGCTACACCTTCGGTTCG	CSVAGTGSEGYTF	In	VDJ	1	38	1.6365766262403528E-4	1.8951484200446856E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	4	8	2	7	25	35	45	37	52													Vb 4	CSVAGTGSEGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCTCGGACAGTTTCACAGATACGCAGTATTTTGGCCCA	CSASDSFTDTQYF	In	VDJ	1	36	1.550441014332966E-4	1.7954037663581233E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	1	5	2	4	3	25	32	42	36	45													Vb 4	CSASDSFTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGACAGGGGGCACTAATGAAAAACTGTTTTTTGGCAGT	CSVGTGGTNEKLFF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	1	0	2	0	0	25	-1	-1	35	46													Vb 4	CSVGTGGTNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGACGGGGACAGCAGCTCCTACGAGCAGTACGTCGGGCCG	CSVDGDSSSYEQYV	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	5	17	5	20	25	33	45	38	65													Vb 4	CSVDGDSSSYEQYV+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCAGCGGGATAATGAAAAACTGTTTTTTGGCAGT	CSAQRDNEKLFF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	7	6	3	4	3	0	25	32	-1	35	42													Vb 4	CSAQRDNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCGGCGTTTCACAGATACGCAGTATTTTGGCCCA	CSVEDRRFTDTQYF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	0	9	0	2	2	4	25	39	44	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEDRRFTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCGACAGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CSATGNTGELFF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	2	4	1	1	0	25	32	-1	33	39													Vb 4	CSATGNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGATCGGGGGCCTCTCGGGACCCAGTACTTCGGGCCA	CSDRGPLGTQYF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-05	01	7	6	0	7	3	7	25	32	41	35	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSDRGPLGTQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGGAGAGGGCGAAGAGACCCAGTACTTCGGGCCA	CSVGEGEETQYF	In	VDJ	1	30	1.292034178610805E-4	1.496169805298436E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	9	2	3	0	6	25	-1	38	33	44													Vb 4	CSVGEGEETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTGACAGGGAGAGAGACCCAGTACTTCGGGCCA	CSVLTGRETQYF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	3	4	2	2	25	34	43	36	45													Vb 4	CSVLTGRETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCCGGACAGGCATGAGGTAAAGGCTGGAAACACCATATATTTTGGAGAG	CSVPDRHEVKAGNTIYF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	51	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	4	2	3	13	25	33	43	36	56													Vb 4	CSVPDRHEVKAGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCGGGTCCTTACCAAAAACATTCAGTACTTCGGCGCC	CSVRVLTKNIQYF	In	VDJ	1	27	1.1628307607497244E-4	1.3465528247685925E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	6	8	4	2	1	6	25	33	38	34	44						01,02							Vb 4	CSVRVLTKNIQYF+TCRBV29-01+TCRBJ02-04	TCRBV29-01*01	TCRBD02-01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGAGGACGTGGGCTACTATGGCTACACCTTCGGTTCG	CSAEDVGYYGYTF	In	VDJ	1	27	1.1628307607497244E-4	1.3465528247685925E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	7	1	7	3	4	7	25	32	40	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSAEDVGYYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCAATATCTCTGCAGCGTTGAAACAGGGAAGGCTCAGCCCCAGCATTTTGGTGAT	CSVETGKAQPQHF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	6	0	5	42	-1	60	54	65													Vb 4	CSVETGKAQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGAGGGCAGACCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	24	1.0336273428886439E-4		40	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	11	0	3	0	6	25	-1	40	35	46													Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCACTCTCGAGCGGGGGGCCCCTCAGCGACACCGGGGAGCTGTTTTTTGGAGAA	CSALSSGGPLSDTGELFF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	54	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	6	1	3	8	10	25	32	49	40	59													Vb 4	CSALSSGGPLSDTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGTGGCCCTGAAGACAGCAGMWATATCTCTGCAGCGCTAGATATTCCACGGGACAGCACATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	19	8.182883131201764E-5		50	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	22	0	5	0	27	4	31	23	57	50	61													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATGGGACAGGGAATGAAAAACTGTTTTTTGGCAGT	CSVDGTGNEKLFF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	3	5	1	0	25	36	-1	37	46													Vb 4	CSVDGTGNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGCAGTTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSAVYSNQPQHF	In	VDJ	10	647	0.0027864870452039693	0.0032267395467602935	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	5	0	0	4	23	-1	39	36	43													Vb 22	CASSAVYSNQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGAATCAGCGGGCAGGTCTGGAAACACCATATATTTTGGAGAG	CASSEESAGRSGNTIYF	In	VDJ	3	212	9.130374862183021E-4	0.0010572933290775614	51	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	1	6	4	1	4	4	23	39	49	43	53						01,02							Vb 22	CASSEESAGRSGNTIYF+TCRBV02-01+TCRBJ01-03	TCRBV02-01*01	TCRBD02-01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCGGGGGGGGCGCGAGCAATCAGCCCCAGCATTTTGGTGAT	CASGGGASNQPQHF	In	VDJ	3	207	8.915035832414553E-4	0.0010323571656559209	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	8	9	0	1	0	5	23	-1	39	32	44													Vb 22	CASGGGASNQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD02-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGCGGACAGTCAAGAGACCCAGTACTTCGGGCCA	CASSADSQETQYF	In	VDJ	2	156	6.718577728776186E-4	7.780082987551867E-4	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	5	2	1	1	23	36	43	37	44													Vb 22	CASSADSQETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAGGGTTCAGCCAAAAACATTCAGTACTTCGGCGCC	CASSEGSAKNIQYF	In	VDJ	2	140	6.029492833517089E-4	6.982125758059368E-4	42	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-04	01	3	0	9	0	0	3	23	-1	40	37	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSEGSAKNIQYF+TCRBV02-01+TCRBJ02-04	TCRBV02-01*01		TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCGACCGAACCCGACAGGGCCTGCTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	75	3.230085446527012E-4		50	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	3	7	11	5	23	34	52	45	57													Vb 22	X+TCRBV02-01+TCRBJ01-04	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTCGGGCCTCAGGTGGCTACACCTTCGGTTCG		Out	VDJ	1	69	2.971678610804851E-4		38	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-02	01	4	4	4	7	8	0	23	36	-1	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	X+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGCGAGGGCCAGTAATCAGCCCCAGCATTTTGGTGAT	CASSARASNQPQHF	In	VDJ	1	50	2.1533902976846747E-4	2.49361634216406E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	11	0	4	1	5	23	36	42	37	47													Vb 22	CASSARASNQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD02-01*02	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGTTGGGACTTAGCAGCACAGATACGCAGTATTTTGGCCCA	CASRLGLSSTDTQYF	In	VDJ	1	50	2.1533902976846747E-4	2.49361634216406E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	10	0	3	4	23	34	43	37	47						01,02							Vb 22	CASRLGLSSTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCCGACAGGGAGGGACTCAGCCCCAGCATTTTGGTGAT	CASSRQGGTQPQHF	In	VDJ	1	48	2.0672546857772878E-4	2.3938716884774975E-4	42	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-05	01	6	2	3	6	2	6	23	34	43	36	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSRQGGTQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGACGTCGTCGGGGGGGGCCTGAATGAGCAGTTCTTCGGGCCA	CASSDVVGGGLNEQFF	In	VDJ	1	47	2.0241868798235942E-4	2.3439993616342165E-4	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	8	0	7	6	5	23	37	51	43	56													Vb 22	CASSDVVGGGLNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAAAGGCCCCGCCAACTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASKGPANYSNQPQHF	In	VDJ	1	45	1.9380512679162073E-4	2.244254707947654E-4	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	3	9	0	12	0	23	33	-1	45	49						01,02							Vb 22	CASKGPANYSNQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD02-01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCCTGGACTAGGGTTAGGTACGCAGTATTTTGGCCCA	CASSPGLGLGTQYF	In	VDJ	1	43	1.8519156560088202E-4	2.1445100542610916E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	8	8	3	7	23	35	45	38	52						01,02							Vb 22	CASSPGLGLGTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAACCCGGGACAGGGATTTCAGCCCCAGCATTTTGGTGAT	CASNPGQGFQPQHF	In	VDJ	1	41	1.7657800441014333E-4	2.0447654005745293E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	0	3	6	4	3	23	33	46	37	49													Vb 22	CASNPGQGFQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGCCGGGACTCTCAGCGCCGGGGAGCTGTTTTTTGGAGAA	CASSAGTLSAGELFF	In	VDJ	1	39	1.6796444321940464E-4	1.9450207468879667E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	10	6	2	7	23	36	44	38	51						01,02							Vb 22	CASSAGTLSAGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01	TCRBD02-01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCACCGGGGACTGGAGAGCCAGCGAGCAGTACTTCGGGCCG	CASTGDWRASEQYF	In	VDJ	1	39	1.6796444321940464E-4	1.9450207468879667E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	10	6	3	10	23	33	42	36	52						01,02							Vb 22	CASTGDWRASEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGACGGGCGCTGGGGGGCCGATGGCTACACCTTCGGTTCG	CASSDGRWGADGYTF	In	VDJ	1	38	1.6365766262403528E-4	1.8951484200446856E-4	45	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-02	01	3	6	0	6	9	2	23	37	52	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSDGRWGADGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTACTCGGGGGGTTTACGAGCAGTACGTCGGGCCG	CASSTRGVYEQYV	In	VDJ	1	36	1.550441014332966E-4	1.7954037663581233E-4	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	1	17	3	15	23	35	45	38	60													Vb 22	CASSTRGVYEQYV+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAGGGAAGTGGGCCACCCCTCCACTTTGGGAAC	CASSEGSGPPLHF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	39	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-06	01	3	0	8	11	0	7	23	-1	41	37	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSEGSGPPLHF+TCRBV02-01+TCRBJ01-06	TCRBV02-01*01		TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGCGACTGGGGGCGCGCAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	34	1.4643054024255788E-4		49	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	6	0	2	4	4	23	40	50	44	54													Vb 22	X+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGGCAAACGAGGCCAGGGTCCACTGAAGCTTTCTTTGGACAA	CARQTRPGSTEAFF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	4	3	4	11	2	23	31	47	42	49													Vb 22	CARQTRPGSTEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCCTTTGGGACTAGCCCAGACCCAGTACTTCGGGCCA	CASSPLGLAQTQYF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	7	6	5	2	23	35	49	40	51						01,02							Vb 22	CASSPLGLAQTQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCCTTAAACAGGTCAATAATTCACCCCTCCACTTTGGGAAC	CASLKQVNNSPLHF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	8	3	4	5	5	3	23	32	42	37	45													Vb 22	CASLKQVNNSPLHF+TCRBV02-01+TCRBJ01-06	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGGGCTACAGGAATACTCTGGCTACACCTTCGGTTCG	CASSGLQEYSGYTF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	4	7	4	7	23	36	45	40	52													Vb 22	CASSGLQEYSGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAATAGGGGGCGTTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	28	1.2058985667034178E-4		49	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	5	0	0	1	4	23	38	46	39	50													Vb 22	X+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGCAGGGACTAATCAGCCCCAGCATTTTGGTGAT	CASSAGTNQPQHF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	0	10	4	2	0	23	36	-1	38	44						01,02							Vb 22	CASSAGTNQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD02-01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCCTACAGGGGGTTAGGAGGTCTTCTCGGGAAAAACTGTTTTTTGGCAGT	CASLQGVRRSSREKLFF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	51	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	3	1	8	2	17	23	32	42	34	59													Vb 22	CASLQGVRRSSREKLFF+TCRBV02-01+TCRBJ01-04	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGGACTGACCGACTTGTACTCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSEGLTDLYSTNEKLFF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	57	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	2	10	0	0	14	23	-1	43	39	57						01,02							Vb 22	CASSEGLTDLYSTNEKLFF+TCRBV02-01+TCRBJ01-04	TCRBV02-01*01	TCRBD02-01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAAGACGGGGGCAAATGAAAAACTGTTTTTTGGCAGT	CASKTGANEKLFF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	39	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-04	01	7	6	0	5	4	1	23	33	43	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASKTGANEKLFF+TCRBV02-01+TCRBJ01-04	TCRBV02-01*01		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCATAGTGGCAACCCCTGAAGCTTTCTTTGGACAA	CASIVATPEAFF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	36	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-01	01	7	9	0	6	4	5	23	33	40	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASIVATPEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAAAGGGGGCTCTCGGGGAGATTTATGGCTACACCTTCGGTTCG	CASSEKGALGEIYGYTF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	51	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	5	0	5	1	13	23	38	46	39	59													Vb 22	CASSEKGALGEIYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGTGTACTTCTGTGCCAGCAGTGACTTACGGGACTAGCGGGGGGACACCGGGGGCCCAGTCGAGCTGTTTTTTGGAGAA	CASSDLRD*RGDTGGPVELFF	Stop	VDJ	1	52	2.2395259095920618E-4		63	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	0	1	11	3	17	10	26	44	29	61			01,02											CASSDLRD*RGDTGGPVELFF+TCRBV06-04+TCRBJ02-02	TCRBV06-04	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGGAGGGACAGAAGAACGCGAGCAGTACTTCGGGCCG	CGGTEEREQYF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	33	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	13	0	5	6	2	7	28	32	41	34	48			01,02											CGGTEEREQYF+TCRBV06-04+TCRBJ02-07	TCRBV06-04	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTCCCGGGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	18	7.75220507166483E-5		38	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	8	3	4	2	0	28	40	-1	42	47			01,02											X+TCRBV06-04+TCRBJ02-02	TCRBV06-04	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCCTTGGTGTAAGGGGGAATGAGCAGTTCTTCGGGCCA	CASLGVRGNEQFF	In	VDJ	1	69	2.971678610804851E-4	3.441190552186403E-4	39	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	5	1	7	9	0	26	35	-1	44	50														CASLGVRGNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTGGGTGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSWVSSGNTIYF	In	VDJ	1	49	2.1103224917309814E-4	2.443744015320779E-4	42	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-03	01	4	0	9	0	0	4	26	-1	42	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWVSSGNTIYF+TCRBV06-07+TCRBJ01-03	TCRBV06-07*01		TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGGGCCAGATCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	36	1.550441014332966E-4		35	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	5	4	3	2	26	37	43	40	45														X+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTAACAGTGCCAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSNSANSNQPQHF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	45	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	5	0	1	6	26	38	43	39	49														CASSNSANSNQPQHF+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGGATGACTCAAACCTCTGGAAACACCATATATTTTGGAGAG	CASRMTQTSGNTIYF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	2	10	0	3	5	26	37	44	40	49						01,02								CASRMTQTSGNTIYF+TCRBV06-07+TCRBJ01-03	TCRBV06-07*01	TCRBD02-01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCCAGGCCACGGGGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSQATGSSGNTIYF	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	48	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	8	3	0	8	2	26	37	50	45	52						01,02								CASSQATGSSGNTIYF+TCRBV06-07+TCRBJ01-03	TCRBV06-07*01	TCRBD02-01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCCACCCTCCGTGGACTTTCCCAGGGGACCCAGTACTTCGGGCCA		Out	VDJ	1	25	1.0766951488423373E-4		49	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-05	01	6	4	3	7	20	0	26	37	-1	57	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAATCCTATGGGGGAAAGGAGACGGCTACACCTTCGGTTCG	CASSEILWGKGDGYTF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	48	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-02	01	5	6	1	8	10	9	26	38	53	48	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEILWGKGDGYTF+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTAGCGGGGCTCTACTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSSGALLAKNIQYF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	48	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	5	6	3	0	0	7	26	-1	45	38	52														CASSSGALLAKNIQYF+TCRBV06-07+TCRBJ02-04	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCCTGCTAGCGGCGCTTACGAGCAGTACTTCGGGCCG	CASSPASGAYEQYF	In	VDJ	1	57	2.454864939360529E-4	2.8427226300670286E-4	42	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	5	4	4	4	19	31	42	35	46						01,02								CASSPASGAYEQYF+TCRBV07-07+TCRBJ02-07	TCRBV07-07*01	TCRBD02-01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCCCGGGATAAGGGACACTGAAGCTTTCTTTGGACAA	CASSPGIRDTEAFF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	42	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	3	3	2	6	19	31	38	33	44														CASSPGIRDTEAFF+TCRBV07-07+TCRBJ01-01	TCRBV07-07*01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCCAGGACAGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSPGQGTGELFF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	42	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	2	5	3	0	19	31	-1	34	43														CASSPGQGTGELFF+TCRBV07-07+TCRBJ02-02	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCCGAACAGGGAAAATCAGCCCCAGCATTTTGGTGAT	CASSPNRENQPQHF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	42	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	3	4	4	2	19	31	41	35	43														CASSPNRENQPQHF+TCRBV07-07+TCRBJ01-05	TCRBV07-07*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGTTTACGGGGACAGGGGAGAGATACGCAGTATTTTGGCCCA	CASSLRGQGRDTQYF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	45	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	2	5	2	2	19	34	46	36	48														CASSLRGQGRDTQYF+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCAGGTAGCGGGGATGAGCAGTTCTTCGGGCCA	CASSESGSGDEQFF	In	VDJ	11	734	0.0031611769570011024	0.00366062879029684	42	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	3	8	3	0	26	43	-1	46	54		TCRBV10-01,TCRBV10-02												CASSESGSGDEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAAGCCGGCGGGGGTGACGATGAGCAGTTCTTCGGGCCA	CASSEAGGGDDEQFF	In	VDJ	6	381	0.0016408834068357221	0.0019001356527290137	45	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	7	2	8	5	5	26	40	52	45	57		TCRBV10-01,TCRBV10-02												CASSEAGGGDDEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGGGGACAGGGGGCAGAGGTTGGAAACACCATATATTTTGGAGAG	CASRGQGAEVGNTIYF	In	VDJ	4	242	0.0010422409040793826	0.001206910309607405	48	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	0	3	0	6	26	-1	49	37	55		TCRBV10-01,TCRBV10-02												CASRGQGAEVGNTIYF+TCRBV10-X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCGCGTGTGACCTTGGATTTAGGGTAGTACCCAGTACTTCGGGCCA		Out	VDJ	3	214	9.216510474090408E-4		47	TCRBV10	unresolved					TCRBJ02	TCRBJ02-05	01	8	5	3	8	18	4	26	35	57	53	61		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCTTAGAGGAGACAGCCGTTGAAGCTTTCTTTGGACAA	CASSLEETAVEAFF	In	VDJ	3	190	8.182883131201764E-4	9.475742100223428E-4	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	5	7	4	4	18	34	43	38	47		TCRBV07-06,TCRBV07-07												CASSLEETAVEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCTTGCCGGGACTACCGAGAAGACCCAGTACTTCGGGCCA	CASSLAGTTEKTQYF	In	VDJ	3	169	7.2784592061742E-4	8.428423236514523E-4	45	TCRBV11	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	9	6	6	6	18	30	43	36	49		TCRBV11-01,TCRBV11-03				01,02								CASSLAGTTEKTQYF+TCRBV11-X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCGAACGTGGGGCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	149	6.417103087100331E-4		53	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	7	0	0	6	3	23	40	51	46	54		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCATCCTCCTACTTACAGATCCTTCGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	148	6.374035281146637E-4		46	TCRBV12	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	10	3	5	7	11	8	22	29	44	40	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCCAGGAAACAGGAGGGGAAGCTTTCTTTGGACAA	CASSQETGGEAFF	In	VDJ	2	141	6.072560639470782E-4	7.031998084902649E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	0	8	9	0	18	30	-1	39	45		TCRBV07-01,TCRBV07-02												CASSQETGGEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCTGTGTACTTSTGTGCCAGCAGTCTAACCCCCCTGTAGGTCGGGGGGCCTTCTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLTPL*VGGPSNTGELFF	Stop	VDJ	2	110	4.7374586549062846E-4		63	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	8	1	2	17	6	10	22	46	39	52		TCRBV06-01,TCRBV06-04,TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSLTPL*VGGPSNTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGAACGGGATGGGAGAAGGTGTTTTTTGGAGAA		Out	VDJ	2	110	4.7374586549062846E-4		40	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	8	3	15	2	10	23	38	45	40	55		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGCATTGGGACTAGCGGGGATAATGAGCAGTTCTTCGGGCCA	CASSIGTSGDNEQFF	In	VDJ	2	108	4.6513230429988975E-4	5.38621129907437E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	7	4	2	23	34	51	38	53		TCRBV06-04,TCRBV06-08												CASSIGTSGDNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGACCTGAACAGGGACCGACGAACTATGGCTACACCTTCGGTTCG	CASRPEQGPTNYGYTF	In	VDJ	1	101	4.349848401323043E-4	5.037105011171402E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	2	6	7	28	39	51	45	58		TCRBV06-04,TCRBV06-08												CASRPEQGPTNYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGATCCGGGCTCCGGGAGCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSDPGSGSGANVLTF	In	VDJ	1	99	4.263712789415656E-4	4.937360357484839E-4	51	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	8	2	4	11	1	23	35	52	46	53		TCRBV06-04,TCRBV06-08												CASSDPGSGSGANVLTF+TCRBV06-X+TCRBJ02-06	unresolved	TCRBD02-01*02	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTGGGGGTGACAGGGGGCGGCTACACCTTCGGTTCG	CASSLGVTGGGYTF	In	VDJ	1	95	4.091441565600882E-4	4.737871050111714E-4	42	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	0	8	6	0	19	33	-1	39	49		TCRBV11-01,TCRBV11-03												CASSLGVTGGGYTF+TCRBV11-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTACGAATTCAGGTGTCACTGAAGCTTTCTTTGGACAA	CASSTNSGVTEAFF	In	VDJ	1	92	3.9622381477398013E-4	4.5882540695818704E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	4	4	7	3	23	35	46	42	49		TCRBV06-07,TCRBV06-08												CASSTNSGVTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGACTTCCAGATCTCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	89	3.833034729878721E-4		49	TCRBV10	unresolved					TCRBJ02	TCRBJ02-06	01	6	4	5	0	5	5	26	37	45	42	50		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ02-06	unresolved		TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTCGAGGGGGTCCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	89	3.833034729878721E-4		40	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	1	6	1	2	23	40	47	41	49		TCRBV06-04,TCRBV06-08												X+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGTAGAGCAGGGTCAGCCCCAGCATTTTGGTGAT	CASSVEQGQPQHF	In	VDJ	1	86	3.7038313120176403E-4	4.289020108522183E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	3	6	6	0	23	35	-1	41	46		TCRBV06-04,TCRBV06-08												CASSVEQGQPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAAGGCGGGAGCTCCTATAATGAGCAGTTCTTCGGGCCA	CASSEGGSSYNEQFF	In	VDJ	1	74	3.1870176405733185E-4	3.6905521864028087E-4	45	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	2	7	2	7	26	40	49	42	56		TCRBV10-01,TCRBV10-02												CASSEGGSSYNEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCACGGGACGGGGAACGGCTCCGAATGAGCAGTTCTTCGGGCCA	CASTGRGTAPNEQFF	In	VDJ	1	74	3.1870176405733185E-4	3.6905521864028087E-4	45	TCRBV12	unresolved					TCRBJ02	TCRBJ02-01	01	7	0	7	7	1	14	22	32	38	33	52		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTGRGTAPNEQFF+TCRBV12-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAACTAGGCAGACTCTACAATGAGCAGTTCTTCGGGCCA	CASSELGRLYNEQFF	In	VDJ	1	72	3.100882028665932E-4	3.5908075327162467E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	2	10	3	7	0	23	38	-1	45	49		TCRBV06-01,TCRBV06-07,TCRBV06-08				01,02								CASSELGRLYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGCCGACAGGGGACGAGCAGTACTTCGGGCCG	CASSEPTGDEQYF	In	VDJ	1	71	3.057814222712238E-4	3.540935205872965E-4	39	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	2	5	2	0	26	41	-1	43	51		TCRBV10-01,TCRBV10-02												CASSEPTGDEQYF+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGTTCGTTAAAAACCGGAGCAGTCTATGGCTACACCTTCGGTTCG	CASSLKTGAVYGYTF	In	VDJ	1	68	2.9286108048511575E-4	3.3913182253431215E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	9	10	2	4	13	4	23	31	48	44	52		TCRBV06-07,TCRBV06-08												CASSLKTGAVYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACACGAGGCAGGACACTGAAGCTTTCTTTGGACAA	CASSYTRQDTEAFF	In	VDJ	1	64	2.756339581036384E-4	3.191828917969997E-4	42	TCRBV06	unresolved					TCRBJ01	TCRBJ01-01	01	2	4	4	3	6	0	23	38	-1	44	48		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYTRQDTEAFF+TCRBV06-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGAGAACAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASREQGNTGELFF	In	VDJ	1	62	2.6702039691289966E-4	3.092084264283434E-4	42	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	3	1	3	0	26	37	-1	40	46		TCRBV10-01,TCRBV10-02												CASREQGNTGELFF+TCRBV10-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCATATACAGGGCGGACCTCCCTCCACTTTGGGAAC		Out	VDJ	1	61	2.627136163175303E-4		34	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	10	3	3	14	3	7	28	35	44	38	51		TCRBV06-04,TCRBV06-07												X+TCRBV06-X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGCTCGGGACAGAGCAACACTGAAGCTTTCTTTGGACAA	CASSSGQSNTEAFF	In	VDJ	1	56	2.4117971334068356E-4	2.792850303223747E-4	42	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	2	3	3	26	37	47	40	50		TCRBV10-01,TCRBV10-02												CASSSGQSNTEAFF+TCRBV10-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGCACTAGCTTCAGTGAGCAGTTCTTCGGGCCA	CASSTSFSEQFF	In	VDJ	1	53	2.2825937155457552E-4	2.6432333226939034E-4	36	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	3	7	9	1	5	26	37	44	38	49		TCRBV10-01,TCRBV10-02				01,02								CASSTSFSEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCACCCGTCGTGAGGGGAAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	49	2.1103224917309814E-4		44	TCRBV06	unresolved					TCRBJ02	TCRBJ02-03	01	7	5	2	3	9	2	26	36	50	45	52		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGCAGGGCTTGGAAACACCATATATTTTGGAGAG	CASSAGLGNTIYF	In	VDJ	1	48	2.0672546857772878E-4	2.3938716884774975E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	4	3	3	1	2	26	38	44	39	46		TCRBV06-07,TCRBV06-08												CASSAGLGNTIYF+TCRBV06-X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTCTGGGGGTACGGGAGATACGCAGTATTTTGGCCCA	CASSDSGGTGDTQYF	In	VDJ	1	46	1.9811190738699006E-4	2.2941270347909352E-4	45	TCRBV06	unresolved					TCRBJ02	TCRBJ02-03	01	0	6	1	5	1	6	23	40	46	41	52		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSGGTGDTQYF+TCRBV06-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTACGTTCTAGCAGAGGGAGAGACCCAGTACTTCGGGCCA	CASSYVLAEGETQYF	In	VDJ	1	42	1.8088478500551269E-4	2.0946377274178103E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	4	7	4	6	6	28	40	51	46	57		TCRBV06-04,TCRBV06-08				01,02								CASSYVLAEGETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGTCGGGACTGGGGGGAAAAACTGTTTTTTGGCAGT	CASSRDWGEKLFF	In	VDJ	1	39	1.6796444321940464E-4	1.9450207468879667E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	6	0	10	8	2	5	18	29	37	31	42		TCRBV07-02,TCRBV07-08				01,02								CASSRDWGEKLFF+TCRBV07-X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAGCAAAACTAGCGGGCTCCCGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	39	1.6796444321940464E-4		52	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	3	4	4	8	6	26	38	55	46	61		TCRBV06-01,TCRBV06-07				01,02								X+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACCCGGGAGGGATCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYPGGISGANVLTF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	51	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	2	8	0	0	1	2	23	38	47	39	49		TCRBV06-07,TCRBV06-08												CASSYPGGISGANVLTF+TCRBV06-X+TCRBJ02-06	unresolved	TCRBD02-01*02	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCTTAGGTTCTTGGCAGGGGGCTGGAAACACCATATATTTTGGAGAG	CASSLGSWQGAGNTIYF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	51	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	4	1	2	8	0	18	34	-1	42	49		TCRBV07-06,TCRBV07-07												CASSLGSWQGAGNTIYF+TCRBV07-X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCACCCCTCGAGCGGGGGGGCCTAACGGGGAGCTGTTTTTTGGAGAA	CASTPRAGGPNGELFF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	48	TCRBV12	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	12	6	0	7	12	5	26	31	53	43	58		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASTPRAGGPNGELFF+TCRBV12-X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGGCCCCGGGGATCGGGGAGGGACGGGGAGCTGTTTTTTGGAGAA	CASRPRGSGRDGELFF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	48	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	9	0	7	13	1	19	30	50	43	51		TCRBV07-06,TCRBV07-07												CASRPRGSGRDGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAACCTGGGACAGAGACCGACCTTTTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	33	1.4212375964718854E-4		59	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	5	3	6	12	22	34	47	40	59		TCRBV06-01,TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACCTCCATCAGGAGAATGAGCAGTTCTTCGGGCCA	CASSYLHQENEQFF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	42	TCRBV06	unresolved					TCRBJ02	TCRBJ02-01	01	2	4	4	7	6	2	26	41	51	47	53		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYLHQENEQFF+TCRBV06-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCRGCCRTGTATCKCTGTGCCAGCAGTCCTCGCCTATACCTCTACACAGATACGCAGTATTTTGGCCCA	CASSPRLYLYTDTQYF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	48	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	9	2	7	8	19	30	40	37	48		TCRBV07-02,TCRBV07-07				01,02								CASSPRLYLYTDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCACCGAAAATTATGAAGGATAGGGCTATGGCTACACCTTCGGTTCG	CASTENYEG*GYGYTF	Stop	VDJ	1	31	1.3351019845644983E-4		48	TCRBV06	unresolved					TCRBJ01	TCRBJ01-02	01	7	5	3	4	18	0	23	33	-1	51	55		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTENYEG*GYGYTF+TCRBV06-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGGSGACTYGGCTGTGTATCTCTGTGCCAGCAGTGAGGACAAGCATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	30	1.292034178610805E-4		43	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	6	0	3	4	22	33	41	36	45		TCRBV07-01,TCRBV07-05												X+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAACGCCGGACAGCAAGAGACCCAGTACTTCGGGCCA	CANAGQQETQYF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	36	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	1	5	2	5	0	28	35	-1	40	46		TCRBV06-04,TCRBV06-07												CANAGQQETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCYRTGTATCKCTGTGCCAGAAGCTTGGGACTAGCGGGGGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	28	1.2058985667034178E-4		46	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	0	2	3	0	0	18	-1	-1	32	46		TCRBV07-05,TCRBV07-06												X+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGTTGGGGACCTATCCTTCGAGGCTTTCTTTGGACAA	CASSVGDLSFEAFF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	42	TCRBV06	unresolved					TCRBJ01	TCRBJ01-01	01	5	0	7	11	4	12	26	38	47	42	59		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGDLSFEAFF+TCRBV06-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCGGGACAGGGGGACGAGCAGTTCTTCGGGCCA	CASSESGQGDEQFF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	42	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	1	10	0	2	23	-1	51	40	53		TCRBV10-01,TCRBV10-02												CASSESGQGDEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTGGGACACGTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSWDTSNTGELFF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	6	0	0	3	26	-1	45	39	48		TCRBV06-07,TCRBV06-08												CASSWDTSNTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGGGTCGGGCACACAGATACGCAGTATTTTGGCCCA	CASRVGHTDTQYF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	39	TCRBV06	unresolved					TCRBJ02	TCRBJ02-03	01	6	8	0	2	4	1	23	34	42	38	43		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRVGHTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTCGGAGGAGATCTAGCCCACGAGAAAGGCCAACGTCCTGACTTTCGGGGCC	CASSSEEI*PTRKANVLTF	Stop	VDJ	1	24	1.0336273428886439E-4		57	TCRBV11	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	4	4	7	6	10	10	18	31	46	41	56		TCRBV11-01,TCRBV11-03				01,02								CASSSEEI*PTRKANVLTF+TCRBV11-X+TCRBJ02-06	unresolved	TCRBD02-01	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCYCAGACWTCTGTWTACTTCTGTGCCAGCACCAACCGGGACGGATACTATGGCTACACCTTCGGTTCG	CASTNRDGYYGYTF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	42	TCRBV06	unresolved					TCRBJ01	TCRBJ01-02	01	7	0	7	3	6	4	26	36	47	42	51		TCRBV06-07,TCRBV06-09		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTNRDGYYGYTF+TCRBV06-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGTAMSCTCYCAGACATCTGTGTACTTCTGTGCCAGCAGTGAAGCTGCAGGGGGATACGAGCAGTACGTCGGGCCG	CASSEAAGGYEQYV	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	1	17	2	14	24	41	50	43	64		TCRBV06-01,TCRBV06-04												CASSEAAGGYEQYV+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCACCGAGGACAGGGCTCCCTACGAGCAGTACGTCGGGCCG	CATEDRAPYEQYV	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	1	3	17	4	18	28	35	47	39	65		TCRBV06-04,TCRBV06-07												CATEDRAPYEQYV+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAGCCGGCGGGGTTGGGGACACCTTCGGTTCG	CASSEAGGVGDTF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	7	3	12	2	6	23	40	48	42	54		TCRBV06-01,TCRBV06-07												CASSEAGGVGDTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGTCCCCGCCCGAGGGCACCCCTCCACTTTGGGAAC	CASSPRPRAPLHF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	11	0	11	8	0	23	35	-1	43	48		TCRBV06-08,TCRBV06-09												CASSPRPRAPLHF+TCRBV06-X+TCRBJ01-06	unresolved	TCRBD02-01*02	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCGGCCACGACTCCTACGAGCAGTACGTCGGGCCG	CASSGHDSYEQYV	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	10	17	6	15	18	30	40	36	55		TCRBV07-02,TCRBV07-08				01,02								CASSGHDSYEQYV+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCTTAGATAGCTCTGGAAACACCATATATTTTGGAGAG	CASSLDSSGNTIYF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	1	5	8	0	1	0	19	35	-1	36	39		TCRBV07-06,TCRBV07-07				01,02								CASSLDSSGNTIYF+TCRBV07-X+TCRBJ01-03	unresolved	TCRBD02-01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACCCAGGGTATAATTCACCCCTCCACTTTGGGAAC	CASSYPGYNSPLHF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	4	3	4	1	0	23	38	-1	39	44		TCRBV06-07,TCRBV06-08												CASSYPGYNSPLHF+TCRBV06-X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGGGGACTCRGCYGTGTATCTCTGTGCCAGCAGCTATGGGGTTGGCCAGCCCCAGCATTTTGGTGAT	CASSYGVGQPQHF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	39	TCRBV07	unresolved					TCRBJ01	TCRBJ01-05	01	4	6	2	7	2	5	22	35	41	37	46		TCRBV07-02,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGVGQPQHF+TCRBV07-X+TCRBJ01-05	unresolved		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCGGGACTAGCGCTTCAAATACGCAGTATTTTGGCCCA	CASSGTSASNTQYF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	6	7	0	6	19	-1	41	31	47		TCRBV07-05,TCRBV07-06				01,02								CASSGTSASNTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTACAGTTCCTAGGAGACCTATGGCTACACCTTTGGTTCG	CASSYSS*ETYGYTF	Stop	VDJ	1	18	7.75220507166483E-5		45	TCRBV06	unresolved		unresolved			TCRBJ01	TCRBJ01-02	01	5	3	5	20	1	28	28	40	45	41	73		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02										CASSYSS*ETYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	unresolved	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAGGAAGTAACTATGGCTACACCTTCGGTTCG	CASSLGSNYGYTF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	39	TCRBV07	TCRBV07-01	01				TCRBJ01	TCRBJ01-02	01	4	1	8	1	2	2	22	35	40	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGSNYGYTF+TCRBV07-01+TCRBJ01-02	TCRBV07-01*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCTCCCCCGGACAGGGGCTTTCTAATGAAAAACTGTTTTTTGGCAGT	YASSSPGQGLSNEKLFF	In	VDJ	1	70	3.0147464167585447E-4	3.491062879029684E-4	51	TCRBV07	TCRBV07-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	1	2	3	5	4	22	35	49	40	53														YASSSPGQGLSNEKLFF+TCRBV07-03+TCRBJ01-04	TCRBV07-03*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCTTCACGGCGGGGGGGCTATACAATGAGCAGTTCTTCGGGCCA	CASSFTAGGLYNEQFF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	48	TCRBV07	TCRBV07-08		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	7	0	4	4	3	20	34	47	38	50			01,02											CASSFTAGGLYNEQFF+TCRBV07-08+TCRBJ02-01	TCRBV07-08	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCCAGGGGTTATAACTATGGCTACACCTTCGGTTCG	CASSESRGYNYGYTF	In	VDJ	32	2181	0.00939308847850055	0.01087715448451963	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	2	1	0	3	23	-1	46	40	49													Vb 12	CASSESRGYNYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAACCCGGGACAGGGGGTCTATGGCTACACCTTCGGTTCG	CASNPGQGVYGYTF	In	VDJ	21	1388	0.005977811466372657	0.00692227896584743	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	1	4	4	1	23	33	48	37	49													Vb 12	CASNPGQGVYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTAGGGACCGGACCTACAATGAGCAGTTCTTCGGGCCA	CASSRDRTYNEQFF	In	VDJ	18	1196	0.005150909592061742	0.005964730290456431	42	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-01	01	5	0	7	2	1	4	23	35	41	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSRDRTYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGCCCGGGAGAGGGGCACATCCAAAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	10	694	0.0029889057331863285		55	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	2	8	2	5	2	14	23	38	46	40	60													Vb 12	X+TCRBV10-02+TCRBJ01-04	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCTGGGGGTGGAGGTCAGCCCCAGCATTTTGGTGAT	CASSESGGGGQPQHF	In	VDJ	5	342	0.0014729189636163175	0.001705633578040217	45	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-05	01	0	6	1	6	1	6	23	40	46	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESGGGGQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGAGGGCAATTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSERAISNQPQHF	In	VDJ	4	269	0.001158523980154355	0.0013415655920842643	45	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-05	01	2	5	3	0	0	4	23	-1	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSERAISNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGAACCCATCGGAGACCCAGTACTTCGGGCCA	CASSENPSETQYF	In	VDJ	4	248	0.0010680815876515986	0.0012368337057133737	39	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-05	01	2	3	7	5	1	6	23	38	41	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSENPSETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTAAGCCACTTCTAACAAAGCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	133	5.728018191841235E-4		55	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-06	01	1	3	6	5	12	4	23	39	54	51	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-02+TCRBJ02-06	TCRBV10-02*01		TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGTCGATACAGAACTAAGCTATGGCTACACCTTCGGTTCG	CASSVDTELSYGYTF	In	VDJ	2	102	4.3929162072767365E-4	5.086977338014683E-4	45	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-02	01	4	3	5	4	5	7	23	36	45	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSVDTELSYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGATAGTATCGGACTAGCCTACACAGATACGCAGTATTTTGGCCCA	CASRDSIGLAYTDTQYF	In	VDJ	1	93	4.005305953693495E-4	4.6381263964251514E-4	51	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	1	7	2	10	3	23	34	52	44	55						01,02							Vb 12	CASRDSIGLAYTDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTTTGCGACAGAAAACACTGAAGCTTTCTTTGGACAA	CASSFATENTEAFF	In	VDJ	1	86	3.7038313120176403E-4	4.289020108522183E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	5	2	5	2	23	35	45	40	47													Vb 12	CASSFATENTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGCCGGGACACCTTCGAGTTTATAATTCACCCCTCCACTTTGGGAAC	CASSEPGHLRVYNSPLHF	In	VDJ	1	72	3.100882028665932E-4	3.5908075327162467E-4	54	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	0	6	4	2	10	23	38	46	40	56													Vb 12	CASSEPGHLRVYNSPLHF+TCRBV10-02+TCRBJ01-06	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGCCGACAGGGGGCCCGCTGAAGCTTTCTTTGGACAA	CASRADRGPAEAFF	In	VDJ	1	72	3.100882028665932E-4	3.5908075327162467E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	0	6	4	3	23	34	48	38	51													Vb 12	CASRADRGPAEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCAAGTGAGGTTGGAGCTGACTATGGCTACACCTTCGGTTCG	CASSESSEVGADYGYTF	In	VDJ	1	60	2.58406835722161E-4	2.992339610596872E-4	51	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	10	2	3	10	3	23	40	54	50	57													Vb 12	CASSESSEVGADYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGGTGGGGATACGCAGTATTTTGGCCCA	CASSEGGDTQYF	In	VDJ	1	56	2.4117971334068356E-4	2.792850303223747E-4	36	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-03	01	2	0	9	6	3	0	23	38	-1	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSEGGDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGGGACTTTCTATACGAGCTGTACTTCGGGCCG	CASSGDFLYELYF	In	VDJ	1	54	2.3256615214994487E-4	2.693105649537185E-4	39	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	10	12	0	13	23	-1	42	36	55						01,02							Vb 12	CASSGDFLYELYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD02-01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACACGTTCGGAGGGAATGACCCTCCACTTTGGGAAC	CASTRSEGMTLHF	In	VDJ	1	52	2.2395259095920618E-4	2.5933609958506224E-4	39	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	7	10	0	14	7	5	23	33	46	40	51													Vb 12	CASTRSEGMTLHF+TCRBV10-02+TCRBJ01-06	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCCCCGGGGACAGGGCACATCGGGGGGAAACACCATATATTTTGGAGAG	CASSPRGQGTSGGNTIYF	In	VDJ	1	51	2.1964581036383683E-4	2.5434886690073414E-4	54	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	3	4	5	10	23	35	49	40	59													Vb 12	CASSPRGQGTSGGNTIYF+TCRBV10-02+TCRBJ01-03	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCATCGGGGGGTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	49	2.1103224917309814E-4		47	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	0	8	1	4	2	0	23	40	-1	42	49													Vb 12	X+TCRBV10-02+TCRBJ01-06	TCRBV10-02*01	TCRBD02-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGAGGGAGACAGCTAACTATGGCTACACCTTCGGTTCG	CASSESRETANYGYTF	In	VDJ	1	48	2.0672546857772878E-4	2.3938716884774975E-4	48	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-02	01	0	2	5	0	6	0	23	40	-1	46	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESRETANYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTCATCCGGGCCTGGGGTAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	47	2.0241868798235942E-4		46	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-05	01	5	6	2	3	12	1	23	35	51	47	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCGATGGGGGGCACGAGCAGTACTTCGGGCCG	CASSDGGHEQYF	In	VDJ	1	46	1.9811190738699006E-4	2.2941270347909352E-4	36	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-07	01	6	6	0	5	5	0	23	34	-1	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSDGGHEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAAAACCCCGGGGACGTTAATTGGGACCAACGTCCTGACTTTCGGGGCC	CASKTPGTLIGTNVLTF	In	VDJ	1	43	1.8519156560088202E-4	2.1445100542610916E-4	51	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-06	01	7	0	7	8	8	11	23	33	46	41	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASKTPGTLIGTNVLTF+TCRBV10-02+TCRBJ02-06	TCRBV10-02*01		TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCGGGACACTTACACAGATACGCAGTATTTTGGCCCA	CASSRDTYTDTQYF	In	VDJ	1	38	1.6365766262403528E-4	1.8951484200446856E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	6	2	1	4	23	35	42	36	46													Vb 12	CASSRDTYTDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCCGAATCCAGACCGAGGACACTGAAGCTTTCTTTGGACAA	CASRIQTEDTEAFF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	8	11	1	3	12	0	23	32	-1	44	48													Vb 12	CASRIQTEDTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCCAGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPGSNQPQHF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	4	0	1	0	23	35	-1	36	40													Vb 12	CASSPGSNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGATCTAGCGGGGGGGGAGATACGCAGTATTTTGGCCCA	CASRSSGGGDTQYF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	4	0	5	2	1	23	34	48	36	49													Vb 12	CASRSSGGGDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGTAGAGGAGGCGGGACCCAACTCCCTCACAGATACGCAGTATTTTGGCCCA	CASSVEEAGPNSLTDTQYF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	57	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	7	3	2	8	11	23	36	50	44	61													Vb 12	CASSVEEAGPNSLTDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCGGGACTAGCGGGGCTGGGGAGGTGCAGTATTTTGGCCCA	CASGTSGAGEVQYF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	0	3	11	0	10	23	-1	45	32	55													Vb 12	CASGTSGAGEVQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTACGGAGATGGGTATGGCTACACCTTCGGTTCG	CASSEYGDGYGYTF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	10	2	5	2	5	23	39	45	41	50													Vb 12	CASSEYGDGYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCCTGACAGGGGACACTGAAGCTTTCTTTGGACAA	CASSLTGDTEAFF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	3	3	0	23	34	-1	37	45													Vb 12	CASSLTGDTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACCGAGGGCCTAGGCAATGAGCAGTTCTTCGGGCCA	CASTEGLGNEQFF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	39	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	11	0	6	2	6	23	33	40	35	46													Vb 12	CASTEGLGNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCCACGTTTGGTGCGCTCCCAGACATCTGTGTATTCTGCGCCAGCAGTGAGTCCAGGGGTTATAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	23	9.905595369349503E-5		44	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	19	4	2	1	18	3	37	35	59	53	62													Vb 12	X+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGACGGAGACAGGGGGCTACTATGGCTACACCTTCGGTTCG	CASSESTETGGYYGYTF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	51	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	0	3	6	1	23	40	56	46	57													Vb 12	CASSESTETGGYYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAGCCACGTTTGGTGCGCTCCCAGACATCTGTGTATTCTGCGCCAGCAACCCGGGACAGGGGGTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	18	7.75220507166483E-5		41	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	19	0	1	4	15	1	40	38	64	53	65													Vb 12	X+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGATAAGAACTGAAGCTTTCTTTGGACAA	CAISEIRTEAFF	In	VDJ	2	165	7.106187982359426E-4	8.228933929141398E-4	36	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-01	01	2	2	8	5	4	0	23	38	-1	42	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISEIRTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAATTTAGTCGGGGCTAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	68	2.9286108048511575E-4		40	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-02	01	10	7	0	2	8	2	24	31	44	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCACCGACCCCAATGAAAAACTGTTTTTTGGCAGT	CAITDPNEKLFF	In	VDJ	1	42	1.8088478500551269E-4	2.0946377274178103E-4	36	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-04	01	7	2	7	5	2	3	24	34	39	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAITDPNEKLFF+TCRBV10-03+TCRBJ01-04	TCRBV10-03*01		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGAGGACCGAGGGTGGCTACACCTTCGGTTCG	CAISERTEGGYTF	In	VDJ	1	40	1.7227122381477397E-4	1.994893073731248E-4	39	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	11	0	7	6	0	23	38	-1	44	49													Vb 12	CAISERTEGGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGGGGGGCTAGCGGGCAACGCCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	33	1.4212375964718854E-4		52	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	4	17	6	21	23	38	52	44	73						01,02							Vb 12	X+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD02-01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGAGGGGACATCAATTAACTATGGCTACACCTTCGGTTCG	CASSEGTSINYGYTF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	6	1	0	5	24	-1	45	39	50													Vb 12	CASSEGTSINYGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCCCCGGGCACTGAAGCTTTCTTTGGACAA	CAISESPGTEAFF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	39	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	4	4	2	0	23	40	-1	42	46						01,02							Vb 12	CAISESPGTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD02-01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCTCGACCACGGGGGGCCCGAACATTCAGTACTTCGGCGCC	CASSTTGGPNIQYF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	42	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	10	8	1	7	9	4	24	31	47	40	51													Vb 12	CASSTTGGPNIQYF+TCRBV10-03+TCRBJ02-04	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGCGTCAGGGGTCCCAGGCTATGGCTACACCTTCGGTTCG	CASSASGVPGYGYTF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	2	4	0	7	24	-1	46	41	53													Vb 12	CASSASGVPGYGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAACTCAGGGAACTGAAGCTTTCTTTGGACAA	CASRTQGTEAFF	In	VDJ	63	4277	0.018420100606394707	0.02133039419087137	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	5	4	1	27	38	47	42	48			01,02										Vb 17	CASRTQGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGACACTCGGAGGACCGGGGAGCTGTTTTTTGGAGAA	CASSMDTRRTGELFF	In	VDJ	47	3192	0.013747243660418964	0.015919246728375358	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	3	1	6	5	0	8	27	-1	46	41	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMDTRRTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGGGGAGCGGGATCGTACAATGAGCAGTTCTTCGGGCCA	CASGGAGSYNEQFF	In	VDJ	33	2214	0.00953521223814774	0.011041733163102458	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	6	3	4	5	3	27	36	48	41	51			01,02										Vb 17	CASGGAGSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCACCATGACAGGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSTMTGATGELFF	In	VDJ	17	1151	0.004957104465270121	0.0057403048196616666	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	2	4	6	1	27	38	52	44	53			01,02										Vb 17	CASSTMTGATGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGGGCCGGACTGGAGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	7	495	0.002131856394707828		46	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	8	7	0	0	0	10	27	-1	41	36	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCATCCGGGACAGGGGTCCAATGAGCAGTTCTTCGGGCCA	CASHPGQGSNEQFF	In	VDJ	7	474	0.0020414140022050717	0.0023639482923715287	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	2	6	5	2	27	36	51	41	53			01,02										Vb 17	CASHPGQGSNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGACTCTGATGGGTCTGACACTGAAGCTTTCTTTGGACAA	CASRDSDGSDTEAFF	In	VDJ	7	452	0.001946664829106946	0.00225422917331631	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	1	10	3	0	12	27	-1	43	38	55			01,02			01,02							Vb 17	CASRDSDGSDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCTCAACCCCGAACACTGAAGCTTTCTTTGGACAA	CASTSTPNTEAFF	In	VDJ	5	347	0.0014944528665931643	0.0017305697414618576	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	7	3	7	1	5	3	27	37	44	42	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTSTPNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAATTGGACAGGGGAGGCACAGATACGCAGTATTTTGGCCCA	CASKLDRGGTDTQYF	In	VDJ	5	308	0.0013264884233737597	0.001536067666773061	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	1	2	1	4	2	27	37	50	41	52			01,02										Vb 17	CASKLDRGGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTCCTCTCTAACTATGGCTACACCTTCGGTTCG	CASSIVLSNYGYTF	In	VDJ	4	269	0.001158523980154355	0.0013415655920842643	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	4	10	0	2	2	27	43	47	45	49			01,02			01,02							Vb 17	CASSIVLSNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTAGAGACGGCTTATGGCTACACCTTCGGTTCG	CASSVETAYGYTF	In	VDJ	4	267	0.0011499104189636163	0.001331591126715608	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	0	2	7	5	0	4	27	-1	47	44	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSVETAYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGACAGATACGCAGTATTTTGGCCCA	CASSIGTDTQYF	In	VDJ	4	240	0.001033627342888644	0.0011969358442387489	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	1	0	10	3	0	0	27	-1	-1	43	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCCGGGAAGCTACGGAAACACCATATATTTTGGAGAG	CASSPPGSYGNTIYF	In	VDJ	3	233	0.0010034798787210584	0.001162025215448452	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	8	3	4	4	6	27	39	48	43	54			01,02										Vb 17	CASSPPGSYGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01*02	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGTACAGGGGAAGCGGGCAGTATGAGCAGTTCTTCGGGCCA	CASSTYRGSGQYEQFF	In	VDJ	3	227	9.776391951488424E-4	0.0011321018193424833	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	2	8	3	11	27	40	50	43	61			01,02										Vb 17	CASSTYRGSGQYEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGAAGGCGCCTATGGCTACACCTTCGGTTCG	CASSIEGAYGYTF	In	VDJ	3	225	9.690256339581037E-4	0.001122127353973827	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	3	5	4	4	3	3	27	41	47	44	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIEGAYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGACAGGGGATAAGGGGCACTGAAGCTTTCTTTGGACAA	CASSRQGIRGTEAFF	In	VDJ	3	215	9.259578280044102E-4	0.001072255027130546	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	4	2	8	27	38	48	40	56			01,02										Vb 17	CASSRQGIRGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCCAGGGGACACTGAAGCTTTCTTTGGACAA	CASSIPGDTEAFF	In	VDJ	3	207	8.915035832414553E-4	0.0010323571656559209	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	3	2	0	27	41	-1	43	49			01,02										Vb 17	CASSIPGDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCTCCCTCCCTCCGGGACAGATAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	202	8.699696802646086E-4		47	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	0	5	2	12	2	27	35	54	47	56			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACGACAAAACCAAAAAGCTTTCTTTGGACAA	CASRRQNQKAFF	In	VDJ	3	200	8.613561190738699E-4	9.97446536865624E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	6	9	2	8	27	38	44	40	52			01,02										Vb 17	CASRRQNQKAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCTCCTTATCGACTTTAGGCATTCAGTACTTCGGCGCC	CASSLSTLGIQYF	In	VDJ	3	193	8.312086549062844E-4	9.625359080753272E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	9	2	10	9	9	5	27	35	48	44	53			01,02			01,02							Vb 17	CASSLSTLGIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD02-01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTAGGGACTTAGGGGACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	3	186	8.01061190738699E-4		47	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	0	10	2	2	6	27	39	47	41	53			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCAACTCCTATAGCACAACACAGATACGCAGTATTTTGGCCCA	CASSIQLL*HNTDTQYF	Stop	VDJ	3	182	7.838340683572216E-4		51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	5	7	2	10	4	27	41	55	51	59			01,02			01,02							Vb 17	CASSIQLL*HNTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGGCCCGCGGAGGGGTACAGCGACCCAGTCGGGATCTGCAGTATTTTGGCCCA		Out	VDJ	3	181	7.795272877618522E-4		49	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	13	10	0	11	6	23	27	31	43	37	66			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAATGGGGGGAAGCCCCCATAATTCACCCCTCCACTTTGGGAAC	CASSIMGGSPHNSPLHF	In	VDJ	3	179	7.709137265711135E-4	8.927146504947335E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	2	9	1	5	2	8	27	42	50	44	58			01,02										Vb 17	CASSIMGGSPHNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD02-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACAGGAGGGGGTGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRQEGVGSYNEQFF	In	VDJ	3	174	7.493798235942668E-4	8.677784870730928E-4	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	6	5	1	0	5	4	27	38	49	43	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRQEGVGSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTACAGCGCGACAAATCACATCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	3	173	7.450730429988975E-4		53	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-06	01	5	2	6	5	8	9	27	39	51	47	60			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-06	TCRBV19-01		TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCTCCCTCGTCCCTGATGGTACGCAGTATTTTGGCCCA	CASLVPDGTQYF	In	VDJ	3	169	7.2784592061742E-4	8.428423236514523E-4	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	11	0	10	8	15	0	27	33	-1	48	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASLVPDGTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCTGGGCCCCTCGGCGGCTACACCTTCGGTTCG	CASSSGPLGGYTF	In	VDJ	2	168	7.235391400220507E-4	8.378550909671241E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	8	0	8	3	8	27	39	46	42	54			01,02										Vb 17	CASSSGPLGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCCTGGGTTGGAACCGGGGAGCTGTTTTTTGGAGAA	CASSIAWVGTGELFF	In	VDJ	2	164	7.063120176405733E-4	8.179061602298117E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	1	0	9	5	3	5	27	43	49	46	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIAWVGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCCGAACAAGAACAGGGGCTTATCAGCCCCAGCATTTTGGTGAT	CARTRTGAYQPQHF	In	VDJ	2	161	6.933916758544653E-4	8.029444621768273E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	3	2	5	9	3	27	33	49	42	52			01,02										Vb 17	CARTRTGAYQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGGTCCACAGATACGCAGTATTTTGGCCCA	CASSMRSTDTQYF	In	VDJ	2	155	6.675509922822491E-4	7.730210660708586E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	11	1	2	0	2	27	-1	45	41	47			01,02										Vb 17	CASSMRSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCGGCTGGGGGTCGCTTCAATCAGCCCCAGCATTTTGGTGAT	CAAGGRFNQPQHF	In	VDJ	2	154	6.632442116868798E-4	7.680338333865305E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	12	6	1	3	4	6	27	32	41	36	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CAAGGRFNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATCCGAGCGGGGGCTCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	151	6.503238699007718E-4		49	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	6	2	1	4	3	27	42	54	46	57			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCATGGACAGGGGTTCCTACAATGAGCAGTTCTTCGGGCCA	CASTMDRGSYNEQFF	In	VDJ	2	148	6.374035281146637E-4	7.381104372805617E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	1	2	1	4	1	27	37	50	41	51			01,02										Vb 17	CASTMDRGSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGAACAGTGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSEQWDTGELFF	In	VDJ	2	147	6.330967475192944E-4	7.331232045962336E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	5	3	2	4	27	39	45	41	49			01,02										Vb 17	CASSEQWDTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCCCGTAGCTATGGCTACACCTTCGGTTCG	CASSRSYGYTF	In	VDJ	2	143	6.15869625137817E-4	7.131742738589211E-4	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	8	5	8	4	5	0	27	36	-1	41	44			01,02			01,02							Vb 17	CASSRSYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGAGTGGGACAGGGCCACAGATACGCAGTATTTTGGCCCA	CASSEWDRATDTQYF	In	VDJ	2	142	6.115628445424477E-4	7.08187041174593E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	3	2	5	1	27	38	52	43	53			01,02										Vb 17	CASSEWDRATDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGGGACTAGCGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGLAGAYNEQFF	In	VDJ	2	140	6.029492833517089E-4	6.982125758059368E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	2	2	0	27	39	-1	41	55			01,02										Vb 17	CASSPGLAGAYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCAATTCTCCTTTGGGAGTGGGGGTTCACCCCTCCACTTTGGGAAC	CASSQFSFGSGGSPLHF	In	VDJ	2	137	5.900289415656009E-4	6.832508777529524E-4	51	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-06	01	5	6	1	9	18	0	27	39	-1	57	62			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSQFSFGSGGSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01		TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCACAGGGTACTCTAACTATGGCTACACCTTCGGTTCG	CASSTTGYSNYGYTF	In	VDJ	2	135	5.814153803748622E-4	6.732764123842962E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	3	0	2	4	27	40	48	42	52			01,02										Vb 17	CASSTTGYSNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCAGGGTAGGGTCGGATACGCAGTATTTTGGCCCA	CASSIRVGSDTQYF	In	VDJ	2	132	5.684950385887542E-4	6.583147143313119E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	3	6	0	8	27	-1	46	41	54			01,02										Vb 17	CASSIRVGSDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCGGGCCCGGTCCTATGGCTACACCTTCGGTTCG	CASSPRARSYGYTF	In	VDJ	2	131	5.641882579933848E-4	6.533274816469837E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	5	8	0	4	4	6	27	39	47	43	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPRARSYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGCAGAATGAAAAACTGTTTTTTGGCAGT	CASSMQNEKLFF	In	VDJ	2	127	5.469611356119073E-4	6.333785509096713E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	5	5	1	0	27	41	-1	42	45			01,02										Vb 17	CASSMQNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCGACACGCCATCCAAGAGACCCAGTACTTCGGGCCA	CASRHAIQETQYF	In	VDJ	2	121	5.211204520396913E-4	6.034551548037025E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	2	6	1	1	6	27	36	41	37	47			01,02										Vb 17	CASRHAIQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCACACAGGGAGGTCAGCTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	120	5.16813671444322E-4		44	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	7	3	3	6	4	8	27	37	47	41	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTCAGAATATCGGGGTGCGGACTATGGCTACACCTTCGGTTCG	CASSISEYRGADYGYTF	In	VDJ	2	118	5.082001102535833E-4	5.884934567507181E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	8	3	3	10	5	27	41	56	51	61			01,02										Vb 17	CASSISEYRGADYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTCGACGGACAGCAGAACACTGAAGCTTTCTTTGGACAA	CASSLDGQQNTEAFF	In	VDJ	2	115	4.952797684674751E-4	5.735317586977338E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	1	7	2	27	38	51	45	53			01,02										Vb 17	CASSLDGQQNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCGGACAGGGCGTGCTGAAGCTTTCTTTGGACAA	CASSTRTGRAEAFF	In	VDJ	2	112	4.823594266813671E-4	5.585700606447494E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	3	6	3	4	27	40	51	43	55			01,02										Vb 17	CASSTRTGRAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGCCAGGGGATCCTACAATGAGCAGTTCTTCGGGCCA	CASSMARGSYNEQFF	In	VDJ	2	110	4.7374586549062846E-4	5.485955952760932E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	2	1	3	1	27	41	50	44	51			01,02										Vb 17	CASSMARGSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGAGGGGGGGGCCCTGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	110	4.7374586549062846E-4		46	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	9	0	1	2	6	27	40	49	42	55			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGAAATCCTAGCGGGGAGGACCGGGGAGCTGTTTTTTGGAGAA	CASEILAGRTGELFF	In	VDJ	2	109	4.694390848952591E-4	5.436083625917651E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	8	4	3	5	6	3	27	36	51	42	54			01,02										Vb 17	CASEILAGRTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCAGGCAGAATTCACCCCTCCACTTTGGGAAC	CASTRQNSPLHF	In	VDJ	2	107	4.608255237045204E-4	5.336338972231088E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	4	4	7	1	3	27	37	42	38	45			01,02										Vb 17	CASTRQNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGATCGACAGGGACCAACTGAAGCTTTCTTTGGACAA	CASSDRQGPTEAFF	In	VDJ	2	105	4.522119625137817E-4	5.236594318544526E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	5	4	4	27	39	50	43	54			01,02										Vb 17	CASSDRQGPTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCTAATGCGGGACCAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPNAGPSNQPQHF	In	VDJ	2	105	4.522119625137817E-4	5.236594318544526E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	7	3	1	7	3	27	38	51	45	54			01,02										Vb 17	CASSPNAGPSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGCCCTGGACGGCCAGCCCCAGCATTTTGGTGAT	CASSIALDGQPQHF	In	VDJ	2	102	4.3929162072767365E-4	5.086977338014683E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	3	1	7	7	6	3	27	41	51	47	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIALDGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCGGTCTAACTATGGCTACACCTTCGGTTCG	CASSIRSNYGYTF	In	VDJ	1	99	4.263712789415656E-4	4.937360357484839E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	8	5	0	1	1	27	41	45	42	46			01,02			01,02							Vb 17	CASSIRSNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCACGGGGGGGACAGGGTGGATCCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	99	4.263712789415656E-4		49	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	6	7	6	27	38	54	45	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCGAGGGACACAGATACGCAGTATTTTGGCCCA	CASTPRDTDTQYF	In	VDJ	1	99	4.263712789415656E-4	4.937360357484839E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	11	0	2	4	1	27	37	46	41	47			01,02										Vb 17	CASTPRDTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATCCTAGCGGCTCTAGCACAGATACGCAGTATTTTGGCCCA	CASNPSGSSTDTQYF	In	VDJ	1	99	4.263712789415656E-4	4.937360357484839E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	4	5	0	3	4	27	37	47	40	51			01,02			01,02							Vb 17	CASNPSGSSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCTAGTAGTATGAGATACAGGGGGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	98	4.220644983461963E-4		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	1	0	5	0	27	41	-1	46	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGTGGCAGGATGGTTGGCTACACCTTCGGTTCG	CASSIGGRMVGYTF	In	VDJ	1	98	4.220644983461963E-4	4.887488030641558E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	4	7	4	5	27	43	51	47	56			01,02										Vb 17	CASSIGGRMVGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAACCACTGACGGGACCCTTAACAAATACGCAGTATTTTGGCCCA		Out	VDJ	1	97	4.177577177508269E-4		44	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	10	0	7	7	9	9	27	34	48	43	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGTAGGGAGTACAATGAGCAGTTCTTCGGGCCA	CASSIGREYNEQFF	In	VDJ	1	96	4.1345093715545756E-4	4.787743376954995E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	9	2	4	5	0	27	41	-1	46	51			01,02										Vb 17	CASSIGREYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGCAGGAGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSPQEGSGNTIYF	In	VDJ	1	93	4.005305953693495E-4	4.6381263964251514E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	10	0	0	5	0	27	39	-1	44	50			01,02										Vb 17	CASSPQEGSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01*02	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCTATCTCTGTGCCAGTAGTATAGGGCACTCCGTCCGGGACACCCCATCCTTTAATCAGCCCCAGCATTTTGGTGAT	CASSIGHSVRDTPSFNQPQHF	In	VDJ	1	92	3.9622381477398013E-4	4.5882540695818704E-4	63	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	0	6	4	12	11	8	24	42	36	53			01,02										Vb 17	CASSIGHSVRDTPSFNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAATGGGACGGACTGAAGCTTTCTTTGGACAA	CASSIMGRTEAFF	In	VDJ	1	92	3.9622381477398013E-4	4.5882540695818704E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	2	0	7	5	2	2	27	42	49	44	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIMGRTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGGACTCTGATGGGTCTGACACTGAAACTTTCTTTGGACAA	CASKDSDGSDTETFF	In	VDJ	1	92	3.9622381477398013E-4	4.5882540695818704E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	1	10	12	1	21	27	37	43	38	64			01,02			01,02							Vb 17	CASKDSDGSDTETFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCCGACAGGTGAACACTGAAGCTTTCTTTGGACAA	CASSLRQVNTEAFF	In	VDJ	1	91	3.919170341786108E-4	4.5383817427385894E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	4	0	4	0	27	39	-1	43	49			01,02										Vb 17	CASSLRQVNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCGGGACAGGGGAACTGAAGCTTTCTTTGGACAA	CASSIRDRGTEAFF	In	VDJ	1	89	3.833034729878721E-4	4.438637089052027E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	2	5	2	1	27	41	53	43	54			01,02										Vb 17	CASSIRDRGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTTCCGATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	88	3.7899669239250275E-4		37	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	8	2	8	0	4	0	27	36	-1	40	42			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCCGGGACAGAGGGGACGAGCAGTACGTCGGGCCG	CASSLRDRGDEQYV	In	VDJ	1	86	3.7038313120176403E-4	4.289020108522183E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	17	4	17	27	39	50	43	67			01,02										Vb 17	CASSLRDRGDEQYV+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCCGGGACAGCCTATGGCTACACCTTCGGTTCG	CASTPGTAYGYTF	In	VDJ	1	86	3.7038313120176403E-4	4.289020108522183E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	5	4	5	1	27	37	49	42	50			01,02										Vb 17	CASTPGTAYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGACTAGCGGGGGTTAGAGAGACCCAGTACTTCGGGCCA	CASSRLAGVRETQYF	In	VDJ	1	85	3.6607635060639473E-4	4.239147781678902E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	2	2	4	1	4	27	39	52	40	56			01,02										Vb 17	CASSRLAGVRETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCGTTTCGACAGAGACCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	85	3.6607635060639473E-4		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	2	5	17	7	19	27	35	47	42	66			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGCTTTCTATCTCTGTGCCAGTACCCCAACGCCCCTAGCGGGGGGGCTAATATTCACAGATACGCAGTATTTTGGCCCA	CASTPTPLAGGLIFTDTQYF	In	VDJ	1	84	3.6176957001102537E-4	4.1892754548356206E-4	60	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	4	0	2	11	8	14	24	47	35	55			01,02										Vb 17	CASTPTPLAGGLIFTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCCGATAAAGGGACAGCCCCAGCATTTTGGTGAT	CASSTPIKGQPQHF	In	VDJ	1	84	3.6176957001102537E-4	4.1892754548356206E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	4	0	8	7	10	0	27	40	-1	50	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTPIKGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCAGGGACAGGACAATGAGCAGTTCTTCGGGCCA	CASQGQDNEQFF	In	VDJ	1	83	3.57462789415656E-4	4.1394031279923395E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	4	5	2	0	27	36	-1	38	46			01,02										Vb 17	CASQGQDNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAGGGGTGAATCAGCCCCAGCATTTTGGTGAT	CASSTGVNQPQHF	In	VDJ	1	83	3.57462789415656E-4	4.1394031279923395E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	2	4	0	2	27	-1	46	40	48			01,02										Vb 17	CASSTGVNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGAAGAGGGTCAGATACGCAGTATTTTGGCCCA	CASSRRGSDTQYF	In	VDJ	1	82	3.5315600882028666E-4	4.0895308011490585E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	11	0	4	4	1	27	39	48	43	49			01,02										Vb 17	CASSRRGSDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCGGGACTAGCGGGGGGACTACGAGCAGTACTTCGGGCCG	CASSTRD*RGDYEQYF	Stop	VDJ	1	82	3.5315600882028666E-4		48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	0	1	3	3	1	27	40	58	43	59			01,02										Vb 17	CASSTRD*RGDYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCAAGGGGCACACAGATACGCAGTATTTTGGCCCA	CASTKGHTDTQYF	In	VDJ	1	81	3.488492282249173E-4	4.039658474305777E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	5	2	2	3	2	27	37	45	40	47			01,02										Vb 17	CASTKGHTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGGGGGGGCCTGTCCGGTAATGAAAAACTGTTTTTTGGCAGT	CASSRGGLSGNEKLFF	In	VDJ	1	79	3.4023566703417864E-4	3.939913820619215E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	8	0	4	0	9	27	-1	47	39	56			01,02										Vb 17	CASSRGGLSGNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTGACGCTAGCGGGGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSLTLAGGYNEQFF	In	VDJ	1	78	3.359288864388093E-4	3.8900414937759333E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	0	4	6	0	27	39	-1	45	57			01,02										Vb 17	CASSLTLAGGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGCAGACAGGGGGCCCAAGCACTGAAGCTTTCTTTGGACAA	CASSRQTGGPSTEAFF	In	VDJ	1	77	3.316221058434399E-4	3.8401691669326523E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	0	4	4	5	27	40	54	44	59			01,02										Vb 17	CASSRQTGGPSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCGGGACAGGGGGATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	77	3.316221058434399E-4		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	1	0	3	1	27	38	52	41	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCGGGACAGGTTCCTCTATGGCTACACCTTCGGTTCG	CASSTRDRFLYGYTF	In	VDJ	1	74	3.1870176405733185E-4	3.6905521864028087E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	4	4	3	5	27	40	51	43	56			01,02										Vb 17	CASSTRDRFLYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCCCACAGGAGGATTAATGAAAAAACTGTTTTTTGGCAGT	CASRPTGGLMKKLFF	In	VDJ	1	74	3.1870176405733185E-4	3.6905521864028087E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	6	3	4	9	4	11	27	38	47	42	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRPTGGLMKKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGACCAGGGAGGGATGCCTGAAGCTTTCTTTGGACAA	CASRDQGGMPEAFF	In	VDJ	1	72	3.100882028665932E-4	3.5908075327162467E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	0	6	6	4	27	38	51	44	55			01,02										Vb 17	CASRDQGGMPEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCTCCAAGGAGACAGACAAAAACATTCAGTACTTCGGCGCC	CASKETDKNIQYF	In	VDJ	1	70	3.0147464167585447E-4	3.491062879029684E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	11	2	5	3	8	1	27	33	46	41	47			01,02										Vb 17	CASKETDKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCTCTAGCAGGTTCGAATTCACCCCTCCACTTTGGGAAC	CASTPLAGSNSPLHF	In	VDJ	1	69	2.971678610804851E-4	3.441190552186403E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	7	4	7	7	5	7	27	37	47	42	54			01,02			01,02							Vb 17	CASTPLAGSNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD02-01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGGGGACAGCTAACTATGGCTACACCTTCGGTTCG	CASSGGTANYGYTF	In	VDJ	1	68	2.9286108048511575E-4	3.3913182253431215E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	0	3	0	27	39	-1	42	49			01,02										Vb 17	CASSGGTANYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCAGACAGGGGGATACACCTTCGGTTCG	CASSIDQTGGYTF	In	VDJ	1	68	2.9286108048511575E-4	3.3913182253431215E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	1	11	3	1	27	44	56	47	57			01,02										Vb 17	CASSIDQTGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCGATTTGTTGGGAGAAAGGGGAAACTGTTTTTTGGCAGT	CASSTRFVGRKGKLFF	In	VDJ	1	67	2.885542998897464E-4	3.3414458984998405E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	4	5	2	11	18	0	27	40	-1	58	63			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTRFVGRKGKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTAAGGTCGAAAGGCCATTCCCTACGAGCAGTACTTCGGGCCG	CAS*GRKAIPYEQYF	Stop	VDJ	1	66	2.842475192943771E-4		45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	8	5	4	2	2	14	27	36	41	38	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CAS*GRKAIPYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGACAAGGGACAGGGGGATGGAAACACCATATATTTTGGAGAG	CASSDKGQGDGNTIYF	In	VDJ	1	66	2.842475192943771E-4	3.2915735716565594E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	1	3	5	1	27	39	55	44	56			01,02										Vb 17	CASSDKGQGDGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGTCCGGGACAGTCAAGTTCTCTGGAAACACCATATATTTTGGAGAG	CASSIGSGTVKFSGNTIYF	In	VDJ	1	64	2.756339581036384E-4	3.191828917969997E-4	57	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	5	0	7	7	24	38	52	45	59			01,02										Vb 17	CASSIGSGTVKFSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACCAGGGACAGATAACTATGGCTACACCTTCGGTTCG	CASSIPGTDNYGYTF	In	VDJ	1	63	2.71327177508269E-4	3.141956591126716E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	5	1	3	1	27	42	52	45	53			01,02										Vb 17	CASSIPGTDNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACAGAGGGGGGATGGCTACACCTTCGGTTCG	CASSIQRGDGYTF	In	VDJ	1	63	2.71327177508269E-4	3.141956591126716E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	2	5	1	6	3	1	27	42	51	45	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIQRGDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCCCGGGACCGTCAATGAGCAGTTCTTCGGGCCA	CASSTPGTVNEQFF	In	VDJ	1	63	2.71327177508269E-4	3.141956591126716E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	4	0	7	6	5	3	27	40	50	45	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTPGTVNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTACAGGGGTTTCATGGCTACACCTTCGGTTCG	CASSLQGFHGYTF	In	VDJ	1	61	2.627136163175303E-4	3.042211937440153E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	2	6	2	4	27	39	48	41	52			01,02										Vb 17	CASSLQGFHGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGATTCTTGGGAGACCCAGTACTTCGGGCCA	CASSDSWETQYF	In	VDJ	1	61	2.627136163175303E-4	3.042211937440153E-4	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	5	0	10	5	7	0	27	39	-1	46	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSDSWETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCACCGGGGGGACGGGGTGGTTCAATGAGCAGTTCTTCGGGCCA	CASSTGGTGWFNEQFF	In	VDJ	1	61	2.627136163175303E-4	3.042211937440153E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	1	6	3	11	27	38	48	41	59			01,02										Vb 17	CASSTGGTGWFNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAAGGAAGGGGACCTAGATCGAACAATGAGCAGTTCTTCGGGCCA	CASKGRGPRSNNEQFF	In	VDJ	1	61	2.627136163175303E-4	3.042211937440153E-4	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	7	0	7	5	7	9	27	37	49	44	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASKGRGPRSNNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCCCTTGCTTGGGGAAACTGAAGCTTTCTTTGGACAA	CASSTPLLGETEAFF	In	VDJ	1	59	2.5410005512679164E-4	2.9424672837535907E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	4	0	8	5	12	1	27	40	56	52	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTPLLGETEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCTAGCGGGGGGGTCCGATGAGCAGTTCTTCGGGCCA	CASSPLAGGSDEQFF	In	VDJ	1	57	2.454864939360529E-4	2.8427226300670286E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	0	8	3	4	27	39	54	42	58			01,02										Vb 17	CASSPLAGGSDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTGGAGGGGGCTAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSIWRGLTNTGELFF	In	VDJ	1	56	2.4117971334068356E-4	2.792850303223747E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	5	0	0	4	3	27	41	52	45	55			01,02										Vb 17	CASSIWRGLTNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGCCCGGGACAGGGACTACGAGCAGTACTTCGGGCCG	CASRARDRDYEQYF	In	VDJ	1	56	2.4117971334068356E-4	2.792850303223747E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	3	5	1	27	38	52	43	53			01,02										Vb 17	CASRARDRDYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCTTGGGTCTCACTATGGCTACACCTTCGGTTCG	CASSIDLGSHYGYTF	In	VDJ	1	54	2.3256615214994487E-4	2.693105649537185E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	0	0	9	3	4	4	27	44	51	48	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIDLGSHYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCACCCCTAGTCTAGATACGCAGTATTTTGGCCCA	CASSTPSLDTQYF	In	VDJ	1	53	2.2825937155457552E-4	2.6432333226939034E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	8	5	5	3	27	38	47	43	50			01,02			01,02							Vb 17	CASSTPSLDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCTTAGACAGGGGAATGGACTATGGCTACACCTTCGGTTCG	CASTLDRGMDYGYTF	In	VDJ	1	51	2.1964581036383683E-4	2.5434886690073414E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	2	3	5	5	27	37	50	42	55			01,02										Vb 17	CASTLDRGMDYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTTGAAGGGAACTGAAGCTTTCTTTGGACAA	CASLKGTEAFF	In	VDJ	1	49	2.1103224917309814E-4	2.443744015320779E-4	33	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	8	0	8	5	5	0	27	36	-1	41	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASLKGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGCCGGGACACTTACTCTGGAAACACCATATATTTTGGAGAG	CASSGRDTYSGNTIYF	In	VDJ	1	48	2.0672546857772878E-4	2.3938716884774975E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	6	0	4	4	27	39	49	43	53			01,02										Vb 17	CASSGRDTYSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCGGACAGGCGTCCATGAACACTGAAGCTTTCTTTGGACAA	CASSIGGQASMNTEAFF	In	VDJ	1	48	2.0672546857772878E-4	2.3938716884774975E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	4	0	2	6	27	43	52	45	58			01,02										Vb 17	CASSIGGQASMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGAGGGACAACTCGTATCCCTGAAGCTTTCTTTGGACAA	CASSIGGTTRIPEAFF	In	VDJ	1	48	2.0672546857772878E-4	2.3938716884774975E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	6	6	2	10	27	43	51	45	61			01,02										Vb 17	CASSIGGTTRIPEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCAGACAGGCGAGTACTAATTCACCCCTCCACTTTGGGAAC	CATRQASTNSPLHF	In	VDJ	1	47	2.0241868798235942E-4	2.3439993616342165E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	10	2	4	6	3	7	27	34	43	37	50			01,02										Vb 17	CATRQASTNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAAAGCTTACTGGCCCCAGCATTTTGGTGAT	CASSIKAYWPQHF	In	VDJ	1	46	1.9811190738699006E-4	2.2941270347909352E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	3	10	9	8	1	27	41	52	49	53			01,02			01,02							Vb 17	CASSIKAYWPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCATCGGCCCCTGACAGGGATCAGTTGGCTACACCTTCGGTTCG	CASSIGP*QGSVGYTF	Stop	VDJ	1	46	1.9811190738699006E-4		48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	7	11	6	27	38	56	49	62			01,02										Vb 17	CASSIGP*QGSVGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCAGGGACAGGCAGAATCAGCCCCAGCATTTTGGTGAT	CASTRDRQNQPQHF	In	VDJ	1	46	1.9811190738699006E-4	2.2941270347909352E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	0	4	4	3	3	27	37	48	40	51			01,02										Vb 17	CASTRDRQNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTCGGGACAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSVGTATNEKLFF	In	VDJ	1	45	1.9380512679162073E-4	2.244254707947654E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	5	0	3	0	27	39	-1	42	49			01,02										Vb 17	CASSVGTATNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGGGACAGGTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	45	1.9380512679162073E-4		40	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	4	17	1	16	27	40	49	41	65			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGAGGGGGGCCTCTATGGCTACACCTTCGGTTCG	CASREGGLYGYTF	In	VDJ	1	44	1.8949834619625137E-4	2.194382381104373E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	6	5	1	4	2	4	27	38	46	40	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASREGGLYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTTACCGGGACAGGGGGCTACTATGGCTACACCTTCGGTTCG	CASSFTGTGGYYGYTF	In	VDJ	1	40	1.7227122381477397E-4	1.994893073731248E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	0	3	6	1	27	39	57	45	58			01,02										Vb 17	CASSFTGTGGYYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGGGGGCGGTTCGATACGCAGTATTTTGGCCCA	CASSMRGRFDTQYF	In	VDJ	1	38	1.6365766262403528E-4	1.8951484200446856E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	5	0	6	1	5	27	41	49	42	54			01,02										Vb 17	CASSMRGRFDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCTGGGATCCTCGGGAACACTGAAGCTTTCTTTGGACAA	CASSPGILGNTEAFF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	6	0	8	1	4	7	27	38	46	42	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPGILGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCGGGGACAGATACACTTATGCGAACGCCGGGGAGCTGTTTTTTGGAGAA	CASTGDRYTYANAGELFF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	0	5	6	3	17	27	37	47	40	64			01,02										Vb 17	CASTGDRYTYANAGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTCCAGCCTAGGGATTCAGTACTTCGGCGCC	CASSMSSLGIQYF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-04	01	3	5	3	10	9	0	27	41	-1	50	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMSSLGIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01		TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGGGAAGGGCGGGTCGCTATGGCTACACCTTCGGTTCG	CASKGRAGRYGYTF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	7	7	4	4	8	3	27	37	50	45	53			01,02			01,02							Vb 17	CASKGRAGRYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGAGGGTCCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSIRGSGTGELFF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	11	0	4	1	5	27	42	48	43	53			01,02										Vb 17	CASSIRGSGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAATTCGCCGGCAGGGGACAGCGGGGAGCTGTTTTTTGGAGAA	CASSINSPAGDSGELFF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	0	5	7	13	0	27	42	-1	55	62			01,02										Vb 17	CASSINSPAGDSGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGCAAGCCACGTTTGGTGCCAAAAGAACCCGACAGCTTCTATCTCTGTGCCAGTAGAACTCAGGGAACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	31	1.3351019845644983E-4		35	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	25	4	3	5	22	1	46	38	65	60	66			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCTCCTATGGCTACACCTTCGGTTCG	CASSFSYGYTF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	4	10	4	2	1	27	39	43	41	44			01,02			01,02							Vb 17	CASSFSYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAAACAGGGAACCTGAAGCTTTCTTTGGACAA	CASSTNREPEAFF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	6	3	3	27	40	49	43	52			01,02										Vb 17	CASSTNREPEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCTCAGGGAACAGCCAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	28	1.2058985667034178E-4		47	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	7	4	3	0	3	7	27	37	45	40	52			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAAGCTACGGGACAGGAAAGATTTGGAACCTTCGGTTCG	CASSKATGQERFGTF	In	VDJ	1	27	1.1628307607497244E-4	1.3465528247685925E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	4	14	7	11	27	40	55	47	66			01,02										Vb 17	CASSKATGQERFGTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCAACGGACAGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSNGQGNQPQHF	In	VDJ	1	27	1.1628307607497244E-4	1.3465528247685925E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	4	2	4	0	27	38	-1	42	49			01,02										Vb 17	CASSNGQGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGAATGGACGGCCTTTCTGACGAGCAGTACTTCGGGCCG	CASSRMDGLSDEQYF	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	4	1	7	5	4	10	27	40	48	44	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSRMDGLSDEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGTCCACCGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	24	1.0336273428886439E-4		44	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	1	0	9	3	0	7	27	-1	46	43	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACCGACGGTTTCTAATGAAAAACTGTTTTTTGGCAGT	CASSIPTVSNEKLFF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	2	2	7	3	2	5	27	42	47	44	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIPTVSNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGACATAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSRHNSNQPQHF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	6	0	2	3	27	38	44	40	47			01,02										Vb 17	CASSRHNSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGGGGAGGTCCGAGAGAGACCCAGTACTTCGGGCCA	CASSIGGGPRETQYF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	9	1	4	3	6	27	41	50	44	56			01,02										Vb 17	CASSIGGGPRETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATGAGGACGGCGGGGGGCCCGCCAATGAGCAGTTCTTCGGGCCA	CASSIDEDGGGPANEQFF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	7	1	6	8	5	27	44	60	52	65			01,02										Vb 17	CASSIDEDGGGPANEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCAAGCAAGAGGTCCTCCACTGAAGCTTTCTTTGGACAA	CASKRSSTEAFF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	12	11	1	4	6	5	27	32	42	38	47			01,02										Vb 17	CASKRSSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCTAGTATCTCAACCCCGAACACTGAAGCTTTCTTTGGACAA	CASISTPNTEAFF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	7	3	7	1	5	3	27	37	44	42	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASISTPNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGTCCCCGCGGGATTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	21	9.044239250275634E-5		47	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	7	3	0	7	1	27	40	53	47	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGATTGTGGGGTGGGGACTATGGCTACACCTTCGGTTCG	CASSRLWGGDYGYTF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	6	6	2	3	8	5	27	38	50	46	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSRLWGGDYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTTACAGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLTGAGELFF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	2	6	4	0	27	38	-1	42	49			01,02										Vb 17	CASSLTGAGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCACGTCGGGGGGTACCAGCTTGGGCTACACCTTCGGTTCG	CASTSGGTSLGYTF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	9	8	1	8	5	10	27	35	47	40	57			01,02										Vb 17	CASTSGGTSLGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATAAACAGGGATTGAACACTGAAGCTTTCTTTGGACAA	CASNKQGLNTEAFF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	3	0	4	2	27	37	47	41	49			01,02										Vb 17	CASNKQGLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGACACTCGGAGGACCGGGGAGCTGTTTTTGGAGAA		Out	VDJ	1	18	7.75220507166483E-5		44	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	3	1	6	18	0	20	27	-1	46	41	66			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGTAGGTCGAGAGACCCAGTACTTCGGGCCA	CASSVGRETQYF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	6	5	4	4	3	3	27	38	44	41	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSVGRETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAACGGGATCCACCGGGGAGCTGTTTTTTGGAGAA	CASSETGSTGELFF	In	VDJ	1	99	4.263712789415656E-4	4.937360357484839E-4	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	8	3	4	1	2	23	38	44	39	46													Vb 11	CASSETGSTGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAGGAGGTTATCGCCGAGCAGTACGTCGGGCCG	CASSEEVIAEQYV	In	VDJ	1	90	3.8761025358324147E-4	4.488509415895308E-4	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	1	17	0	18	23	-1	42	37	60													Vb 11	CASSEEVIAEQYV+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCTGACGGGAGGCGGGAYACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	65	2.7994073869900773E-4		40	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	8	8	1	5	3	6	23	32	42	35	48													Vb 11	X+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACACGGGGGGAGACTCCCCTAGGAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	41	1.7657800441014333E-4		55	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	8	1	2	2	14	23	37	46	39	60													Vb 11	X+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD02-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAACCAAGGGGGACGAGCAGTACTTCGGGCCG	CASSETKGDEQYF	In	VDJ	1	41	1.7657800441014333E-4	2.0447654005745293E-4	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	5	1	5	4	0	23	38	-1	42	48													Vb 11	CASSETKGDEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATATTACTTGGGGACAGCCTACAATGAGCAGTTCTTCGGGCCA	CASSEYYLGTAYNEQFF	In	VDJ	1	38	1.6365766262403528E-4	1.8951484200446856E-4	51	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	5	2	7	0	23	40	-1	47	54													Vb 11	CASSEYYLGTAYNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAAGGCGGGGACAGTTGAAGCTTTCTTTGGACAA	CASKAGTVEAFF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	36	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	5	7	5	1	23	33	45	38	46													Vb 11	CASKAGTVEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCAATGTCTTCGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSNVFGGNTEAFF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	45	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	2	1	9	0	23	34	-1	43	49													Vb 11	CASSNVFGGNTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD02-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCTCGAACCCACCGGGGAGCTGTTTTTTGGAGAA	CASSLEPTGELFF	In	VDJ	2	117	5.038933296582139E-4	5.8350622406639E-4	39	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-02	01	4	2	8	4	2	3	23	36	40	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSLEPTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01		TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCGTACGAACCTCAATGAACACTGAAGCTTTCTTTGGACAA	CASSVRTSMNTEAFF	In	VDJ	1	82	3.5315600882028666E-4	4.0895308011490585E-4	45	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-01	01	5	2	8	0	4	7	23	35	41	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSVRTSMNTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAAGGCAGGGACACTGAAGCTTTCTTTGGACAA	CASSQEGRDTEAFF	In	VDJ	1	62	2.6702039691289966E-4	3.092084264283434E-4	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	3	3	3	0	23	40	-1	43	48													Vb 7.1	CASSQEGRDTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGTCCACCACCCCGGGACAGGGAAGAGGAACGGCTATACCTTCGGTTCG	CASSQVHHPGTGKRNGYTF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	57	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	3	14	11	15	23	39	59	50	74													Vb 7.1	CASSQVHHPGTGKRNGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCGCCCAGGGGACAGTAGGTATGGCTACACCTTCGGTTCG	CASSRPGDSRYGYTF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	5	5	6	4	23	36	49	42	53													Vb 7.1	CASSRPGDSRYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCATGGGACAGGGAGCATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	32	1.378169790518192E-4		44	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	0	3	8	1	3	23	37	47	38	50													Vb 7.1	X+TCRBV04-01+TCRBJ01-06	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGGGGGCCTACAAGGGGATAGCAATCAGCCCCAGCATTTTGGTGAT	XASSQGGLQGDSNQPQHF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	54	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	5	2	0	10	1	22	38	53	48	54													Vb 7.1	XASSQGGLQGDSNQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCATTGACTGTGGGTAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	24	1.0336273428886439E-4		43	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	2	10	3	2	6	23	37	43	39	49						01,02							Vb 7.1	X+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGCCGAAGTAACAGGACAGAGAGTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	33	2211	0.009522291896361631		56	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	1	5	1	11	4	25	36	53	47	57			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-06	TCRBV10-01	TCRBD01-01*01	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCGGGGAGGGGAAGCACTGAAGCTTTCTTTGGACAA	CASSESGRGSTEAFF	In	VDJ	2	140	6.029492833517089E-4	6.982125758059368E-4	45	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	9	0	4	1	4	26	43	51	44	55			01,02										Vb 12	CASSESGRGSTEAFF+TCRBV10-01+TCRBJ01-01	TCRBV10-01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCGCTCTTTCGAGACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	123	5.2973401323043E-4		35	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	8	11	2	5	8	0	26	35	-1	43	46			01,02										Vb 12	X+TCRBV10-01+TCRBJ01-01	TCRBV10-01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCGGGACAGGGAGACGAGCAGTACTTCGGGCCG	CASSESGQGDEQYF	In	VDJ	1	90	3.8761025358324147E-4	4.488509415895308E-4	42	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	3	5	0	2	26	-1	52	43	54			01,02										Vb 12	CASSESGQGDEQYF+TCRBV10-01+TCRBJ02-07	TCRBV10-01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGCAGACGGGACGGGGGAATGAAAAACTGTTTTTTGGCAGT	CASSEQTGRGNEKLFF	In	VDJ	1	81	3.488492282249173E-4	4.039658474305777E-4	48	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	2	8	2	5	9	0	26	41	-1	50	56			01,02										Vb 12	CASSEQTGRGNEKLFF+TCRBV10-01+TCRBJ01-04	TCRBV10-01	TCRBD02-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCGGGGGCAGGGGAGGCCACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	73	3.143949834619625E-4		52	TCRBV10	TCRBV10-01					TCRBJ02	TCRBJ02-05	01	0	4	2	2	5	6	26	43	54	48	60			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-01+TCRBJ02-05	TCRBV10-01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGGTCCCAGTCGGGAGGAACCCTCCACTTTGGGAAC	CASRSQSGGTLHF	In	VDJ	1	60	2.58406835722161E-4	2.992339610596872E-4	39	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	6	8	1	14	8	2	26	37	52	45	54			01,02										Vb 12	CASRSQSGGTLHF+TCRBV10-01+TCRBJ01-06	TCRBV10-01	TCRBD02-01*02	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGGCGGCAGTACAGTAACTGAAGCTTTCTTTGGACAA	CASSGGSTVTEAFF	In	VDJ	1	50	2.1533902976846747E-4	2.49361634216406E-4	42	TCRBV10	TCRBV10-01					TCRBJ01	TCRBJ01-01	01	4	3	5	5	8	2	26	39	51	47	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSGGSTVTEAFF+TCRBV10-01+TCRBJ01-01	TCRBV10-01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGATTTACTAGCGGGGGGCCCCGACGAGCAGTACTTCGGGCCG	CASSDLLAGGPDEQYF	In	VDJ	1	46	1.9811190738699006E-4	2.2941270347909352E-4	48	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	3	1	5	3	5	26	40	55	43	60			01,02										Vb 12	CASSDLLAGGPDEQYF+TCRBV10-01+TCRBJ02-07	TCRBV10-01	TCRBD02-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCGGGGTCGGGCGATGAGCAGTTCTTCGGGCCA	CASSESGSGDEQFF	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	42	TCRBV10	TCRBV10-01					TCRBJ02	TCRBJ02-01	01	0	6	2	8	0	7	26	-1	47	43	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESGSGDEQFF+TCRBV10-01+TCRBJ02-01	TCRBV10-01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTTACGTGAAAAACTGTTTTTTGGCAGT	CASSELREKLFF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	36	TCRBV10	TCRBV10-01					TCRBJ01	TCRBJ01-04	01	1	3	7	7	1	1	26	42	45	43	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSELREKLFF+TCRBV10-01+TCRBJ01-04	TCRBV10-01		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTTTTACCGGACAGGGGCCCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	145	6.244831863285557E-4		56	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	1	2	0	4	3	22	37	50	41	53														X+TCRBV12-01+TCRBJ02-06	TCRBV12-01*01	TCRBD01-01*01	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCCTCTCAAGGGGGACGAGCAGTACGTCGGGCCG		Out	VDJ	1	58	2.497932745314223E-4		38	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	5	1	17	6	12	22	34	46	40	58														X+TCRBV12-01+TCRBJ02-07	TCRBV12-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGTTGCCCCTAGACAGGGCCCGAGGGAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	49	2.1103224917309814E-4		53	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	2	3	7	9	8	22	33	49	42	57														X+TCRBV12-01+TCRBJ01-06	TCRBV12-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTAGCAGGGATGAACACTGAAGCTTTCTTTGGACAA	CATSRVAGMNTEAFF	In	VDJ	3	223	9.60412072767365E-4	0.0011121528886051707	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	0	3	1	18	34	42	37	43														CATSRVAGMNTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTCTGAGGGGGGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CATSRV*GGSSYNSPLHF	Stop	VDJ	3	195	8.398222160970231E-4		54	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-06	01	1	5	1	0	4	3	18	34	44	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRV*GGSSYNSPLHF+TCRBV15-01+TCRBJ01-06	TCRBV15-01*01		TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGCCCGGGACAGAGGAACACCCGGGGAGCTGTTTTTTGGAGAA	CATSARDRGTPGELFF	In	VDJ	3	184	7.924476295479603E-4	9.176508139163741E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	5	6	4	8	18	30	41	34	49														CATSARDRGTPGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGCCAGGGACTAACACTGAAGCTTTCTTTGGACAA	CATSREPGTNTEAFF	In	VDJ	1	97	4.177577177508269E-4	4.8376157037982766E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	0	10	2	4	0	18	35	-1	39	45						01,02								CATSREPGTNTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD02-01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGAAGCGGGGGGGTTTAGGGGCAATCAGCCCCAGCATTTTGGTGAT	CATSREAGGFRGNQPQHF	In	VDJ	1	88	3.7899669239250275E-4	4.388764762208746E-4	54	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	6	0	2	3	7	18	32	45	35	52														CATSREAGGFRGNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD02-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTATGGGACACGGCTATGGCTACACCTTCGGTTCG	CATSSMGHGYGYTF	In	VDJ	1	80	3.4454244762954794E-4	3.989786147462496E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	6	4	3	3	18	32	41	35	44														CATSSMGHGYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCCGGGGGTCTTTTTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	59	2.5410005512679164E-4		50	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	0	8	2	3	2	6	18	35	43	37	49														X+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01	TCRBD02-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGGTGGGGGAGGAACTGAAGCTTTCTTTGGACAA	CATSRDGGGGTEAFF	In	VDJ	1	43	1.8519156560088202E-4	2.1445100542610916E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	9	1	5	6	1	18	35	47	41	48														CATSRDGGGGTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACAGGGGGGACTACAATGAGCAGTTCTTCGGGCCA	CATSRDRGDYNEQFF	In	VDJ	1	43	1.8519156560088202E-4	2.1445100542610916E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	1	3	0	2	18	-1	42	35	44														CATSRDRGDYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGGGCGGCCAATCAGCCCCAGCATTTTGGTGAT	CATSRDRAANQPQHF	In	VDJ	1	38	1.6365766262403528E-4	1.8951484200446856E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-05	01	0	8	0	3	2	3	18	35	41	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDRAANQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGATTTCCCGGGACAAGGAATCCTCGGGGTAACATTCAGTACTTCGGCGCC	CATSRFPGTRNPRGNIQYF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	57	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	2	0	6	7	6	15	18	33	45	39	60														CATSRFPGTRNPRGNIQYF+TCRBV15-01+TCRBJ02-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACGCAGCCATGTACCTGTGTGCCACCAGGTGGGACAGGGCCCCCATCGGAGGCTACACCTTCGGTTCG	CATRWDRAPIGGYTF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	8	2	11	18	29	40	31	51														CATRWDRAPIGGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGACAGTGAGCACAGATACGCAGTATTTTGGCCCA	CATSRTVSTDTQYF	In	VDJ	1	30	1.292034178610805E-4	1.496169805298436E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	2	5	0	0	2	18	-1	37	32	39														CATSRTVSTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAACGGGACAGGGGTCTGCTGACTATGGCTACACCTTCGGTTCG	CATSRTGQGSADYGYTF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	2	3	2	7	18	33	45	35	52														CATSRTGQGSADYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGGGGGGAGTACTGAAGCTTTCTTTGGACAA	CASSLGGSTEAFF	In	VDJ	4	269	0.001158523980154355	0.0013415655920842643	39	TCRBV07	TCRBV07-02	01				TCRBJ01	TCRBJ01-01	01	1	6	1	5	0	3	18	-1	39	34	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGSTEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATCTCTGTGCCAGCACCCCGGGGGGGGCCCGTGAAGCTTTCTTTGGACAA	CASTPGGAREAFF	In	VDJ	2	110	4.7374586549062846E-4	5.485955952760932E-4	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	0	7	3	5	18	28	39	31	44														CASTPGGAREAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD02-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCCAGGGGCAGCCTACGAGCAGTACGTCGGGCCG	CASSPGAAYEQYV	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	2	17	1	18	18	30	37	31	55														CASSPGAAYEQYV+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATCTCTGTGCCAGCGGGCGGGGCAGGCAAGAGACCCAGTACTTCGGGCCA	CASGRGRQETQYF	In	VDJ	1	30	1.292034178610805E-4	1.496169805298436E-4	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	8	7	3	2	2	4	18	27	35	29	39														CASGRGRQETQYF+TCRBV07-02+TCRBJ02-05	TCRBV07-02*01	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTACCCGCAAGGAATGAGCAGTTCTTCGGGCCA	CASSLPARNEQFF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	39	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-01	01	2	5	4	7	6	0	18	33	-1	39	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLPARNEQFF+TCRBV07-02+TCRBJ02-01	TCRBV07-02*01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCATGACTACTACAGATACGCAGTATTTTGGCCCA	CASSMTTTDTQYF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	9	3	2	2	18	30	37	32	39						01,02								CASSMTTTDTQYF+TCRBV07-02+TCRBJ02-03	TCRBV07-02*01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCGAGAGGACAGCCCAGCCCCAGCATTTTGGTGAT	CASSERTAQPQHF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	5	7	4	2	18	30	40	34	42														CASSERTAQPQHF+TCRBV07-02+TCRBJ01-05	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGACAGGGGGCTTATGGCTACACCTTCGGTTCG	CASSFGQGAYGYTF	In	VDJ	66	4428	0.01907042447629548	0.022083466326204917	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	0	5	1	1	18	32	44	33	45														CASSFGQGAYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTGTTGAGTCAGGCGGCTGAAGCTTTCTTTGGACAA	CASSLVLSQAAEAFF	In	VDJ	41	2739	0.011796272050716648	0.01366003032237472	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	4	4	6	10	3	18	32	46	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVLSQAAEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGAACGGGGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSLGTGSSYNSPLHF	In	VDJ	15	1027	0.004423063671444322	0.005121887966804979	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	3	8	3	0	5	2	18	32	42	37	44						01,02								CASSLGTGSSYNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD02-01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGGGGAGGTGGCTGTGCTCAATCAGCCCCAGCATTTTGGTGAT	CASSSGEVAVLNQPQHF	In	VDJ	14	922	0.00397085170893054	0.004598228534950527	51	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	4	4	2	3	0	13	18	-1	37	31	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGEVAVLNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCGGTTAACTCAAAGGGGGGAGACCCAGTACTTCGGGCCA	CASSLRLTQRGETQYF	In	VDJ	12	781	0.003363595644983462	0.0038950287264602618	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	5	1	5	13	0	18	32	-1	45	51														CASSLRLTQRGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGGGACAGGGTTTGAAGCTTTCTTTGGACAA	CASSLEGTGFEAFF	In	VDJ	7	502	0.0021620038588754135	0.0025035908075327165	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	3	7	1	2	18	35	45	36	47														CASSLEGTGFEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGGACAGGGGGCAGATGGCTACACCTTCGGTTCG	CASSWGQGADGYTF	In	VDJ	6	415	0.00178731394707828	0.00206970156399617	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	0	6	1	2	18	31	44	32	46														CASSWGQGADGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTGGACAGGGTGAATTCTCTGGAAACACCATATATTTTGGAGAG	CASSGQGEFSGNTIYF	In	VDJ	6	409	0.001761473263506064	0.002039778167890201	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	3	0	1	6	18	29	38	30	44														CASSGQGEFSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGRACCGGGACAGGGAACTATGGCTACACCTTCGGTTCG	CASRTGTGNYGYTF	In	VDJ	6	399	0.0017184054575523704	0.0019899058410469198	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	2	4	0	18	29	-1	33	42														CASRTGTGNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACTCCCCGGGGGCGTCACAATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	5	360	0.0015504410143329659		49	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	7	6	0	0	6	7	18	28	40	34	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCGGGCGGGGGAGTCCTACGAGCAGTACTTCGGGCCG	CASSFRAGESYEQYF	In	VDJ	5	336	0.0014470782800441015	0.0016757101819342482	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	7	2	1	4	2	18	32	43	36	45														CASSFRAGESYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGACAGAGAGTTATGGAAGGGCTACACCTTCGGTTCG	CASSWDRELWKGYTF	In	VDJ	5	336	0.0014470782800441015	0.0016757101819342482	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	5	8	0	13	18	-1	38	31	51														CASSWDRELWKGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTTGACGGAGGGGATTTCGCGCAGTATTTTGGCCCA	CASSVDGGDFAQYF	In	VDJ	4	298	0.0012834206174200662	0.0014861953399297797	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	0	10	6	7	18	30	42	36	49														CASSVDGGDFAQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTACCGGGGGGCGGGGCCAGAGACCCAGTACTTCGGGCCA	CASSYRGAGPETQYF	In	VDJ	4	283	0.001218818908489526	0.001411386849664858	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	1	4	4	7	18	29	40	33	47														CASSYRGAGPETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGGGACAGGGGGATCCTACGAGCAGTACTTCGGGCCG	CASSLEGTGGSYEQYF	In	VDJ	4	241	0.0010379341234840133	0.001201923076923077	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	1	1	1	1	18	35	47	36	48														CASSLEGTGGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGACAGGGAGACACTGAAGCTTTCTTTGGACAA	CASSLGQGDTEAFF	In	VDJ	3	234	0.0010077866593164277	0.00116701244813278	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	3	0	2	18	-1	41	32	43														CASSLGQGDTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTGCAGGGCCCTTCTAATACGCAGTATTTTGGCCCA	CASSLLQGPSNTQYF	In	VDJ	3	225	9.690256339581037E-4	0.001122127353973827	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	3	7	3	8	18	33	41	36	49														CASSLLQGPSNTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGTGGGACAGGGGCACTTGGAGGCTACACCTTCGGTTCG	CASSLSGTGALGGYTF	In	VDJ	3	211	9.087307056229328E-4	0.0010523060963932333	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	2	8	3	8	18	33	46	36	54														CASSLSGTGALGGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGTGGGGGGTACAGGATGAAGCTTTCTTTGGACAA	CASSPWGVQDEAFF	In	VDJ	3	195	8.398222160970231E-4	9.725103734439834E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	1	7	4	7	18	30	40	34	47														CASSPWGVQDEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTTCTAGCGGGGCTACAGATACGCAGTATTTTGGCCCA	CASSSSSGATDTQYF	In	VDJ	3	177	7.623001653803749E-4	8.827401851260773E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	4	3	3	3	2	18	31	43	34	45														CASSSSSGATDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGCCGGGACAGGGTCTGAAGCTTTCTTTGGACAA	CASSFAGTGSEAFF	In	VDJ	2	160	6.890848952590959E-4	7.979572294924992E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	6	4	1	18	32	45	36	46														CASSFAGTGSEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCACAAGGTGGTTAGGGGATAGCTACACCTTCGGTTCG	CASSLTRWLGDSYTF	In	VDJ	2	153	6.589374310915104E-4	7.630466007022024E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	5	2	9	14	3	18	30	49	44	52														CASSLTRWLGDSYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGACTACTAGCGGGGTTCTACAATGAGCAGTTCTTCGGGCCA	CASSLGLLAGFYNEQFF	In	VDJ	2	151	6.503238699007718E-4	7.530721353335462E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	3	3	3	6	2	18	32	48	38	50														CASSLGLLAGFYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAGAGTCATACAATGAGCAGTTCTTCGGGCCA	CASSLGESYNEQFF	In	VDJ	2	144	6.201764057331864E-4	7.181615065432493E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	11	2	4	0	5	18	-1	37	34	42														CASSLGESYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGATTGGGACATCCTCTACAATGAGCAGTTCTTCGGGCCA	CASSFDWDILYNEQFF	In	VDJ	2	142	6.115628445424477E-4	7.08187041174593E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	6	3	5	4	18	32	43	37	47														CASSFDWDILYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTCTGGGACAGCTCCTACGAGCAGTACTTCGGGCCG	CASSVWDSSYEQYF	In	VDJ	2	137	5.900289415656009E-4	6.832508777529524E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	0	4	0	18	30	-1	34	41														CASSVWDSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGCTTGGGGGTTTCAGGGAGACCCAGTACTTCGGGCCA	CASSPLGGFRETQYF	In	VDJ	2	133	5.728018191841235E-4	6.6330194701564E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	6	1	5	6	7	18	30	41	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLGGFRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAACCCGGACGGGGGGGCGGCGGAAGATACGCAGTATTTTGGCCCA	CASNPDGGAAEDTQYF	In	VDJ	2	132	5.684950385887542E-4	6.583147143313119E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	8	0	5	7	7	18	28	43	35	50														CASNPDGGAAEDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGCTCGCGGTCCCGGCCCCGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQGSRSRPRSYNEQFF	In	VDJ	2	123	5.2973401323043E-4	6.134296201723588E-4	57	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	7	5	0	8	11	18	30	42	38	53						01,02								CASSQGSRSRPRSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCGCAGCGGGGGCTACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLAAAGATNTGELFF	In	VDJ	2	121	5.211204520396913E-4	6.034551548037025E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	6	2	0	6	3	18	32	46	38	49														CASSLAAAGATNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGAGGTTAGGGGCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	2	119	5.125068908489526E-4		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	5	2	0	7	0	18	30	-1	37	42														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTGGGGAGAGAGCACTGAAGCTTTCTTTGGACAA	CASSLWGESTEAFF	In	VDJ	2	116	4.995865490628446E-4	5.785189913820619E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	9	2	4	3	4	18	32	40	35	44														CASSLWGESTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGGGACAGGGAGGCCAGCCCCAGCATTTTGGTGAT	CASSLEGQGGQPQHF	In	VDJ	2	115	4.952797684674751E-4	5.735317586977338E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	3	7	3	4	18	32	44	35	48														CASSLEGQGGQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACTAGGACAGTATGGCGGGGAGCTGTTTTTTGGAGAA	CASRLGQYGGELFF	In	VDJ	2	115	4.952797684674751E-4	5.735317586977338E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	5	7	4	5	18	29	39	33	44														CASRLGQYGGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGATGGGAGCCTACGAGCAGTACGTCGGGCCG	CASSFGMGAYEQYV	In	VDJ	2	114	4.909729878721058E-4	5.685445260134057E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	8	3	17	0	21	18	-1	37	32	58														CASSFGMGAYEQYV+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACACCCACCGGGCAGGGCACAGATACGCAGTATTTTGGCCCA	CASTPTGQGTDTQYF	In	VDJ	2	114	4.909729878721058E-4	5.685445260134057E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	7	4	4	1	11	0	18	28	-1	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTPTGQGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGACAGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	113	4.866662072767365E-4		41	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	3	2	0	18	32	-1	34	43														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTCGGACAGCTTTATGGCTACACCTTCGGTTCG	CASSLVGQLYGYTF	In	VDJ	2	110	4.7374586549062846E-4	5.485955952760932E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	5	5	4	3	18	32	42	36	45														CASSLVGQLYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACAAGGTGTTTCCTACTGAAGCTTTCTTTGGACAA	CASSLDKVFPTEAFF	In	VDJ	2	110	4.7374586549062846E-4	5.485955952760932E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	0	5	4	5	2	8	18	35	40	37	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDKVFPTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTTATAATTGCGGGGGGGCACACAGATACGCAGTATTTTGGCCCA	CASSFIIAGGHTDTQYF	In	VDJ	2	107	4.608255237045204E-4	5.336338972231088E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	0	2	7	2	18	32	48	39	50														CASSFIIAGGHTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGACCCAGGGAGTTCGGGGCTACACCTTCGGTTCG	CASSQTQGVRGYTF	In	VDJ	1	100	4.3067805953693494E-4	4.98723268432812E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	5	4	3	8	6	7	18	30	41	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQTQGVRGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGGACAGCCGATCAGCCCCAGCATTTTGGTGAT	CASSFGTADQPQHF	In	VDJ	1	99	4.263712789415656E-4	4.937360357484839E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	5	5	1	3	18	32	40	33	43														CASSFGTADQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCAGGGGGCTCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSARGLGANVLTF	In	VDJ	1	98	4.220644983461963E-4	4.887488030641558E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	4	0	4	2	2	18	30	40	32	42														CASSARGLGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTATTCGTTCATTGGACTAAGCACTGAGACCCAGTACTTCGGGCCA	CASSLYSFIGLSTETQYF	In	VDJ	1	91	3.919170341786108E-4	4.5383817427385894E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	1	9	5	13	6	18	32	51	45	57						01,02								CASSLYSFIGLSTETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCTGTGTAAGGCAGGGGGAATCCTACGAGCAGTACTTCGGGCCG	CASCVRQGESYEQYF	In	VDJ	1	89	3.833034729878721E-4	4.438637089052027E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	4	1	1	9	2	18	27	43	36	45														CASCVRQGESYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGAGAGGTCGGAACTCCGGCTAATGAACACTGAAGCTTTCTTTGGACAA	CASSERSELRLMNTEAFF	In	VDJ	1	85	3.6607635060639473E-4	4.239147781678902E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	1	0	2	16	18	30	36	32	52														CASSERSELRLMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGGAAACCTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSWGNLNTGELFF	In	VDJ	1	84	3.6176957001102537E-4	4.1892754548356206E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	4	0	8	1	1	5	18	31	36	32	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWGNLNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTTACAGGGTTCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPLQGSSGANVLTF	In	VDJ	1	84	3.6176957001102537E-4	4.1892754548356206E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	3	3	0	5	3	18	30	41	35	44														CASSPLQGSSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGTGGAGGGGCGATGAACAATGAGCAGTTCTTCGGGCCA	CASSLGGGAMNNEQFF	In	VDJ	1	82	3.5315600882028666E-4	4.0895308011490585E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	0	5	4	7	18	32	42	36	49														CASSLGGGAMNNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCGGACTAGCGGGGGCCCCCCCGGATAACACAGATACGCAGTATTTTGGCCCA	CASSTGLAGAPPDNTDTQYF	In	VDJ	1	82	3.5315600882028666E-4	4.0895308011490585E-4	60	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	1	2	2	3	13	18	30	46	33	59														CASSTGLAGAPPDNTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACTAAGTCTGCTCGCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	81	3.488492282249173E-4		52	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	7	3	6	5	14	5	18	28	45	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACTGGGGATAGTCACCGGGGAGCTGTTTTTTGGAGAA	CASRLGIVTGELFF	In	VDJ	1	79	3.4023566703417864E-4	3.939913820619215E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	6	0	8	4	4	4	18	29	37	33	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRLGIVTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACGGGACAGGGGTAGTGCTTCTGGAAACACCATATATTTTGGAGAG	CASSLRDRGSASGNTIYF	In	VDJ	1	72	3.100882028665932E-4	3.5908075327162467E-4	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	0	2	1	1	7	18	33	44	34	51														CASSLRDRGSASGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTGAGGGTTTGAGTAATTCACCCCTCCACTTTGGGAAC	CASSLGEGLSNSPLHF	In	VDJ	1	71	3.057814222712238E-4	3.540935205872965E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	1	11	0	6	2	6	18	34	41	36	47														CASSLGEGLSNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAAAAGGGGGGACAGCGGAGCAGTACTTCGGGCCG	CASSSKGGTAEQYF	In	VDJ	1	71	3.057814222712238E-4	3.540935205872965E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	5	7	8	2	18	31	46	39	48														CASSSKGGTAEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTACAGGGATCGAAAGACCCAGTACTTCGGGCCA	CASSPYRDRKTQYF	In	VDJ	1	71	3.057814222712238E-4	3.540935205872965E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	3	6	4	6	18	30	40	34	46														CASSPYRDRKTQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTACAGGGGACGTCCAGATACGCAGTATTTTGGCCCA	CASSSYRGRPDTQYF	In	VDJ	1	69	2.971678610804851E-4	3.441190552186403E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	3	2	4	3	5	18	31	41	34	46														CASSSYRGRPDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCAACAGGGAACGAGGGGAGCTGTTTTTTGGAGAA	CASSSNRERGELFF	In	VDJ	1	69	2.971678610804851E-4	3.441190552186403E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	3	8	3	5	18	31	40	34	45														CASSSNRERGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGCAGGGGCAGGAGACTGAAGCTTTCTTTGGACAA	CASSLQGQETEAFF	In	VDJ	1	68	2.9286108048511575E-4	3.3913182253431215E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	5	3	6	18	30	39	33	45														CASSLQGQETEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTCTACAAAACCTATTGACAGGGAAAAACTGTTTTTTGGCAGT	CASSSTKPIDREKLFF	In	VDJ	1	65	2.7994073869900773E-4	3.241701244813278E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	4	8	16	0	18	29	-1	45	51														CASSSTKPIDREKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTAGCGGGGTTAATGAGCAGTTCTTCGGGCCA	CASSLGSGVNEQFF	In	VDJ	1	64	2.756339581036384E-4	3.191828917969997E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	5	3	7	1	2	18	34	43	35	45														CASSLGSGVNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCCGAAAGGACTAGCGGAGCTACGAGCAGTACTTCGGGCCG	CASSLRKD*RSYEQYF	Stop	VDJ	1	64	2.756339581036384E-4		48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	5	3	8	2	18	30	48	38	50						01,02								CASSLRKD*RSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGCGGGGACCCAAGCCCATCGGGCGACCCAGTACTTCGGGCCA	CASAGTQAHRATQYF	In	VDJ	1	62	2.6702039691289966E-4	3.092084264283434E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	8	7	3	7	0	17	18	-1	33	27	50														CASAGTQAHRATQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCGACCGGGGGCAAGGGGGAGACCCAGTACTTCGGGCCA	CASSATGGKGETQYF	In	VDJ	1	62	2.6702039691289966E-4	3.092084264283434E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	6	0	5	6	6	18	30	42	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSATGGKGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCGAAGCGGGGGGCGGGAGACCCAGTACTTCGGGCCA	CASSLRSGGRETQYF	In	VDJ	1	61	2.627136163175303E-4	3.042211937440153E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	6	1	5	4	3	18	32	45	36	48														CASSLRSGGRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGCCGTGGGACCGGATGGCAGGAACGAGCAGTACGTCGGGCCG		Out	VDJ	1	61	2.627136163175303E-4		50	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	0	7	17	7	24	18	30	42	37	66				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCGCGGGAGTCTAGCGACCGGGGGGGTATACACAGATACGCAGTATTTTGGCCCA	CASTRGSLATGGVYTDTQYF	In	VDJ	1	61	2.627136163175303E-4	3.042211937440153E-4	60	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	8	0	2	19	4	18	28	55	47	59														CASTRGSLATGGVYTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAAGGCAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLEGSSGANVLTF	In	VDJ	1	60	2.58406835722161E-4	2.992339610596872E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	3	1	8	0	0	6	18	-1	35	32	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGSSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGGGCCATTTTGAACACTGAAGCTTTCTTTGGACAA	CASSLRAILNTEAFF	In	VDJ	1	60	2.58406835722161E-4	2.992339610596872E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	2	5	3	0	0	6	18	-1	37	33	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRAILNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCAAAGGGATGGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSKGMGANVLTF	In	VDJ	1	60	2.58406835722161E-4	2.992339610596872E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	4	0	8	4	5	2	18	31	40	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSKGMGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGATCTGGGGGGGCGTTAACCTCTACGCAGTATTTTGGCCCA	CASSQGSGGALTSTQYF	In	VDJ	1	60	2.58406835722161E-4	2.992339610596872E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	9	0	8	9	10	18	30	46	39	56														CASSQGSGGALTSTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATCGGGGGCTACACAGATACGCAGTATTTTGGCCCA	CASSIGGYTDTQYF	In	VDJ	1	59	2.5410005512679164E-4	2.9424672837535907E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	6	0	2	3	2	18	30	39	33	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSIGGYTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTCGTTGGTACCAGATACGCAGTATTTTGGCCCA	CASSPSLVPDTQYF	In	VDJ	1	58	2.497932745314223E-4	2.8925949569103096E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	0	10	4	8	3	18	30	40	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSLVPDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAAGGTCAGCCAGGAGAAAAACTGTTTTTTGGCAGT	CASSLEGQPGEKLFF	In	VDJ	1	56	2.4117971334068356E-4	2.792850303223747E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	4	8	11	1	18	32	47	43	48														CASSLEGQPGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCCCGGCTGACACTGAAGCTTTCTTTGGACAA	CASSLVPADTEAFF	In	VDJ	1	56	2.4117971334068356E-4	2.792850303223747E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	1	9	0	3	4	2	18	34	41	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVPADTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGGACTACCGGGGAGACCCAGTACTTCGGGCCA	CASSFGTTGETQYF	In	VDJ	1	53	2.2825937155457552E-4	2.6432333226939034E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	0	9	5	1	5	18	32	40	33	45						01,02								CASSFGTTGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCCGCTTTTCAGGCCTGGGGGAGACCCAGTACTTCGGGCCA	CASSRRFSGLGETQYF	In	VDJ	1	52	2.2395259095920618E-4	2.5933609958506224E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	4	4	5	10	7	18	30	44	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRRFSGLGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACCAGACTAGCGGGGGGACCTTAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	52	2.2395259095920618E-4		50	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	6	2	1	5	4	5	18	29	46	33	51														X+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGATCGGGACTGAGGACGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	49	2.1103224917309814E-4		47	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	0	10	4	6	7	18	30	42	36	49						01,02								X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAATGCTCTGGAGGCTTCTGTTGGCTACACCTTCGGTTCG	CASNALEASVGYTF	In	VDJ	1	49	2.1103224917309814E-4	2.443744015320779E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	7	10	1	7	7	7	18	28	40	35	47														CASNALEASVGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAAACCAGGGAAGTGAAAAACTGTTTTTTGGCAGT	CASSPNQGSEKLFF	In	VDJ	1	48	2.0672546857772878E-4	2.3938716884774975E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	3	7	6	3	18	30	41	36	44														CASSPNQGSEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGAGACAGGGGGGATCCTACGAGCAGTACTTCGGGCCG	CASRRQGGSYEQYF	In	VDJ	1	47	2.0241868798235942E-4	2.3439993616342165E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	1	1	2	2	18	29	40	31	42														CASRRQGGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCCGCTTTCGGTATGGCTACACCTTCGGTTCG	CASSLVRFRYGYTF	In	VDJ	1	47	2.0241868798235942E-4	2.3439993616342165E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	8	5	5	8	0	18	34	-1	42	45						01,02								CASSLVRFRYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAAGGGGGGAGTTATATGGCTACACCTTCGGTTCG	CASSQRGELYGYTF	In	VDJ	1	47	2.0241868798235942E-4	2.3439993616342165E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	5	5	1	5	3	6	18	30	39	33	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQRGELYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAAACTGGGCCATCTCTGGAAACACCATATATTTTGGAGAG	CASSQNWAISGNTIYF	In	VDJ	1	47	2.0241868798235942E-4	2.3439993616342165E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	8	0	0	7	3	18	30	41	37	44														CASSQNWAISGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCCTAAGCACAGATACGCAGTATTTTGGCCCA	CASSLVLSTDTQYF	In	VDJ	1	46	1.9811190738699006E-4	2.2941270347909352E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	4	9	0	2	0	18	34	-1	36	39						01,02								CASSLVLSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGACTGCCCGATACAATGAGCAGTTCTTCGGGCCA	CASSFGTARYNEQFF	In	VDJ	1	45	1.9380512679162073E-4	2.244254707947654E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	10	4	1	6	18	32	39	33	45						01,02								CASSFGTARYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCCAGCGGAGGGAGGAGTGTATGAAAAACTGTTTTTTGGCAGT	CASTPAEGGVYEKLFF	In	VDJ	1	45	1.9380512679162073E-4	2.244254707947654E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	7	9	1	6	10	5	18	28	44	38	49														CASTPAEGGVYEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAAAGAGGGGACATTGAAGCTTTCTTTGGACAA		Out	VDJ	1	44	1.8949834619625137E-4		41	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	6	7	7	1	18	32	45	39	46														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTAGAAAGGGAGGGGATGATGCCCAGTACTTCGGGCCA	CASSSRKGGDDAQYF	In	VDJ	1	44	1.8949834619625137E-4	2.194382381104373E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	9	0	9	7	7	18	31	45	38	52														CASSSRKGGDDAQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACAGGGGATACTATGGCTACACCTTCGGTTCG	CASSLDRGYYGYTF	In	VDJ	1	43	1.8519156560088202E-4	2.1445100542610916E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	2	3	0	2	18	-1	41	32	43														CASSLDRGYYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCTCCAGGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLVSRAGANVLTF	In	VDJ	1	43	1.8519156560088202E-4	2.1445100542610916E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	4	3	2	4	0	18	34	-1	38	43														CASSLVSRAGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAGGAACAGCAGGAAAACTGTTTTTTGGCAGT	CASSLEGTAGKLFF	In	VDJ	1	43	1.8519156560088202E-4	2.1445100542610916E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	3	5	10	4	4	18	35	43	39	47														CASSLEGTAGKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCGAAGAGAGACAGGGCATCGCTCAGCCCCAGCATTTTGGTGAT	CASTEERQGIAQPQHF	In	VDJ	1	41	1.7657800441014333E-4	2.0447654005745293E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	3	6	9	6	18	28	44	37	50														CASTEERQGIAQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGCGGTTGATGAACACTGAAGCTTTCTTTGGACAA	CASSLGRLMNTEAFF	In	VDJ	1	40	1.7227122381477397E-4	1.994893073731248E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	7	0	0	0	6	18	-1	37	32	43														CASSLGRLMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTCCAACGGGGGGATAATTCACCCCTCCACTTTGGGAAC	CASSFQRGDNSPLHF	In	VDJ	1	39	1.6796444321940464E-4	1.9450207468879667E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	6	8	1	5	7	0	18	29	-1	36	43														CASSFQRGDNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGTTAAGCGCCTACGGGAGTGGCTACACCTTCGGTTCG	CASSLGLSAYGSGYTF	In	VDJ	1	39	1.6796444321940464E-4	1.9450207468879667E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	8	2	7	13	0	18	34	-1	47	53														CASSLGLSAYGSGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTAGCGGGGTAATTTTCCCCCACGAGCAGTTCTTCGGGCCA	CASSPSGVIFPHEQFF	In	VDJ	1	39	1.6796444321940464E-4	1.9450207468879667E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	10	1	14	18	30	40	31	54														CASSPSGVIFPHEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAACCGGGGGCCTAAGGTACGAGCAGTACTTCGGGCCG	CASSPTGGLRYEQYF	In	VDJ	1	39	1.6796444321940464E-4	1.9450207468879667E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	6	0	4	6	6	18	30	42	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTGGLRYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAGGACTAGTGGCTTTAGGGAGACCCAGTACTTCGGGCCA	CASSLRTSGFRETQYF	In	VDJ	1	38	1.6365766262403528E-4	1.8951484200446856E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	1	8	5	2	10	18	32	41	34	51						01,02								CASSLRTSGFRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGACAGACCTCCAATCAGCCCCAGCATTTTGGTGAT	CASSSGQTSNQPQHF	In	VDJ	1	38	1.6365766262403528E-4	1.8951484200446856E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	5	3	2	5	18	31	39	33	44														CASSSGQTSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCTTAAAAGCAGGGGGACAGGGCAATGAGCAGTTCTTCGGGCCA	CASLKAGGQGNEQFF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	3	6	11	0	18	27	-1	38	47														CASLKAGGQGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAGGACACCGGGGGGAGCAGTACTTCGGGCCG	CASSLEGHRGEQYF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	2	7	7	0	18	35	-1	42	48														CASSLEGHRGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTAGTGTGGGGGACGGCCTCCCGGCTACACCTTCGGTTCG		Out	VDJ	1	37	1.5935088202866592E-4		47	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	4	0	7	8	9	8	18	31	45	40	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCGGCCCCGGAGGCGAGCAGTACTTCGGGCCG	CASSLGGPGGEQYF	In	VDJ	1	36	1.550441014332966E-4	1.7954037663581233E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	10	1	6	8	0	18	34	-1	42	47														CASSLGGPGGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGGGACGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSQGRANTEAFF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	5	0	7	1	2	4	18	30	37	32	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGRANTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGAAAGGGAGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSSKGRGTGELFF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	9	0	4	5	1	18	31	43	36	44														CASSSKGRGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCAGGGGGGAACCAGGGACGGGTGAGGCTACACCTTCGGTTCG		Out	VDJ	1	33	1.4212375964718854E-4		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	1	8	1	17	18	31	39	32	56														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGATTTAACGGACAGGGGGCAACTGAAGCTTTCTTTGGACAA	CASSRFNGQGATEAFF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	0	5	9	1	18	30	50	39	51														CASSRFNGQGATEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCGACAGGGGGTTGGTGAAAAACTGTTTTTTGGCAGT	CASSPRQGVGEKLFF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	1	7	4	4	18	30	43	34	47														CASSPRQGVGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTGGAATAAATAACTATAGCTACACCTTCGGTTCG	CASSPGINNYSYTF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	3	9	9	13	2	18	30	47	43	49						01,02								CASSPGINNYSYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGGACAGGGTCAGCCTATGGCTACACCTTCGGTTCG	CASSQGTGSAYGYTF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	4	3	5	18	30	42	33	47														CASSQGTGSAYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGTCGGGGGATCTCACCGGGGAGCTGTTTTTTGGAGAA	CASRSGDLTGELFF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	8	2	4	2	4	18	29	37	31	41														CASRSGDLTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGGGGGGAGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSLVGGGGTDTQYF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	9	0	1	4	1	18	34	45	38	46														CASSLVGGGGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTACAGGGTCCCCTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	31	1.3351019845644983E-4		43	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	3	17	2	21	18	30	38	32	59														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGCGGGGGACAGGGGATGGCTACACCTTCGGTTCG	CASSQRGTGDGYTF	In	VDJ	1	30	1.292034178610805E-4	1.496169805298436E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	2	6	6	0	18	30	-1	36	46														CASSQRGTGDGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTTCTTAGGTTCTCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	29	1.2489663726571114E-4		49	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	3	5	4	0	6	4	18	32	41	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACTGACAGGGACAGGGACCTACAATGAGCAGTTCTTCGGGCCA	CASSLLTGTGTYNEQFF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	3	2	6	1	18	33	48	39	49														CASSLLTGTGTYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGTTCACGAATAACTATGGCTACACCTTCGGTTCG	CASSLFTNNYGYTF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	5	2	8	1	8	1	18	30	40	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLFTNNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGTCTCCGCACGGCACAGATACGCAGTATTTTGGCCCA	CASSRSPHGTDTQYF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	8	5	1	0	10	18	-1	33	30	43						01,02								CASSRSPHGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCTCCAGTCTGTACACTAACTATGGCTACACCTTCGGTTCG	CASSSLYTNYGYTF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	3	6	0	10	0	18	27	-1	37	40														CASSSLYTNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGCAGGCTGAGAACACTGAAGCTTTCTTTGGACAA	CASSLEQAENTEAFF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	4	4	1	4	4	18	32	40	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEQAENTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTGGGGACAGGGGATAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	28	1.2058985667034178E-4		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	0	2	4	3	2	18	34	47	37	49														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCGTAGTAAAAGAGACCCAGTACTTCGGGCCA	CASSLVVVKETQYF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	5	8	3	3	3	18	34	40	37	43						01,02								CASSLVVVKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTAGAGGTACAGGGACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSRGTGTGANVLTF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	3	3	2	8	1	18	31	45	39	46														CASSSRGTGTGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCACAAATAGGGGGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSSQIGGLNTEAFF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	4	5	1	0	7	2	18	31	44	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSQIGGLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGGGGGTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	26	1.1197629547960309E-4		46	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	3	5	1	0	2	2	18	32	40	34	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGATCCAGACCGGGGGGGAGACCCAGTACTTCGGGCCA	CASSLIQTGGETQYF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	8	1	5	9	0	18	32	-1	41	48														CASSLIQTGGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTGGGCGGGGGGGAGCGAATACGCAGTATTTTGGCCCA	CASSLGGRGGANTQYF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	7	0	7	4	5	18	34	47	38	52														CASSLGGRGGANTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGVNTGELFF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	1	0	9	1	0	1	18	-1	37	34	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGVNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCACACAGGGTATGGACGAGCAGTACTTCGGGCCG	CASSSTQGMDEQYF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	3	5	4	5	18	31	41	35	46														CASSSTQGMDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGAACTGACAGGGGAGTACGGCTACACCTTCGGTTCG	CASSELTGEYGYTF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	2	8	5	5	18	30	43	35	48														CASSELTGEYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAACCCCTAGGTGGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	26	1.1197629547960309E-4		47	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	7	6	1	1	10	0	18	28	-1	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCTGGGCCATACAATGAGCAGTTCTTCGGGCCA	CASSLSGPYNEQFF	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	8	0	4	3	2	18	33	40	36	42														CASSLSGPYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGAGGAGAAGCCAACGTCCTGACTTTCGGGGCC	CASSLGGEANVLTF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	3	9	1	7	0	4	18	-1	38	32	42														CASSLGGEANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGACCCTCAGGGAATCATCGCAATCAGCCCCAGCATTTTGGTGAT	CASS*PSGNHRNQPQHF	Stop	VDJ	1	24	1.0336273428886439E-4		51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	3	2	6	7	18	31	42	37	49														CASS*PSGNHRNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGACGAGGACGGAGGATGGGGATACGCAGTATTTTGGCCCA	CASSPTRTEDGDTQYF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	1	6	11	5	18	30	46	41	51														CASSPTRTEDGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCACTCTGGAGGGTGGACAGGGGATTTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	24	1.0336273428886439E-4		53	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	2	4	13	4	18	30	52	43	56														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCAGGGGGTTCGGCACAGATACGCAGTATTTTGGCCCA	CASSTRGFGTDTQYF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	1	1	2	4	18	30	39	32	43														CASSTRGFGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCGAGCGTCTGGAAACACCATATATTTTGGAGAG	CASSLRASGNTIYF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	3	6	6	1	3	0	18	32	-1	35	39						01,02								CASSLRASGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGGCAGAAAACTATGGCTACACCTTCGGTTCG	CASSLVAENYGYTF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	5	2	3	2	18	34	40	37	42														CASSLVAENYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCGACTAGCGAGGGAGACCCAGTACTTCGGGCCA	CASSLRLARETQYF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	2	6	5	2	3	18	32	42	34	45						01,02								CASSLRLARETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGGAAGACAGTGCCGTTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	9.474917309812569E-5		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	5	3	6	7	18	30	41	36	48														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTCGAAGGGACAGGGACCCAATGAGCAGTTCTTCGGGCCA	CASSSKGQGPNEQFF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	6	6	3	18	29	44	35	47														CASSSKGQGPNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAACCGAGACATTAACTATGGCTACACCTTCGGTTCG	CASSLNRDINYGYTF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	6	1	6	1	18	33	43	39	44														CASSLNRDINYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTTGGAAACAGGGGACCGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	21	9.044239250275634E-5		52	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	2	0	7	4	18	30	44	37	48														X+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTATCCCACTGATTGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	21	9.044239250275634E-5		47	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	3	10	2	7	5	18	30	40	37	45						01,02								X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATGGGGACCCCCCAAGAGACCCAGTACTTCGGGCCA	CASSMGTPQETQYF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	0	7	1	3	3	18	30	38	33	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSMGTPQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCTTACACGGGCAGGGAATGAGCAGTTCTTCGGGCCA	CASTLTRAGNEQFF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	4	3	7	12	0	18	28	-1	40	45														CASTLTRAGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGTGGGGTCCGGCAATGAGCAGTTCTTCGGGCCA	CASSLVGSGNEQFF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	1	6	2	6	1	5	18	34	39	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGSGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCAAAGGAACCGCTATGGCTACACCTTCGGTTCG	CASSLQRNRYGYTF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	3	1	8	4	5	4	18	32	40	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQRNRYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCCTAACTAGCGGGGGGATCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	19	8.182883131201764E-5		49	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	3	1	4	6	2	18	30	48	36	50														X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGATTCTCCTCAGACAGGGGGGACACCCCTCCACTTTGGGAAC	CASSLDSPQTGGTPLHF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	2	1	11	9	2	18	35	53	44	55														CASSLDSPQTGGTPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATGGGGCTGATGAACACTGAAGCTTTCTTTGGACAA	CASSLMGLMNTEAFF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	7	0	0	2	3	18	33	40	35	43														CASSLMGLMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTCATCAACAGGGGGAAACACTGAAGCTTTCTTTGGACAA	CASSSSTGGNTEAFF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	1	2	5	1	18	31	44	36	45														CASSSSTGGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAAAGACAGTGAACACTGAAGCTTTCTTTGGACAA	CASSPKTVNTEAFF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	5	0	5	0	18	30	-1	35	40														CASSPKTVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGTATTTTTGTGCTAGTGGTTTGGCGACACTCCCCGGGACTAGCGGGGTCAGGAGATTCGGCTGTTTTTTGGAGAA		Out	VDJ	40	2721	0.01171875		62	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	0	3	13	11	12	8	24	48	35	60														X+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGTCCTTGACCAGCGGGGGGGTCAATGAGCAGTTCTTCGGGCCA	CASGLSLTSGGVNEQFF	In	VDJ	4	276	0.0011886714443219404	0.0013764762208745612	51	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	6	0	6	9	1	26	41	60	50	61														CASGLSLTSGGVNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGTCCCTGACTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASGLSLTSGSTDTQYF	In	VDJ	3	173	7.450730429988975E-4	8.627912543887647E-4	51	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	2	4	0	5	0	26	41	-1	46	56						01,02								CASGLSLTSGSTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAAACCGCGGGGTGGGGATACGCAGTATTTTGGCCCA	CASKPRGGDTQYF	In	VDJ	2	143	6.15869625137817E-4	7.131742738589211E-4	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	12	7	3	6	9	4	26	31	46	40	50														CASKPRGGDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGTATTGACACTAAATCAGCCCCAGCATTTTGGTGAT	CASVLTLNQPQHF	In	VDJ	2	139	5.986425027563396E-4	6.932253431216087E-4	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-05	01	7	2	6	4	4	3	26	36	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASVLTLNQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGAAGCGGGGGGTTTGAAAAACATTCAGTACTTCGGCGCC	CASGLEAGGLKNIQYF	In	VDJ	2	135	5.814153803748622E-4	6.732764123842962E-4	48	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	1	6	1	4	1	4	26	42	52	43	56														CASGLEAGGLKNIQYF+TCRBV12-05+TCRBJ02-04	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGTTAGCCCGGGGGGTAGGCCAGATACGCAGTATTTTGGCCCA	CASVSPGGRPDTQYF	In	VDJ	2	113	4.866662072767365E-4	5.635572933290775E-4	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	8	1	4	6	5	26	36	49	42	54														CASVSPGGRPDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGTGGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASGLWGSSYNEQFF	In	VDJ	2	106	4.5651874310915103E-4	5.286466645387807E-4	45	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-01	01	2	6	1	0	1	2	26	41	47	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLWGSSYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCCTGGGGTCTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	78	3.359288864388093E-4		37	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-06	01	5	6	2	10	4	2	26	38	46	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ01-06	TCRBV12-05*01		TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTTACGGTCATCCAGATACGCAGTATTTTGGCCCA	CASYGHPDTQYF	In	VDJ	1	76	3.2731532524807056E-4	3.7902968400893713E-4	36	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	8	5	4	2	5	26	35	40	37	45						01,02								CASYGHPDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCTGGGGGTTTCGGTGAGCAGTTCTTCGGGCCA	CASGPGGFGEQFF	In	VDJ	1	76	3.2731532524807056E-4	3.7902968400893713E-4	39	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-01	01	5	6	1	9	3	6	26	38	46	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGPGGFGEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCGCGGGGGGTGCTTCACCCCTCCACTTTGGGAAC	CASAGGASPLHF	In	VDJ	1	76	3.2731532524807056E-4	3.7902968400893713E-4	36	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	12	7	1	9	4	3	26	31	43	35	46														CASAGGASPLHF+TCRBV12-05+TCRBJ01-06	TCRBV12-05*01	TCRBD02-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGGCCCCTAACCCCAGCTTTCTTTGGACAA	CASGLGPLTPAFF	In	VDJ	1	59	2.5410005512679164E-4	2.9424672837535907E-4	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-01	01	1	9	0	10	0	10	26	-1	45	42	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLGPLTPAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCATCCGGGACAGGGACAACACTGAAGCTTTCTTTGGACAA	CASIRDRDNTEAFF	In	VDJ	1	40	1.7227122381477397E-4	1.994893073731248E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	12	0	3	2	8	2	26	31	48	39	50														CASIRDRDNTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACTCCTCCCGGGACAGTCACTGAAGCTTTCTTTGGACAA	CASTPPGTVTEAFF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	12	0	5	4	13	1	26	31	51	44	52														CASTPPGTVTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGGGCATATGATACGCAGTATTTTGGCCCA	CASGLGAYDTQYF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	8	0	6	0	4	26	-1	46	42	50														CASGLGAYDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGCTTGATCGGTGAAGCTTTCTTTGGACAA	CASGLGLIGEAFF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	8	5	7	7	0	26	42	-1	49	52						01,02								CASGLGLIGEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD02-01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCGTGACAGATAACTATGGCTACACCTTCGGTTCG	CASTVTDNYGYTF	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	12	2	5	1	9	1	26	31	45	40	46														CASTVTDNYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTATCGGGCGGAGTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	8.613561190738698E-5		43	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-02	01	0	8	0	5	3	4	26	43	50	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGCAAGCCACGTTTGGTGGAACCCAGGGACTCAGCTGTGTATTTTGTGCCAGCAGCTCTGCATACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	19	8.182883131201764E-5		35	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-02	01	17	4	5	3	4	11	46	46	53	50	64				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGTTGCCCTCTGGAAACACCATATATTTTGGAGAG	CASGLLPSGNTIYF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	42	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-03	01	2	10	0	0	2	1	26	41	45	43	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLLPSGNTIYF+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01		TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAATGGCGGGGGGGCGGATGAGCAGTTCTTCGGGCCA	CASNGGGADEQFF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	12	7	0	8	8	3	26	31	48	39	51														CASNGGGADEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGAAGGGACAATAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	41	2737	0.011787658489525909		46	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	0	6	4	3	1	20	37	46	40	47														X+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCCACCGGAGCAGGTATGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	8	533	0.0022955140573318635		47	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-05	01	4	4	4	3	9	4	20	33	46	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAGAAGGCCCCAACTAGGAGGCAGACGAGACGAGCAGTACGTCGGGCCG		Out	VDJ	2	138	5.943357221609702E-4		56	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	3	8	17	10	24	20	35	50	45	74						01,02								X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGCAGGCCCCCACGGAGTACGTCGGGCCG	CASSQSQAPTEYV	In	VDJ	2	137	5.900289415656009E-4	6.832508777529524E-4	39	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-07	01	0	4	4	17	1	15	20	37	42	38	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQSQAPTEYV+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCGACGTAGGACAGGGAGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	72	3.100882028665932E-4		41	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	3	9	7	2	20	31	46	38	48														X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GAGACACGGCACTGTATCTCTGCGCCGGGGGGTGGGAAGGTATACTCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	53	2.2825937155457552E-4		43	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	11	9	1	4	0	15	20	-1	32	26	47														X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD02-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCGCCCGTGGAAGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	46	1.9811190738699006E-4		40	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-05	01	4	1	8	4	6	2	20	33	42	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCATCTAGAAACGGCCAGGACACCGAGTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	43	1.8519156560088202E-4		55	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	6	4	14	6	20	34	53	48	59														X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCGGACTAGCCCCAGAGACCCAGTACTTCGGGCCA	CASSGLAPETQYF	In	VDJ	1	40	1.7227122381477397E-4	1.994893073731248E-4	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	1	7	4	1	3	20	31	40	32	43						01,02								CASSGLAPETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTGCTCCCGGGACAGGGAAGCAAAAGCCCAGTACTTCGGGCCA		Out	VDJ	1	39	1.6796444321940464E-4		47	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	3	9	6	9	20	32	47	38	56														X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GAGACACGGCACTGTATCTCTGCGCCGCTAGCAGTCGGGGCCTCTGAAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	35	1.5073732083792723E-4		43	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-03	01	11	7	0	5	10	6	20	26	41	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCACCCCGGCTTAGGACAAGCTTTCTTTGGACAA	CASSHPGLGQAFF	In	VDJ	1	30	1.292034178610805E-4	1.496169805298436E-4	39	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-01	01	3	1	7	9	10	0	20	34	-1	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHPGLGQAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTGTTGGGAGGGGGAGGGATCTATGGCTACACCTTCGGTTCG	CASSLLGGGGIYGYTF	In	VDJ	1	30	1.292034178610805E-4	1.496169805298436E-4	48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	9	0	4	6	8	20	31	44	37	52														CASSLLGGGGIYGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCCTTTTGACAGCTAGCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	20	8.613561190738698E-5		47	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-05	01	6	2	5	3	7	5	20	31	43	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATGACGGCGGGGCAGGGGAGCCCAGTACTTCGGGCCA	CASSQ*RRGRGAQYF	Stop	VDJ	1	18	7.75220507166483E-5		45	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-05	01	1	4	2	9	10	2	20	36	52	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQ*RRGRGAQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGTTCCCAGGAGACCTATGGCTACACCTTCGGTTCG	CASSYSSQETYGYTF	In	VDJ	44	2961	0.012752377342888643	0.014767195978295563	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	2	4	4	4	6	4	23	38	48	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSSQETYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAAGGGATGACACTGAAGCTTTCTTTGGACAA	CASSLRDDTEAFF	In	VDJ	19	1255	0.005405009647188533	0.006258977018831791	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	4	0	8	3	3	2	23	36	43	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRDDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGTTTGGGGAGGCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	15	983	0.0042335653252480706		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	9	1	3	5	1	23	38	49	43	50														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGCTGGGGGACTTACAGAGTACACCTTCGGTTCG	CASSPAGGLTEYTF	In	VDJ	14	913	0.003932090683572216	0.004553343440791574	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	0	10	11	8	7	23	35	49	43	56						01,02								CASSPAGGLTEYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCTATGGACTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASTLWTSGSTDTQYF	In	VDJ	7	483	0.0020801750275633957	0.002408833386530482	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	1	4	0	6	0	23	33	-1	39	50						01,02								CASTLWTSGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATGGCAGGGGGTTATGGCTACACCTTCGGTTCG	CASMAGGYGYTF	In	VDJ	6	425	0.0018303817530319734	0.002119573890839451	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	1	5	3	1	23	33	43	36	44														CASMAGGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGATGGGCAGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSYDGQSNQPQHF	In	VDJ	5	344	0.0014815325248070561	0.0017156080434088733	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	8	0	1	3	2	23	38	45	41	47														CASSYDGQSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGCCAAGGGGACAGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CAAKGTGSNQPQHF	In	VDJ	5	341	0.0014686121830209482	0.001700646345355889	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	0	3	1	6	0	23	29	-1	35	44														CAAKGTGSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGACCTCGGGACAGGGGGCGAAAAACTGTTTTTTGGCAGT	CASSSDLGTGGEKLFF	In	VDJ	4	289	0.001244659592061742	0.0014413102457708268	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	0	8	8	0	23	36	-1	44	56														CASSSDLGTGGEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAGGACAGGACTCCCTTCTCTTCGGTTCG	CASSLGQDSLLF	In	VDJ	4	278	0.0011972850055126793	0.0013864506862432174	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	4	16	2	10	23	36	45	38	55														CASSLGQDSLLF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCGGGGACGGTCCGCTGTGGCCCCAGCATTTTGGTGAT	CATGDGPLWPQHF	In	VDJ	4	274	0.0011800578831312018	0.0013665017555059048	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	10	0	7	9	3	11	23	30	38	33	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATGDGPLWPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCTCGGGCGTGACAGGGGGGGGAGTTGGCTACACCTTCGGTTCG	CAISSGVTGGGVGYTF	In	VDJ	4	265	0.0011412968577728777	0.0013216166613469519	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	1	7	9	6	23	34	52	43	58														CAISSGVTGGGVGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGAGGCGGGAACGAAAAACTGTTTTTTGGCAGT	CAISGGGNEKLFF	In	VDJ	4	236	0.0010164002205071665	0.0011769869135014363	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	7	3	8	4	2	23	35	45	39	47														CAISGGGNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCTCGGAGGGGGATACGCAGTATTTTGGCCCA	CASSFSEGDTQYF	In	VDJ	3	199	8.570493384785006E-4	9.924593041812958E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	10	0	6	0	1	23	-1	46	40	47														CASSFSEGDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGTATATGAGCTTCGCACAGATACGCAGTATTTTGGCCCA	CASSEVYELRTDTQYF	In	VDJ	3	197	8.484357772877619E-4	9.824848388126396E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	11	1	1	0	12	23	-1	39	35	51														CASSEVYELRTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGTGTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSYGVSNQPQHF	In	VDJ	3	189	8.139815325248071E-4	9.425869773380147E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	2	0	10	0	0	3	23	-1	40	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGVSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTATCGTCGACAGGGAACATCTATGGCTACACCTTCGGTTCG	CASSLSSTGNIYGYTF	In	VDJ	3	188	8.096747519294377E-4	9.375997446536866E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	3	4	7	5	23	36	50	43	55														CASSLSSTGNIYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCGGGCGTTCAGCCCCAGCATTTTGGTGAT	CASSPGVQPQHF	In	VDJ	2	155	6.675509922822491E-4	7.730210660708586E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	8	0	6	3	2	23	34	41	37	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGVQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTATTAGACAGCGGCTATGGCTACACCTTCGGTTCG	CASSVLDSGYGYTF	In	VDJ	2	149	6.417103087100331E-4	7.430976699648898E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	2	5	4	6	3	23	35	46	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVLDSGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACATCTTACAGGGCGAACTGAAGCTTTCTTTGGACAA	CASRHLTGRTEAFF	In	VDJ	2	138	5.943357221609702E-4	6.882381104372806E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	5	7	3	23	34	47	41	50														CASRHLTGRTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGAACTTCAGGGTTACACTGAAGCTTTCTTTGGACAA	CASSELQGYTEAFF	In	VDJ	2	135	5.814153803748622E-4	6.732764123842962E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	3	7	2	23	34	46	41	48														CASSELQGYTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCTTGACTAGCGGGGGGGGCGAGCAGTTCTTCGGGCCA	CASTLTSGGGEQFF	In	VDJ	2	134	5.771085997794928E-4	6.682891796999681E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	2	0	10	4	2	23	33	51	37	53														CASTLTSGGGEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCGGACTGTTACCGGGGAGCTGTTTTTTGGAGAA	CASTRTVTGELFF	In	VDJ	2	131	5.641882579933848E-4	6.533274816469837E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	1	10	5	3	3	23	33	41	36	44						01,02								CASTRTVTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGTTGGGCAGCCCATGGGACGCAGTATTTTGGCCCA	CAISGWAAHGTQYF	In	VDJ	2	122	5.254272326350606E-4	6.084423874880306E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	8	0	9	4	10	23	35	43	39	53														CAISGWAAHGTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGGGGGTTCGGGGGACGAGGATGAAAAACTGTTTTTTGGCAGT	CAGGSGDEDEKLFF	In	VDJ	2	121	5.211204520396913E-4	6.034551548037025E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	11	8	2	6	7	6	23	29	42	36	48														CAGGSGDEDEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATTTTGACAGGGACGAGACGAGCAGTACGTCGGGCCG		Out	VDJ	2	116	4.995865490628446E-4		37	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	2	3	17	4	17	23	30	41	34	58														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCCCCCGAGGGGCTGGGAGGAAAAACTGTTTTTTGGCAGT	CASSDPPRGWEEKLFF	In	VDJ	2	115	4.952797684674751E-4	5.735317586977338E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	5	5	2	8	9	7	23	35	49	44	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDPPRGWEEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGGACGGTAGTAGCACAGATACGCAGTATTTTGGCCCA	CASSPDGSSTDTQYF	In	VDJ	2	113	4.866662072767365E-4	5.635572933290775E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	5	1	7	0	2	6	23	35	41	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPDGSSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCTGGAGGCCTTCCGGTCGGGAGTGACAAGAGACCCAGTACTTCGGGCCA	CAWRPSGRE*QETQYF	Stop	VDJ	2	112	4.823594266813671E-4		48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	11	8	2	2	15	3	23	29	50	44	53														CAWRPSGRE*QETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGAGGGGGCAATAACAGATACGCAGTATTTTGGCCCA	CASTEGAITDTQYF	In	VDJ	2	112	4.823594266813671E-4	5.585700606447494E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	5	0	3	3	4	23	33	43	36	47														CASTEGAITDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCGATCGACAGCCAGCGTCCCACTGAAGCTTTCTTTGGACAA	CASSYPIDSQRPTEAFF	In	VDJ	2	103	4.43598401323043E-4	5.136849664857964E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	5	4	6	9	23	38	49	44	58														CASSYPIDSQRPTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTACAGGGCGGAGGGACTGAAGCTTTCTTTGGACAA	CASSLQGGGTEAFF	In	VDJ	2	102	4.3929162072767365E-4	5.086977338014683E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	4	3	3	5	1	7	23	36	43	37	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQGGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGGGGGACAGGGAGGAATACGCAGTATTTTGGCCCA		Out	VDJ	2	102	4.3929162072767365E-4		41	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	3	7	3	4	23	34	46	37	50														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCYAGCAGAATAACCGGGGGAGGTCAGCCCCAGCATTTTGGTGAT	CASRITGGGQPQHF	In	VDJ	1	101	4.349848401323043E-4	5.037105011171402E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	8	2	6	6	3	23	34	46	40	49						01,02								CASRITGGGQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATTCCGCGGACACCTCACCCCTCCACTTTGGGAAC	CASSYSADTSPLHF	In	VDJ	1	100	4.3067805953693494E-4	4.98723268432812E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	1	6	10	6	2	23	37	48	43	50														CASSYSADTSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCTTTGGACAGCCTCGAGCAGTACTTCGGGCCG	CASSPLDSLEQYF	In	VDJ	1	100	4.3067805953693494E-4	4.98723268432812E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	5	6	6	3	23	34	46	40	49														CASSPLDSLEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCCCTCCAGGGACAGGGGTTTGAAAAACTGTTTTTTGGCAGT	CASALQGQGFEKLFF	In	VDJ	1	98	4.220644983461963E-4	4.887488030641558E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	0	2	7	8	2	23	32	50	40	52														CASALQGQGFEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCGGCCGGACTCCTAAATTCACCCCTCCACTTTGGGAAC	CASSPAGLLNSPLHF	In	VDJ	1	94	4.0483737596471884E-4	4.687998723268433E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	6	1	10	7	7	4	23	34	46	41	50						01,02								CASSPAGLLNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTAGAACTTTTAATGAGCAGTTCTTCGGGCCA	CASSSRTFNEQFF	In	VDJ	1	93	4.005305953693495E-4	4.6381263964251514E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	4	8	7	0	7	23	-1	40	36	47						01,02								CASSSRTFNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGAGGGAGGAATAAGAAACACCATATATTTTGGAGAG	CASSYEGGIRNTIYF	In	VDJ	1	93	4.005305953693495E-4	4.6381263964251514E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	2	9	1	5	2	5	23	38	46	40	51														CASSYEGGIRNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCCGTGACAGGGCGCATGAAAAACTGTTTTTTGGCAGT	CAIRDRAHEKLFF	In	VDJ	1	87	3.746899117971334E-4	4.338892435365464E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	10	2	3	6	5	3	23	30	42	35	45														CAIRDRAHEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGCTGGGGGCAAGGCTACACCTTCGGTTCG	CASSGWGQGYTF	In	VDJ	1	86	3.7038313120176403E-4	4.289020108522183E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	6	0	8	4	2	23	35	45	39	47														CASSGWGQGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATTAGCCCGATTACAGGGTTGAATTGGAAAAACTGTTTTTTGGCAGT	CASN*PDYRVELEKLFF	Stop	VDJ	1	84	3.6176957001102537E-4		51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	3	3	8	8	8	23	37	51	45	59														CASN*PDYRVELEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGCCGGGACAGGGGATAGCAATCAGCCCCAGCATTTTGGTGAT	CAAGTGDSNQPQHF	In	VDJ	1	83	3.57462789415656E-4	4.1394031279923395E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	0	2	0	3	1	23	29	42	32	43														CAAGTGDSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCACCGGGACATCGAACACCGGGGAGCTGTTTTTTGGAGAA	CAITGTSNTGELFF	In	VDJ	1	82	3.5315600882028666E-4	4.0895308011490585E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	0	6	0	5	1	23	30	41	35	42														CAITGTSNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGACGGCGAAGTGCTTTGTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	80	3.4454244762954794E-4		49	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	6	0	7	3	0	14	23	-1	39	34	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGCGGTTGACACAGATACGCAGTATTTTGGCCCA	CASSYGAVDTDTQYF	In	VDJ	1	79	3.4023566703417864E-4	3.939913820619215E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	7	0	2	0	6	23	-1	43	38	49														CASSYGAVDTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGTGGTCCGGAGGGAGAGACCCAGTACTTCGGGCCA	CAISGGPEGETQYF	In	VDJ	1	74	3.1870176405733185E-4	3.6905521864028087E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	10	0	4	8	0	23	35	-1	43	49														CAISGGPEGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCAAAAAGGGGACCGAGAAACTATGGCTACACCTTCGGTTCG	CASSKRGPRNYGYTF	In	VDJ	1	74	3.1870176405733185E-4	3.6905521864028087E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	8	0	7	2	8	5	23	32	45	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKRGPRNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGAAGGGCGGAGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	72	3.100882028665932E-4		50	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	2	5	3	0	3	5	23	38	45	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCTACAGGGTCGGGCTCACCCCTCCATTTTGGGAAC	CASRPTGSGSPLHF	In	VDJ	1	72	3.100882028665932E-4	3.5908075327162467E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	3	22	4	18	23	34	44	38	62														CASRPTGSGSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGTAGCAGGACGGGACTCTGAAGCTTTCTTTGGACAA	CASSYVAGRDSEAFF	In	VDJ	1	71	3.057814222712238E-4	3.540935205872965E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	0	10	6	10	0	23	38	-1	48	54						01,02								CASSYVAGRDSEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAAAGTTGGCCATCCTGAGAGCGGGGAGCTGTTTTTTGGAGAA	CASSKVGHPESGELFF	In	VDJ	1	66	2.842475192943771E-4	3.2915735716565594E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	6	9	0	7	7	11	23	34	44	41	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKVGHPESGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCCAAGGGGACCACAGATACGCAGTATTTTGGCCCA	CASSDSKGTTDTQYF	In	VDJ	1	61	2.627136163175303E-4	3.042211937440153E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	0	7	2	4	0	23	40	-1	44	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSKGTTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCATCCTGGACAGCTAACAATGAGCAGTTCTTCGGGCCA	CASSSSWTANNEQFF	In	VDJ	1	60	2.58406835722161E-4	2.992339610596872E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	5	5	6	3	23	36	48	42	51														CASSSSWTANNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGCCGTAATGAAAAACTGTTTTTTGGCAGT	CASSYGRNEKLFF	In	VDJ	1	60	2.58406835722161E-4	2.992339610596872E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	9	0	4	0	2	23	-1	41	38	43														CASSYGRNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGCGACTATGGCTACACCTTCGGTTCG	CASSYSDYGYTF	In	VDJ	1	60	2.58406835722161E-4	2.992339610596872E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	6	6	3	0	0	23	-1	-1	38	42						01,02								CASSYSDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATCCCCCGCCGGGGGGTATGGGAGGCTACACCTTCGGTTCG	CASSDPPPGGMGGYTF	In	VDJ	1	60	2.58406835722161E-4	2.992339610596872E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	1	8	10	7	23	35	52	45	59														CASSDPPPGGMGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCCCGGAGGTTGCTGAAGCTTTCTTTGGACAA	CASSPPEVAEAFF	In	VDJ	1	59	2.5410005512679164E-4	2.9424672837535907E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	1	6	6	3	23	34	45	40	48														CASSPPEVAEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTCCCCCACAGGGATGGACCTACAATGAGCAGTTCTTCGGGCCA	CASSYSPPQGWTYNEQFF	In	VDJ	1	56	2.4117971334068356E-4	2.792850303223747E-4	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	3	2	6	5	23	40	52	46	57														CASSYSPPQGWTYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGCCAGGGAAGATACTATGGCTACACCTTCGGTTCG	CASSYRQGRYYGYTF	In	VDJ	1	55	2.3687293274531423E-4	2.742977976380466E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	3	3	5	23	38	46	41	51														CASSYRQGRYYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCTACCGGAAATCCGGCGGATGGCTACACCTTCGGTTCG	CASSATGNPADGYTF	In	VDJ	1	55	2.3687293274531423E-4	2.742977976380466E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	7	5	6	15	0	23	35	-1	50	54						01,02								CASSATGNPADGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATACGAGTGCCAAAAACATTCAGTACTTCGGCGCC	CASSYTSAKNIQYF	In	VDJ	1	54	2.3256615214994487E-4	2.693105649537185E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	11	2	1	3	1	23	37	43	40	44														CASSYTSAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGCTCGCTGGGGCGATTTGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	54	2.3256615214994487E-4		52	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	7	0	8	9	6	23	40	54	49	60														X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAGGGGACACACCATGGGTTCCTATAATTCACCCCTCCACTTTGGGAAC	CASRRGHTMGSYNSPLHF	In	VDJ	1	54	2.3256615214994487E-4	2.693105649537185E-4	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	6	1	3	10	23	34	43	37	53														CASRRGHTMGSYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTTCCCCGGAGACTATGGCTACACCTTCGGTTCG	CASRFPGDYGYTF	In	VDJ	1	52	2.2395259095920618E-4	2.5933609958506224E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	10	2	3	7	0	23	34	-1	41	45														CASRFPGDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACAGGGGGCCCACTGAAGCTTTCTTTGGACAA	CASSDRGPTEAFF	In	VDJ	1	50	2.1533902976846747E-4	2.49361634216406E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	0	4	0	1	23	-1	45	35	46														CASSDRGPTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAGGGAGTTAGACACTGAAGCTTTCTTTGGACAA	CASRRELDTEAFF	In	VDJ	1	50	2.1533902976846747E-4	2.49361634216406E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	2	3	2	4	23	34	41	36	45														CASRRELDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGTAACCTAAACAATGAGCAGTTCTTCGGGCCA	CASSGNLNNEQFF	In	VDJ	1	49	2.1103224917309814E-4	2.443744015320779E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	9	5	6	1	23	35	44	41	45						01,02								CASSGNLNNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACAGCCGGGACAGGGGTTGAAAATGAGCAGTTCTTCGGGCCA	CATAGTGVENEQFF	In	VDJ	1	49	2.1103224917309814E-4	2.443744015320779E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	0	2	7	5	5	23	30	45	35	50														CATAGTGVENEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTATGGCRCCCATTATGGCTACACCTTCGGTTCG	CASSYYGXHYGYTF	In	VDJ	1	48	2.0672546857772878E-4	2.3938716884774975E-4	42	TCRBV06	TCRBV06-08	01	unresolved			TCRBJ01	TCRBJ01-02	01	1	9	0	5	2	6	23	39	44	41	50				TCRBD01,TCRBD02										CASSYYGXHYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	unresolved	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGGACAGGGGGACAGATACGCAGTATTTTGGCCCA	CASSLDRGTDTQYF	In	VDJ	1	47	2.0241868798235942E-4	2.3439993616342165E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	1	3	1	0	23	36	-1	37	47														CASSLDRGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATACCGGGACAGGAGATCAGCCCCAGCATTTTGGTGAT	CASSYTGTGDQPQHF	In	VDJ	1	44	1.8949834619625137E-4	2.194382381104373E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	4	5	4	2	23	37	49	41	51														CASSYTGTGDQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCTCACAGTCCGGGGCTCTAGAGAAGGGGCAGTACGTCGGGCCG		Out	VDJ	1	42	1.8088478500551269E-4		41	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	12	5	2	17	22	7	23	28	55	50	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGCAACCGGGGAGACAGGGTCATTTCATCAGCCCCAGCATTTTGGTGAT	CAATGETGSFHQPQHF	In	VDJ	1	42	1.8088478500551269E-4	2.0946377274178103E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	2	3	5	11	7	23	29	47	40	54														CAATGETGSFHQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTACAAAGGGGCTTCCAAACGCAGTATTTTGGCCCA		Out	VDJ	1	42	1.8088478500551269E-4		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	5	2	9	5	7	23	40	50	45	57														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTACCCTCGGCTAGGACGGTCGGTAGCTGAAGCTTTCTTTGGACAA	CASYPRLGRSVAEAFF	In	VDJ	1	40	1.7227122381477397E-4	1.994893073731248E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	8	1	7	6	12	9	23	32	48	44	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASYPRLGRSVAEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGGGACAGGGCTATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	40	1.7227122381477397E-4		41	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	4	1	3	23	36	46	37	49														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGTCTCCGGGGTTATCCCGGGGAGCTGTTTTTTGGAGAA	CASSYRLRGYPGELFF	In	VDJ	1	40	1.7227122381477397E-4	1.994893073731248E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	8	3	6	6	5	23	38	49	44	54														CASSYRLRGYPGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCACTAAAGAACAGAGCAACTATGGCTACACCTTCGGTTCG	CAITKEQSNYGYTF	In	VDJ	1	39	1.6796444321940464E-4	1.9450207468879667E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	10	3	5	2	10	3	23	30	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAITKEQSNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGTTATGAGACAAATGAACACTGAAGCTTTCTTTGGACAA	CASSVMRQMNTEAFF	In	VDJ	1	39	1.6796444321940464E-4	1.9450207468879667E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	6	0	8	2	23	34	46	42	48														CASSVMRQMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCTGGGATATGGGGGCAATGAGCAGTTCTTCGGGCCA	CASTLGYGGNEQFF	In	VDJ	1	39	1.6796444321940464E-4	1.9450207468879667E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	7	6	1	6	11	0	23	33	-1	44	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTLGYGGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTTGGGGACAGCCACTAATTCACCCCTCCACTTTGGGAAC	CASSYSLGTATNSPLHF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	0	5	6	4	4	23	40	51	44	55														CASSYSLGTATNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCTCGACAGGCAGGACTGAAGCTTTCTTTGGACAA	CASSFSTGRTEAFF	In	VDJ	1	36	1.550441014332966E-4	1.7954037663581233E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	4	5	0	4	23	-1	46	40	50														CASSFSTGRTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTCGGCCCAACCAATGAGCAGTTCTTCGGGCCA	CASSVGPTNEQFF	In	VDJ	1	36	1.550441014332966E-4	1.7954037663581233E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	5	9	0	6	3	5	23	35	41	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGPTNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCACTCCCCCCCTGGGGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	36	1.550441014332966E-4		46	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	0	6	1	3	7	0	23	40	-1	47	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCGCACTAGCGGGCTACGAGCAGTACTTCGGGCCG	CATALAGYEQYF	In	VDJ	1	36	1.550441014332966E-4	1.7954037663581233E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	10	3	4	3	4	0	23	30	-1	34	43						01,02								CATALAGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGGAGGCGGGGGCGGAATAGATACGCAGTATTTTGGCCCA	CAGGGGGIDTQYF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	11	7	2	5	4	6	23	29	40	33	46														CAGGGGGIDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGCCCGAGGGGGCCCCTCACAGATACGCAGTATTTTGGCCCA	CASGPRGPLTDTQYF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	5	0	2	6	4	23	32	45	38	49														CASGPRGPLTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCGCGGGGGGCACATATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	35	1.5073732083792723E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	7	1	4	2	6	23	36	46	38	52														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACTGGTGCGTCAGGGACCTAGTACTTCGGGCCA	CASSTGASGT*YF	Stop	VDJ	1	35	1.5073732083792723E-4		39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	5	0	7	12	12	2	23	35	52	47	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTGASGT*YF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATCATACAGGGATCTAGCACAGATACGCAGTATTTTGGCCCA	CASIIQGSSTDTQYF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	3	3	0	4	4	23	33	43	37	47														CASIIQGSSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAAAGGGCCCCCCGCCAGGCTACACCTTCGGTTCG		Out	VDJ	1	33	1.4212375964718854E-4		46	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	0	5	3	8	3	10	23	40	47	43	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTAAATCACAGGATGGGAACTATGGCTACACCTTCGGTTCG	CASSYSKSQDGNYGYTF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	4	2	6	5	23	40	51	46	56														CASSYSKSQDGNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCCGACAGGGTAGCACAGATACGCAGTATTTTGGCCCA	CAIRQGSTDTQYF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	2	3	0	3	1	23	30	40	33	41														CAIRQGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCAGGATAAGAACTATAGCTACACCTTCGGTTCG	CASSSQDKNYSYTF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	4	4	4	9	2	12	23	36	42	38	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSQDKNYSYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTCCGCCCTAGCGGGGGGCCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLRPSGGPSGANVLTF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	5	4	1	0	7	2	23	35	53	42	55														CASSLRPSGGPSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTAGATCGGCGGGAGCAGTACGTCGGGCCA	CASSLDRREQYV	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02			6	7	2	20	9	7	23	34	50	43	57								TCRBJ02-01,TCRBJ02-05						CASSLDRREQYV+TCRBV06-08+TCRBJ02-X	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGGAAAGGACAGGGGGGATACGAGCAGTACGTCGGGCCG	CAIRKGQGGYEQYV	In	VDJ	1	30	1.292034178610805E-4	1.496169805298436E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	1	17	4	15	23	34	48	38	63														CAIRKGQGGYEQYV+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACGGACAGGGGGGATGAGCAGTTCTTCGGGCCA	CASSTDRGDEQFF	In	VDJ	1	30	1.292034178610805E-4	1.496169805298436E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	1	8	2	1	23	35	47	37	48														CASSTDRGDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACCGTAGGGGCTTCTGAGGGCACTGAAGCTTTCTTTGGACAA	CASSYTVGASEGTEAFF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	51	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	5	2	4	5	10	23	38	48	43	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYTVGASEGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAGGGGTCGAACACTGAAGCTTTCTTTGGACAA	CASSYQGSNTEAFF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	1	0	2	23	-1	44	38	46														CASSYQGSNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCCGGGGGGCCCCGGCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	28	1.2058985667034178E-4		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	8	1	7	4	6	23	35	46	39	52														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGCCGGGACAGGGGATTGGCTACACCTTCGGTTCG	CASSLPGQGIGYTF	In	VDJ	1	27	1.1628307607497244E-4	1.3465528247685925E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	2	7	4	2	23	36	50	40	52														CASSLPGQGIGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTTTCTAGACGCGGTGGGCACTGAAGCTTTCTTTGGACAA	CASSDFLDAVGTEAFF	In	VDJ	1	27	1.1628307607497244E-4	1.3465528247685925E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	4	8	4	2	10	23	39	45	41	55						01,02								CASSDFLDAVGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACATTCATCTGGGGGTCTAACTATGGCTACACCTTCGGTTCG	CASTFIWGSNYGYTF	In	VDJ	1	27	1.1628307607497244E-4	1.3465528247685925E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	7	6	1	0	9	1	23	33	47	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTFIWGSNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGGAGCAGCTAACTATGGCTACACCTTCGGTTCG	CASSYGGAANYGYTF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	2	6	1	0	0	5	23	-1	43	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGGAANYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACATCGGACTAGCGACACCAACAGATACGCAGTATTTTGGCCCA	CASSYIGLATPTDTQYF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	1	6	3	3	6	23	38	50	41	56						01,02								CASSYIGLATPTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGACTAGCGGGGGCCCAAGAGACCCAGTACTTCGGGCCA	CASSYGLAGAQETQYF	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	1	2	1	0	1	23	-1	51	38	52														CASSYGLAGAQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGGAGGGGGGCCAGGGAGCCAGATACGCAGTATTTTGGCCCA	CAIRRGAREPDTQYF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	6	5	1	4	1	10	23	34	41	35	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIRRGAREPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTTCGACCTCGGGTAGCGATACGCAGTATTTTGGCCCA	CASSYSSTSGSDTQYF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	5	7	6	12	0	23	40	-1	52	56						01,02								CASSYSSTSGSDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGAGACAGGGGTTGGATGAGCAGTTCTTCGGGCCA	CASSERQGLDEQFF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	2	8	4	4	23	35	47	39	51														CASSERQGLDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGGGTCCTCGGCGGGGACAGATACGCAGTATTTTGGCCCA	CASSDSGSSAGTDTQYF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	7	3	3	10	0	23	40	-1	50	56														CASSDSGSSAGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTATCTTTCGGGGAGACCCAGTACTTCGGGCCA	CASSLSFGETQYF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	8	4	5	8	0	23	35	-1	43	47						01,02								CASSLSFGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAACTATCCGGGGGGGCTAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSNYPGGLNTGELFF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	8	0	2	3	3	23	39	50	42	53														CASSNYPGGLNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCCGTCGACAGTCTGATCACAGTGCCCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	24	1.0336273428886439E-4		58	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	5	3	7	15	23	34	46	41	61														X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCTGTGTACTTGTGTGCCAGCAGTAACTTTCAAGGAGCTCGTAGCAGGGAACAGTTTTACAATGAGCAGTTCTTCGGGCCA	CASSNFQGARSREQFYNEQFF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	63	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	4	3	4	16	8	12	28	49	44	57														CASSNFQGARSREQFYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGGCTAGCGGGGGGCAATGAGCAGTTCTTCGGGCCA	CASGLAGGNEQFF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	4	1	6	3	0	23	32	-1	35	46														CASGLAGGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCCTCCCAGCGCCCCAACACGAGCAGTTCTTCGGGCCA	CAISLPAPQHEQFF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	6	6	10	6	9	23	34	44	40	53						01,02								CAISLPAPQHEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTTGGACAGGGAATAATGAGCAATTCTTCGGGCCA	CASSVWTGNNEQFF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	3	16	4	12	23	35	47	39	59														CASSVWTGNNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGATGGGACAGGGGAATAATCAGCCCCAGCATTTTGGTGAT	CASSEMGQGNNQPQHF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	2	4	5	3	23	35	50	40	53														CASSEMGQGNNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGGAGTCGGGGGCCTCCGGGGAGCTGTTTTTTGGAGAA	CASSPESGASGELFF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	5	6	0	6	8	2	23	35	49	43	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPESGASGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGGACCTCAGATACGCAGTATTTTGGCCCA	CASSRTSDTQYF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	6	1	7	4	2	2	23	34	40	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTSDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTCCTTCGGAAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFPSETNTGELFF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	4	1	8	0	7	2	23	36	46	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFPSETNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGGGCCAGACAAAACTATGGCTACACCTTCGGTTCG	CASSYSRARQNYGYTF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	11	0	2	0	8	23	-1	45	40	53														CASSYSRARQNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTGGGACGGGGAATAAGAACCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	21	9.044239250275634E-5		50	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	0	7	17	3	28	23	35	43	38	71				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCACCTGGGGCGATTGGGAAAGCTTTCTTTGGACAA	CASSPPGAIGKAFF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	7	0	9	6	8	23	35	46	41	54														CASSPPGAIGKAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGGACGAGTCGGGGCGAGAACACTGAAGCTTTCTTTGGACAA	CAIRTSRGENTEAFF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	7	0	1	8	2	23	34	47	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIRTSRGENTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCACTAGAAGATACGCAGTATTTTGGCCCA	CASSSLEDTQYF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	3	8	5	1	1	23	36	42	37	43						01,02								CASSSLEDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGATAAGGATCCGGGGAGCTGTTTTTTGGAGAA	CASSG*GSGELFF	Stop	VDJ	1	20	8.613561190738698E-5		39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	5	1	8	6	0	7	23	-1	38	35	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSG*GSGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACTCGGACTAGCGGGAACAGATACGCAGTATTTTGGCCCA	CASRLGLAGTDTQYF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	1	3	3	4	0	23	34	-1	38	50														CASRLGLAGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCTCGGGCGTGACAGGGGGGGAGTTGGCTACACCTTCGGTTCG		Out	VDJ	1	19	8.182883131201764E-5		47	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	1	7	9	5	23	34	52	43	57														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCCCCCGGGGGGCGCGATCTATGGCTACACCTTCGGTTCG	CASSYSPPGGAIYGYTF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	8	1	4	5	6	23	40	52	45	58														CASSYSPPGGAIYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCTCAGAGGGCTATGGCTACACCTTCGGTTCG	CASSYSSEGYGYTF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	11	0	4	4	0	23	40	-1	44	49														CASSYSSEGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCACGGACTAGCGGGGGGGCCTGGGGCAGATACGCAGTATTTTGGCCCA	CASSHGLAGGPGADTQYF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	1	0	4	4	7	23	34	53	38	60														CASSHGLAGGPGADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCACTCCCCCAGTTAAAGACAGGCCCCCTTAATATGGCTACACCTTCGGTTCG	CAITPPVKDRPP*YGYTF	Stop	VDJ	1	18	7.75220507166483E-5		54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	2	4	5	17	9	23	30	53	47	62														CAITPPVKDRPP*YGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCTACAGGGGGCGCATACTGAAGCTTTCTTTGGACAA	CASSSLQGAHTEAFF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	0	5	4	4	23	36	49	40	53														CASSSLQGAHTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACCCCCGGACAGAATTCACCCCTCCACTTTGGGAAC	CASSYTPGQNSPLHF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	1	5	7	6	0	23	38	-1	44	50														CASSYTPGQNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGACAGGGCTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSEDRASNQPQHF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	3	0	2	1	23	35	45	37	46														CASSEDRASNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCGACAGATGAACACTGAAGCTTTCTTTGGACAA	CASSPRQMNTEAFF	In	VDJ	35	2361	0.010168308985667035	0.011774856367698691	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	5	0	2	1	24	38	45	40	46													Vb 18	CASSPRQMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTGGACGGGACGGGGAGCTGTTTTTTGGAGAA	CASSPPGRDGELFF	In	VDJ	16	1090	0.004694390848952591	0.005436083625917651	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	8	3	7	4	0	24	41	-1	45	50													Vb 18	CASSPPGRDGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGAGACCATAGCACAGATACGCAGTATTTTGGCCCA	CASSPRDHSTDTQYF	In	VDJ	13	897	0.0038631821940463065	0.004473547717842323	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	1	2	7	0	2	3	24	40	45	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRDHSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCAGGGTATATACACTGAAGCTTTCTTTGGACAA	CASSPQGIYTEAFF	In	VDJ	12	779	0.0033549820837927235	0.0038850542610916056	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	3	3	1	5	24	38	44	39	49													Vb 18	CASSPQGIYTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACAGCTAGCGAGATAAGCACAGATACGCAGTATTTTGGCCCA	CASSPTASEISTDTQYF	In	VDJ	9	598	0.002575454796030871	0.0029823651452282156	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	6	0	4	5	24	39	49	43	54						01,02							Vb 18	CASSPTASEISTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGATCAGAGCCGACAGCCCCAGCATTTTGGTGAT	CASSDQSRQPQHF	In	VDJ	6	409	0.001761473263506064	0.002039778167890201	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	5	4	5	7	3	6	24	36	42	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSDQSRQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACGACAGGGGCGGGTACGCAGTATTTTGGCCCA	CASSPTTGAGTQYF	In	VDJ	6	394	0.0016968715545755237	0.0019649696776252792	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	2	2	8	3	4	24	38	49	41	53													Vb 18	CASSPTTGAGTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGCGGACAGGGTCAGGGGGAGCAGTACTTCGGGCCG	CASSPRGQGQGEQYF	In	VDJ	6	374	0.0016107359426681368	0.001865225023938717	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	3	7	2	7	24	40	50	42	57													Vb 18	CASSPRGQGQGEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAATGGAGATGAACACTGAAGCTTTCTTTGGACAA	CASSPMEMNTEAFF	In	VDJ	5	351	0.0015116799889746417	0.0017505186721991702	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	10	2	0	2	1	24	39	45	41	46													Vb 18	CASSPMEMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAATCGACAGGCGCTTCGCGAAAAACTGTTTTTTGGCAGT		Out	VDJ	5	331	0.0014255443770672548		44	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	4	8	3	8	24	36	45	39	53													Vb 18	X+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCATACCGACAGGGATAGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	5	310	0.0013351019845644983		47	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	3	3	7	4	24	36	50	43	54													Vb 18	X+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCATAACCAGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSITRGQETQYF	In	VDJ	4	293	0.0012618867144432195	0.0014612591765081392	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	2	1	6	0	24	35	-1	41	47													Vb 18	CASSITRGQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCCTGGGAAGGACGGTGAAGCTTTCTTTGGACAA	CASSPPGKDGEAFF	In	VDJ	4	278	0.0011972850055126793	0.0013864506862432174	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	0	8	7	4	7	24	38	46	42	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPGKDGEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGGACAGGGGGCTTCAGCTATGGCTACACCTTCGGTTCG	CASSPGTGGFSYGYTF	In	VDJ	4	276	0.0011886714443219404	0.0013764762208745612	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	0	4	1	5	24	38	51	39	56													Vb 18	CASSPGTGGFSYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCATTACTGGTGGTCGATCGGTTCTTTTGGCAGT	CASSHYWWSIGSF	In	VDJ	4	242	0.0010422409040793826	0.001206910309607405	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	6	3	10	19	5	16	24	35	43	40	59						01,02							Vb 18	CASSHYWWSIGSF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGACTCTGGAAACACCATATATTTTGGAGAG	CASSPPDSGNTIYF	In	VDJ	3	227	9.776391951488424E-4	0.0011321018193424833	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	0	1	8	0	0	0	24	-1	-1	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPDSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCAGGGGGCTTAGAGACCCAGTACTTCGGGCCA	CASSPPGGLETQYF	In	VDJ	3	199	8.570493384785006E-4	9.924593041812958E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	5	0	4	0	2	24	-1	48	41	50													Vb 18	CASSPPGGLETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCACGACAGGGAACCCCCTCAGGTGGCTACACCTTCGGTTCG	CASSSRQGTPSGGYTF	In	VDJ	2	153	6.589374310915104E-4	7.630466007022024E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	3	7	0	12	24	-1	47	40	59													Vb 18	CASSSRQGTPSGGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTGGGACAGGTCTGCGTGGGTCCCAGCATTTTGGTGAT	CASSGTGLRGSQHF	In	VDJ	2	146	6.28789966923925E-4	7.281359719119055E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	4	11	1	11	24	35	44	36	55													Vb 18	CASSGTGLRGSQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCGATGGGGGGTACGAGCAGTACGTCGGGCCG	CASSDGGYEQYV	In	VDJ	2	143	6.15869625137817E-4	7.131742738589211E-4	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	9	1	17	4	13	24	35	45	39	58													Vb 18	CASSDGGYEQYV+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAGGGAGGGCAGGTGAACAATGAGCAGTTCTTCGGGCCA	CASSPQGGQVNNEQFF	In	VDJ	2	143	6.15869625137817E-4	7.131742738589211E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	9	0	5	1	7	24	40	48	41	55													Vb 18	CASSPQGGQVNNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTGGGGGCAGACTTCCAAGAGACCCAGTACTTCGGGCCA	CASSLGADFQETQYF	In	VDJ	2	132	5.684950385887542E-4	6.583147143313119E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	6	0	1	1	6	24	37	44	38	50													Vb 18	CASSLGADFQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAAGAGGACTAGCGGGGAACACAGATACGCAGTATTTTGGCCCA	CASSRGLAGNTDTQYF	In	VDJ	2	116	4.995865490628446E-4	5.785189913820619E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	1	3	2	3	2	24	36	51	39	53													Vb 18	CASSRGLAGNTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGAAACGTTGATACGCAGTATTTTGGCCCA	CASSPGNVDTQYF	In	VDJ	2	111	4.7805264608599777E-4	5.535828279604213E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	3	0	8	6	0	6	24	-1	42	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGNVDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCTAGGACCGGGTACGGAAACGCAGTATTTTGGCCCA	CASSLGPGTETQYF	In	VDJ	2	104	4.4790518191841237E-4	5.186721991701245E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	6	1	7	9	4	11	24	35	43	39	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSLGPGTETQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGCTTCGGGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPASGATNEKLFF	In	VDJ	2	102	4.3929162072767365E-4	5.086977338014683E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	2	8	2	0	4	0	24	39	-1	43	49													Vb 18	CASSPASGATNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGTCGGACAGTCGGGGAGCAAAAACATTCAGTACTTCGGCGCC	CASSVGQSGSKNIQYF	In	VDJ	1	95	4.091441565600882E-4	4.737871050111714E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	1	5	3	3	8	24	36	45	39	53													Vb 18	CASSVGQSGSKNIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTAGACTCAACGACAGGGGAGGAGGTCGGGAACACTGAAGCTTTCTTTGGACAA	CASSLDSTTGEEVGNTEAFF	In	VDJ	1	92	3.9622381477398013E-4	4.5882540695818704E-4	60	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	2	1	10	10	21	34	52	44	62													Vb 18	CASSLDSTTGEEVGNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCCCGCTGAGAGACGGAGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	87	3.746899117971334E-4		47	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	8	10	2	0	12	0	24	33	-1	45	49													Vb 18	X+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCGACAGGGGATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	85	3.6607635060639473E-4		46	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	2	0	3	1	24	38	49	41	50													Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCACCGGGCCGAACAATGAGCAGTTCTTCGGGCCA	CASSPTGPNNEQFF	In	VDJ	1	84	3.6176957001102537E-4	4.1892754548356206E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	3	8	0	5	4	3	24	38	46	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPTGPNNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCGATGCCGGGGCTCATGGCTACACCTTCGGTTCG	CASSDAGAHGYTF	In	VDJ	1	79	3.4023566703417864E-4	3.939913820619215E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	6	7	0	6	7	2	24	35	47	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSDAGAHGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTTTCGAGCGGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLSSGGNTGELFF	In	VDJ	1	78	3.359288864388093E-4	3.8900414937759333E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	6	2	1	5	0	24	37	-1	42	50													Vb 18	CASSLSSGGNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAAAGACAGGGAGTAATGAAAAACTGTTTTTTGGCAGT	CASSKTGSNEKLFF	In	VDJ	1	78	3.359288864388093E-4	3.8900414937759333E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	3	4	2	2	24	36	45	38	47													Vb 18	CASSKTGSNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCAAAGGCCAGGGGCAGGGCATTCAGTACTTCGGCGCC	CASSPKGQGQGIQYF	In	VDJ	1	70	3.0147464167585447E-4	3.491062879029684E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	4	2	9	7	5	24	38	51	45	56													Vb 18	CASSPKGQGQGIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGCCGGGACCAGCCCCAGCATTTTGGTGAT	CASSPGRDQPQHF	In	VDJ	1	70	3.0147464167585447E-4	3.491062879029684E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	2	0	7	7	4	0	24	39	-1	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGRDQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGGGGGTCGAATCTAGCACAGATACGCAGTATTTTGGCCCA	CASSGVESSTDTQYF	In	VDJ	1	64	2.756339581036384E-4	3.191828917969997E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	6	6	1	0	0	8	24	-1	40	35	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSGVESSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGTTAGACATGACTACCGACTACGAGCAGTACTTCGGGCCG	CASSPLDMTTDYEQYF	In	VDJ	1	63	2.71327177508269E-4	3.141956591126716E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	2	9	3	9	4	24	38	52	47	56						01,02							Vb 18	CASSPLDMTTDYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTGCCAGATTTAAATCCTACGAGCAGTACTTCGGGCCG	CASSPPARFKSYEQYF	In	VDJ	1	60	2.58406835722161E-4	2.992339610596872E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	5	1	3	7	24	41	47	44	54													Vb 18	CASSPPARFKSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCAGGGAGGGGACAGATACGCAGTATTTTGGCCCA	CASSLREGTDTQYF	In	VDJ	1	55	2.3687293274531423E-4	2.742977976380466E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	9	0	3	3	1	24	37	47	40	48													Vb 18	CASSLREGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTATGAGCAGAACCACCGGGGAGCTGTTTTTTGGAGAA	CASSPMSRTTGELFF	In	VDJ	1	52	2.2395259095920618E-4	2.5933609958506224E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	3	4	5	4	6	3	24	38	47	44	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPMSRTTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGTTTAGGCAGGGTGGCGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	52	2.2395259095920618E-4		46	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	3	8	8	4	24	38	51	46	55													Vb 18	X+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACCCAGGACAGGGGTAATGAGCAGTTCTTCGGGCCA	CASSPTQDRGNEQFF	In	VDJ	1	52	2.2395259095920618E-4	2.5933609958506224E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	2	7	5	1	24	39	53	44	54													Vb 18	CASSPTQDRGNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAAATAAACAGGGGTGGCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	52	2.2395259095920618E-4		43	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	2	17	5	17	24	36	48	41	65													Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCTCCAACACCGGCGGGGGGTACGTGTTAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	47	2.0241868798235942E-4		61	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	7	1	2	12	9	20	34	54	46	63													Vb 18	X+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCGACTAGCGGGGCAGCAGATACGCAGTATTTTGGCCCA	CASSPTSGAADTQYF	In	VDJ	1	47	2.0241868798235942E-4	2.3439993616342165E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	2	3	4	3	3	24	35	49	38	52													Vb 18	CASSPTSGAADTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGCTCCGGGATACTCACTGAAGCTTTCTTTGGACAA	CASSRSGILTEAFF	In	VDJ	1	45	1.9380512679162073E-4	2.244254707947654E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	8	3	4	4	4	24	37	46	41	50													Vb 18	CASSRSGILTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCACCGGGACTAGCGGGGTGAGCACAGATACGCAGTATTTTGGCCCA	CASTGTSGVSTDTQYF	In	VDJ	1	45	1.9380512679162073E-4	2.244254707947654E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	0	3	0	3	2	24	33	49	36	51													Vb 18	CASTGTSGVSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACAGGGAACCCCCAAGAGACCCAGTACTTTGGGCCA	CASSTGNPQETQYF	In	VDJ	1	43	1.8519156560088202E-4	2.1445100542610916E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02			5	3	3	22	0	24	24	-1	42	36	66								TCRBJ02-01,TCRBJ02-05					Vb 18	CASSTGNPQETQYF+TCRBV18-01+TCRBJ02-X	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGGGCGGACTGAAGCTTTCTTTGGACAA	CASSPGRTEAFF	In	VDJ	1	41	1.7657800441014333E-4	2.0447654005745293E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	8	0	5	1	2	24	38	43	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGRTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGTATCCCACGGACTTATAATTCACCCCTCCACTTTGGGAAC	CASSPSIPRTYNSPLHF	In	VDJ	1	41	1.7657800441014333E-4	2.0447654005745293E-4	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	2	1	10	4	10	0	24	39	-1	49	54						01,02							Vb 18	CASSPSIPRTYNSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD02-01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGCCGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPPPTNTGELFF	In	VDJ	1	38	1.6365766262403528E-4	1.8951484200446856E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	0	2	8	0	3	0	24	41	-1	44	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPPTNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGTTTAACGGGGGGCAACGATGAGCAGTTCTTCGGGCCA	CASSPGLTGGNDEQFF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	8	1	8	8	5	24	38	53	46	58													Vb 18	CASSPGLTGGNDEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTGGACAGGGCGGCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	35	1.5073732083792723E-4		40	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	3	7	1	3	24	37	46	38	49													Vb 18	X+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTTACGGGGCCTAACACTGAAGCTTTCTTTGGACAA	CASSLTGPNTEAFF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	4	7	0	2	4	2	24	37	46	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSLTGPNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGGCGACAGGGTTGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	32	1.378169790518192E-4		41	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	3	3	3	3	24	35	45	38	48													Vb 18	X+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCTCGGGACTAGATGGCTATGAGCAGTTCTTCGGGCCA	CASSSGLDGYEQFF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	8	8	3	6	24	35	46	38	52						01,02							Vb 18	CASSSGLDGYEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAATGGGACCCGAAGCTTTCTTTGGACAA	CASSPMGPEAFF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	2	0	7	8	2	2	24	39	46	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPMGPEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGACAGGGGAGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGTGEDTGELFF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	0	2	3	0	3	24	-1	49	39	52													Vb 18	CASSPGTGEDTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACTATCCTGGGGGCTCCGATTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	25	1.0766951488423373E-4		49	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	6	0	4	8	7	24	36	50	44	57													Vb 18	X+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCAGGACAGGGCTTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSQDRASYNSPLHF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	1	3	1	3	2	24	35	46	38	48													Vb 18	CASSQDRASYNSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCACTACAGGGAGAGAAGAAAAACTGTTTTTTGGCAGT	CASSTTGREEKLFF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	3	8	4	6	24	35	45	39	51													Vb 18	CASSTTGREEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGGGACTGGACCGAACACTGAAGCTTTCTTTGGACAA	CASSGTGPNTEAFF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	0	10	1	0	5	24	-1	42	36	47						01,02							Vb 18	CASSGTGPNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTCTGCATACTATGGCTACACCTTCGGTTCG	CASSSAYYGYTF	In	VDJ	86	5813	0.025035315600882027	0.028990783593999363	36	TCRBV12						TCRBJ01	TCRBJ01-02	01	6	4	6	3	5	1	26	37	44	42	45		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSAYYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCGACAGGGGGGGTCACTGAAGCTTTCTTTGGACAA	CSARATGGVTEAFF	In	VDJ	67	4512	0.019432194046306504	0.022502393871688477	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	1	4	3	3	26	37	49	40	52		TCRBV20-01,TCRBV20-or09_02												CSARATGGVTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGGGGCAGACAGGAGCTCCTACGAGCAGTACGTCGGGCCG	CATSDGADRSSYEQYV	In	VDJ	57	3817	0.016438981532524807	0.019036267156080432	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	4	17	6	19	24	39	51	45	70		TCRBV24-01,TCRBV24-or09_02												CATSDGADRSSYEQYV+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGAACATTGGGATCACTGAAGCTTTCTTTGGACAA	CASRNIGITEAFF	In	VDJ	54	3649	0.015715442392502756	0.01819841206511331	39	TCRBV24						TCRBJ01	TCRBJ01-01	01	7	0	8	4	7	1	24	35	46	42	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRNIGITEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTAGAGGGCGTGACGAACACTGAAGCTTTCTTTGGACAA	CASSLEGVTNTEAFF	In	VDJ	39	2638	0.011361287210584345	0.01315631982125758	45	TCRBV12						TCRBJ01	TCRBJ01-01	01	1	5	3	1	0	6	26	-1	46	42	52		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGVTNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCCCCGGGGTAGCGGATCAAGAGACCCAGTACTTCGGGCCA	CATSAPGVADQETQYF	In	VDJ	25	1713	0.007377515159867696	0.008543129588254069	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	5	5	2	9	2	24	37	52	46	54		TCRBV24-01,TCRBV24-or09_02				01,02								CATSAPGVADQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCAGAGTGCGGGTTATGGCTACACCTTCGGTTCG	CATSDQSAGYGYTF	In	VDJ	25	1666	0.007175096471885336	0.008308729652090648	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	7	4	5	7	1	24	38	50	45	51		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDQSAGYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATGCGGGGGGGGCCTACGAGCAGTACTTCGGGCCG	CASSQDAGGAYEQYF	In	VDJ	22	1472	0.006339581036383682	0.007341206511330993	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	7	0	2	1	1	23	40	50	41	51	TCRBV01,TCRBV04													CASSQDAGGAYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCGGGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGGAYNEQFF	In	VDJ	16	1067	0.0045953348952590956	0.005321377274178104	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	0	2	2	0	24	36	-1	38	46		TCRBV24-01,TCRBV24-or09_02												CASSPGGAYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGACAACAGGGGGCCTATAATTCACCCCTCCACTTTGGGAAC	CASRQQGAYNSPLHF	In	VDJ	16	1061	0.00456949421168688	0.005291453878072136	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	1	2	3	0	22	33	-1	36	44	TCRBV02,TCRBV12													CASRQQGAYNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGTGAAGGGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	16	1054	0.004539346747519294		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	5	2	6	3	0	23	39	-1	42	47	TCRBV01,TCRBV04													X+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTGGTTCGGGATGACCAGCCCCAGCATTTTGGTGAT	CASSLVRDDQPQHF	In	VDJ	15	986	0.004246485667034178	0.004917411426747526	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	8	3	7	4	4	26	40	49	44	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSLVRDDQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD02-01*02	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATACGGCGGGGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLYGGVSYNEQFF	In	VDJ	12	832	0.003583241455347299	0.004149377593360996	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	7	3	0	7	1	24	36	49	43	50		TCRBV24-01,TCRBV24-or09_02												CASSLYGGVSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACGATTGGGGTAAGGAGTGAAGCTTTCTTTGGACAA	CSTIGVRSEAFF	In	VDJ	11	739	0.003182710859977949	0.0036855649537184806	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	8	6	2	7	6	7	26	32	42	38	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSTIGVRSEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCTTTTTCACACCTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSAPLFHTSNTGELFF	In	VDJ	11	737	0.0031740972987872105	0.0036755904883498244	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	6	0	10	3	26	35	48	45	51		TCRBV20-01,TCRBV20-or09_02												CSAPLFHTSNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCGACGGGGGGAGTCACTGAAGCTTTCTTTGGACAA	CSARATGGVTEAFF	In	VDJ	11	716	0.003083654906284454	0.003570858601978934	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	1	4	5	3	26	37	49	42	52		TCRBV20-01,TCRBV20-or09_02												CSARATGGVTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGTCATGGGGGGATTCGGATACGCAGTATTTTGGCCCA	CSAGSWGDSDTQYF	In	VDJ	8	561	0.0024161039140022053	0.0027978375359080754	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	9	1	6	7	5	26	35	48	42	53		TCRBV20-01,TCRBV20-or09_02												CSAGSWGDSDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAATGGGTTCCTTGGGTAGCTTCCTATAATTCACCCCTCCACTTTGGGAAC	CAISEWVPWVASYNSPLHF	In	VDJ	8	527	0.002269673373759647	0.0026282716246409195	57				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	2	5	7	1	13	1	23	38	55	51	56	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-08,TCRBV10-03				01,02								CAISEWVPWVASYNSPLHF+X+TCRBJ01-06		TCRBD02-01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAAGAAGAGACAGGGGGAAACACCATATATTTTGGAGAG	CASSEEETGGNTIYF	In	VDJ	8	520	0.002239525909592062	0.0025933609958506223	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	2	3	4	4	0	23	39	-1	43	50	TCRBV02,TCRBV12													CASSEEETGGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGTCCGGTGATCACTTGGGAAGATACGCAGTATTTTGGCCCA	CASSPVITWEDTQYF	In	VDJ	8	517	0.0022266055678059537	0.002578399297797638	45	unresolved						TCRBJ02	TCRBJ02-03	01	6	0	8	5	14	0	18	29	-1	43	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPVITWEDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGGCTACGGGGGAAAGGGAGCAGTTCTTCGGGCCA	CRATGEREQFF	In	VDJ	7	496	0.0021361631753031973	0.0024736674114267474	33	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	8	2	10	0	5	26	-1	42	36	47		TCRBV20-01,TCRBV20-or09_02												CRATGEREQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCGCGTGACGCAGCAGCCTCCGGTGAGACCCAGTACTTCGGGCCA	CSARPRDAAASGETQYF	In	VDJ	7	485	0.0020887885887541347	0.0024188078518991383	51	TCRBV20						TCRBJ02	TCRBJ02-05	01	2	2	7	5	6	15	26	38	47	44	62		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPRDAAASGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTAGTCTGAGTCCGATCCCTGAAGCTTTCTTTGGACAA	CASSSLSPIPEAFF	In	VDJ	7	460	0.0019811190738699006	0.0022941270347909353	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	2	6	5	8	26	38	46	43	54		TCRBV12-03,TCRBV12-04												CASSSLSPIPEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTAAACCGGGACTAGCGGGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	6	385	0.0016581105292171995		53	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	4	1	6	0	26	39	-1	45	57		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTATCCTCCGGGACGGAAGAGACCCAGTACTTCGGGCCA	CASSLSSGTEETQYF	In	VDJ	6	374	0.0016107359426681368	0.001865225023938717	45	unresolved						TCRBJ02	TCRBJ02-05	01	2	0	7	3	6	2	18	33	44	39	46	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSSGTEETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACTAATAGACAGGCTTCCCCCTCCTACGAGCAGTACTTCGGGCCG	CSARTNRQASPSYEQYF	In	VDJ	6	371	0.0015978156008820286	0.0018502633258857325	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	4	0	7	7	26	38	51	45	58		TCRBV20-01,TCRBV20-or09_02												CSARTNRQASPSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTTCATGGGGAAGCCAATGAGCAGTTCTTCGGGCCA	CATSDFHGEANEQFF	In	VDJ	5	365	0.0015719749173098126	0.0018203399297797638	45	TCRBV24						TCRBJ02	TCRBJ02-01	01	1	0	8	6	5	3	24	41	50	46	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDFHGEANEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTGGGCGGGGGGGCTCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	5	358	0.001541827453142227		43	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	0	6	3	2	24	37	49	40	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCTGTAGCGGGGGCCTTATACAATGAGCAGTTCTTCGGGCCA	CASSSVAGALYNEQFF	In	VDJ	5	341	0.0014686121830209482	0.001700646345355889	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	5	2	4	4	5	24	36	49	40	54		TCRBV24-01,TCRBV24-or09_02												CASSSVAGALYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCCCTCACTGGGGACAGCTATAATTCACCCCTCCACTTTGGGAAC	CASSQDPLTGDSYNSPLHF	In	VDJ	5	332	0.001429851157662624	0.0016557612511969358	57	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	0	5	3	11	0	24	41	-1	52	59		TCRBV03-01,TCRBV03-02												CASSQDPLTGDSYNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAATGATTTGCCAGGCCGAAAACATTCAGTACTTCGGCGCC		Out	VDJ	5	320	0.0013781697905181918		43	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	4	4	5	1	3	24	42	47	43	50		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD01-01*01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCGGGGAGGCTGGTGGCTACACCTTCGGTTCG	CSAPGEAGGYTF	In	VDJ	5	318	0.0013695562293274531	0.0015859399936163422	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	9	1	7	5	4	26	34	45	39	49		TCRBV20-01,TCRBV20-or09_02												CSAPGEAGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCACCGGGCCCGGGACAGGGACCGGGGCCAACGTCCTGACTTTCGGGGCC	CSATTGPGTGTGANVLTF	In	VDJ	5	311	0.0013394087651598676	0.0015510293648260452	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	0	3	4	11	3	26	36	56	47	59		TCRBV20-01,TCRBV20-or09_02												CSATTGPGTGTGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD01-01*01	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCCCGGGGGGCAGCCCCAGCATTTTGGTGAT	CASSHPGGQPQHF	In	VDJ	4	290	0.0012489663726571113	0.0014462974784551549	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	8	1	7	3	0	26	40	-1	43	50		TCRBV03-01,TCRBV03-02												CASSHPGGQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTCCACAACTCCTTCACAGATACGCAGTATTTTGGCCCA	CATSDFHNSFTDTQYF	In	VDJ	4	280	0.0012058985667034179	0.0013964251516118736	48	TCRBV24						TCRBJ02	TCRBJ02-03	01	1	3	6	2	2	7	24	41	46	43	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDFHNSFTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCAAAGACACTTCTCAAGAGACCCAGTACTTCGGGCCA	CASSKDTSQETQYF	In	VDJ	4	279	0.0012015917861080486	0.0013914379189275455	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	6	2	3	5	22	34	41	37	46	TCRBV07,TCRBV11													CASSKDTSQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCACCTCACAGGGAGCGCTGAAAAACTGTTTTTTGGCAGT	CASSHLTGSAEKLFF	In	VDJ	4	276	0.0011886714443219404	0.0013764762208745612	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	3	7	6	5	24	36	48	42	53	TCRBV24,TCRBV27													CASSHLTGSAEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCTTGGTAGGGCCATTCAGTACTTCGGCGCC	CASSQDLGRAIQYF	In	VDJ	4	275	0.0011843646637265711	0.001371488988190233	42	TCRBV03						TCRBJ02	TCRBJ02-04	01	0	5	3	9	7	1	26	43	54	50	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDLGRAIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03		TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGATGAGGTGGCGGTACCAGATACGCAGTATTTTGGCCCA	CSAGDEVAVPDTQYF	In	VDJ	4	273	0.0011757511025358323	0.0013615145228215767	45	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	0	8	4	1	14	26	35	40	36	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGDEVAVPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGGTCAACAGGGTCTGCCAAAAACATTCAGTACTTCGGCGCC	CASRSTGSAKNIQYF	In	VDJ	4	272	0.001171444321940463	0.0013565272901372486	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	3	3	1	4	3	23	34	44	38	47	TCRBV02,TCRBV12													CASRSTGSAKNIQYF+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAAGAGGGCGGAGGTAGCTCTGGAAACACCATATATTTTGGAGAG	CASSEEGGGSSGNTIYF	In	VDJ	4	271	0.0011671375413450937	0.0013515400574529205	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	1	10	1	0	5	3	23	39	49	44	52	TCRBV02,TCRBV12													CASSEEGGGSSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGCAAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLQTNTGELFF	In	VDJ	4	269	0.001158523980154355	0.0013415655920842643	42	unresolved						TCRBJ02	TCRBJ02-02	01	3	4	6	0	1	2	18	32	35	33	37	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQTNTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTACAGGGGGCTGGTGAAGCTTTCTTTGGACAA	CASSLQGAGEAFF	In	VDJ	4	260	0.001119762954796031	0.0012966804979253112	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	0	7	1	3	26	39	49	40	52		TCRBV03-01,TCRBV03-02												CASSLQGAGEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TTTCTGTGCCAGCAGCCAAGATCGCCCAACCGGTCTCGCAGGGTGACACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	4	258	0.001111149393605292		64	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	3	2	17	4	4	21	43	38	47		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGTCGGACAGGTACGCGAGCAGTACTTCGGGCCG	CASSVGQVREQYF	In	VDJ	4	248	0.0010680815876515986	0.0012368337057133737	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	4	6	2	4	23	36	45	38	49	TCRBV02,TCRBV09													CASSVGQVREQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTACCAGGGGCTTCAATGAACACTGAAGCTTTCTTTGGACAA	CSVPGASMNTEAFF	In	VDJ	4	247	0.0010637748070562293	0.0012318464730290456	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	2	0	3	6	26	33	42	36	48		TCRBV20-01,TCRBV20-or09_02												CSVPGASMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGATTCCCTCCTAGCGGGGGGGAACACCTACGAGCAGTACTTCGGGCCG	CSADSLLAGGNTYEQYF	In	VDJ	4	240	0.001033627342888644	0.0011969358442387489	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	4	0	2	9	4	26	35	56	44	60		TCRBV20-01,TCRBV20-or09_02												CSADSLLAGGNTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGAAACGGGACTAGGTGGGTATGAGCAGTTCTTCGGGCCA	CATETGLGGYEQFF	In	VDJ	3	225	9.690256339581037E-4	0.001122127353973827	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	9	0	8	8	5	6	24	33	46	38	52		TCRBV24-01,TCRBV24-or09_02				01,02								CATETGLGGYEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGGACAGGGGGACTATAGCAATCAGCCCCAGCATTTTGGTGAT	CATSDGQGDYSNQPQHF	In	VDJ	3	221	9.517985115766262E-4	0.0011021784232365145	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	1	0	1	4	24	38	49	39	53		TCRBV24-01,TCRBV24-or09_02												CATSDGQGDYSNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCGGTGAACACTGAAGCTTTCTTTGGACAA	CASSLAVNTEAFF	In	VDJ	3	216	9.302646085997795E-4	0.001077242259814874	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	0	0	10	0	0	0	26	-1	-1	43	45		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAVNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGGACGGTGGAACACTGAAGCTTTCTTTGGACAA	CASGRWNTEAFF	In	VDJ	3	207	8.915035832414553E-4	0.0010323571656559209	36	TCRBV24						TCRBJ01	TCRBJ01-01	01	11	1	7	1	2	4	24	31	37	33	41		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGRWNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAAAGACCTGAGGGACAATGAGCAGTTCTTCGGGCCA	CSAKDLRDNEQFF	In	VDJ	3	206	8.87196802646086E-4	0.0010273699329715928	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	11	0	5	9	0	26	34	-1	43	48		TCRBV20-01,TCRBV20-or09_02												CSAKDLRDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCGGACAGGGGGAGGCACTGAAGCTTTCTTTGGACAA	CSATRTGGGTEAFF	In	VDJ	3	202	8.699696802646086E-4	0.0010074210022342803	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	1	4	3	3	26	36	49	39	52		TCRBV20-01,TCRBV20-or09_02												CSATRTGGGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAACCGGGGGCTCTACACCTTCGGTTCG	CASSQDNRGLYTF	In	VDJ	3	192	8.269018743109151E-4	9.57548675390999E-4	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	0	6	0	10	5	1	26	43	54	48	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDNRGLYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCCGGGGGCAGGGGATGAAAAACTGTTTTTTGGCAGT	CASSPGAGDEKLFF	In	VDJ	3	191	8.225950937155457E-4	9.525614427066709E-4	42	unresolved						TCRBJ01	TCRBJ01-04	01	5	4	2	6	7	0	23	35	-1	42	48	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGAGDEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGATCCACTGTGGGAGAGACCCAGTACTTCGGGCCA	CASRSTVGETQYF	In	VDJ	3	189	8.139815325248071E-4	9.425869773380147E-4	39	TCRBV12						TCRBJ02	TCRBJ02-05	01	6	0	9	4	9	0	26	37	-1	46	49		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRSTVGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAGTTGGTACGAGACCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	188	8.096747519294377E-4		52	TCRBV24						TCRBJ02	TCRBJ02-02	01	6	2	7	0	14	0	24	36	-1	50	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCAGGGTGACTGAAGCTTTCTTTGGACAA	CASSQARVTEAFF	In	VDJ	3	188	8.096747519294377E-4	9.375997446536866E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	5	1	2	26	42	48	43	50		TCRBV03-01,TCRBV03-02												CASSQARVTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAATTGGGGACAGCTACTAATGAAAAACTGTTTTTTGGCAGT	CASSQELGTATNEKLFF	In	VDJ	3	186	8.01061190738699E-4	9.276252792850303E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	0	5	2	4	2	23	40	51	44	53	TCRBV01,TCRBV04													CASSQELGTATNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATACCCACACAGATACGCAGTATTTTGGCCCA	CASSQDTHTDTQYF	In	VDJ	3	184	7.924476295479603E-4	9.176508139163741E-4	42	TCRBV03						TCRBJ02	TCRBJ02-03	01	0	3	7	2	1	3	26	43	46	44	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDTHTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAGCGGAGGGGGACACCAAAAATGATAATTCACCCCTCCACTTTGGGAAC	CASSEAEGDTKNDNSPLHF	In	VDJ	3	183	7.88140848952591E-4	9.12663581232046E-4	57	unresolved						TCRBJ01	TCRBJ01-06	01	0	0	6	5	5	9	23	40	51	45	60	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEAEGDTKNDNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGAGGGAGATGGAAGCTTTCTTTGGACAA	CSARDRREMEAFF	In	VDJ	3	180	7.752205071664829E-4	8.977018831790616E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	10	0	8	2	5	26	40	48	42	53		TCRBV20-01,TCRBV20-or09_02												CSARDRREMEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCACGGGGCAGCAATGGCAGAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	179	7.709137265711135E-4		44	TCRBV24						TCRBJ02	TCRBJ02-01	01	9	7	0	7	3	12	24	33	41	36	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTGGTAGCGGGGGCTCACCGGGGAGCTGTTTTTTGGAGAA	CSARDW*RGLTGELFF	Stop	VDJ	3	179	7.709137265711135E-4		48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	5	2	4	4	2	26	40	53	44	55		TCRBV20-01,TCRBV20-or09_02												CSARDW*RGLTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCTTTGGGCCGAGACAGGGGTGGAAACACCATATATTTTGGAGAG	CASSPLGRDRGGNTIYF	In	VDJ	3	173	7.450730429988975E-4	8.627912543887647E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	2	2	3	11	0	23	36	-1	47	55	TCRBV01,TCRBV04													CASSPLGRDRGGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTTTCTCGGGACTAGGGAAAGGGGGGACCCAGTACTTCGGGCCA	CASSFFSGLGKGGTQYF	In	VDJ	3	173	7.450730429988975E-4	8.627912543887647E-4	51	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	0	8	7	6	10	26	40	54	46	64		TCRBV12-03,TCRBV12-04				01,02								CASSFFSGLGKGGTQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAATGGGTCTCTGGTAATGAAAAACTGTTTTTTGGCAGT	CSAQWVSGNEKLFF	In	VDJ	3	171	7.364594818081588E-4	8.528167890201085E-4	42	TCRBV20						TCRBJ01	TCRBJ01-04	01	5	0	9	4	4	7	26	35	42	39	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAQWVSGNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGAGGGTGGCGGACGCCTACAATGAGCAGTTCTTCGGGCCA	CSAKRVADAYNEQFF	In	VDJ	3	171	7.364594818081588E-4	8.528167890201085E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	11	0	2	1	9	26	36	42	37	51		TCRBV20-01,TCRBV20-or09_02												CSAKRVADAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCGAGCAGGGCTGGACGGGGAGCTGTTTTTTGGAGAA	CASSPRAGLDGELFF	In	VDJ	2	168	7.235391400220507E-4	8.378550909671241E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	3	7	6	5	26	39	50	45	55		TCRBV03-01,TCRBV03-02												CASSPRAGLDGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGTCTTTAAATTCACCCCTCCACTTTGGGAAC	CASSQESLNSPLHF	In	VDJ	2	165	7.106187982359426E-4	8.228933929141398E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	0	4	10	7	2	3	26	43	47	45	50		TCRBV03-01,TCRBV03-02				01,02								CASSQESLNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD02-01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCGGAGGGGCAGGGCGGAGGGGAGCTGTTTTTTGGAGAA	CASSPEGQGGGELFF	In	VDJ	2	163	7.02005237045204E-4	8.129189275454836E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	10	0	8	2	10	18	30	38	32	48	TCRBV07,TCRBV11													CASSPEGQGGGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATGGGGATATAATTCACCCCTCCACTTTGGGAAC	CASSLWGYNSPLHF	In	VDJ	2	162	6.976984564498346E-4	8.079316948611554E-4	42	TCRBV24						TCRBJ01	TCRBJ01-06	01	6	0	8	4	5	0	24	36	-1	41	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLWGYNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24		TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGTGTCGAGCGGGGGCCGTCCTACGAGCAGTACGTCGGGCCG	CASSVERGPSYEQYV	In	VDJ	2	162	6.976984564498346E-4	8.079316948611554E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	6	2	17	5	19	23	34	47	39	66	TCRBV01,TCRBV04													CASSVERGPSYEQYV+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTCCTACAACYTCCTAGCACAGATACGCAGTATTTTGGCCCA	CATSDFLQXPSTDTQYF	In	VDJ	2	160	6.890848952590959E-4	7.979572294924992E-4	51	TCRBV24						TCRBJ02	TCRBJ02-03	01	1	3	6	0	3	7	24	41	47	44	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDFLQXPSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTACTTTTAACTGAAGCTTTCTTTGGACAA	CATSVLLTEAFF	In	VDJ	2	159	6.847781146637266E-4	7.929699968081711E-4	36	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	3	10	5	1	4	24	37	41	38	45		TCRBV24-01,TCRBV24-or09_02				01,02								CATSVLLTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGCTACGACACGAATCTGCAGTTCTTCGGGCCG	CSARGYDTNLQFF	In	VDJ	2	158	6.804713340683573E-4	7.87982764123843E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	6	15	7	13	26	37	48	44	61		TCRBV20-01,TCRBV20-or09_02												CSARGYDTNLQFF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGGAGGCAGGGGGCCAGCCCCAGCATTTTGGTGAT	CASSLEAGGQPQHF	In	VDJ	2	156	6.718577728776186E-4	7.780082987551867E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	0	7	5	0	18	32	-1	37	45	TCRBV05,TCRBV11													CASSLEAGGQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGGCTCGAGCTCCTACAATGAGTAGTTCTTCGGGCCA	CASSLGSSSYNE*FF	Stop	VDJ	2	156	6.718577728776186E-4		45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	8	0	14	2	19	24	36	42	38	61		TCRBV24-01,TCRBV24-or09_02												CASSLGSSSYNE*FF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCCGTTCCCCAGGGCCCTTCATCTCTCCTCCACTTTGGGAAC		Out	VDJ	2	156	6.718577728776186E-4		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	9	4	3	15	8	12	24	33	46	41	58		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAGAAGGGGACAGGAGTCAGGAATGAGCAGTTCTTCGGGCCA	CASSEKGTGVRNEQFF	In	VDJ	2	154	6.632442116868798E-4	7.680338333865305E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	4	7	4	7	23	37	49	41	56	TCRBV02,TCRBV09													CASSEKGTGVRNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGGGCCCGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASRARGSTDTQYF	In	VDJ	2	154	6.632442116868798E-4	7.680338333865305E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	8	2	0	4	0	22	33	-1	37	43		TCRBV12-03,TCRBV12-04												CASRARGSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATCCCCAGATACGCAGTATTTTGGCCCA	CASSQSPDTQYF	In	VJ	2	154	6.632442116868798E-4	7.680338333865305E-4	36	TCRBV03						TCRBJ02	TCRBJ02-03	01	2	0	0	4	0	4	26	-1	41	-1	45		TCRBV03-01,TCRBV03-02												CASSQSPDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCTGGCAAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGGAACATTGGGATCACTGAAGCTTTCTTTGGACAA	CASRNIGITEAFF	In	VDJ	2	153	6.589374310915104E-4	7.630466007022024E-4	39							TCRBJ01	TCRBJ01-01	01	6	0	8	4	7	1	42	53	64	60	65	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRNIGITEAFF+X+TCRBJ01-01			TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGAACCCCGGGTCCGTAAATCCACTATGGCTACACCTTCGGTTCG		Out	VDJ	2	153	6.589374310915104E-4		52	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	8	4	3	7	11	26	39	50	46	61		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCATCCTGAGGGGGAGTAGCTATGGCTACACCTTCGGTTCG	CASSSILRGSSYGYTF	In	VDJ	2	152	6.546306504961411E-4	7.580593680178743E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	5	1	4	9	5	24	36	51	45	56		TCRBV24-01,TCRBV24-or09_02												CASSSILRGSSYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATCCCGGGAATGAGCAGTTCTTCGGGCCA	CASSHPGNEQFF	In	VDJ	2	151	6.503238699007718E-4	7.530721353335462E-4	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	8	4	7	3	0	26	40	-1	43	47		TCRBV03-01,TCRBV03-02				01,02								CASSHPGNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCTACCTCGGAGAACACCTACAATGAGCAGTTCTTCGGGCCA	CASSPTSENTYNEQFF	In	VDJ	2	150	6.460170893054024E-4	7.480849026492181E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	10	2	2	8	4	24	36	48	44	52	TCRBV09,TCRBV21													CASSPTSENTYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTCCTCCGGGAATCAATACAATGAGCAGTTCTTCGGGCCA	CATSDSSGNQYNEQFF	In	VDJ	2	147	6.330967475192944E-4	7.331232045962336E-4	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	3	4	6	5	24	38	49	44	54		TCRBV24-01,TCRBV24-or09_02												CATSDSSGNQYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATTCGGTGACGACTGAAGCTTTCTTTGGACAA	CASSHSVTTEAFF	In	VDJ	2	147	6.330967475192944E-4	7.331232045962336E-4	39	TCRBV03						TCRBJ01	TCRBJ01-01	01	3	2	7	5	6	1	26	40	49	46	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHSVTTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCCGGACTAGCGGGGGGGGAAAATTACAATGAGCAGTTCTTCGGGCCA	CASSPGLAGGENYNEQFF	In	VDJ	2	144	6.201764057331864E-4	7.181615065432493E-4	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	1	0	4	3	6	19	31	49	34	55	TCRBV05,TCRBV11													CASSPGLAGGENYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGGGACGGAAACACAGATACGCAGTATTTTGGCCCA	CSARDGNTDTQYF	In	VDJ	2	142	6.115628445424477E-4	7.08187041174593E-4	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	0	7	2	1	5	26	35	41	36	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDGNTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTCCCGAGCGGGGGGATTACTTGGCAGATACGCAGTATTTTGGCCCA	CATSPERGDYLADTQYF	In	VDJ	2	139	5.986425027563396E-4	6.932253431216087E-4	51	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	6	1	4	4	9	24	36	49	40	58		TCRBV24-01,TCRBV24-or09_02												CATSPERGDYLADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCATCGATCCCTGCGGAGCTATGGCTACACCTTCGGTTCG		Out	VDJ	2	138	5.943357221609702E-4		41	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	8	7	5	4	9	2	24	34	47	43	49		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCTTCTGACAAATGTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	2	138	5.943357221609702E-4		47	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	6	1	6	4	26	40	50	46	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCGGACCTTGGAGATGGCTACACCTTCGGTTCG	CASSPDLGDGYTF	In	VDJ	2	137	5.900289415656009E-4	6.832508777529524E-4	39	TCRBV12						TCRBJ01	TCRBJ01-02	01	6	1	7	6	3	7	26	37	44	40	51		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPDLGDGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAAGCAGTGCGGGGCCCTGAACACTGAAGCTTTCTTTGGACAA	CASSKQCGALNTEAFF	In	VDJ	2	136	5.857221609702315E-4	6.782636450686243E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	7	3	0	7	3	26	38	51	45	54		TCRBV03-01,TCRBV03-02												CASSKQCGALNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGAAACAGGGCTCGCCATGGGTACGCAGTATTTTGGCCCA	CSARETGLAMGTQYF	In	VDJ	2	134	5.771085997794928E-4	6.682891796999681E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	3	8	4	11	26	37	47	41	58		TCRBV20-01,TCRBV20-or09_02												CSARETGLAMGTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGTGGGGGAGGTTCGAGCAATCAGCCCCAGCATTTTGGTGAT	CASGGGSSNQPQHF	In	VDJ	2	131	5.641882579933848E-4	6.533274816469837E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	9	9	1	1	3	4	23	31	40	34	44	TCRBV02,TCRBV12													CASGGGSSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCTGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSSWGNTEAFF	In	VDJ	2	131	5.641882579933848E-4	6.533274816469837E-4	39	TCRBV24						TCRBJ01	TCRBJ01-01	01	6	6	2	1	4	0	24	36	-1	40	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSWGNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCTGACAACAGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	131	5.641882579933848E-4		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	6	0	4	4	24	36	44	40	48		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTCAGGACAGGGAATTTGGGGAACGCATGGCTACACCTTCGGTTCG	CASSQDSGQGIWGTHGYTF	In	VDJ	2	130	5.598814773980155E-4	6.483402489626556E-4	57	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	3	6	4	14	24	41	53	45	67		TCRBV03-01,TCRBV03-02												CASSQDSGQGIWGTHGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTGACATTATAATTCACCCCTCCACTTTGGGAAC	CASSQD*HYNSPLHF	Stop	VDJ	2	129	5.55574696802646E-4		45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	2	6	4	2	1	26	43	49	45	50		TCRBV03-01,TCRBV03-02												CASSQD*HYNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGGGTAGCGGGGGGGCGGAGGCGCAGTATTTTGGCCCA	CSARDRGSGGAEAQYF	In	VDJ	2	128	5.512679162072767E-4	6.383657835939994E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	5	0	10	6	6	26	40	57	46	63		TCRBV20-01,TCRBV20-or09_02												CSARDRGSGGAEAQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGACACTTACGGGACCTACGAGCAGTACGTCGGGCCA	CASSQDTYGTYEQYV	In	VDJ	2	128	5.512679162072767E-4	6.383657835939994E-4	45	unresolved						TCRBJ02			0	0	7	20	7	14	23	40	52	47	66	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01			TCRBJ02-01,TCRBJ02-05						CASSQDTYGTYEQYV+X+TCRBJ02-X	unresolved		TCRBJ02	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTGGACCGGGACAGGGCACTTTTTCGGGCCG	CSAWTGTGHFF	In	VDJ	2	127	5.469611356119073E-4	6.333785509096713E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	16	6	6	26	35	50	41	56		TCRBV20-01,TCRBV20-or09_02												CSAWTGTGHFF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTATCTTATTCCCTCCGACAATGAGCAGTTCTTCGGGCCA	CASSYLIPSDNEQFF	In	VDJ	2	127	5.469611356119073E-4	6.333785509096713E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	10	5	3	11	26	38	43	41	54		TCRBV03-01,TCRBV03-02				01,02								CASSYLIPSDNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTCACAGACAATGAGCAGTTCTTCGGGCCA	CATSDFTDNEQFF	In	VDJ	2	126	5.42654355016538E-4	6.283913182253432E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	3	5	5	1	0	24	41	-1	42	46		TCRBV24-01,TCRBV24-or09_02												CATSDFTDNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCAACAGGGATCCTACAATGAGCAGTTCTTCGGGCCA	CATSDQQGSYNEQFF	In	VDJ	2	126	5.42654355016538E-4	6.283913182253432E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	3	3	1	2	1	24	39	47	41	48		TCRBV24-01,TCRBV24-or09_02												CATSDQQGSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACCAGGACTAGCGGGGGCCCCGGAGACCCAGTACTTCGGGCCA	CSAPGLAGAPETQYF	In	VDJ	2	126	5.42654355016538E-4	6.283913182253432E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	1	2	5	4	5	26	34	51	38	56		TCRBV20-01,TCRBV20-or09_02												CSAPGLAGAPETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTCCCGCAAGATACTCTCAGGGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	126	5.42654355016538E-4		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	8	4	4	4	15	0	26	32	-1	47	51		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGCCGTCTGGGGATCATACTATGGCTACACCTTCGGTTCG	CASSAVWGSYYGYTF	In	VDJ	2	126	5.42654355016538E-4	6.283913182253432E-4	45	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	0	8	3	8	4	26	38	50	46	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAVWGSYYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGACAGTTTCGGCCCAGCATTTTGGTGAT	CSARETVSAQHF	In	VDJ	2	125	5.383475744211687E-4	6.23404085541015E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	2	5	11	0	6	26	-1	45	40	51		TCRBV20-01,TCRBV20-or09_02												CSARETVSAQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGTGGACTAGCGGGGGGCCCCGAGCAGTACGTCGGGCCG	CASGLAGGPEQYV	In	VDJ	2	125	5.383475744211687E-4	6.23404085541015E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	10	1	1	17	2	14	24	31	47	33	61	TCRBV06,TCRBV10													CASGLAGGPEQYV+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTACTGGAACGACCCAAGAGACCCAGTACTTCGGGCCA	CSVTGTTQETQYF	In	VDJ	2	123	5.2973401323043E-4	6.134296201723588E-4	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	7	1	8	1	5	5	26	33	41	38	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSVTGTTQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGCCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSARGLSGANVLTF	In	VDJ	2	123	5.2973401323043E-4	6.134296201723588E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	8	0	0	0	2	26	-1	41	37	43		TCRBV20-01,TCRBV20-or09_02												CSARGLSGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD01-01*01	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGGCCGGGTGTAACTGGAAACACCATATATTTTGGAGAG	CASRPGVTGNTIYF	In	VDJ	2	123	5.2973401323043E-4	6.134296201723588E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	8	4	2	2	5	26	37	43	39	48		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASRPGVTGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD02-01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGGCAGGGCCTAGCACAGATACGCAGTATTTTGGCCCA	CATSEAGPSTDTQYF	In	VDJ	2	122	5.254272326350606E-4	6.084423874880306E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	3	0	2	3	24	38	45	40	48		TCRBV24-01,TCRBV24-or09_02												CATSEAGPSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGCCGGGACTAGCCATTGCTAGCACAGATACGCAGTATTTTGGCCCA	CSAEPGLAIASTDTQYF	In	VDJ	2	122	5.254272326350606E-4	6.084423874880306E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	7	0	5	7	26	35	49	40	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSAEPGLAIASTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGTCTTGGACAGGCTATGGCTACACCTTCGGTTCG	CASSQSWTGYGYTF	In	VDJ	2	122	5.254272326350606E-4	6.084423874880306E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	4	4	5	0	26	40	-1	45	52		TCRBV03-01,TCRBV03-02												CASSQSWTGYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGCAGGGGGACACTGAAGCTTTCTTTGGACAA	CASSQGQGDTEAFF	In	VDJ	2	121	5.211204520396913E-4	6.034551548037025E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	1	3	2	0	26	42	-1	44	51		TCRBV03-01,TCRBV03-02												CASSQGQGDTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCTTTGACGGAGCATGGTATGGCTACACCTTCGGTTCG	CASSFDGAWYGYTF	In	VDJ	2	120	5.16813671444322E-4	5.984679221193744E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	10	2	5	6	5	23	35	45	41	50	TCRBV09,TCRBV12													CASSFDGAWYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCAATGACCCCATCGGACAGGTCACAGATACGCAGTATTTTGGCCCA	CASSNDPIGQVTDTQYF	In	VDJ	2	120	5.16813671444322E-4	5.984679221193744E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	4	2	12	1	18	30	49	42	50	TCRBV07,TCRBV11													CASSNDPIGQVTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGTGGGGGCGTACTATGGCTACACCTTCGGTTCG	CSAKVGAYYGYTF	In	VDJ	2	120	5.16813671444322E-4	5.984679221193744E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	6	0	3	4	2	26	36	46	40	48		TCRBV20-01,TCRBV20-or09_02												CSAKVGAYYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTAGGGAAAACAGGGGGCAAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	119	5.125068908489526E-4		46	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	0	4	8	2	26	35	52	43	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGTACAGGGGCGATCCAGACCAGCCAATGAGCAGTTCTTCGGGCCA	CATSDLVQGRSRPANEQFF	In	VDJ	2	117	5.038933296582139E-4	5.8350622406639E-4	57	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	2	6	2	14	24	42	51	44	65		TCRBV24-01,TCRBV24-or09_02												CATSDLVQGRSRPANEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTAGGGGATGTAGGGTGAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	2	117	5.038933296582139E-4		49	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	5	2	2	2	11	26	39	46	41	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTTTTGGGGGGGCCGAAGACAATGAGCAGTTCTTCGGGCCA	CSAPFGGAEDNEQFF	In	VDJ	2	116	4.995865490628446E-4	5.785189913820619E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	9	0	5	6	6	26	35	48	41	54		TCRBV20-01,TCRBV20-or09_02												CSAPFGGAEDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGATCCGGGGGCTATGATACTGAAGCTTTCTTTGGACAA	CATRSGGYDTEAFF	In	VDJ	2	115	4.952797684674751E-4	5.735317586977338E-4	42	TCRBV24						TCRBJ01	TCRBJ01-01	01	7	6	0	5	4	6	24	35	45	39	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATRSGGYDTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGAACTCCTATGGCTACACCTTCGGTTCG	CSARGNSYGYTF	In	VDJ	2	114	4.909729878721058E-4	5.685445260134057E-4	36	TCRBV20						TCRBJ01	TCRBJ01-02	01	1	1	8	4	0	4	26	-1	42	39	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGNSYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCCCGGACAGGGAGAAGTTGGAGTAATGAGCAGTTCTTCGGGCCA	CASSSRTGRSWSNEQFF	In	VDJ	2	114	4.909729878721058E-4	5.685445260134057E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	3	7	4	12	26	38	50	42	62		TCRBV03-01,TCRBV03-02												CASSSRTGRSWSNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCTGAGGCCTTCTCTGGAAACACCATATATTTTGGAGAG	CASSPEAFSGNTIYF	In	VDJ	2	113	4.866662072767365E-4	5.635572933290775E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	4	11	1	0	2	4	23	36	42	38	46	TCRBV01,TCRBV04													CASSPEAFSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGTCGGGACAGTTTTGGTACTATGGCTACACCTTCGGTTCG	CSAPSGQFWYYGYTF	In	VDJ	2	113	4.866662072767365E-4	5.635572933290775E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	3	6	7	26	34	47	40	54		TCRBV20-01,TCRBV20-or09_02												CSAPSGQFWYYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATCCCGGGACCCACAGGGCAGAGACCCAGTACTTCGGGCCA	CSANPGTHRAETQYF	In	VDJ	2	111	4.7805264608599777E-4	5.535828279604213E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	3	4	12	1	26	36	54	48	55		TCRBV20-01,TCRBV20-or09_02												CSANPGTHRAETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGGGGTAATGAAAAACTGTTTTTTGGCAGT	CASSQGGNEKLFF	In	VDJ	2	111	4.7805264608599777E-4	5.535828279604213E-4	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	9	1	4	0	0	26	-1	-1	40	46		TCRBV03-01,TCRBV03-02												CASSQGGNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGGAGCACTGAAGCTTTCTTTGGACAA	CASSQDRSTEAFF	In	VDJ	2	111	4.7805264608599777E-4	5.535828279604213E-4	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	10	2	4	2	0	26	43	-1	45	49		TCRBV03-01,TCRBV03-02												CASSQDRSTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGCTAGCGGAGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSQGLAEDTGELFF	In	VDJ	2	110	4.7374586549062846E-4	5.485955952760932E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	4	5	3	2	3	26	42	51	44	54		TCRBV03-01,TCRBV03-02				01,02								CASSQGLAEDTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATACGGGGGCGCGGTGTACAATGAGCAGTTCTTCGGGCCA	CASSLYGGAVYNEQFF	In	VDJ	2	109	4.694390848952591E-4	5.436083625917651E-4	48	unresolved						TCRBJ02	TCRBJ02-01	01	1	6	0	4	2	6	23	39	47	41	53	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLYGGAVYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGGCTAGCGGGGGATGCCGATACGCAGTATTTTGGCCCA	CSASGLAGDADTQYF	In	VDJ	2	109	4.694390848952591E-4	5.436083625917651E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	4	2	6	4	5	26	37	51	41	56		TCRBV20-01,TCRBV20-or09_02												CSASGLAGDADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCCTTTGGACTAGTGGGGGTGTATCTGAGCAGTTCTTCGGGCCA	CASSLLWTSGGVSEQFF	In	VDJ	2	109	4.694390848952591E-4	5.436083625917651E-4	51	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	8	9	6	12	26	39	52	45	64		TCRBV03-01,TCRBV03-02				01,02								CASSLLWTSGGVSEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCAACAAGACAACAGGGGAACTGGAAGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	108	4.6513230429988975E-4		52	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	2	8	10	8	19	31	48	41	56	TCRBV05,TCRBV11													X+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGGACACAGGGGATGAGCAGTTCTTCGGGCCA	CATSEDTGDEQFF	In	VDJ	2	108	4.6513230429988975E-4	5.38621129907437E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	2	8	4	0	24	38	-1	42	49		TCRBV24-01,TCRBV24-or09_02												CATSEDTGDEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACGGGGGCGAACACTGAAGCTTTCTTTGGACAA	CSARDTGANTEAFF	In	VDJ	2	108	4.6513230429988975E-4	5.38621129907437E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	6	0	1	3	0	26	40	-1	43	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDTGANTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCGGGAGCTAGCGAGCAGATACGTAGTATTTTGGCCCA		Out	VDJ	2	108	4.6513230429988975E-4		41	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	6	13	8	11	26	34	48	42	59		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTGGGCACCTACGAGCAGTACTTCGGGCCG	CASSLGTYEQYF	In	VDJ	2	108	4.6513230429988975E-4	5.38621129907437E-4	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	8	0	2	1	1	26	39	44	40	45		TCRBV03-01,TCRBV03-02												CASSLGTYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGAGCGATAGCGGGAGCGGGGACGGGAGAGACCCAGTACTTCGGGCCA	CASRAIAGAGTGETQYF	In	VDJ	2	107	4.608255237045204E-4	5.336338972231088E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	5	2	4	5	10	18	29	43	34	53	TCRBV07,TCRBV11													CASRAIAGAGTGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACTACAGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLLQGSYNEQFF	In	VDJ	2	106	4.5651874310915103E-4	5.286466645387807E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	3	0	5	0	24	36	-1	41	47		TCRBV24-01,TCRBV24-or09_02												CASSLLQGSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCTCGGGTAGGGGAGCCAAAAACATTCAGTACTTCGGCGCC	CASSPSGRGAKNIQYF	In	VDJ	2	105	4.522119625137817E-4	5.236594318544526E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	5	2	0	8	0	26	39	-1	47	52		TCRBV03-01,TCRBV03-02												CASSPSGRGAKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD01-01*01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGCCCCGACACTAGCTACGAGCAGTACTTCGGGCCG	CASSQGPDTSYEQYF	In	VDJ	2	105	4.522119625137817E-4	5.236594318544526E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	3	8	3	8	0	26	42	-1	50	55		TCRBV03-01,TCRBV03-02				01,02								CASSQGPDTSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCGGGCGAAAACACTGAAGCTTTCTTTGGACAA	CATSDSGENTEAFF	In	VDJ	2	104	4.4790518191841237E-4	5.186721991701245E-4	42	TCRBV24						TCRBJ01	TCRBJ01-01	01	2	8	0	2	1	3	24	40	45	41	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDSGENTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACACCGGGACTAGCGGTAGAAGAGACCCAGTACTTCGGGCCA	CSATPGLAVEETQYF	In	VDJ	2	104	4.4790518191841237E-4	5.186721991701245E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	5	3	4	3	26	36	51	40	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSATPGLAVEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGTGGCCGTTGGTCTGTTACTGCGAGATACGCAGTATTTTGGCCCA	CSAVAVGLLLRDTQYF	In	VDJ	2	104	4.4790518191841237E-4	5.186721991701245E-4	48	TCRBV20						TCRBJ02	TCRBJ02-03	01	6	9	0	5	3	18	26	34	40	37	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAVAVGLLLRDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGTCCCCCGGAACGCTGGAAACACCATATATTTTGGAGAG	CSARDVPRNAGNTIYF	In	VDJ	2	103	4.43598401323043E-4	5.136849664857964E-4	48	TCRBV20						TCRBJ01	TCRBJ01-03	01	0	1	8	2	8	3	26	40	51	48	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDVPRNAGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCGAGAAGCAGGATTCACAGATACGCAGTATTTTGGCCCA	CASSREAGFTDTQYF	In	VDJ	2	102	4.3929162072767365E-4	5.086977338014683E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	4	2	7	3	18	30	41	37	44	TCRBV07,TCRBV11													CASSREAGFTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGAGGACGTTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAEDVSSYNEQFF	In	VDJ	2	102	4.3929162072767365E-4	5.086977338014683E-4	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	6	1	7	0	3	5	26	34	41	37	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAEDVSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGAGGAACGGGACAGGGGGCTGAACATTCAGTACTTCGGCGCC	CASSQEEERDRGLNIQYF	In	VDJ	2	102	4.3929162072767365E-4	5.086977338014683E-4	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	0	0	7	8	2	26	43	63	51	65		TCRBV03-01,TCRBV03-02												CASSQEEERDRGLNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD01-01*01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCTAGCTCGACCCTTTTGGGCCTTCATGGCTTTCTTTGGACAA		Out	VDJ	1	101	4.349848401323043E-4		44	unresolved						TCRBJ01	TCRBJ01-01	01	8	8	0	11	15	7	18	27	46	42	53	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSLKGNTEAFF	In	VDJ	1	100	4.3067805953693494E-4	4.98723268432812E-4	39	TCRBV24						TCRBJ01	TCRBJ01-01	01	6	5	3	1	4	0	24	36	-1	40	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKGNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTAGTCCCGGGACAGGGAAGCTATGGCTACACCTTCGGTTCG	CASSLVPGQGSYGYTF	In	VDJ	1	100	4.3067805953693494E-4	4.98723268432812E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	3	4	4	3	22	38	51	42	54		TCRBV12-03,TCRBV12-04												CASSLVPGQGSYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTCCCTAGCGGGGAGGCCGAGACCCAGTACTTCGGGCCA	CSAFPSGEAETQYF	In	VDJ	1	100	4.3067805953693494E-4	4.98723268432812E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	4	3	5	4	5	26	35	48	39	53		TCRBV20-01,TCRBV20-or09_02												CSAFPSGEAETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTGGACGGGACAGGGGTACACAGATACGCAGTATTTTGGCCCA	CSAWTGQGYTDTQYF	In	VDJ	1	100	4.3067805953693494E-4	4.98723268432812E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	2	2	5	2	26	35	50	40	52		TCRBV20-01,TCRBV20-or09_02												CSAWTGQGYTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAAGGGGAAAGGCAGCAATCAGCCCCAGCATTTTGGTGAT	CSARDKGKGSNQPQHF	In	VDJ	1	100	4.3067805953693494E-4	4.98723268432812E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	5	2	1	2	6	26	40	47	42	53		TCRBV20-01,TCRBV20-or09_02												CSARDKGKGSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAAAGTACTAGCGGGGGGACCCTGAGCACAGATACGCAGTATTTTGGCCCA	CSAKSTSGGTLSTDTQYF	In	VDJ	1	100	4.3067805953693494E-4	4.98723268432812E-4	54	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	3	1	0	7	6	26	34	53	41	59		TCRBV20-01,TCRBV20-or09_02												CSAKSTSGGTLSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCTACTTGACTAGCTCGATCCTTAAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	100	4.3067805953693494E-4		46	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	9	2	7	5	6	11	26	31	44	37	55		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGAGACAGGGGATGAGTCTTGAGGGGACTAGGACAGATACGCAGTATTTTGGCCCA	CASSPRQGMSLEGTRTDTQYF	In	VDJ	1	99	4.263712789415656E-4	4.937360357484839E-4	63							TCRBJ02	TCRBJ02-03	01	5	2	2	3	4	21	18	30	42	34	63	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRQGMSLEGTRTDTQYF+X+TCRBJ02-03			TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAGTGGACGGAGGATGAAGCTTTCTTTGGACAA	CASSEWTEDEAFF	In	VDJ	1	99	4.263712789415656E-4	4.937360357484839E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	1	7	8	1	22	34	47	42	48	TCRBV02,TCRBV12													CASSEWTEDEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAATACCTGGCCTTAGGGGGTCAGCCCCAGCATTTTGGTGAT	CASSQEYLALGGQPQHF	In	VDJ	1	99	4.263712789415656E-4	4.937360357484839E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	5	1	6	12	0	23	40	-1	52	58	TCRBV01,TCRBV04													CASSQEYLALGGQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGAACTAGCGGGGGGGCTTGGTGAGCAGTTCTTCGGGCCA	CSARELAGGLGEQFF	In	VDJ	1	98	4.220644983461963E-4	4.887488030641558E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	3	0	9	3	5	26	37	53	40	58		TCRBV20-01,TCRBV20-or09_02												CSARELAGGLGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAAAATTTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQEKFSSYNEQFF	In	VDJ	1	98	4.220644983461963E-4	4.887488030641558E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	5	8	0	6	0	26	43	-1	49	52		TCRBV03-01,TCRBV03-02				01,02								CASSQEKFSSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGAAAGGGGGCCACGAGACCCAGTACTTCGGGCCA	CATSDLKGGHETQYF	In	VDJ	1	97	4.177577177508269E-4	4.8376157037982766E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	5	0	5	2	3	24	42	51	44	54		TCRBV24-01,TCRBV24-or09_02												CATSDLKGGHETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTCCCTCAACATTTGGCGCAGATACGCAGTATTTTGGCCCA	CASSPSTFGADTQYF	In	VDJ	1	97	4.177577177508269E-4	4.8376157037982766E-4	45	unresolved						TCRBJ02	TCRBJ02-03	01	5	3	6	4	6	7	22	34	43	40	50	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSTFGADTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCGGGTCGGGGGGCCACCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	96	4.1345093715545756E-4		47	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	1	2	8	4	26	35	50	43	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTATAGGGGGAAGATATGGCTACACCTTCGGTTCG	CASSFIGGRYGYTF	In	VDJ	1	96	4.1345093715545756E-4	4.787743376954995E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	5	1	5	3	4	26	40	49	43	53		TCRBV12-03,TCRBV12-04												CASSFIGGRYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACCCCCACTCCTCAGTGGGAGGGAGGGAGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	95	4.091441565600882E-4		62				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	0	3	16	7	18	33	56	49	63	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03												X+X+TCRBJ01-01		TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCTACAAAAGTTTACGTGTCGATACGCAGTATTTTGGCCCA	CASSYKSLRVDTQYF	In	VDJ	1	94	4.0483737596471884E-4	4.687998723268433E-4	45	TCRBV24						TCRBJ02	TCRBJ02-03	01	7	3	6	6	2	14	24	35	40	37	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYKSLRVDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGAAGGGAGCGGGGGGGCAATTACAATGAGCAGTTCTTCGGGCCA	CASSQGRERGGNYNEQFF	In	VDJ	1	93	4.005305953693495E-4	4.6381263964251514E-4	54	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	6	0	4	6	4	26	42	58	48	62		TCRBV03-01,TCRBV03-02												CASSQGRERGGNYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGCCGACGGGTGGAGGGGCTACACCTTCGGTTCG	CASSLADGWRGYTF	In	VDJ	1	92	3.9622381477398013E-4	4.5882540695818704E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	10	1	8	8	0	18	35	-1	43	48	TCRBV05,TCRBV07,TCRBV11													CASSLADGWRGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGCCTAGTAGCCGCGGGGGCAGATACGCAGTATTTTGGCCCA	CSARLVAAGADTQYF	In	VDJ	1	92	3.9622381477398013E-4	4.5882540695818704E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	2	4	12	0	26	35	-1	47	54		TCRBV20-01,TCRBV20-or09_02												CSARLVAAGADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCCAGGGACAGGGAAAGGCTGAAGCTTTCTTTGGACAA	CSARGQGQGKAEAFF	In	VDJ	1	91	3.919170341786108E-4	4.5383817427385894E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	3	6	4	5	26	39	52	43	57		TCRBV20-01,TCRBV20-or09_02												CSARGQGQGKAEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCGGGCGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CSARPGGGQETQYF	In	VDJ	1	89	3.833034729878721E-4	4.438637089052027E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	7	2	1	4	0	26	38	-1	42	49		TCRBV20-01,TCRBV20-or09_02												CSARPGGGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGACCGGACAGAACCGCCTACGAGCAGTACTTCGGGCCG	CSAGPDRTAYEQYF	In	VDJ	1	88	3.7899669239250275E-4	4.388764762208746E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	5	2	5	5	26	35	46	40	51		TCRBV20-01,TCRBV20-or09_02												CSAGPDRTAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGACGTTTTCCTTTTTGGCATCATCAGCCCCAGCATTTTGGTGAT	CASSRRFPFWHHQPQHF	In	VDJ	1	88	3.7899669239250275E-4	4.388764762208746E-4	51	TCRBV03						TCRBJ01	TCRBJ01-05	01	5	2	7	5	1	18	26	38	42	39	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRRFPFWHHQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGTGGGTACAGGGATTCCTAACTATGGCTACACCTTCGGTTCG	CASSVGTGIPNYGYTF	In	VDJ	1	87	3.746899117971334E-4	4.338892435365464E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	3	0	5	4	23	36	47	41	51	TCRBV02,TCRBV09													CASSVGTGIPNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTGGGGACAGGGGGCGACGTCCAATACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	87	3.746899117971334E-4		55	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	0	3	1	10	19	33	46	34	56	TCRBV07,TCRBV11													X+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTAAAGCGGGGGCCGAGATGGGGAATGAGCAGTTCTTCGGGCCA	CASSLKAGAEMGNEQFF	In	VDJ	1	87	3.746899117971334E-4	4.338892435365464E-4	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	6	2	7	4	11	26	39	51	43	62		TCRBV03-01,TCRBV03-02												CASSLKAGAEMGNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCCCGAGGGACAGGGGGTGCCCAGCATTTTGGTGAT	CSAARGTGGAQHF	In	VDJ	1	86	3.7038313120176403E-4	4.289020108522183E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	1	11	6	2	26	35	52	41	54		TCRBV20-01,TCRBV20-or09_02												CSAARGTGGAQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACTAGGGACAGAAACACAGATACGCAGTATTTTGGCCCA	CSTRDRNTDTQYF	In	VDJ	1	86	3.7038313120176403E-4	4.289020108522183E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	5	2	0	3	26	-1	43	37	46		TCRBV20-01,TCRBV20-or09_02												CSTRDRNTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACGGATGACAGGGGAGGTGTTTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	86	3.7038313120176403E-4		50	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	2	2	9	7	6	26	39	54	46	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTGTGGCCCATGGAATGCGAGCAGTACGTCGGGCCG		Out	VDJ	1	85	3.6607635060639473E-4		44	TCRBV24						TCRBJ02	TCRBJ02-07	01	2	1	8	17	9	14	24	40	52	49	66		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGACCCCCGGGGAACCTTGAAGGCTACACCTTCGGTTCG	CSARPPGNLEGYTF	In	VDJ	1	85	3.6607635060639473E-4	4.239147781678902E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	3	8	7	9	26	35	47	42	56		TCRBV20-01,TCRBV20-or09_02												CSARPPGNLEGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGTATTAACGGACAGGGGATTCTGGCTACACCTTCGGTTCG	CASRY*RTGDSGYTF	Stop	VDJ	1	85	3.6607635060639473E-4		45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	2	7	8	4	26	37	54	45	58		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRY*RTGDSGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCCCTGACAGGGGAGAGTGGTATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	84	3.6176957001102537E-4		52				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	2	0	3	9	18	30	41	33	50	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCGGCAGGGAATGGGAGCAGTTCTTCGGGCCA		Out	VDJ	1	84	3.6176957001102537E-4		43	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	3	10	3	5	24	42	50	45	55		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGCGTTAGATACGCAGTATTTTGGCCCA	CSASALDTQYF	In	VDJ	1	84	3.6176957001102537E-4	4.1892754548356206E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	7	6	5	1	2	26	37	41	38	43		TCRBV20-01,TCRBV20-or09_02				01,02								CSASALDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCATGCAAGATACGCAGTATTTTGGCCCA	CASSMQDTQYF	In	VDJ	1	84	3.6176957001102537E-4	4.1892754548356206E-4	33	TCRBV03						TCRBJ02	TCRBJ02-03	01	5	4	6	5	3	0	26	38	-1	41	43		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSMQDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCGCCCACGTGGGGGGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	84	3.6176957001102537E-4		41	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	10	9	0	3	10	0	24	31	-1	41	48	TCRBV06,TCRBV10													X+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGGGACAGGGGTCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	84	3.6176957001102537E-4		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	1	2	6	0	1	24	-1	46	37	47	TCRBV06,TCRBV10													X+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGAGGCCCCGCACAAGAGACCCAGTACTTCGGGCCA	CSASGGPAQETQYF	In	VDJ	1	83	3.57462789415656E-4	4.1394031279923395E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	10	1	2	1	7	26	37	43	38	50		TCRBV20-01,TCRBV20-or09_02												CSASGGPAQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTGGAGGGACGGGCTAGCGGGGGTAAGTGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	82	3.5315600882028666E-4		53	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	4	2	9	12	6	24	36	58	48	64		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGACCGGGACACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSDRDTSGANVLTF	In	VDJ	1	82	3.5315600882028666E-4	4.0895308011490585E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	0	6	0	2	1	24	38	46	40	47		TCRBV24-01,TCRBV24-or09_02												CASSDRDTSGANVLTF+TCRBV24-X+TCRBJ02-06	TCRBV24	TCRBD01-01*01	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAACAGAGTTCACCCCTCCACTTTGGGAAC	CASSEQSSPLHF	In	VDJ	1	81	3.488492282249173E-4	4.039658474305777E-4	36	unresolved			unresolved			TCRBJ01	TCRBJ01-06	01	5	3	5	9	3	2	23	34	41	37	43	TCRBV02,TCRBV09			TCRBD01,TCRBD02										CASSEQSSPLHF+X+TCRBJ01-06	unresolved	unresolved	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATACGGGGAGGGCGGGGAGCTGTTTTTTGGAGAA	CASSLYGEGGELFF	In	VDJ	1	80	3.4454244762954794E-4	3.989786147462496E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	9	0	7	7	0	24	36	-1	43	50		TCRBV24-01,TCRBV24-or09_02												CASSLYGEGGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCGGGGGGACAGATACGCAGTATTTTGGCCCA	CATSGGTDTQYF	In	VDJ	1	80	3.4454244762954794E-4	3.989786147462496E-4	36	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	8	1	3	0	0	24	-1	-1	35	42		TCRBV24-01,TCRBV24-or09_02												CATSGGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCTAGCGGATTACAATGAGCAGTTCTTCGGGCCA	CSARLADYNEQFF	In	VDJ	1	80	3.4454244762954794E-4	3.989786147462496E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	5	4	1	2	26	37	45	38	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSARLADYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCCCTGGACCGCCTTCGGCCAAACTGTTTTTTGGCAGT	CASSPGPPSAKLFF	In	VDJ	1	79	3.4023566703417864E-4	3.939913820619215E-4	42	unresolved						TCRBJ01	TCRBJ01-04	01	5	1	7	11	3	11	19	31	38	34	49	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGPPSAKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCAGACAGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CATSDQTGAYNEQFF	In	VDJ	1	79	3.4023566703417864E-4	3.939913820619215E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	2	2	3	0	24	38	-1	41	49		TCRBV24-01,TCRBV24-or09_02												CATSDQTGAYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGGGACCGGGACAAAAGACTGAAGCTTTCTTTGGACAA	CASRGPGQKTEAFF	In	VDJ	1	79	3.4023566703417864E-4	3.939913820619215E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	6	5	6	4	26	37	49	43	53		TCRBV03-01,TCRBV03-02												CASRGPGQKTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCTCGGGGGTGCTTGGAATGAGTAGTTCTTCGGGCCA	CASSQDLGGAWNE*FF	Stop	VDJ	1	79	3.4023566703417864E-4		48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	2	14	3	14	26	43	52	46	66		TCRBV03-01,TCRBV03-02												CASSQDLGGAWNE*FF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCATCCGGGACAGGGGGAGAGATGGCTACACCTTCGGTTCG	CAIRDRGRDGYTF	In	VDJ	1	78	3.359288864388093E-4	3.8900414937759333E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	0	1	6	3	4	24	31	45	34	49		TCRBV24-01,TCRBV24-or09_02												CAIRDRGRDGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCTGGGACAGCTGGAAACACCATATATTTTGGAGAG	CATSDPGTAGNTIYF	In	VDJ	1	78	3.359288864388093E-4	3.8900414937759333E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	0	5	2	4	0	24	38	-1	42	49		TCRBV24-01,TCRBV24-or09_02												CATSDPGTAGNTIYF+TCRBV24-X+TCRBJ01-03	TCRBV24	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGTCGTTTACTTAGCGGGGGGAGAGGGTTAGAGACCCAGTACTTCGGGCCA	CASSRLLSGGRGLETQYF	In	VDJ	1	78	3.359288864388093E-4	3.8900414937759333E-4	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	5	1	4	9	8	23	34	53	43	61	TCRBV01,TCRBV04													CASSRLLSGGRGLETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGACGGGTAAAGGTGAAATCCTACGAGCAGTACTTCGGGCCG	CSAGRVKVKSYEQYF	In	VDJ	1	78	3.359288864388093E-4	3.8900414937759333E-4	45	TCRBV20						TCRBJ02	TCRBJ02-07	01	5	1	7	1	0	14	26	-1	39	35	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGRVKVKSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGTTGGGACTAGCGGGGGTTTAGCCAAAAACATTCAGTACTTCGGCGCC	CSAVGTSGGLAKNIQYF	In	VDJ	1	78	3.359288864388093E-4	3.8900414937759333E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	6	0	2	0	4	3	26	34	52	38	55		TCRBV20-01,TCRBV20-or09_02												CSAVGTSGGLAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCTCTGGTCCATTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	78	3.359288864388093E-4		49	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	5	8	5	19	0	26	39	-1	58	61		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGACAGGCTACAATGAGCAGTTCTTCGGGCCA	CASRTGYNEQFF	In	VDJ	1	77	3.316221058434399E-4	3.8401691669326523E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	2	4	3	0	0	24	-1	-1	35	41		TCRBV24-01,TCRBV24-or09_02												CASRTGYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGGAGAGATACGGCTACACCTTCGGTTCG	CASSQAERYGYTF	In	VDJ	1	77	3.316221058434399E-4	3.8401691669326523E-4	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	10	2	8	1	6	26	42	47	43	53		TCRBV03-01,TCRBV03-02												CASSQAERYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACCCCCTAAGGGTATCAGAGCTATGGCTACACCTTCGGTTCG	CASTP*GYQSYGYTF	Stop	VDJ	1	76	3.2731532524807056E-4		45	TCRBV24						TCRBJ01	TCRBJ01-02	01	11	5	3	4	10	8	24	31	45	41	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTP*GYQSYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCTACCTGGGATGGAACCTTCACCTACAATGAGCAGTTCTTCGGGCCA	CSARATWDGTFTYNEQFF	In	VDJ	1	76	3.2731532524807056E-4	3.7902968400893713E-4	54	TCRBV20						TCRBJ02	TCRBJ02-01	01	3	0	8	2	8	11	26	37	49	45	60		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARATWDGTFTYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACAGGGACAGGAATCTTCACCTCTCCACTTTGGGAAC	CSARQGQESSPLHF	In	VDJ	1	76	3.2731532524807056E-4	3.7902968400893713E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	0	4	16	2	11	26	38	48	40	59		TCRBV20-01,TCRBV20-or09_02												CSARQGQESSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCAGACTACCGCGGGAGCCGCGAAGAGGAGACCCAGTACTTCGGGCCA	CSAPDYRGSREEETQYF	In	VDJ	1	76	3.2731532524807056E-4	3.7902968400893713E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	7	2	5	11	10	26	34	52	45	62		TCRBV20-01,TCRBV20-or09_02												CSAPDYRGSREEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCCGGGACAGCCGGGGTACGCAGTATTTTGGCCCA	CASSRRDSRGTQYF	In	VDJ	1	76	3.2731532524807056E-4	3.7902968400893713E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	5	8	3	6	26	39	49	42	55		TCRBV03-01,TCRBV03-02												CASSRRDSRGTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGATCTTATGGGGGAGACCCAGTACTTCGGGCCA	CSARDLMGETQYF	In	VDJ	1	75	3.230085446527012E-4	3.7404245132460903E-4	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	3	6	2	5	9	0	26	37	-1	46	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDLMGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAAGGTTTGGGACGGGTTCTGTGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	74	3.1870176405733185E-4		52	unresolved						TCRBJ01	TCRBJ01-01	01	2	0	7	5	6	11	18	33	44	39	55	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTATATTGGAGGTGGGGCACCATCAGTTCTTCGGGCCA	CASSILEVGHHQFF	In	VDJ	1	74	3.1870176405733185E-4	3.6905521864028087E-4	42	TCRBV24						TCRBJ02	TCRBJ02-01	01	6	7	0	13	11	5	24	36	52	47	57		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSILEVGHHQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATAACCAAATTGGGACAGGGAACTATGGCTACACCTTCGGTTCG	CATSDNQIGTGNYGYTF	In	VDJ	1	74	3.1870176405733185E-4	3.6905521864028087E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	2	9	0	24	39	-1	48	57		TCRBV24-01,TCRBV24-or09_02												CATSDNQIGTGNYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATTCCTAGCGGGGGGACCCAATGAGCAGTTCTTCGGGCCA	CASSQFLAGGPNEQFF	In	VDJ	1	74	3.1870176405733185E-4	3.6905521864028087E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	4	1	6	3	3	26	41	55	44	58		TCRBV03-01,TCRBV03-02												CASSQFLAGGPNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAACAGGGCCACAGATACGCAGTATTTTGGCCCA	CASSNRATDTQYF	In	VDJ	1	74	3.1870176405733185E-4	3.6905521864028087E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	3	2	1	1	26	38	45	39	46		TCRBV03-01,TCRBV03-02												CASSNRATDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGCGGGGGCCCTCACAGATACGCAGTATTTTGGCCCA	CASSLAAGALTDTQYF	In	VDJ	1	73	3.143949834619625E-4	3.6406798595595277E-4	48				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	7	2	2	1	4	18	35	43	36	47	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAAGALTDTQYF+X+TCRBJ02-03		TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAACTCGGGACGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQELGTATNEKLFF	In	VDJ	1	73	3.143949834619625E-4	3.6406798595595277E-4	51	unresolved						TCRBJ01	TCRBJ01-04	01	0	0	7	0	4	2	23	40	49	44	51	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQELGTATNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCGACCCAGACAATGAGCAGTTCTTCGGGCCA	CSASDPDNEQFF	In	VDJ	1	73	3.143949834619625E-4	3.6406798595595277E-4	36	TCRBV20						TCRBJ02	TCRBJ02-01	01	5	2	7	5	3	4	26	35	41	38	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASDPDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCGATTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	73	3.143949834619625E-4		35	TCRBV20						TCRBJ01	TCRBJ01-02	01	1	2	8	4	2	2	26	39	43	41	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCCCCAGAGACCCAGTACTTCGGGCCA	CSARDPPETQYF	In	VJ	1	73	3.143949834619625E-4	3.6406798595595277E-4	36	TCRBV20						TCRBJ02	TCRBJ02-05	01	0	0	0	4	0	6	26	-1	40	-1	46		TCRBV20-01,TCRBV20-or09_02												CSARDPPETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACACGGGGGGGCCGTCAGATACGCAGTATTTTGGCCCA	CASSQDTGGPSDTQYF	In	VDJ	1	73	3.143949834619625E-4	3.6406798595595277E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	0	4	2	4	26	43	53	45	57		TCRBV03-01,TCRBV03-02												CASSQDTGGPSDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGGACAGGGAGCCAAGAGACCCAGTACTTCGGGCCA	CASSLGTGSQETQYF	In	VDJ	1	73	3.143949834619625E-4	3.6406798595595277E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	1	3	1	0	2	26	-1	50	42	52		TCRBV12-03,TCRBV12-04												CASSLGTGSQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCAACCTAGGAGGTCAACGCAGTATTTTGGCCCA		Out	VDJ	1	72	3.100882028665932E-4		38	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	10	1	9	7	3	24	35	47	42	50		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTCCTCGTGGACAGCGTGAAGCTTTCTTTGGACAA	CASSPRGQREAFF	In	VDJ	1	72	3.100882028665932E-4	3.5908075327162467E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	5	7	6	2	22	34	46	40	48	TCRBV02,TCRBV12													CASSPRGQREAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGCTTGGACAGGGGATGGAATGGATCAGCCCCAGCATTTTGGTGAT	CASSVAWTGDGMDQPQHF	In	VDJ	1	71	3.057814222712238E-4	3.540935205872965E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	1	2	5	3	9	23	39	51	42	60	TCRBV09,TCRBV12													CASSVAWTGDGMDQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGTCTTAGCAGATACGCAGTATTTTGGCCCA	CSARVLADTQYF	In	VDJ	1	71	3.057814222712238E-4	3.540935205872965E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	5	8	4	5	0	26	37	-1	42	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSARVLADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGTACAGGGGAACACTGAAGCTTTCTTTGGACAA	CSAVQGNTEAFF	In	VDJ	1	71	3.057814222712238E-4	3.540935205872965E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	1	3	0	26	34	-1	37	43		TCRBV20-01,TCRBV20-or09_02												CSAVQGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGACTCTTTGGTCGATGGCTACACCTTTGGTTCG	CASSLDSLVDGYTF	In	VDJ	1	70	3.0147464167585447E-4	3.491062879029684E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	1	10	20	0	23	18	-1	37	32	60	TCRBV07,TCRBV11					01,02								CASSLDSLVDGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGCGAGAGGTTCGGCGATGGATGGCTACACCTTCGGTTCG	CATSDARGSAMDGYTF	In	VDJ	1	70	3.0147464167585447E-4	3.491062879029684E-4	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	11	1	6	5	11	24	38	47	43	58		TCRBV24-01,TCRBV24-or09_02												CATSDARGSAMDGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCAGCAGCTCTGGAAACACCATATATTTTGGAGAG	CSARVSSSGNTIYF	In	VDJ	1	70	3.0147464167585447E-4	3.491062879029684E-4	42	TCRBV20						TCRBJ01	TCRBJ01-03	01	1	4	5	0	1	3	26	39	43	40	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVSSSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGAAGCGGGGGAAGGTAGAGAGATCCAGTACTTCGGGCCA	CSARDEAGEGREIQYF	In	VDJ	1	70	3.0147464167585447E-4	3.491062879029684E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	6	2	10	3	13	26	40	51	43	64		TCRBV20-01,TCRBV20-or09_02												CSARDEAGEGREIQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATGGACAGGTCTATGGCTACACCTTCGGTTCG	CSANGQVYGYTF	In	VDJ	1	70	3.0147464167585447E-4	3.491062879029684E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	4	4	2	1	26	36	45	38	46		TCRBV20-01,TCRBV20-or09_02												CSANGQVYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTAATGGGGGGCTCGTCCTACAATGAGCAGTTCTTCGGGCCA	CSAVMGGSSYNEQFF	In	VDJ	1	69	2.971678610804851E-4	3.441190552186403E-4	45	TCRBV20						TCRBJ02	TCRBJ02-01	01	5	6	0	1	6	3	26	35	47	41	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAVMGGSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCCCGGTGTGAGTCAGCCCCAGCATTTTGGTGAT	CASSPPGVSQPQHF	In	VDJ	1	69	2.971678610804851E-4	3.441190552186403E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	8	5	6	4	6	26	39	46	43	52		TCRBV03-01,TCRBV03-02				01,02								CASSPPGVSQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCGAGCAAGATACGGGGGGAAGCTTTCTTTGGACAA		Out	VDJ	1	68	2.9286108048511575E-4		41	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	2	8	11	0	18	30	-1	41	47	TCRBV07,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCACTGCAATCAGAGACAACTACGAGCAGTACTTCGGGCCG	CASTAIRDNYEQYF	In	VDJ	1	68	2.9286108048511575E-4	3.3913182253431215E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	2	6	3	13	1	19	27	44	40	45	TCRBV07,TCRBV11													CASTAIRDNYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACGGAGGGGGGCGCGGATGGCTACACCTTCGGTTCG	CATEGGADGYTF	In	VDJ	1	68	2.9286108048511575E-4	3.3913182253431215E-4	36	TCRBV24						TCRBJ01	TCRBJ01-02	01	10	5	1	6	2	6	24	32	40	34	46		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATEGGADGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCGGGGACTGTTAGCACAGATACGCAGTATTTTGGCCCA	CSARAGTVSTDTQYF	In	VDJ	1	68	2.9286108048511575E-4	3.3913182253431215E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	10	0	4	3	26	37	47	41	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARAGTVSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTACTAGGGAGCACCGGGGAGCTGTTTTTTGGAGAA	CSARVLGSTGELFF	In	VDJ	1	68	2.9286108048511575E-4	3.3913182253431215E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	3	8	4	1	4	26	39	45	40	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARVLGSTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCCCGGAGTGAGGGGCTGTATGGCTACACCTTCGGTTCG	CATSDPRSEGLYGYTF	In	VDJ	1	67	2.885542998897464E-4	3.3414458984998405E-4	48	TCRBV24						TCRBJ01	TCRBJ01-02	01	3	5	2	5	10	3	24	39	54	49	57		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDPRSEGLYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCGGACAGGGTACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSASRTGYSGANVLTF	In	VDJ	1	67	2.885542998897464E-4	3.3414458984998405E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	1	3	0	2	2	26	37	47	39	49		TCRBV20-01,TCRBV20-or09_02												CSASRTGYSGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD01-01*01	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGTCTTTCCCTCACCATATATTTTGGAGAG	CSARDGLSLTIYF	In	VDJ	1	67	2.885542998897464E-4	3.3414458984998405E-4	39	TCRBV20						TCRBJ01	TCRBJ01-03	01	0	0	10	9	1	9	26	40	43	41	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDGLSLTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGACTCCGGGACAGGGGGACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	67	2.885542998897464E-4		52	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	0	1	0	4	0	23	40	-1	44	55	TCRBV01,TCRBV04													X+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTACTTACAGGGGGCCCTGAGCAGTTCTTCGGGCCA	CASSLLTGGPEQFF	In	VDJ	1	66	2.842475192943771E-4	3.2915735716565594E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	3	0	9	3	2	18	33	45	36	47	TCRBV07,TCRBV11													CASSLLTGGPEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTTAGCCGAGGGTGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	65	2.7994073869900773E-4		44	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	11	0	2	5	2	23	37	47	42	49	TCRBV09,TCRBV12													X+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGCTCCCGGATTCTCCTACGAGCAGTACTTCGGGCCG	CASSVAPGFSYEQYF	In	VDJ	1	65	2.7994073869900773E-4	3.241701244813278E-4	45	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	0	1	8	0	5	2	23	39	47	44	49	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSVAPGFSYEQYF+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTTACCAACAATGAGCAGTTCTTCGGGCCA	CATSDFTNNEQFF	In	VDJ	1	65	2.7994073869900773E-4	3.241701244813278E-4	39	TCRBV24						TCRBJ02	TCRBJ02-01	01	1	3	7	5	1	2	24	41	44	42	46		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDFTNNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACCTCGGGGAGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CSTSGRATNEKLFF	In	VDJ	1	65	2.7994073869900773E-4	3.241701244813278E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	8	9	0	0	6	0	26	32	-1	38	45		TCRBV20-01,TCRBV20-or09_02												CSTSGRATNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*02	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACGACTAGCGGGTGGCGACACAGATACGCAGTATTTTGGCCCA	CASSLRLAGGDTDTQYF	In	VDJ	1	65	2.7994073869900773E-4	3.241701244813278E-4	51	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	2	4	2	1	6	26	41	52	42	58		TCRBV12-03,TCRBV12-04				01,02								CASSLRLAGGDTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTACTGCCTAGCGGGGGGCCGGATTGACAGCAGTACGTCGGGCCG	CASSLLPSGGPD*QQYV	Stop	VDJ	1	64	2.756339581036384E-4		51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	4	1	17	7	19	26	38	56	45	75		TCRBV03-01,TCRBV03-02												CASSLLPSGGPD*QQYV+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCGGTTGAGACAAACACTGAAGCTTTCTTTGGACAA	CASSSVETNTEAFF	In	VDJ	1	64	2.756339581036384E-4	3.191828917969997E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	6	2	8	0	26	38	-1	46	50		TCRBV03-01,TCRBV03-02												CASSSVETNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCCCAACCGCCGGGACTAGCGTCTACGAGCAGTACTTCGGGCCG	CASSPTAGTSVYEQYF	In	VDJ	1	63	2.71327177508269E-4	3.141956591126716E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	6	3	9	1	23	35	54	44	55	TCRBV09,TCRBV12					01,02								CASSPTAGTSVYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGCACCTACTCAATTCGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	63	2.71327177508269E-4		44	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	3	10	4	6	7	26	38	47	44	54		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCGTACGGGGTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSVRGSGANVLTF	In	VDJ	1	62	2.6702039691289966E-4	3.092084264283434E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	5	8	3	1	3	1	18	30	38	33	39	TCRBV05,TCRBV11													CASSVRGSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01*01	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTATCGCGGGAATTCCACGAGCAGTACTTCGGGCCG	CASSLSREFHEQYF	In	VDJ	1	62	2.6702039691289966E-4	3.092084264283434E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	7	3	5	5	5	24	36	47	41	52	TCRBV06,TCRBV24,TCRBV27													CASSLSREFHEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGAAGGATGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	62	2.6702039691289966E-4		44	TCRBV24						TCRBJ01	TCRBJ01-05	01	3	1	8	2	3	3	24	39	45	42	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCGGGGACAGGGTCCTCAGCTTTCTTTGGACAA	CSAAGTGSSAFF	In	VDJ	1	62	2.6702039691289966E-4	3.092084264283434E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	10	3	5	26	35	47	38	52		TCRBV20-01,TCRBV20-or09_02												CSAAGTGSSAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCATTAAAGGTGAGGGACCGGGGTCTAGCTTTCTTTGGACAA	CSALKVRDRGLAFF	In	VDJ	1	62	2.6702039691289966E-4	3.092084264283434E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	0	7	10	11	8	26	34	50	45	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSALKVRDRGLAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCACCCCGACTGGCGGCTCATATGGCTACACCTTCGGTTCG	CTPTGGSYGYTF	In	VDJ	1	61	2.627136163175303E-4	3.042211937440153E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	10	2	10	5	4	9	26	30	38	34	47		TCRBV20-01,TCRBV20-or09_02				01,02								CTPTGGSYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCTCGGCGGTGAACACTGAAGCTTTCTTTGGACAA	CASSPSAVNTEAFF	In	VDJ	1	61	2.627136163175303E-4	3.042211937440153E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	7	5	0	5	0	26	39	-1	44	48		TCRBV03-01,TCRBV03-02				01,02								CASSPSAVNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTAGGACTAGCGGGGGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGLAGGYTGELFF	In	VDJ	1	61	2.627136163175303E-4	3.042211937440153E-4	51	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	2	0	3	0	1	26	-1	56	42	57		TCRBV12-03,TCRBV12-04												CASSLGLAGGYTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCGCATTAATCCGGGACAGGGGATTTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSALIRDRGFGANVLTF	In	VDJ	1	60	2.58406835722161E-4	2.992339610596872E-4	57	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	2	3	10	3	18	30	50	40	53	TCRBV07,TCRBV11													CASSALIRDRGFGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCGGGGGGCCCCAAGAGACCCAGTACTTCGGGCCA	CASSSGGPQETQYF	In	VDJ	1	60	2.58406835722161E-4	2.992339610596872E-4	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	1	1	2	2	24	36	45	38	47		TCRBV24-01,TCRBV24-or09_02												CASSSGGPQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAAAGCGGGGGGGGAAAAGCGTGGTCGCAGTATTTTGGCCCA		Out	VDJ	1	60	2.58406835722161E-4		47	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	6	0	10	2	12	26	38	50	40	62		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGTTCCGGGTGCTGCACCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	60	2.58406835722161E-4		43	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	8	4	17	1	23	26	39	44	40	67	TCRBV03,TCRBV12					01,02								X+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCATAGCCCGGAAGAGTACCCCTCCACTTTGGGAAC		Out	VDJ	1	59	2.5410005512679164E-4		41	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	4	5	7	12	2	10	19	31	37	33	47	TCRBV07,TCRBV11					01,02								X+X+TCRBJ01-06	unresolved	TCRBD02-01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCGGAACGGGTCCGGTCCTCAATCAGCCCCAGCATTTTGGTGAT	CASGTGPVLNQPQHF	In	VDJ	1	59	2.5410005512679164E-4	2.9424672837535907E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	11	7	5	3	0	15	24	-1	35	31	50	TCRBV24,TCRBV27					01,02								CASGTGPVLNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCAGGGGGCGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	59	2.5410005512679164E-4		41	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	0	3	1	2	26	39	48	40	50		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCTCGGACTAGACCCTGATACGCAGTATTTTGGCCCA	CASSLGLDPDTQYF	In	VDJ	1	58	2.497932745314223E-4	2.8925949569103096E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	8	6	3	5	23	35	45	38	50	TCRBV06,TCRBV10					01,02								CASSLGLDPDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCAACGACGGAGCCTAGTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	58	2.497932745314223E-4		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	4	8	4	13	0	26	37	-1	50	54		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGAACCTCATGAACACTGAAGCTTTCTTTGGACAA	CSARANLMNTEAFF	In	VDJ	1	58	2.497932745314223E-4	2.8925949569103096E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	1	2	8	0	1	6	26	39	42	40	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARANLMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCCTTAGCGGGGGGGCAGACAATGAGCAGTTCTTCGGGCCA	CSARDPLSGGADNEQFF	In	VDJ	1	58	2.497932745314223E-4	2.8925949569103096E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	0	5	6	3	26	40	57	46	60		TCRBV20-01,TCRBV20-or09_02												CSARDPLSGGADNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACCCTGGGCTAGCGGGGAGGAAGAGCAGTACTTCGGGCCG	CASSPPWASGEEEQYF	In	VDJ	1	58	2.497932745314223E-4	2.8925949569103096E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	4	3	7	9	5	26	39	57	48	62		TCRBV03-01,TCRBV03-02												CASSPPWASGEEEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGAAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSFESSYEQYF	In	VDJ	1	58	2.497932745314223E-4	2.8925949569103096E-4	39	TCRBV12						TCRBJ02	TCRBJ02-07	01	3	2	8	0	1	3	26	40	43	41	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFESSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAAGAGGGCTAGCGGGGGGGCCCCTCAAGAGACCCAGTACTTCGGGCCA	CASKRASGGAPQETQYF	In	VDJ	1	57	2.454864939360529E-4	2.8427226300670286E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	4	0	2	6	5	23	33	51	39	56	TCRBV02,TCRBV09													CASKRASGGAPQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGAGGGGGATACGCAGTATTTTGGCCCA	CASSLEGDTQYF	In	VDJ	1	57	2.454864939360529E-4	2.8427226300670286E-4	36	TCRBV24						TCRBJ02	TCRBJ02-03	01	6	5	2	6	4	0	24	36	-1	40	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAAGTGGACTAGCGGGGGCCTTAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	57	2.454864939360529E-4		50	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	1	2	5	5	4	22	34	52	39	56		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTCCCCCCGGGACTAAACCCCAGACGATACGATACGCAGTATTTTGGCCCA	CSALPPGLNPRRYDTQYF	In	VDJ	1	57	2.454864939360529E-4	2.8427226300670286E-4	54	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	9	6	8	15	26	35	50	43	65		TCRBV20-01,TCRBV20-or09_02				01,02								CSALPPGLNPRRYDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGAAGGGGGCTATGGCTACACCTTCGGTTCG	CSAREEGGYGYTF	In	VDJ	1	57	2.454864939360529E-4	2.8427226300670286E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	1	4	3	0	26	40	-1	43	49		TCRBV20-01,TCRBV20-or09_02												CSAREEGGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTCGGGGGGAAGATACGCAGTATTTTGGCCCA	CASSQVRGEDTQYF	In	VDJ	1	57	2.454864939360529E-4	2.8427226300670286E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	8	1	5	2	1	26	42	51	44	52		TCRBV03-01,TCRBV03-02												CASSQVRGEDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGGGACGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRDDSNQPQHF	In	VDJ	1	56	2.4117971334068356E-4	2.792850303223747E-4	39	unresolved						TCRBJ01	TCRBJ01-05	01	6	1	7	0	0	2	23	-1	38	34	40	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRDDSNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGAAGGGACTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	56	2.4117971334068356E-4		38	TCRBV20						TCRBJ01	TCRBJ01-05	01	1	0	7	6	4	0	26	39	-1	43	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCACCCCGACAGGGTCCGGTGGCTACACCTTCGGTTCG	CASTPTGSGGYTF	In	VDJ	1	55	2.3687293274531423E-4	2.742977976380466E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	3	7	4	5	23	33	44	37	49	TCRBV02,TCRBV12													CASTPTGSGGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGATGGGGCAGTGGCGGCTACACCTTCGGTTCG	CSARDRWGSGGYTF	In	VDJ	1	55	2.3687293274531423E-4	2.742977976380466E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	7	0	8	5	6	26	40	50	45	56		TCRBV20-01,TCRBV20-or09_02												CSARDRWGSGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAACCGGGACAACTTTTACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	55	2.3687293274531423E-4		49	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	0	6	0	4	7	26	36	46	40	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACTCGGGGTTTCCTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	55	2.3687293274531423E-4		44	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	0	8	3	10	2	5	26	43	50	45	55		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD02-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGAAGTCGTCACGCATGTCTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	54	2.3256615214994487E-4		56	unresolved						TCRBJ01	TCRBJ01-02	01	6	2	7	4	26	0	24	35	-1	61	64	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTGCACCTCGTGGCAACCTACGAGCAGTACTTCGGGCCG	CASSLHLVATYEQYF	In	VDJ	1	54	2.3256615214994487E-4	2.693105649537185E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	9	0	2	9	2	18	32	44	41	46	TCRBV07,TCRBV11													CASSLHLVATYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAAGGGAAAAACACTGAAGCTTTCTTTGGACAA	CASSEGKNTEAFF	In	VDJ	1	54	2.3256615214994487E-4	2.693105649537185E-4	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	5	0	8	2	3	2	22	34	41	37	43		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGKNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCACTACAGGTGGCTGGCTACACCTTCGGTTCG	CSAPLQVAGYTF	In	VDJ	1	54	2.3256615214994487E-4	2.693105649537185E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	4	7	5	4	26	35	45	40	49		TCRBV20-01,TCRBV20-or09_02												CSAPLQVAGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTTATTGAAGGCGGGCGGGAGAGCACAGATACGCAGTATTTTGGCCCA	CASSFIEGGRESTDTQYF	In	VDJ	1	54	2.3256615214994487E-4	2.693105649537185E-4	54	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	7	2	0	14	0	26	38	-1	52	59		TCRBV03-01,TCRBV03-02												CASSFIEGGRESTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCATGGGTTACGCTCTGGAAACACCATATATTTTGGAGAG	CASSHGLRSGNTIYF	In	VDJ	1	54	2.3256615214994487E-4	2.693105649537185E-4	45	unresolved						TCRBJ01	TCRBJ01-03	01	3	0	9	0	1	5	23	37	41	38	46	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHGLRSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCTGGGGGACAGGCGCCGGTACCGGGGAGCTGTTTTTTGGAGAA	CASSWGTGAGTGELFF	In	VDJ	1	53	2.2825937155457552E-4	2.6432333226939034E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	4	5	3	7	23	35	46	38	53	TCRBV09,TCRBV12													CASSWGTGAGTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTTTACAGTGACCTTAACACTGAAGCTTTCTTTGGACAA	CASSFYSDLNTEAFF	In	VDJ	1	53	2.2825937155457552E-4	2.6432333226939034E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	5	2	2	7	18	32	38	34	45	TCRBV05,TCRBV11													CASSFYSDLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGGCTCGGCGCATACAATGAGCAGTTCTTCGGGCCA	CASRLGAYNEQFF	In	VDJ	1	53	2.2825937155457552E-4	2.6432333226939034E-4	39	unresolved						TCRBJ02	TCRBJ02-01	01	6	9	0	4	4	3	23	34	41	38	44	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRLGAYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTTTGGGACAGTAGCCTACGAGCAGTACTTCGGGCCG	CASSQDFGTVAYEQYF	In	VDJ	1	53	2.2825937155457552E-4	2.6432333226939034E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	5	2	4	3	26	43	54	47	57		TCRBV03-01,TCRBV03-02												CASSQDFGTVAYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGAAGGGCAGGGGATTAATTCACCCCTCCACTTTGGGAAC	CASSLEGQGINSPLHF	In	VDJ	1	52	2.2395259095920618E-4	2.5933609958506224E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	4	2	6	4	2	18	35	45	39	47	TCRBV07,TCRBV11													CASSLEGQGINSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCAACCGCGGACAGCTCATACAATGAGCAGTTCTTCGGGCCA	CASSSTADSSYNEQFF	In	VDJ	1	52	2.2395259095920618E-4	2.5933609958506224E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	5	4	7	4	18	31	44	38	48	TCRBV07,TCRBV11													CASSSTADSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTTTCGGACAGGGCGGCAGATACGCAGTATTTTGGCCCA	CSALSDRAADTQYF	In	VDJ	1	52	2.2395259095920618E-4	2.5933609958506224E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	3	4	5	3	26	35	48	40	51		TCRBV20-01,TCRBV20-or09_02												CSALSDRAADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAGGGARACTGAAGCTTTCTTTGGACAA	CSARRETEAFF	In	VDJ	1	52	2.2395259095920618E-4	2.5933609958506224E-4	33	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	9	2	5	2	0	26	37	-1	39	44		TCRBV20-01,TCRBV20-or09_02												CSARRETEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAGCGCCGGGGGCCACTAATGAAAAACTGTTTTTTGGCAGT	CASSLAPGATNEKLFF	In	VDJ	1	51	2.1964581036383683E-4	2.5434886690073414E-4	48	unresolved						TCRBJ01	TCRBJ01-04	01	0	6	0	2	3	1	19	36	45	39	46	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAPGATNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAGACAGGGCGGGCGGAAACACCATATATTTTGGAGAG	CASSLDRAGGNTIYF	In	VDJ	1	51	2.1964581036383683E-4	2.5434886690073414E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	3	4	3	5	24	36	46	39	51	TCRBV24,TCRBV27													CASSLDRAGGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATAACAGGGGGCGCTACAGATACGCAGTATTTTGGCCCA	CSAITGGATDTQYF	In	VDJ	1	51	2.1964581036383683E-4	2.5434886690073414E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	3	0	3	2	3	26	36	47	38	50		TCRBV20-01,TCRBV20-or09_02												CSAITGGATDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGAGGCCTAGGGGAGACCCAGTACTTCGGGCCA	CSASGGLGETQYF	In	VDJ	1	51	2.1964581036383683E-4	2.5434886690073414E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	10	1	5	1	7	26	37	43	38	50		TCRBV20-01,TCRBV20-or09_02												CSASGGLGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCTATTCAAAGGGGCGAAAAACTGTTTTTTGGCAGT	CSAAIQRGEKLFF	In	VDJ	1	51	2.1964581036383683E-4	2.5434886690073414E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	5	2	8	10	1	26	34	49	44	50		TCRBV20-01,TCRBV20-or09_02												CSAAIQRGEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCATCAGGGGGAACACAGATACGCAGTATTTTGGCCCA	CASSSIRGNTDTQYF	In	VDJ	1	50	2.1533902976846747E-4	2.49361634216406E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	1	2	5	2	24	36	48	41	50		TCRBV24-01,TCRBV24-or09_02												CASSSIRGNTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCGCCCGGACAGGGGTTGTTATGTACTATGGCTACACCTTCGGTTCG	CASARTGVVMYYGYTF	In	VDJ	1	50	2.1533902976846747E-4	2.49361634216406E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	1	2	3	4	9	23	32	45	36	54	TCRBV24,TCRBV27													CASARTGVVMYYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGAATGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	50	2.1533902976846747E-4		34	TCRBV12						TCRBJ02	TCRBJ02-07	01	3	0	10	6	5	0	26	40	-1	45	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGTAACCGAGAACACTGAAGCTTTCTTTGGACAA	CASSLVTENTEAFF	In	VDJ	1	50	2.1533902976846747E-4	2.49361634216406E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	1	2	8	1	5	0	26	42	-1	47	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVTENTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGTTGGGGGCAGGCGGCTACACCTTCGGTTCG		Out	VDJ	1	49	2.1103224917309814E-4		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	6	0	8	2	4	23	39	47	41	51	TCRBV09,TCRBV21													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTCGATTCCGGGACAGGGCTACACCTTCGGTTCG		Out	VDJ	1	49	2.1103224917309814E-4		38	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	8	8	0	24	35	-1	43	50	TCRBV02,TCRBV21													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCAAGTCCAAGGCCCCTACGAGCAGTACTTCGGGCCG	CASSQVQGPYEQYF	In	VDJ	1	49	2.1103224917309814E-4	2.443744015320779E-4	42	TCRBV24						TCRBJ02	TCRBJ02-07	01	6	5	4	2	8	2	24	36	47	44	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVQGPYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCGGGACAGGGACACCGGGGAGCTGTTTTTTGGAGAA	CATSDRDRDTGELFF	In	VDJ	1	49	2.1103224917309814E-4	2.443744015320779E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	3	3	1	0	24	39	-1	40	49		TCRBV24-01,TCRBV24-or09_02												CATSDRDRDTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTGACAGGGGGGGATAATTCACCCCTCCACTTTGGGAAC	CSARDLTGGDNSPLHF	In	VDJ	1	49	2.1103224917309814E-4	2.443744015320779E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	2	1	5	3	2	26	40	52	43	54		TCRBV20-01,TCRBV20-or09_02												CSARDLTGGDNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAAGTACAGGGGGAATGAACACTGAAGCTTTCTTTGGACAA	CSARDLSTGGMNTEAFF	In	VDJ	1	49	2.1103224917309814E-4	2.443744015320779E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	1	0	7	2	26	40	55	47	57		TCRBV20-01,TCRBV20-or09_02												CSARDLSTGGMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAGGACAGGGGGGAGAGAGACCCAGTACTTCGGGCCA	CSARTGGRETQYF	In	VDJ	1	49	2.1103224917309814E-4	2.443744015320779E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	1	4	2	3	26	34	46	36	49		TCRBV20-01,TCRBV20-or09_02												CSARTGGRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTTGGGATGAAGCTTTCTTTGGACAA	CASSQGWDEAFF	In	VDJ	1	49	2.1103224917309814E-4	2.443744015320779E-4	36	TCRBV03						TCRBJ01	TCRBJ01-01	01	1	0	8	7	3	0	26	42	-1	45	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGWDEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCACTCTGATGGGCGGGGGGCTAGATACGCAGTATTTTGGCCCA	CASTTLMGGGLDTQYF	In	VDJ	1	49	2.1103224917309814E-4	2.443744015320779E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	7	1	5	12	2	26	36	56	48	58		TCRBV03-01,TCRBV03-02												CASTTLMGGGLDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAACTGGGGATACGCAGTATTTTGGCCCA	CASSETGDTQYF	In	VDJ	1	48	2.0672546857772878E-4	2.3938716884774975E-4	36	unresolved						TCRBJ02	TCRBJ02-03	01	2	0	9	6	3	0	23	38	-1	41	44	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSETGDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCGGCAGGGGGGGCGCGCACTGAAGCTTTCTTTGGACAA	CASSPAGGARTEAFF	In	VDJ	1	48	2.0672546857772878E-4	2.3938716884774975E-4	45	unresolved						TCRBJ01	TCRBJ01-01	01	5	4	1	4	4	6	18	30	41	34	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPAGGARTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAGTCGAGACAGAGTAATGAAAAACTGTTTTTTGGCAGT	CASSQESRQSNEKLFF	In	VDJ	1	48	2.0672546857772878E-4	2.3938716884774975E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	2	5	4	5	2	18	35	45	40	47	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQESRQSNEKLFF+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGATCCTCCGGGGGGAAGGGGAGACCCAGTACTTCGGGCCA	CASSQILRGEGETQYF	In	VDJ	1	48	2.0672546857772878E-4	2.3938716884774975E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	8	1	5	7	5	26	40	54	47	59		TCRBV03-01,TCRBV03-02												CASSQILRGEGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAATCGAGTCCACCCCTCCACTTTGGGAAC	CASSQESSPPLHF	In	VDJ	1	48	2.0672546857772878E-4	2.3938716884774975E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	0	11	2	11	3	2	23	40	46	43	48	TCRBV01,TCRBV04													CASSQESSPPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01*02	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCAGGACGACTAGCTCCTACGAGCAGTACTTCGGGCCG	CASSFRTTSSYEQYF	In	VDJ	1	48	2.0672546857772878E-4	2.3938716884774975E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	2	8	0	6	0	26	40	-1	46	52		TCRBV12-03,TCRBV12-04				01,02								CASSFRTTSSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCAGACAGCTCTTTACTTCTGTGCCACCAGGCATTTCTCCACTGGGGAATTGGGTAATAGCAATCAGCCCCAGCATTTTGGTGAT	CATRHFSTGELGNSNQPQHF	In	VDJ	1	48	2.0672546857772878E-4	2.3938716884774975E-4	60	TCRBV24						TCRBJ01	TCRBJ01-05	01	7	0	8	0	14	9	21	32	50	46	59		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATRHFSTGELGNSNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTACTAGTCCCCGCAGATACGCAGTATTTTGGCCCA	CASSLLVPADTQYF	In	VDJ	1	47	2.0241868798235942E-4	2.3439993616342165E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	8	4	0	6	18	-1	37	33	43	TCRBV07,TCRBV11					01,02								CASSLLVPADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCCCCGAGGTGGGCAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	47	2.0241868798235942E-4		46	unresolved						TCRBJ01	TCRBJ01-01	01	4	8	0	1	9	1	18	31	44	40	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGGGGGGGGGACTGCCCAGCCCCAGCATTTTGGTGAT	CASSGGGTAQPQHF	In	VDJ	1	47	2.0241868798235942E-4	2.3439993616342165E-4	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	9	0	7	0	7	24	-1	44	37	51		TCRBV24-01,TCRBV24-or09_02												CASSGGGTAQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCCCGGGACAGGGACAAGAGACCCAGTACTTCGGGCCA	CSVPGQGQETQYF	In	VDJ	1	47	2.0241868798235942E-4	2.3439993616342165E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	0	3	2	4	1	26	33	46	37	47		TCRBV20-01,TCRBV20-or09_02												CSVPGQGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCGGACTGGCGGTCGACCCAGTACTTCGGGCCA	CSAADWRSTQYF	In	VDJ	1	47	2.0241868798235942E-4	2.3439993616342165E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	1	10	7	2	7	26	35	42	37	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSAADWRSTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGAGTCAGGCGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	47	2.0241868798235942E-4		37	TCRBV20						TCRBJ02	TCRBJ02-03	01	6	4	4	4	6	2	26	34	44	40	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGGAAAATGAAAAACTGTTTTTTGGCAGT	CSAPENEKLFF	In	VDJ	1	47	2.0241868798235942E-4	2.3439993616342165E-4	33	TCRBV20						TCRBJ01	TCRBJ01-04	01	6	1	8	5	3	1	26	34	40	37	41		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPENEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAAGGGGAAGCGAGCAGTATGTCGGGCCG	CASSQERGSEQYV	In	VDJ	1	47	2.0241868798235942E-4	2.3439993616342165E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	5	2	17	1	14	26	43	49	44	63		TCRBV03-01,TCRBV03-02												CASSQERGSEQYV+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATCGGGCGTCAGGGTTAATTCACCCCTCCACTTTGGGAAC	CASSLSGVRVNSPLHF	In	VDJ	1	46	1.9811190738699006E-4	2.2941270347909352E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	4	3	6	11	1	24	36	52	47	53	TCRBV24,TCRBV27													CASSLSGVRVNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCAGGGGGCGGAAGATACGCAGTATTTTGGCCCA	CASSQGAEDTQYF	In	VDJ	1	46	1.9811190738699006E-4	2.2941270347909352E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	4	0	5	1	3	24	35	44	36	47		TCRBV24-01,TCRBV24-or09_02												CASSQGAEDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCTAGCAGTGAATACCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSEYLSGANVLTF	In	VDJ	1	46	1.9811190738699006E-4	2.2941270347909352E-4	45	unresolved						TCRBJ02	TCRBJ02-06	01	5	2	8	0	0	6	22	-1	36	34	42	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEYLSGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTTAGCGGGGGGACACGGGAGTTCTTCGGGCCA	CSARDFSGGTREFF	In	VDJ	1	46	1.9811190738699006E-4	2.2941270347909352E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	1	14	3	7	26	40	53	43	60		TCRBV20-01,TCRBV20-or09_02												CSARDFSGGTREFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCCGATGCGATACAGGTTCTATTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	45	1.9380512679162073E-4		52	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	4	4	10	6	18	30	45	40	51	TCRBV07,TCRBV11													X+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGACCCCTCTCCGGTAGCTCTTCAGTACTTCGGCGCC	CASSLDPSPVALQYF	In	VDJ	1	45	1.9380512679162073E-4	2.244254707947654E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	1	5	7	11	12	2	18	34	50	46	52	TCRBV07,TCRBV11					01,02								CASSLDPSPVALQYF+X+TCRBJ02-04	unresolved	TCRBD02-01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCGGCAGTTCTATGGCTACACCTTCGGTTCG	CATSDRQFYGYTF	In	VDJ	1	45	1.9380512679162073E-4	2.244254707947654E-4	39	TCRBV24						TCRBJ01	TCRBJ01-02	01	4	4	5	4	4	2	24	38	45	42	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDRQFYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGGTCGGGGGGTCCCCAGTCGATGAGCAGTTCTTCGGGCCA	CSARAVGGSPVDEQFF	In	VDJ	1	45	1.9380512679162073E-4	2.244254707947654E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	8	1	8	4	10	26	39	50	43	60		TCRBV20-01,TCRBV20-or09_02												CSARAVGGSPVDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCTCGGCGGGTTAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	45	1.9380512679162073E-4		49	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	7	4	0	4	3	26	42	51	46	54		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGCCACGGACAGACCGAACACTGAAGCTTTCTTTGGACAA	CASSATDRPNTEAFF	In	VDJ	1	45	1.9380512679162073E-4	2.244254707947654E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	5	1	4	3	24	37	47	41	50	TCRBV06,TCRBV10	TCRBV06-01,TCRBV10-03												CASSATDRPNTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGCAGATCAGAACACTGAAGCTTTCTTTGGACAA	CASSFADQNTEAFF	In	VDJ	1	45	1.9380512679162073E-4	2.244254707947654E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	5	1	2	4	26	40	45	42	49		TCRBV12-03,TCRBV12-04												CASSFADQNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTACCTCCAGGGGGCAAGGACTGAAGCTTTCTTTGGACAA	CASSYLQGARTEAFF	In	VDJ	1	44	1.8949834619625137E-4	2.194382381104373E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	0	5	6	4	24	36	50	42	54		TCRBV24-01,TCRBV24-or09_02												CASSYLQGARTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCAACCGGGAGAGCTCACCCCTCCACTTTGGGAAC	CASSPNRESSPLHF	In	VDJ	1	44	1.8949834619625137E-4	2.194382381104373E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	6	8	2	10	6	3	24	36	48	42	51		TCRBV24-01,TCRBV24-or09_02												CASSPNRESSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD02-01*02	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTAAGGACAGAAATCAGCCCCAGCATTTTGGTGAT	CASSKDRNQPQHF	In	VDJ	1	44	1.8949834619625137E-4	2.194382381104373E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	5	4	2	1	24	36	44	38	45		TCRBV24-01,TCRBV24-or09_02												CASSKDRNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGTCTTAATTCCTACGAGCAGTACTTCGGGCCG	CASSQGLNSYEQYF	In	VDJ	1	44	1.8949834619625137E-4	2.194382381104373E-4	42	TCRBV03						TCRBJ02	TCRBJ02-07	01	3	0	9	1	0	7	26	-1	43	40	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGLNSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGGCCAGGCCAAAAACATTCAGTACTTCGGCGCC	CASSQEGQAKNIQYF	In	VDJ	1	44	1.8949834619625137E-4	2.194382381104373E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	8	0	1	0	3	26	-1	47	43	50		TCRBV03-01,TCRBV03-02												CASSQEGQAKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD01-01*01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGACGGGCGAATTCACCCCTCCACTTTGGGAAC	CASRRANSPLHF	In	VDJ	1	44	1.8949834619625137E-4	2.194382381104373E-4	36	TCRBV03						TCRBJ01	TCRBJ01-06	01	6	8	0	7	2	1	26	37	43	39	44		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRANSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03		TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAGCGGGGGGGACCCAAGAGACCCAGTACTTCGGGCCA	CASSLAGGTQETQYF	In	VDJ	1	43	1.8519156560088202E-4	2.1445100542610916E-4	45				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	9	0	1	0	2	18	-1	42	35	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAGGTQETQYF+X+TCRBJ02-05		TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTACAAGGGGGGGCTGCGGGACAGCCTCAGCATTTTGGTGAT	CSVQGGAAGQPQHF	In	VDJ	1	43	1.8519156560088202E-4	2.1445100542610916E-4	42	TCRBV20						TCRBJ01	TCRBJ01-05	01	7	0	5	13	16	3	26	33	56	49	59		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSVQGGAAGQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAATACAGAGGATTCATATGGCTACACCTTCGGTTCG	CSANTEDSYGYTF	In	VDJ	1	43	1.8519156560088202E-4	2.1445100542610916E-4	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	3	5	5	4	8	26	34	42	38	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSANTEDSYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTCCCGACAGCGGTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	43	1.8519156560088202E-4		40	TCRBV03						TCRBJ02	TCRBJ02-07	01	5	2	5	17	5	16	26	38	48	43	64		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACGGGACAGTCAATCAGCCCCAGCATTTTGGTGAT	CASSHGTVNQPQHF	In	VDJ	1	43	1.8519156560088202E-4	2.1445100542610916E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	5	3	1	1	26	40	48	41	49		TCRBV03-01,TCRBV03-02												CASSHGTVNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGACCGGACAGATACGCAGTATTTTGGCCCA	CASSQDDRTDTQYF	In	VDJ	1	43	1.8519156560088202E-4	2.1445100542610916E-4	42	TCRBV03						TCRBJ02	TCRBJ02-03	01	0	2	7	3	1	3	26	43	47	44	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDDRTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAGARGACTCRGCYSYKTATCTYTGCGCCAGCAGCCGAACAGGGTGGTCTGGAAACACCATATATTTTGGAGAG	CASSRTGWSGNTIYF	In	VDJ	1	43	1.8519156560088202E-4	2.1445100542610916E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	3	1	2	3	23	36	44	38	47	TCRBV01,TCRBV05													CASSRTGWSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGACACTTACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPTLTGANVLTF	In	VDJ	1	43	1.8519156560088202E-4	2.1445100542610916E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	2	2	4	26	38	44	40	48		TCRBV12-03,TCRBV12-04												CASSPTLTGANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD01-01*01	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCGCCGGAGGGACATCCGGGGCCGGGCCATCAGCCCCAGCATTTTGGTGAT	CASSSPEGHPGPGHQPQHF	In	VDJ	1	42	1.8088478500551269E-4	2.0946377274178103E-4	57	TCRBV05						TCRBJ01	TCRBJ01-05	01	3	0	6	5	7	14	19	32	45	39	59		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPEGHPGPGHQPQHF+TCRBV05-X+TCRBJ01-05	TCRBV05		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCTCGGGTGGGGGGGAGAATGAGCAGTTCTTCGGGCCA	CSARDPSGGGENEQFF	In	VDJ	1	42	1.8088478500551269E-4	2.0946377274178103E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	9	0	7	10	2	26	40	57	50	59		TCRBV20-01,TCRBV20-or09_02												CSARDPSGGGENEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
MRGGGACTCAGCYSTGTAYYTCTGTGCCAGCAGCCGGGACATCCTCACTGAAGCTTTCTTTGGACAA	CASSRDILTEAFF	In	VDJ	1	42	1.8088478500551269E-4	2.0946377274178103E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	6	4	3	4	22	32	41	35	45	TCRBV05,TCRBV12													CASSRDILTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGCGGACTAGCGGGAGGACAGATACGCAGTATTTTGGCCCA	CASSPRTSGRTDTQYF	In	VDJ	1	42	1.8088478500551269E-4	2.0946377274178103E-4	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	1	1	3	3	0	26	39	-1	42	56		TCRBV03-01,TCRBV03-02												CASSPRTSGRTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCAGCTTCTACATCTGCAGTGCTAGAGATGCGAGACTAGCGGGGGGCGGGGACTCCTACAATGAGCAGTTCTTCGGGCCA	CSARDARLAGGGDSYNEQFF	In	VDJ	1	42	1.8088478500551269E-4	2.0946377274178103E-4	60	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	2	1	0	5	6	15	29	47	34	53		TCRBV20-01,TCRBV20-or09_02												CSARDARLAGGGDSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGACCTCGGGCGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPTSGATNEKLFF	In	VDJ	1	42	1.8088478500551269E-4	2.0946377274178103E-4	48	TCRBV12						TCRBJ01	TCRBJ01-04	01	5	8	0	0	8	1	26	38	50	46	51		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTSGATNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCGGGGTACAGAACACTGAAGCTTTCTTTGGACAA	CASGVQNTEAFF	In	VDJ	1	41	1.7657800441014333E-4	2.0447654005745293E-4	36	unresolved						TCRBJ01	TCRBJ01-01	01	7	6	2	1	0	4	23	-1	36	32	40	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGVQNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCSRGGGACTCAGCTGTGTATYTYTGTGCCAGCAGCTCCGGGACAGGTGAAGAAGCTTTCTTTGGACAA	CASSSGTGEEAFF	In	VDJ	1	41	1.7657800441014333E-4	2.0447654005745293E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	4	8	2	4	22	35	45	37	49	TCRBV07,TCRBV12													CASSSGTGEEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTTTGAGTAGAGCAAGAGACCCAGTACTTCGGGCCA	CARSF*VEQETQYF	Stop	VDJ	1	41	1.7657800441014333E-4		42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	5	8	2	5	2	18	32	40	37	42	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03				01,02								CARSF*VEQETQYF+X+TCRBJ02-05		TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCTGGTGGGGGTGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLSGGGGTGELFF	In	VDJ	1	41	1.7657800441014333E-4	2.0447654005745293E-4	48							TCRBJ02	TCRBJ02-02	01	6	6	1	4	9	3	24	36	50	45	53	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSGGGGTGELFF+X+TCRBJ02-02			TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAGCGTTGAGGAGACCCAGTACTTCGGGCCA	CASSLSVEETQYF	In	VDJ	1	41	1.7657800441014333E-4	2.0447654005745293E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	6	6	5	3	5	24	36	43	39	48		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLSVEETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGGATAGGGATCTCCTACGAGCAGTACTTCGGGCCG	CSAGIGISYEQYF	In	VDJ	1	41	1.7657800441014333E-4	2.0447654005745293E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	6	0	8	0	1	7	26	34	39	35	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGIGISYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACCAGGCGGGGGAGGCAATGAGCAGTTCTTCGGGCCA	CSAPGGGGNEQFF	In	VDJ	1	41	1.7657800441014333E-4	2.0447654005745293E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	7	2	6	5	3	26	34	46	39	49		TCRBV20-01,TCRBV20-or09_02												CSAPGGGGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCTGGCGGAGCGGGGGATACAAGAGACCCAGTACTTCGGGCCA	CASSQDLAERGIQETQYF	In	VDJ	1	41	1.7657800441014333E-4	2.0447654005745293E-4	54	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	6	2	2	8	3	26	43	59	51	62		TCRBV03-01,TCRBV03-02												CASSQDLAERGIQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCTGACAGGATACGAGCAGTACGTCGGGCCG	CASSQDLTGYEQYV	In	VDJ	1	41	1.7657800441014333E-4	2.0447654005745293E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	4	17	3	14	26	43	52	46	66		TCRBV03-01,TCRBV03-02												CASSQDLTGYEQYV+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGCCTCGGGGCGGGTTGGTGAGCAGTTCTTCGGGCCA	CASSASGRVGEQFF	In	VDJ	1	41	1.7657800441014333E-4	2.0447654005745293E-4	42	TCRBV12						TCRBJ02	TCRBJ02-01	01	5	7	0	9	5	7	26	38	48	43	55		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSASGRVGEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTTGGGGGGGGCACTGAAGCTTTCTTTGGACAA	CASSLGGGTEAFF	In	VDJ	1	41	1.7657800441014333E-4	2.0447654005745293E-4	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	9	0	4	4	1	26	37	48	41	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSLGGGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCCGGGCGGGGGGACCTTACAATGAGCAGTTCTTCGGGCCA	CASRAGGPYNEQFF	In	VDJ	1	40	1.7227122381477397E-4	1.994893073731248E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	7	1	4	3	4	23	32	43	35	47	TCRBV02,TCRBV12													CASRAGGPYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCTAGACAGGGGGCGATCTCTGCTATAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	40	1.7227122381477397E-4		59	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	4	0	0	0	12	18	-1	43	35	55	TCRBV07,TCRBV11													X+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCTGCGTGGGTTCTGGAGGCCAACGTCCTGACTTTCGGGGCC	CASSPAWVLEANVLTF	In	VDJ	1	40	1.7227122381477397E-4	1.994893073731248E-4	48	unresolved						TCRBJ02	TCRBJ02-06	01	5	0	9	6	7	7	18	30	40	37	47	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPAWVLEANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCCGAGGTCCTTACTATGGCTACACCTTCGGTTCG	CASSPRGPYYGYTF	In	VDJ	1	40	1.7227122381477397E-4	1.994893073731248E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	11	1	3	4	5	24	36	44	40	49		TCRBV24-01,TCRBV24-or09_02												CASSPRGPYYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTAGGGTCAGGGGGGCACAATGAGCAGTTCTTCGGGCCA	CASSLGSGGHNEQFF	In	VDJ	1	40	1.7227122381477397E-4	1.994893073731248E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	4	1	5	3	2	22	38	48	41	50		TCRBV12-03,TCRBV12-04												CASSLGSGGHNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCGTACTAGCGTCAATTGGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	40	1.7227122381477397E-4		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	3	6	8	4	9	26	39	50	43	59		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTGCGGACGGCGGGGGCAAGGGCTACACCTTCGGTTCG	CSATADGGGKGYTF	In	VDJ	1	40	1.7227122381477397E-4	1.994893073731248E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	7	2	8	9	4	26	36	52	45	56		TCRBV20-01,TCRBV20-or09_02												CSATADGGGKGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCTATTAGCGGGGTTGGGGAGCTGTTTTTTGGAGAA	CSAPISGVGELFF	In	VDJ	1	40	1.7227122381477397E-4	1.994893073731248E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	5	3	8	6	2	26	34	48	40	50		TCRBV20-01,TCRBV20-or09_02												CSAPISGVGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGTCAGCAGTCCGTGGGACAGGAAGTTTTCCGAGCAGTACGTCGGGCCG	CVSSPWDRKFSEQYV	In	VDJ	1	39	1.6796444321940464E-4	1.9450207468879667E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	4	17	4	19	24	36	48	40	67		TCRBV24-01,TCRBV24-or09_02												CVSSPWDRKFSEQYV+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCGACAGGGAGGGGCTACACCTTCGGTTCG	CASSSTGRGYTF	In	VDJ	1	39	1.6796444321940464E-4	1.9450207468879667E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	8	2	3	24	36	45	38	48		TCRBV24-01,TCRBV24-or09_02												CASSSTGRGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGGACTAGCGGACAAGAGACCCAGTACTTCGGGCCA	CATGTSGQETQYF	In	VDJ	1	39	1.6796444321940464E-4	1.9450207468879667E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	9	0	5	2	0	1	24	-1	44	33	45		TCRBV24-01,TCRBV24-or09_02				01,02								CATGTSGQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGACAGGGGATAATGAAGCTTTCTTTGGACAA	CATSGTGDNEAFF	In	VDJ	1	39	1.6796444321940464E-4	1.9450207468879667E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	2	7	0	4	24	-1	46	37	50		TCRBV24-01,TCRBV24-or09_02												CATSGTGDNEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCATGGGTTAAGGACACTGAAGCTTTCTTTGGACAA	CSAWVKDTEAFF	In	VDJ	1	39	1.6796444321940464E-4	1.9450207468879667E-4	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	0	9	3	2	6	26	34	39	36	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAWVKDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGAGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLRSGANVLTF	In	VDJ	1	39	1.6796444321940464E-4	1.9450207468879667E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	3	11	1	1	0	0	26	-1	-1	40	44		TCRBV12-03,TCRBV12-04												CASSLRSGANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD02-01*02	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCAGGGGGGAGAGACTGAAGCTTTCTTTGGACAA	CASSQGGETEAFF	In	VDJ	1	38	1.6365766262403528E-4	1.8951484200446856E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	1	5	0	5	23	-1	42	35	47	TCRBV09,TCRBV21													CASSQGGETEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCCCTTGGTGGGCACAATGAGCAGTTCTTCGGGCCA	CASSSLGGHNEQFF	In	VDJ	1	38	1.6365766262403528E-4	1.8951484200446856E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	8	0	5	8	0	18	31	-1	39	43	TCRBV05,TCRBV11													CASSSLGGHNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ACGACTCGGCCSTGTATCTCTGTGCCAGCAGCTTAGGTGACGGGTATGGCTACACCTTCGGTTCG	CASSLGDGYGYTF	In	VDJ	1	38	1.6365766262403528E-4	1.8951484200446856E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	8	4	5	4	0	18	34	-1	38	42	TCRBV05,TCRBV07					01,02								CASSLGDGYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCCGGGACAACTCCTACAATGAGCAGTTCTTCGGGCCA	CASRDNSYNEQFF	In	VDJ	1	38	1.6365766262403528E-4	1.8951484200446856E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	11	0	6	0	3	1	24	31	40	34	41		TCRBV24-01,TCRBV24-or09_02												CASRDNSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGGTATTGGGGGCTGGCAAGAGACCCAGTACTTCGGGCCA	CSAKGIGGWQETQYF	In	VDJ	1	38	1.6365766262403528E-4	1.8951484200446856E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	6	0	2	8	3	26	36	50	44	53		TCRBV20-01,TCRBV20-or09_02												CSAKGIGGWQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCGCCCCAGGGGACACCAACTACGAGCAGTACTTCGGGCCG	CSAPGDTNYEQYF	In	VDJ	1	38	1.6365766262403528E-4	1.8951484200446856E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	0	6	3	8	4	26	31	45	39	49		TCRBV20-01,TCRBV20-or09_02												CSAPGDTNYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGATCTAACTCCATTTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	38	1.6365766262403528E-4		50	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	2	7	4	19	0	26	38	-1	57	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCGCAGGGCGGGCCACTGAAGCTTTCTTTGGACAA	CASSRAGRATEAFF	In	VDJ	1	38	1.6365766262403528E-4	1.8951484200446856E-4	42	TCRBV03						TCRBJ01	TCRBJ01-01	01	4	4	3	4	3	5	26	39	47	42	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRAGRATEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTAGTCCCTTCTGGGACAGGGGGTCGTGGCTACACCTTCGGTTCG	CASSLVPSGTGGRGYTF	In	VDJ	1	38	1.6365766262403528E-4	1.8951484200446856E-4	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	1	7	8	3	26	42	61	50	64		TCRBV12-03,TCRBV12-04												CASSLVPSGTGGRGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCGCAACGACACGACCATACTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSATTRPYSNTGELFF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	6	0	5	10	19	31	40	36	50	TCRBV07,TCRBV11													CASSATTRPYSNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTGGGGGGGCCCCCCGGCAATGAGCAGTTCTTCGGGCCA	CASSLGGPPGNEQFF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	9	0	6	0	8	18	-1	39	32	47	TCRBV07,TCRBV11													CASSLGGPPGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCTCGGACAGACTCTTCGGGGGAGCAGTACTTCGGGCCG	CASSSRTDSSGEQYF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	5	7	3	11	18	31	40	34	51	TCRBV07,TCRBV11													CASSSRTDSSGEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAACGACGGGAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASNDGNSNQPQHF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	11	8	3	0	7	1	24	31	43	38	44	TCRBV06,TCRBV24													CASNDGNSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCGACCAGGGGGAAACTGAAGCTTTCTTTGGACAA	CSARDPDQGETEAFF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	1	5	7	2	26	40	54	47	56		TCRBV20-01,TCRBV20-or09_02												CSARDPDQGETEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGCATCAGGGCAACGCTACACCTTCGGTTCG	CASSQEASGQRYTF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	3	9	5	4	26	43	53	48	57		TCRBV03-01,TCRBV03-02												CASSQEASGQRYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCACGATTGGGTCGAGCAGTACTTCGGGCCG	CASSHDWVEQYF	In	VDJ	1	37	1.5935088202866592E-4	1.8452760932014044E-4	36	unresolved						TCRBJ02	TCRBJ02-07	01	3	0	9	6	5	1	23	37	45	42	46	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHDWVEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGCTATAGGCACTGAAGCTTTCTTTGGACAA	CASSVAIGTEAFF	In	VDJ	1	36	1.550441014332966E-4	1.7954037663581233E-4	39	unresolved			unresolved			TCRBJ01	TCRBJ01-01	01	0	5	4	4	4	0	23	39	-1	43	46	TCRBV09,TCRBV12			TCRBD01,TCRBD02										CASSVAIGTEAFF+X+TCRBJ01-01	unresolved	unresolved	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGAGAAAAGCCCCTGGGGGACCCCTCCTACGAGCAGTACTTCGGGCCG	CASREKPLGDPSYEQYF	In	VDJ	1	36	1.550441014332966E-4	1.7954037663581233E-4	51	unresolved						TCRBJ02	TCRBJ02-07	01	5	0	7	0	14	2	23	34	53	48	55	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASREKPLGDPSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCACACGGCGGGGGGCCTACGAGCAGTACGTCGGGCCG	CASTRRGAYEQYV	In	VDJ	1	36	1.550441014332966E-4	1.7954037663581233E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	7	1	17	4	15	23	33	45	37	60	TCRBV02,TCRBV09													CASTRRGAYEQYV+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGGACAGTTCGTGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLGQFVAGELFF	In	VDJ	1	36	1.550441014332966E-4	1.7954037663581233E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	2	5	6	0	7	18	-1	39	34	46	TCRBV07,TCRBV11													CASSLGQFVAGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCATAAGGGGGAACTAGCGGGCGGGTGCTCATCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	36	1.550441014332966E-4		61				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	3	4	3	10	11	18	30	49	40	60	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03				01,02								X+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGAGGCTGAACTCGAGCAGTACTTCGGGCCG	CASSLEAELEQYF	In	VDJ	1	36	1.550441014332966E-4	1.7954037663581233E-4	39							TCRBJ02	TCRBJ02-07	01	1	5	4	6	0	7	18	-1	37	34	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEAELEQYF+X+TCRBJ02-07			TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTGGCGGCGGTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSFGGGSSYNEQFF	In	VDJ	1	36	1.550441014332966E-4	1.7954037663581233E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	7	5	0	4	6	24	36	44	40	50		TCRBV24-01,TCRBV24-or09_02				01,02								CASSFGGGSSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGCCGGGGTAGCACAGATACGCAGTATTTTGGCCCA	CATSGRGSTDTQYF	In	VDJ	1	36	1.550441014332966E-4	1.7954037663581233E-4	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	3	0	2	1	24	37	44	39	45		TCRBV24-01,TCRBV24-or09_02												CATSGRGSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCTGGAAGGTCCTACAATGAGCAGTTCTTTGGGCCA	CATSDSGRSYNEQFF	In	VDJ	1	36	1.550441014332966E-4	1.7954037663581233E-4	45	TCRBV24						TCRBJ02			2	1	8	22	2	24	24	40	45	42	69		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01			TCRBJ02-01,TCRBJ02-05						CATSDSGRSYNEQFF+TCRBV24-X+TCRBJ02-X	TCRBV24		TCRBJ02	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGTACAGGGGAGGAGGGACTGAAGCTTTCTTTGGACAA	CSAKYRGGGTEAFF	In	VDJ	1	36	1.550441014332966E-4	1.7954037663581233E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	2	5	3	7	26	36	46	39	53		TCRBV20-01,TCRBV20-or09_02												CSAKYRGGGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACCCGGCCACACAGATACGCAGTATTTTGGCCCA	CASSQPGHTDTQYF	In	VDJ	1	36	1.550441014332966E-4	1.7954037663581233E-4	42	TCRBV03						TCRBJ02	TCRBJ02-03	01	2	9	0	2	3	2	26	41	47	44	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQPGHTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCCCGGGCTCGCAGTATTTTGGCCCA	CASSPPGSQYF	In	VDJ	1	36	1.550441014332966E-4	1.7954037663581233E-4	33	TCRBV12						TCRBJ02	TCRBJ02-03	01	5	8	0	10	5	1	26	38	47	43	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPGSQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCAATGAGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSPMRDTGELFF	In	VDJ	1	36	1.550441014332966E-4	1.7954037663581233E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	11	0	3	6	0	26	37	-1	43	48		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPMRDTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*02	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTTTCGACAGGGGTGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSFDRGGTGELFF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	2	4	4	3	23	34	46	38	49	TCRBV02,TCRBV09													CASSFDRGGTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAGGTAGCGGGGGGCTCCCGGCGTCCCAGTACTTCGGGCCA	CASSEGSGGLPASQYF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	5	1	9	6	10	23	34	50	40	60	TCRBV02,TCRBV09													CASSEGSGGLPASQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCTCGTGGACTGCCTCCACAGATACGCAGTATTTTGGCCCA	CASSSWTASTDTQYF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	10	2	4	5	23	35	44	39	49	TCRBV09,TCRBV21					01,02								CASSSWTASTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGTTCAAGGGATCTATAGCTAACTATGGCTACACCTTCGGTTCG	CASSLFKGSIANYGYTF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	51	TCRBV05						TCRBJ01	TCRBJ01-02	01	1	0	8	0	5	7	19	34	43	39	50		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLFKGSIANYGYTF+TCRBV05-X+TCRBJ01-02	TCRBV05		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCTTAGACGGTAGGGCCAAGGAGGATGGCTACACCTTCGGTTCG	CASSLDGRAKEDGYTF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	10	1	6	13	0	19	35	-1	48	53	TCRBV07,TCRBV11													CASSLDGRAKEDGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCGCCTCTGGGATGTGAACACTGAAGCTTTCTTTGGACAA	CASRLWDVNTEAFF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	42							TCRBJ01	TCRBJ01-01	01	8	0	8	0	7	2	18	27	38	34	40	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRLWDVNTEAFF+X+TCRBJ01-01			TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCGGGACGGGTGTATCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGTGVSYNEQFF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	48	unresolved						TCRBJ02	TCRBJ02-01	01	5	0	7	1	3	7	18	30	38	33	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGTGVSYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCCATACCGGGACAGGGGGCTTTTGAACACTGAAGCTTTCTTTGGACAA	CASSPYRDRGLLNTEAFF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	0	0	7	3	18	30	49	37	52	TCRBV07,TCRBV11													CASSPYRDRGLLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCCCACACCGGGACTAGCGACGATCTTTCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	35	1.5073732083792723E-4		58	TCRBV25			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	6	2	8	10	23	34	52	42	62		TCRBV25-01,TCRBV25-or09_02				01,02								X+TCRBV25-X+TCRBJ02-03	TCRBV25	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCGGGACAATTACAATGAGCAGTTCTTCGGGCCA	CASSRDNYNEQFF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	6	4	2	2	24	35	43	37	45		TCRBV24-01,TCRBV24-or09_02												CASSRDNYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGACAGGGGAGCCCCAGCATTTTGGTGAT	CATSDLTGEPQHF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	2	8	0	0	24	-1	-1	42	49		TCRBV24-01,TCRBV24-or09_02												CATSDLTGEPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAATTGGGTGCAGATACGCAGTATTTTGGCCCA	CASSQELGADTQYF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	42	unresolved						TCRBJ02	TCRBJ02-03	01	0	0	9	4	3	2	23	40	46	43	48	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQELGADTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGAGCCACAGGGGGCGTCACTGAAGCTTTCTTTGGACAA	CSARATGGVTEAFF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	0	4	2	2	26	39	50	41	52		TCRBV20-01,TCRBV20-or09_02												CSARATGGVTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGGGGCAGGCACTGAAGCTTTCTTTGGACAA	CSAREGAGTEAFF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	6	0	4	0	3	26	-1	46	40	49		TCRBV20-01,TCRBV20-or09_02												CSAREGAGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGCCCGCCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	35	1.5073732083792723E-4		34	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	6	7	5	1	5	26	34	38	35	43		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGACCGGGCTAGTTCCTTCGGTTCG	CASSQGDRASSF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	36	TCRBV03						TCRBJ01	TCRBJ01-02	01	1	0	7	15	0	10	26	-1	47	42	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGDRASSF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGACAGACAGCCAAGGGCAGTACTTCGGGCCG	CASSLTDSQGQYF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	5	9	0	10	26	-1	45	40	55		TCRBV12-03,TCRBV12-04												CASSLTDSQGQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTCCACCGGGACGAATAATAAAAAACTGTTTTTTGGCAGT	CASSSTGTNNKKLFF	In	VDJ	1	35	1.5073732083792723E-4	1.745531439514842E-4	45	TCRBV12						TCRBJ01	TCRBJ01-04	01	4	0	7	9	5	8	26	39	49	44	57		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSTGTNNKKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAATCGACTAGCGTCTCAATGAGCAGTTCTTCGGGCCA	CASSLID*RLNEQFF	Stop	VDJ	1	34	1.4643054024255788E-4		45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	2	6	6	3	3	18	33	44	36	47	TCRBV07,TCRBV11					01,02								CASSLID*RLNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCAAGCAACAGGGGGCGGCTACGAGCAGTACGTCGGGCCG	CASSQATGGGYEQYV	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	0	17	6	16	18	30	45	36	61	TCRBV07,TCRBV11													CASSQATGGGYEQYV+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCGCTCGGTGGACGGAAACACTGAAGCTTTCTTTGGACAA	CATRSVDGNTEAFF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	42	TCRBV24						TCRBJ01	TCRBJ01-01	01	9	1	7	2	8	3	24	33	45	41	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATRSVDGNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCACCAGTGATGGGGCAGACAGGAGCTCCTACGAGCAGTACGTCGGGCCG	CATSDGADRSSYEQYV	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	4	17	6	19	33	48	60	54	79		TCRBV24-01,TCRBV24-or09_02												CATSDGADRSSYEQYV+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTGTCGGACAGAAATGGCTACACCTTCGGTTCG	CASSLSDRNGYTF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	5	6	3	2	22	36	45	39	47		TCRBV12-03,TCRBV12-04												CASSLSDRNGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTAAGGGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSKGLNTEAFF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	2	0	1	1	22	34	40	35	41		TCRBV12-03,TCRBV12-04												CASSKGLNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCGACAGGGGGGTCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	34	1.4643054024255788E-4		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	1	4	3	2	26	37	49	40	51		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAAGGCTAGCGGGGGTGGAGATACGCAGTATTTTGGCCCA	CSARDKASGGGDTQYF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	4	2	5	5	3	26	40	55	45	58		TCRBV20-01,TCRBV20-or09_02												CSARDKASGGGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCGCCTCCCTACTATGGCTACACCTTCGGTTCG	CASSSPPYYGYTF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	10	0	3	2	6	26	38	42	40	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPPYYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCACGCCTCAGGGATCCAAGAGACCCAGTACTTCGGGCCA	CASSPHASGIQETQYF	In	VDJ	1	34	1.4643054024255788E-4	1.6956591126715607E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	3	1	9	2	26	39	53	48	55		TCRBV03-01,TCRBV03-02												CASSPHASGIQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTCTACAGTGGAGGCTACACCTTCGGTTCG	CASSVYSGGYTF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	5	8	2	4	23	37	43	39	47	TCRBV09,TCRBV12													CASSVYSGGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAGGGACAGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLGTGGYNEQFF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	1	1	3	0	0	18	-1	-1	34	44	TCRBV07,TCRBV11													CASSLGTGGYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCGACCCCCGGGATCTCTTCTCTGGAAACACCATATATTTTGGAGAG	CASSDPRDLFSGNTIYF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	8	3	0	6	6	18	30	41	36	47	TCRBV05,TCRBV11													CASSDPRDLFSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACTAAGGGACAGGGGTACTATGGCTACACCTTCGGTTCG	CATKGQGYYGYTF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	0	2	3	3	1	24	32	45	35	46		TCRBV24-01,TCRBV24-or09_02												CATKGQGYYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGCCCCAATACAAACAGATACGCAGTATTTTGGCCCA	CSAGAPIQTDTQYF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	7	0	3	0	10	26	-1	40	35	50		TCRBV20-01,TCRBV20-or09_02												CSAGAPIQTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTAGGGCTAGCGGGCCGCGGGGCCAACGTCCTGACTTTCGGGGCC	CSARDLGLAGRGANVLTF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	54	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	0	4	4	4	7	4	26	40	55	47	59		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLGLAGRGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD02-01	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGAAGAGCCTCGTCGGGAGGAGAGACCCAGTACTTCGGGCCA	CSARDRRASSGGETQYF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	8	1	4	14	0	26	40	-1	54	61		TCRBV20-01,TCRBV20-or09_02												CSARDRRASSGGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGAACTAGCGCTTTCGGCAATGAGCAGTTCTTCGGGCCA	CASSQGTSAFGNEQFF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	3	6	6	2	7	26	42	51	44	58		TCRBV03-01,TCRBV03-02				01,02								CASSQGTSAFGNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGATCCTTCTTTTGAAGCTTTCTTTGGACAA	CASSLDPSFEAFF	In	VDJ	1	33	1.4212375964718854E-4	1.6457867858282797E-4	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	3	1	8	7	0	9	26	-1	43	40	52		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDPSFEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAATCGAAGATTGGTAGTGGGACAGGACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	32	1.378169790518192E-4		59	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	0	4	3	16	0	18	33	-1	49	57	TCRBV07,TCRBV11													X+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAACTCCTGGGATGAGGGCGGGGAAGATACGCAGTATTTTGGCCCA	CASNSWDEGGEDTQYF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	7	3	5	15	1	18	28	49	43	50	TCRBV07,TCRBV11													CASNSWDEGGEDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCTCAGGGGACAGATACGCAGTATTTTGGCCCA	CASSPQGTDTQYF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	2	3	3	0	24	36	-1	39	45		TCRBV24-01,TCRBV24-or09_02												CASSPQGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCATGGACAGAAATCAGCCCCAGCATTTTGGTGAT	CASSMDRNQPQHF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	1	5	4	3	1	24	35	44	38	45		TCRBV24-01,TCRBV24-or09_02												CASSMDRNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCAGCGGGGCCCGGGTGAAAAACTGTTTTTTGGCAGT	CATQRGPGEKLFF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	9	6	3	7	1	6	24	33	41	34	47		TCRBV24-01,TCRBV24-or09_02												CATQRGPGEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD02-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCTCGATCGTCCCCACGGGGTAATGAAAAACTGTTTTTTGGCAGT	CATSDPRSSPRGNEKLFF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	54	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	8	3	4	15	0	24	39	-1	54	59		TCRBV24-01,TCRBV24-or09_02												CATSDPRSSPRGNEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD02-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCCCAGCGGGGATGGGAATGAGCAGTTCTTCGGGCCA	CSAPPSGDGNEQFF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	3	7	6	5	26	35	48	41	53		TCRBV20-01,TCRBV20-or09_02												CSAPPSGDGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGCAGCAACTATGGCTACACCTTCGGTTCG	CSARGSNYGYTF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	8	0	2	0	3	26	-1	41	37	44		TCRBV20-01,TCRBV20-or09_02												CSARGSNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTAGGTATACAGGGGGCAATGGCTACACCTTCGGTTCG	CASSPRYTGGNGYTF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	0	6	8	1	26	39	56	47	57		TCRBV03-01,TCRBV03-02												CASSPRYTGGNGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGTAMSCTCYCAGACATCTGTGTACTTCTGTGCCAGCAGTGCCTTGGGGGTTTTTAACACAGATACGCAGTATTTTGGCCCA	CASSALGVFNTDTQYF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	48	unresolved						TCRBJ02	TCRBJ02-03	01	4	6	1	2	4	7	24	37	46	41	53	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSALGVFNTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTTGTGGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSFVGGNTEAFF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	1	1	3	0	26	40	-1	43	49		TCRBV12-03,TCRBV12-04												CASSFVGGNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCAGGGCTCATCTCAATCAGCCCCAGCATTTTGGTGAT	CASSSRAHLNQPQHF	In	VDJ	1	32	1.378169790518192E-4	1.5959144589849984E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	3	3	1	7	26	39	45	40	52		TCRBV12-03,TCRBV12-04												CASSSRAHLNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGWGACWCKGCWSTGTATYTCTGYGCCAGCAGCCTGACAGGGGAGACTGAGCAGTTCTTCGGGCCA	CASSLTGETEQFF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	2	9	3	4	20	31	42	34	46	TCRBV03,TCRBV23													CASSLTGETEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGACGGACTAAACCTGGGCGAGCAGTACGTCGGGCCG	CASSLDGLNLGEQYV	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	1	9	17	1	19	18	35	42	36	61	TCRBV07,TCRBV11					01,02								CASSLDGLNLGEQYV+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTAGCGGGGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSVAGGYNEQFF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	42				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	9	0	4	0	0	18	-1	-1	35	42	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSVAGGYNEQFF+X+TCRBJ02-01		TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCTAACGGGACGTATAAATGAAAAACTGTTTTTTGGCAGT	CASSLTGRINEKLFF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	45	unresolved						TCRBJ01	TCRBJ01-04	01	5	0	7	5	5	5	18	30	40	35	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTGRINEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCCCTAAGCGGCAGGGCGATTCACCCTTCCACTTTGGGAAC	CASPKRQGDSPFHF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	42	unresolved						TCRBJ01	TCRBJ01-06	01	11	4	3	17	11	11	24	31	47	42	58	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASPKRQGDSPFHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAGGCCGGCACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	31	1.3351019845644983E-4		41	TCRBV24						TCRBJ01	TCRBJ01-02	01	6	5	4	4	3	7	24	36	42	39	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCGACAGGGGGTAGATTCACCCCTCCACTTTGGGAAC	CASSRQGVDSPLHF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	2	1	8	1	3	24	36	46	37	49	TCRBV24,TCRBV27													CASSRQGVDSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGTCCAAGGCAGGGTGGCGGCGGGGAGCTGTTTTTTGGAGAA	CATGPRQGGGGELFF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	9	4	3	7	9	6	24	33	47	42	53		TCRBV24-01,TCRBV24-or09_02												CATGPRQGGGGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCWSKSASWCAKCTGTGTACTTCTGTGCCAGCCTGACCTACTACACAAGACAGTCCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASLTYYTRQSPNTGELFF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	57	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	2	5	0	16	4	22	31	52	47	56	TCRBV06,TCRBV12													CASLTYYTRQSPNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCCGCCCCGGCCGCGGGGAGTCCTATGGCTACACCTTCGGTTCG	CASRPGRGESYGYTF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	8	7	3	4	10	4	22	31	47	41	51		TCRBV12-03,TCRBV12-04												CASRPGRGESYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGACCTCCTGTATCAGGGACCGCTGGCTACACCTTCGGTTCG	CASRPPVSGTAGYTF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	45	unresolved						TCRBJ01	TCRBJ01-02	01	6	0	7	7	13	3	23	34	52	47	55	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPPVSGTAGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGACTAGCCGGAAAATGAGCAGTTCTTCGGGCCA	CSAGD*PENEQFF	Stop	VDJ	1	31	1.3351019845644983E-4		39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	7	7	1	5	26	35	45	36	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGD*PENEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACACTCGGGTACAGATACGCAGTATTTTGGCCCA	CSARHSGTDTQYF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	8	4	3	4	1	26	38	46	42	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSARHSGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGTTCGCCGGGACAGTGGTCCTACGAGCAGTACTTCGGGCCG	CASSRSPGQWSYEQYF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	5	1	7	3	26	39	53	46	56		TCRBV03-01,TCRBV03-02												CASSRSPGQWSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTACCCACACTGGACAGGCCGTAATCTCACCCCTCCACTTTGGGAAC	CASSTHTGQAVISPLHF	In	VDJ	1	31	1.3351019845644983E-4	1.546042132141717E-4	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	4	10	9	8	26	38	54	47	62		TCRBV12-03,TCRBV12-04												CASSTHTGQAVISPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAAGTCAATGCAGAAGAGGGGGAGGGGACGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	30	1.292034178610805E-4		52	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	9	0	5	17	3	18	28	52	45	55	TCRBV07,TCRBV11													X+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGATTGGAGCGGGGGTCCCTCCACAGATACGCAGTATTTTGGCCCA	CAISDWSGGPSTDTQYF	In	VDJ	1	30	1.292034178610805E-4	1.496169805298436E-4	51				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	6	2	2	6	6	23	35	49	41	55	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03												CAISDWSGGPSTDTQYF+X+TCRBJ02-03		TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCCTGGGGGGGCTTTAGGGGAGCAGTTCTTCGGGCCA	CASSPGGALGEQFF	In	VDJ	1	30	1.292034178610805E-4	1.496169805298436E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	9	0	10	3	8	24	36	46	39	54	TCRBV24,TCRBV27													CASSPGGALGEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGATAGGCAGAGCGGGGGCTACACCTTCGGTTCG	CASSDRQSGGYTF	In	VDJ	1	30	1.292034178610805E-4	1.496169805298436E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	6	4	8	9	0	22	34	-1	43	49	TCRBV02,TCRBV12					01,02								CASSDRQSGGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGTCCGGGTTACTGAACACTGAAGCTTTCTTTGGACAA	CSARDGSGLLNTEAFF	In	VDJ	1	30	1.292034178610805E-4	1.496169805298436E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	4	0	6	4	26	40	50	46	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDGSGLLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCTCCGTCGGACCCCAACGGCGAGCAGTACTTCGGGCCG	CSARPPSDPNGEQYF	In	VDJ	1	30	1.292034178610805E-4	1.496169805298436E-4	45	TCRBV20						TCRBJ02	TCRBJ02-07	01	2	1	7	6	8	8	26	38	50	46	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPPSDPNGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCAAGATGAAGGGGGCAGGTTCTTCGGGCCA	CASSPQDEGGRFF	In	VDJ	1	30	1.292034178610805E-4	1.496169805298436E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	5	0	15	10	2	26	39	56	49	58		TCRBV03-01,TCRBV03-02												CASSPQDEGGRFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTCGACAGGGGTCAGGAAACACCATATATTTTGGAGAG	CASSRQGSGNTIYF	In	VDJ	1	30	1.292034178610805E-4	1.496169805298436E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	2	4	1	3	26	38	47	39	50	TCRBV12,TCRBV21													CASSRQGSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGGGGGACTCCGCGGAGGTTCACCCCTCCACTTTGGGAAC	CASSGGLRGGSPLHF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	3	0	10	9	1	9	23	36	43	37	52	TCRBV09,TCRBV12					01,02								CASSGGLRGGSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGGGGCAGGCTATGAACACTGAAGCTTTCTTTGGACAA	CASSLGQAMNTEAFF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	45	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	4	0	2	3	19	35	41	37	44		TCRBV05-06,TCRBV05-07												CASSLGQAMNTEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCATGTATCKCTGTGCCAGCAGCTTATTCGTGGGGGGCTGGGAGACCCAGTACTTCGGGCCA	CASSLFVGGWETQYF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	45	unresolved						TCRBJ02	TCRBJ02-05	01	2	6	0	5	6	3	19	34	46	40	49	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLFVGGWETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCCACGTTTGGTGCATCCTGAAGACAGCAGTTCTACATCTGCAGTGCTAGGGCGACAGGGGGGGTCACTGAAGCTTTCTTTGGACAA	CSARATGGVTEAFF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	1	4	3	3	39	50	62	53	65		TCRBV20-01,TCRBV20-or09_02												CSARATGGVTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAACGGCGACGGATTTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLTATDLAKNIQYF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	51	unresolved						TCRBJ02	TCRBJ02-04	01	2	1	8	0	8	3	18	33	44	41	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTATDLAKNIQYF+X+TCRBJ02-04	unresolved		TCRBJ02-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGGACTCGGCCSTGTATCTCTGTGCCAGCAGCTTTCGTTCGATCGATGAGCAGTTCTTCGGGCCA	CASSFRSIDEQFF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	39	unresolved						TCRBJ02	TCRBJ02-01	01	3	2	8	8	6	3	18	32	40	38	43	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFRSIDEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCTCCCCCCACGGAACACTGAAGCTTTCTTTGGACAA	CASSLPPRNTEAFF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	3	7	1	9	1	22	33	44	42	45		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLPPRNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTACAGGGCTGGGGGAACCAAGAGACCCAGTACTTCGGGCCA	CSVQGWGNQETQYF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	3	3	0	1	8	26	33	40	34	48		TCRBV20-01,TCRBV20-or09_02												CSVQGWGNQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGATTAACGGGGACTTACAAGAGACCCAGTACTTCGGGCCA	CSAREINGDLQETQYF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	0	10	2	8	2	26	40	54	48	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSAREINGDLQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGGGTCGGGAGTACAATGAGCAGTTCTTCGGGCCA	CSAPGREYNEQFF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	2	4	7	0	26	34	-1	41	47		TCRBV20-01,TCRBV20-or09_02												CSAPGREYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTAAGGGACATTCTTCTGGAAACACCATATATTTTGGAGAG	CASSKGHSSGNTIYF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	6	1	3	4	26	37	46	40	50		TCRBV03-01,TCRBV03-02												CASSKGHSSGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTACTTTACCCAGTCTAGCTAACTATGGCTACACCTTCGGTTCG	CASSPTLPSLANYGYTF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	51	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	4	8	0	14	0	26	39	-1	53	57		TCRBV03-01,TCRBV03-02				01,02								CASSPTLPSLANYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGATGGGGACAGGGGTCACCCCTCCACTTTGGGAAC	CASRWGQGSPLHF	In	VDJ	1	29	1.2489663726571114E-4	1.4462974784551548E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	2	10	3	0	26	37	-1	40	50		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRWGQGSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGGGGACTYGGCYSTSTATCTCTGTGCCAGCAGCCAAAGGGGCGGGAGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	28	1.2058985667034178E-4		40	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	7	3	8	7	0	22	34	-1	41	47	TCRBV05,TCRBV07													X+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGGGGACTCRGCYGTGTATCTCTGTGCCAGCAGCTTAGAAGGGAACACTGAAGCTTTCTTTGGACAA	CASSLEGNTEAFF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	1	5	4	1	1	0	22	38	-1	39	42	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCGGACCCCCCGACAGGGAACGCTGAAGCTTTCTTTGGACAA	CASSPDPPTGNAEAFF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	48	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	6	11	4	19	31	49	42	53		TCRBV05-06,TCRBV05-07												CASSPDPPTGNAEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTGGCTAGGACAGGGGGCGGATGGCTATACCTTCGGTTCG	CASSWLGQGADGYTF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	0	14	6	10	24	36	53	42	63		TCRBV24-01,TCRBV24-or09_02												CASSWLGQGADGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGCTCCGGGACAGGGATAGACAAACTGTTTTTTGGCAGT	CATSGSGTGIDKLFF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	3	11	5	6	24	37	51	42	57		TCRBV24-01,TCRBV24-or09_02												CATSGSGTGIDKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTGGACCGTGGTACAAGAGACCCAGTACTTCGGGCCA	CSASWTVVQETQYF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	3	1	7	2	2	7	26	37	43	39	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASWTVVQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAAGGGGATAGCAACAGATACGCAGTATTTTGGCCCA	CSARKGIATDTQYF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	5	2	3	1	6	26	38	44	39	50		TCRBV20-01,TCRBV20-or09_02												CSARKGIATDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGTCCGGGACTAGCGGGGGCAAAAGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	28	1.2058985667034178E-4		50	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	0	2	5	6	6	26	34	54	40	60		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAGGGCTGGGGAGAGGGGCTGAAGCTTTCTTTGGACAA	CASSLGLGRGAEAFF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	45	TCRBV03						TCRBJ01	TCRBJ01-01	01	5	5	2	6	14	0	26	38	-1	52	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGLGRGAEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTACAGGGGATGGGGAAGAATGAGCAGTTCTTCGGGCCA	CASSLQGMGKNEQFF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	2	7	1	9	26	39	47	40	56		TCRBV03-01,TCRBV03-02												CASSLQGMGKNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCAAAGGGACGGAAAATTCACCCCTCCACTTTGGGAAC	CASSRKGTENSPLHF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	45	TCRBV03						TCRBJ01	TCRBJ01-06	01	4	0	7	7	5	4	26	39	49	44	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRKGTENSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03		TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTGACGGGGGGGGTCGGCCAGATACGCAGTATTTTGGCCCA	CASSPDGGGRPDTQYF	In	VDJ	1	28	1.2058985667034178E-4	1.3964251516118735E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	8	0	4	4	6	26	39	51	43	57		TCRBV03-01,TCRBV03-02												CASSPDGGGRPDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGACGATGGGGTGAAAAACTGTTTTTTGGCAGT	CASRRWGEKLFF	In	VDJ	1	27	1.1628307607497244E-4	1.3465528247685925E-4	36	unresolved						TCRBJ01	TCRBJ01-04	01	5	6	2	7	5	0	23	34	-1	39	43	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRWGEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAACCACAGGGGCTGGGGACACTGAAGCTTTCTTTGGACAA	CASSVTTGAGDTEAFF	In	VDJ	1	27	1.1628307607497244E-4	1.3465528247685925E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	2	3	6	6	24	36	49	42	55	TCRBV09,TCRBV21													CASSVTTGAGDTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GCCACGTTTGGTGCATCCTGAAGACAGCAGCTTCTCATCTGCAGTGCTAGGGCGACAGGGGGGGTCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	27	1.1628307607497244E-4		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	19	2	1	4	18	3	40	35	62	53	65		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCCCCAGCCTTTATGAGGCAGACACCCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	27	1.1628307607497244E-4		53	TCRBV24						TCRBJ02	TCRBJ02-02	01	7	2	6	0	13	2	24	35	52	48	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACACCCATGGCAGGGACGGCTATGGCTACACCTTCGGTTCG	CATSDTHGRDGYGYTF	In	VDJ	1	27	1.1628307607497244E-4	1.3465528247685925E-4	48	TCRBV24						TCRBJ01	TCRBJ01-02	01	4	0	7	4	11	2	24	38	54	49	56		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDTHGRDGYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGGGGGCCGGGACAGCCCTACAATGAGCAGTTCTTCGGGCCA	CASRGPGQPYNEQFF	In	VDJ	1	27	1.1628307607497244E-4	1.3465528247685925E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	5	2	6	1	22	33	46	39	47		TCRBV12-03,TCRBV12-04												CASRGPGQPYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTGGCTCGGACAGGGTTACACAAATACGCAGTATTTTGGCCCA	CSAWLGQGYTNTQYF	In	VDJ	1	27	1.1628307607497244E-4	1.3465528247685925E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	3	7	6	8	26	35	49	41	57		TCRBV20-01,TCRBV20-or09_02												CSAWLGQGYTNTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGTTACAGGGGGCAACACCGGGGAGCTGTTTTTTGGAGAA	CSARVTGGNTGELFF	In	VDJ	1	27	1.1628307607497244E-4	1.3465528247685925E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	3	0	2	4	0	26	37	-1	41	50		TCRBV20-01,TCRBV20-or09_02												CSARVTGGNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTTTATACCCTCAGGGCTACACCTTCGGTTCG	CASSLYPQGYTF	In	VDJ	1	27	1.1628307607497244E-4	1.3465528247685925E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	5	8	6	0	26	41	-1	47	50	TCRBV09,TCRBV12													CASSLYPQGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTCCACCGGGACGGATAATGAAAAACTGTTTTTTGGCAGT	CASSSTGTDNEKLFF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	45	TCRBV12						TCRBJ01	TCRBJ01-04	01	4	0	7	4	5	3	22	35	45	40	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSTGTDNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCGCCGACGGGCCTAGCGGGGTACAATGAGCAGTTCTTCGGGCCA	CSASSPTGLAGYNEQFF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	4	3	4	13	0	26	37	-1	50	59		TCRBV20-01,TCRBV20-or09_02												CSASSPTGLAGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGTGGGGGCAGGGTGGCTACACCTTCGGTTCG	CSARDRWGQGGYTF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	6	0	7	5	4	26	40	51	45	55		TCRBV20-01,TCRBV20-or09_02												CSARDRWGQGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGACAGGGTTAATTCACCCCTCCACTTTGGGAAC	CSAKDRVNSPLHF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	1	3	6	1	1	26	36	45	37	46		TCRBV20-01,TCRBV20-or09_02												CSAKDRVNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTCTCGGTCAGGAAAATTCACCCCTCCACTTTGGGAAC	CASSFLGQENSPLHF	In	VDJ	1	26	1.1197629547960309E-4	1.2966804979253112E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	4	4	7	7	2	26	40	51	47	53		TCRBV12-03,TCRBV12-04												CASSFLGQENSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCCCTGAGGAAGATGGCTACACCTTCGGTTCG	CASSPEEDGYTF	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	36	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	11	1	6	3	3	23	35	42	38	45	TCRBV09,TCRBV12													CASSPEEDGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCCCATACAGGGGACCGGGGGCTACACCTTCGGTTCG		Out	VDJ	1	25	1.0766951488423373E-4		41	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	2	8	4	6	23	35	46	39	52	TCRBV09,TCRBV12													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCCGAGATAATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	25	1.0766951488423373E-4		44	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	11	2	0	2	4	19	32	37	34	41		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ01-05	TCRBV05	TCRBD02-01*02	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCTCCGACTACCTTGATGAGGAGACCCAGTACTTCGGGCCA	CASSSDYLDEETQYF	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	2	9	5	2	10	19	32	39	34	49	TCRBV05,TCRBV07					01,02								CASSSDYLDEETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCAACAGGGTGGACGAGTAGAGCAGTACTTCGGGCCG	CASSQQGGRVEQYF	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	3	7	2	10	19	31	39	33	49	TCRBV05,TCRBV11													CASSQQGGRVEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCCCCGGGAGAGACCCAGTACTTCGGGCCA	CATSDPPGETQYF	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	8	4	4	4	0	24	39	-1	43	47		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDPPGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCCACGGGACTCCTACCTACAATGAGCAGTTCTTCGGGCCA	CHGTPTYNEQFF	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	11	0	10	2	3	4	26	29	38	32	42		TCRBV20-01,TCRBV20-or09_02				01,02								CHGTPTYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTACCCGGCCGAGGGCGCGGGTGGCACTGAAGCTTTCTTTGGACAA	CSAYPAEGAGGTEAFF	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	7	4	4	15	3	26	35	55	50	58		TCRBV20-01,TCRBV20-or09_02				01,02								CSAYPAEGAGGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGCTCCCCGGCTAGCAATCAGCCCCAGCATTTTGGTGAT	CSARSPASNQPQHF	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	42	TCRBV20						TCRBJ01	TCRBJ01-05	01	6	9	0	0	9	0	26	34	-1	43	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARSPASNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGAAAATGGGGGCGGGAGCAGTACGTCGGGCCG	CSARKWGREQYV	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	7	2	17	12	7	26	34	53	46	60		TCRBV20-01,TCRBV20-or09_02												CSARKWGREQYV+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACCCTACCGCCGGAGACCCAGTACTTCGGGCCA	CSATLPPETQYF	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	4	9	5	4	6	26	34	41	38	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSATLPPETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTGAGCGACAGGACGCCTGAAGCTTTCTTTGGACAA	CASSLSDRTPEAFF	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	4	6	5	4	26	39	50	44	54		TCRBV03-01,TCRBV03-02												CASSLSDRTPEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGGACAGGGGGACACAGATACGCAGTATTTTGGCCCA	CASSFGQGDTDTQYF	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	1	2	1	1	26	40	51	41	52		TCRBV12-03,TCRBV12-04												CASSFGQGDTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAAGGCCCCCAGCTCTGGAAACACCATATATTTTGGAGAG	CASSLKAPSSGNTIYF	In	VDJ	1	25	1.0766951488423373E-4	1.24680817108203E-4	48	TCRBV12						TCRBJ01	TCRBJ01-03	01	2	4	5	0	8	0	26	41	-1	49	52		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKAPSSGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12		TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCRGCYGTGTATKTYTGTGCCAGCCTCCTTTTGGACGGTCCTCCTAACGAGCAGTACGTCGGGCCG	CASLLLDGPPNEQYV	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	45	unresolved						TCRBJ02	TCRBJ02-07	01	8	1	7	17	8	22	18	27	39	35	61	TCRBV11,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASLLLDGPPNEQYV+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCAAACGGACAGGGGGAGGGATGGCTACACCTTCGGTTCG	CASSQTDRGRDGYTF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	1	6	5	4	18	30	45	35	49	TCRBV07,TCRBV11													CASSQTDRGRDGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACATGGGCTATGGCTACACCTTCGGTTCG	CATSDMGYGYTF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	36	TCRBV24						TCRBJ01	TCRBJ01-02	01	4	0	9	4	3	0	24	38	-1	41	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDMGYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTGAGAAATTCATGGACAGGGGTCTATGGCTACACCTTCGGTTCG	CASSLRNSWTGVYGYTF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	2	4	11	1	23	37	57	48	58	TCRBV24,TCRBV27													CASSLRNSWTGVYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACCGGGACTACTAAATCAGCCCCAGCATTTTGGTGAT	CSARGPGLLNQPQHF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	1	0	9	4	4	3	26	39	50	43	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGPGLLNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAACCGGGGGGCCCCACGGGGAGCTGTTTTTTGGAGAA	CASSQTGGPHGELFF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	8	1	7	2	5	23	38	47	40	52	TCRBV01,TCRBV04													CASSQTGGPHGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGACTTGGATCAGGGGGTCCCTATGGCTACACCTTCGGTTCG	CASRLGSGGPYGYTF	In	VDJ	1	24	1.0336273428886439E-4	1.1969358442387488E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	1	4	8	3	26	37	52	45	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRLGSGGPYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGAGGGTGGGCAGTCAGATCTGGGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	23	9.905595369349503E-5		55	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	11	0	5	1	18	19	33	39	34	57		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ01-05	TCRBV05	TCRBD02-01*02	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCCGGCGGGCAAACAGATACGCAGTATTTTGGCCCA	CASSSGGQTDTQYF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	42	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	7	4	3	3	3	19	32	40	35	43		TCRBV05-06,TCRBV05-07				01,02								CASSSGGQTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGCGGTAGGAATAGCGGGGGGAGAGACCCAGTACTTCGGGCCA	CASSSAVGIAGGETQYF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	51				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	5	1	4	8	0	18	35	-1	43	53	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSSAVGIAGGETQYF+X+TCRBJ02-05		TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCTAGGACTAGCGGGACCAGATACGCAGTATTTTGGCCCA	CASSLGLAGPDTQYF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	2	3	4	0	1	18	-1	45	34	46	TCRBV07,TCRBV11													CASSLGLAGPDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCGCGGGCGGGAATCACAGATACGCAGTATTTTGGCCCA	CASSPRAGITDTQYF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	7	3	2	6	2	18	30	42	36	44	TCRBV05,TCRBV11													CASSPRAGITDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAGCCTCATTTCTTCTGGAAACACCATATATTTTGGAGAG	CASSESLISSGNTIYF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	48	TCRBV06			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	2	6	7	1	0	9	23	-1	41	38	50		TCRBV06-01,TCRBV06-08				01,02								CASSESLISSGNTIYF+TCRBV06-X+TCRBJ01-03	TCRBV06	TCRBD02-01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGGTCCCCAGGGAGGCGGCCGAGCAGTACGTCGGGCCG		Out	VDJ	1	23	9.905595369349503E-5		46	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	9	1	17	11	15	24	36	53	47	68		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGCAGGGGAAAATGGCTACACCTTCGGTTCG	CASSLAGENGYTF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	2	6	4	3	24	36	46	40	49		TCRBV24-01,TCRBV24-or09_02												CASSLAGENGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCAAGACGGTGATGGGTGAAAAACTGTTTTTTGGCAGT	CASSKTVMGEKLFF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	42	TCRBV12						TCRBJ01	TCRBJ01-04	01	6	0	9	7	12	0	22	33	-1	45	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKTVMGEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGCAGGCCCGGGGCTATGGCTACACCTTCGGTTCG	CSARDRQARGYGYTF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	8	3	4	10	0	26	40	-1	50	55		TCRBV20-01,TCRBV20-or09_02												CSARDRQARGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGACCCTTCCCGGGACGGCAGTAACCGACCGGCAGCCGTCGGTTCG		Out	VDJ	1	23	9.905595369349503E-5		49	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	0	7	18	12	22	26	34	51	46	73		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCATAGCGGGGCCCTAGGGGAGACCCAGTACTTCGGGCCA	CSAHSGALGETQYF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	5	3	5	3	8	26	34	45	37	53		TCRBV20-01,TCRBV20-or09_02												CSAHSGALGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGACAGGGGTGAACACTGAAGCTTTCTTTGGACAA	CASSQGTGVNTEAFF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	2	0	0	0	26	-1	-1	42	51		TCRBV03-01,TCRBV03-02												CASSQGTGVNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCCCCGGACAGTTCTCCTACGAGCAGTACTTCGGGCCG	CASSQAPGQFSYEQYF	In	VDJ	1	23	9.905595369349503E-5	1.1470635173954676E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	5	0	5	2	26	42	53	47	55		TCRBV03-01,TCRBV03-02												CASSQAPGQFSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCCCATTTGTGGCAGGGTAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDPHLWQGRNTGELFF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	60	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	3	1	13	3	15	32	50	45	53		TCRBV03-01,TCRBV03-02												CASSQDPHLWQGRNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGCTTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSSASSTDTQYF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	10	0	2	0	18	35	-1	37	39	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSSASSTDTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGTTTGGTGCCCCAACCAGACAGCTCTTACTTCTGTGCCACCAGTGATGGGGCAGACAGGAGCTCCTACGAGCAGTACGTCGGGCCG	CATSDGADRSSYEQYV	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	4	17	6	19	33	48	60	54	79		TCRBV24-01,TCRBV24-or09_02												CATSDGADRSSYEQYV+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTGGTTCTCCATAATTCACCCCTCCACTTTGGGAAC	CASSLVLHNSPLHF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	42	unresolved						TCRBJ01	TCRBJ01-06	01	2	0	10	5	0	6	19	-1	35	33	41	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVLHNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGGTTGGCCGGGACAGGGCACGACGAGCAGTACTTCGGGCCG	CAIRLAGTGHDEQYF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	5	7	4	23	34	50	41	54	TCRBV06,TCRBV10													CAIRLAGTGHDEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCCCCCGACAGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSPPTGMNTEAFF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	0	5	1	22	34	46	39	47		TCRBV12-03,TCRBV12-04												CASSPPTGMNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCCGCGGAGGGTCTCACTCACCCCTCCACTTTGGGAAC	CSAPRGGSHSPLHF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	6	10	0	10	7	6	26	34	47	41	53		TCRBV20-01,TCRBV20-or09_02												CSAPRGGSHSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01*02	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCACAGGAGCTCTGGAAACACCATATATTTTGGAGAG	CSAHRSSGNTIYF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	3	4	0	2	2	26	34	41	36	43		TCRBV20-01,TCRBV20-or09_02												CSAHRSSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGGGGACTCRGCCSTGTATSTCTGTGCCAGCAGCTTAAGCTCAGGGTCAGCAGATACGCAGTATTTTGGCCCA	CASSLSSGSADTQYF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	3	4	5	4	22	36	46	41	50	TCRBV05,TCRBV07,TCRBV11													CASSLSSGSADTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGCTATGGCTACACCTTCGGTTCG	CASSQGYGYTF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	33	TCRBV03						TCRBJ01	TCRBJ01-02	01	3	0	9	4	0	0	26	-1	-1	40	43		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTCACAGGGGGATTGGTTCACCCCTCCACTTTGGGAAC	CASSFHRGIGSPLHF	In	VDJ	1	22	9.474917309812569E-5	1.0971911905521864E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	3	1	9	2	5	26	40	50	42	55		TCRBV12-03,TCRBV12-04												CASSFHRGIGSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTGGCCGGGCTGGGACAGCGCTTAGAAAAACTGTTTTTTGGCAGT	CASSLAGLGQRLEKLFF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	5	8	9	6	18	32	48	41	54	TCRBV05,TCRBV07													CASSLAGLGQRLEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ASCTCCCAGACATCTGTGTACTTSTGTGTAGGTAAGCGGGACACAAAAAAGGGGGACGAACCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	21	9.044239250275634E-5		56	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	13	6	3	3	6	20	23	27	40	33	60	TCRBV06,TCRBV10													X+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACTACAGTCGTACACTGAAGCTTTCTTTGGACAA	CASSELQSYTEAFF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	42	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	5	3	2	4	23	38	44	40	48		TCRBV06-01,TCRBV06-08												CASSELQSYTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCACTCTCCCGGCAGGTGGCGGAGAGACCCAGTACTTCGGGCCA	CASTLPAGGGETQYF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	45	unresolved						TCRBJ02	TCRBJ02-05	01	7	4	4	4	9	6	23	33	46	42	52	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTLPAGGGETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCGGACAGGTCGGCACAGATACGCAGTATTTTGGCCCA	CASSFGQVGTDTQYF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	4	1	3	3	24	36	46	39	49		TCRBV24-01,TCRBV24-or09_02												CASSFGQVGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTTTATACGGCGGGGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLYGGVSYNEQFF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	48				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	7	3	0	3	1	33	49	58	52	59	TCRBV27,TCRBV28	TCRBV27-01,TCRBV28-01												CASSLYGGVSYNEQFF+X+TCRBJ02-01		TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCWMCCAGACMTCTSTGTACTTSTGTGCCAGCAGTTTTTTTCAGGGGGCGAGAGGCTACACCTTCGGTTCG	CASSFFQGARGYTF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	0	8	4	4	23	37	49	41	53	TCRBV06,TCRBV27													CASSFFQGARGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCGGGGACAGCGAATGGCTACACCTTCGGTTCG	CSARSGTANGYTF	In	VDJ	1	21	9.044239250275634E-5	1.0473188637089051E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	5	6	3	3	26	38	48	41	51		TCRBV20-01,TCRBV20-or09_02												CSARSGTANGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TGGCAAGCCACGTTTGGTGGAACCCAGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTCTGCATACTATGGCTACACCTTCGGTTCG	CASSSAYYGYTF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	36							TCRBJ01	TCRBJ01-02	01	4	4	6	3	3	1	45	58	63	61	64	TCRBV07,TCRBV16	TCRBV07-04,TCRBV16-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSAYYGYTF+X+TCRBJ01-02			TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTATGGACAGGACAAACTCCTATGGCTACACCTTCGGTTCG	CASSMDRTNSYGYTF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	4	4	2	8	23	35	44	37	52	TCRBV02,TCRBV12													CASSMDRTNSYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTKGGKGACTYKGCTGTGTATYTCTGTGCCAGCAGCCACGCCCAGGGTCAGCCCCAGCATTTTGGTGAT	CASSHAQGQPQHF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	3	6	6	0	22	34	-1	40	45	TCRBV03,TCRBV07													CASSHAQGQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCRTGTATSKCTGTGCCAGCTCCCTCACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLTSGANVLTF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	42	unresolved						TCRBJ02	TCRBJ02-06	01	8	3	7	0	6	0	18	27	-1	33	35	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTSGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTCACGGACAGGGGGCAGGTTCACCCCTCCACTTTGGGAAC	CASSHGQGAGSPLHF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	0	9	3	3	23	35	49	38	52	TCRBV06,TCRBV24													CASSHGQGAGSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAACGTTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CSARDNVYSNQPQHF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	45	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	3	7	0	2	5	26	40	44	42	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDNVYSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGCGTACAATGAGCAGTTCTTCGGGCCA	CSAREAYNEQFF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	36	TCRBV20						TCRBJ02	TCRBJ02-01	01	0	9	0	4	0	1	26	-1	43	40	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGTTCGGGACAATCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAPFGTISSYNEQFF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	6	0	7	5	26	34	47	41	52		TCRBV20-01,TCRBV20-or09_02												CSAPFGTISSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGAACTAGCAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAELASSYNEQFF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	3	7	0	3	3	26	34	43	37	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSAELASSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCACCCCTGCGATATTTGGGGGTGCGAGCAGTACGTCGGGCCG		Out	VDJ	1	20	8.613561190738698E-5		55	TCRBV03						TCRBJ02	TCRBJ02-07	01	0	6	1	17	18	13	26	43	66	61	79		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTACTGGGACTCTCCAGGTCCGGTTCTTCGGGCCA	CASSTGTLQVRFF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	15	3	11	26	38	47	41	58		TCRBV12-03,TCRBV12-04				01,02								CASSTGTLQVRFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGAAGATCCCAGGGTGGTCACTGAAGCTTTCTTTGGACAA	CASSVEDPRVVTEAFF	In	VDJ	1	20	8.613561190738698E-5	9.97446536865624E-5	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	4	12	4	26	37	54	49	58		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVEDPRVVTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTGGGGCAGCACCTCTGGAAACACCATATATTTTGGAGAG	CASSWGSTSGNTIYF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	45	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	7	0	0	0	5	19	-1	37	32	42		TCRBV05-06,TCRBV05-07												CASSWGSTSGNTIYF+TCRBV05-X+TCRBJ01-03	TCRBV05	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCAAAGGGGGCCCAGAAACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	19	8.182883131201764E-5		47	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	5	0	2	0	7	26	-1	48	41	55		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAGGACTAGCGGGGGAGACCCAGTACTTCGGGCCA	CASSPGLAGETQYF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	1	3	5	2	0	26	39	-1	41	53		TCRBV03-01,TCRBV03-02												CASSPGLAGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTATCGCTAGCGGGGGTGATGAGCAGTTCTTCGGGCCA	CASSQVIASGGDEQFF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	4	2	8	6	2	26	42	58	48	60		TCRBV03-01,TCRBV03-02												CASSQVIASGGDEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAATGGGACAGCAAGAGACCCAGTACTTCGGGCCA	CASSQEMGQQETQYF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	0	5	2	3	0	26	43	-1	46	53		TCRBV03-01,TCRBV03-02												CASSQEMGQQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTGCAGACCGGGGAGACCCAGTACTTCGGGCCA	CASSLQTGETQYF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	8	4	5	7	0	23	36	-1	43	47	TCRBV01,TCRBV04					01,02								CASSLQTGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCACAGAGAAGACCCAGTACTTCGGGCCA	CASSFTEKTQYF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	3	5	6	1	3	26	40	45	41	48		TCRBV12-03,TCRBV12-04												CASSFTEKTQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCTGGGGACTAGCGGGGGTCAATGAGCAGTTCTTCGGGCCA	CASSWGLAGVNEQFF	In	VDJ	1	19	8.182883131201764E-5	9.475742100223428E-5	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	0	2	6	3	1	26	37	54	40	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSWGLAGVNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCSTSTATCTCTGTGCCAGCAGCTATGAGGACAGGGTGCACGGCTACACCTTCGGTTCG	CASSYEDRVHGYTF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	3	8	4	5	19	32	44	36	49	TCRBV05,TCRBV07													CASSYEDRVHGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCRTGTATCTCTGTGCCAGCAGCCCGGGACAGTCTTATCAGCCCCAGCATTTTGGTGAT	CASSPGQSYQPQHF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	5	5	2	4	19	31	40	33	44	TCRBV07,TCRBV11													CASSPGQSYQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGGGACGCAGGGTCTACTGGAAACACCATATATTTTGGAGAG	CASRDAGSTGNTIYF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	4	3	2	5	4	18	29	39	34	43	TCRBV07,TCRBV11													CASRDAGSTGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGATCCGACTAGCACAGATACGCAGTATTTTGGCCCA	CASSLDPTSTDTQYF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	2	10	0	3	0	18	35	-1	38	42	TCRBV05,TCRBV11					01,02								CASSLDPTSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCAGTACCTGGGCGGGGCGGCCGGGGAGCTGTTTTTTGGAGAA	CASSQYLGGAAGELFF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	7	3	6	10	3	18	30	46	40	49	TCRBV07,TCRBV11													CASSQYLGGAAGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GAGACWCGGCMMTGTATCKCTGYGCCAGCAGCTTGGAGGGACAACCCACAGATACGCAGTATTTTGGCCCA	CASSLEGQPTDTQYF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	45	unresolved						TCRBJ02	TCRBJ02-03	01	3	0	6	2	3	3	18	32	41	35	44	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGQPTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCCGTCTGTCTCAGGCGTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	18	7.75220507166483E-5		55	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	4	4	9	14	18	30	43	39	57	TCRBV05,TCRBV07													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
GAAGACTCGGCCSTGTATSTCTGTGCCAGCAGCTTAGGGGGGACAGGGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	18	7.75220507166483E-5		41	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	6	6	0	21	33	-1	39	48	TCRBV04,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCTAGCGGCTTTACGCTACGAGCARTACGTCGGGCCG	CASSLAALRYEQYV	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	42	unresolved						TCRBJ02	TCRBJ02-07	01	0	9	0	17	1	20	19	35	39	36	59	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAALRYEQYV+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGGACGGTATAATTCACCCCTCCACTTTGGGAAC	CASGRYNSPLHF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	36	TCRBV24						TCRBJ01	TCRBJ01-06	01	11	1	7	4	2	2	24	31	37	33	39		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGRYNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24		TCRBJ01-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGGACCCCGACTAGCGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	18	7.75220507166483E-5		46	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	2	6	4	8	0	24	38	-1	46	54		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGGGACTCAGCYSTGTACTTCTGTGCCAGCAGCCCCTTAACTGGGACTGAAGCTTTCTTTGGACAA	CASSPLTGTEAFF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	39	unresolved						TCRBJ01	TCRBJ01-01	01	6	0	9	5	10	0	22	33	-1	43	46	TCRBV12,TCRBV13			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLTGTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCAAGGGGGAAGCCTTAACACTGAAGCTTTCTTTGGACAA	CSASQGGSLNTEAFF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	5	1	2	3	7	26	37	46	40	53		TCRBV20-01,TCRBV20-or09_02												CSASQGGSLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAAACCCCGAGCGGGGGGGCCGGAACCGCAGATACGCAGTATTTTGGCCCA	CSAQTPSGGAGTADTQYF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	54	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	6	0	4	10	9	26	34	54	44	63		TCRBV20-01,TCRBV20-or09_02												CSAQTPSGGAGTADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTAGAGCGTTCCTTGTCATGCAAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	18	7.75220507166483E-5		49	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	6	6	5	3	14	26	38	45	41	59		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTGAGGGTCCGGGAGATACGCAGTATTTTGGCCCA	CASSQGEGPGDTQYF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	11	0	5	2	6	26	42	49	44	55		TCRBV03-01,TCRBV03-02												CASSQGEGPGDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGCGCGAAACGTGGCTACACCTTCGGTTCG	CASSRAKRGYTF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	36	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	7	6	7	2	7	26	37	42	39	49		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSRAKRGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCGTACGGGGTCCATGGCTACACCTTCGGTTCG	CASSPYGVHGYTF	In	VDJ	1	18	7.75220507166483E-5	8.977018831790617E-5	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	3	6	6	3	26	37	48	43	51		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPYGVHGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01*01	TCRBJ01-02*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
CAGCCAGACCTATCTGTACCACTGTGGCAGTCATCGGTCTCATAGCCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	24	1.0336273428886439E-4		53	TCRBV08	TCRBV08-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	6	5	7	5	12	9	22	30	46	42	55						01,02								X+TCRBV08-02+TCRBJ02-06	TCRBV08-02*01	TCRBD02-01	TCRBJ02-06*01	3935B3	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3901	3368	496	35	0	1744	1463	251	30	0	232192	200512	29550	2130	0	0.152990997	8.90605736	0.146677881	9.18873024				152029	0.0234207921	0.0289907828	0.0250353161	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:19	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8633683435530305	MSKCC- Snyder- P01-02		3561.0	
